Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" AAMP ENSG00000127837 "Angio associated migratory cell protein" Q13685 2 218264129-218270178 "Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017717, HPA031868" Approved Supported Microtubules,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Microtubules Cytosol "CAB017717: , HPA031868: AB_2674078" "unprognostic (1.57e-1)" "unprognostic (6.12e-2)" "unprognostic (8.11e-3)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.39e-2)" "unprognostic (5.04e-2)" "prognostic unfavorable (4.94e-7)" "unprognostic (8.94e-2)" "unprognostic (7.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (4.22e-2)" "unprognostic (5.51e-2)" "unprognostic (1.23e-3)" "unprognostic (5.26e-2)" "unprognostic (1.92e-1)" "unprognostic (9.09e-2)" 66.5 66.4 65.0 46.2 66.1 27.5 65.2 67.1 80.1 62.6 63.2 76.3 62.8 61.7 43.8 75.1 60.8 56.1 65.4 65.7 67.2 60.2 77.5 46.6 47.8 69.2 66.6 79.8 70.7 72.7 62.1 54.9 66.4 58.0 58.0 38.4 66.9 58.7 90.4 76.6 61.7 50.7 67.5 53.0 86.9 53.8 67.1 54.0 66.6 62.0 52.6 70.0 57.4 70.3 126.1 104.6 75.1 102.2 111.9 75.7 146.0 89.6 136.3 167.1 124.5 226.2 100.1 64.6 121.8 112.6 158.8 94.3 150.7 133.4 129.3 103.5 200.9 147.4 108.2 237.4 158.9 139.3 92.4 97.8 152.7 172.2 149.7 99.7 97.6 124.3 202.6 82.4 108.9 198.0 112.4 234.9 121.0 182.4 75.4 90.6 97.5 105.8 100.3 160.5 96.2 92.9 59.4 128.7 134.7 119.1 99.1 104.6 84.7 110.2 82.3 81.2 106.8 105.7 198.1 108.4 111.0 88.6 77.4 75.9 166.2 60.3 101.1 209.2 105.1 100.3 90.1 94.9 191.4 105.7 111.1 100.7 26.2 114.9 210.6 114.1 109.3 179.4 65.0 66.1 67.1 80.1 65.7 67.2 69.2 66.6 66.4 67.5 67.1 70.3 57.8 41.7 35.2 11.4 50.4 90.5 86.1 122.9 66.0 47.7 50.7 45.2 35.5 41.5 74.0 42.3 12.5 160.0 42.2 74.3 103.7 95.7 3.5 33.5 46.4 50.6 75.5 34.0 11.5 95.4 130.3 63.4 80.5 38.2 34.8 57.6 42.5 46.2 91.9 63.9 12.9 89.9 93.6 37.0 65.3 8.8 83.3 38.5 62.2 5.6 64.8 80.2 41.2 8.0 10.5 86.6 72.0 74.9 51.2 116.0 99.5 85.3 47.4 37.1 65.7 38.4 86.5 72.0 53.3 70.2 97.3 202.6 44.4 62.5 103.5 119.9 AC013489.1 ENSG00000173867 "Novel transcript" 15 88459501-88546585 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 5 "granulocytes: 1.3;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" HPA048873 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes NA "Cluster 32: T-cells - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA048873: AB_2680541" "unprognostic (3.32e-2)" "unprognostic (9.46e-3)" "unprognostic (1.47e-1)" "unprognostic (1.47e-1)" "unprognostic (2.84e-2)" "unprognostic (6.56e-3)" "unprognostic (4.03e-1)" "unprognostic (1.88e-2)" "unprognostic (1.01e-1)" "unprognostic (1.02e-2)" "unprognostic (2.29e-2)" "unprognostic (1.10e-2)" "unprognostic (2.62e-3)" "unprognostic (1.79e-1)" "unprognostic (4.47e-1)" "unprognostic (2.21e-1)" "unprognostic (1.66e-2)" 0.4 0.4 0.6 0.2 0.6 0.4 1.1 0.7 0.7 0.4 0.9 0.5 0.3 2.2 1.0 0.3 1.0 0.5 0.8 0.5 0.9 0.7 0.8 0.5 0.4 0.6 0.6 2.2 1.0 0.7 0.5 0.7 0.6 0.6 1.3 0.4 0.7 1.4 0.3 0.4 0.9 0.6 0.7 0.4 0.4 0.7 0.5 0.7 1.2 0.5 0.3 0.8 0.3 0.6 0.5 0.8 1.2 0.6 0.6 1.0 0.7 1.0 0.7 0.6 1.1 0.9 0.7 1.2 0.7 0.6 2.1 0.6 0.9 0.3 1.0 1.0 0.5 0.8 0.4 0.8 0.7 1.0 1.1 0.7 0.8 0.4 0.5 1.2 1.0 0.9 0.1 0.4 1.0 0.5 0.6 0.7 0.2 0.4 0.7 1.2 0.6 0.8 0.6 0.4 0.9 0.4 1.4 1.0 0.7 1.5 0.8 0.7 0.5 0.9 0.9 0.5 0.9 0.6 0.9 0.7 0.5 0.0 0.5 0.3 0.7 0.9 0.8 0.9 0.9 0.8 0.8 0.7 1.0 1.1 0.0 0.9 0.6 0.6 0.8 0.9 0.6 0.6 0.7 0.7 0.5 0.9 0.6 0.6 0.7 0.6 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092143.1 ENSG00000198211 "Novel protein (MC1R-TUBB3 readthrough)" 16 89919165-89936092 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 6.6" "Cell type enriched" "Detected in single" 15 "Fibroblasts: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SK-MEL-30: 10.7" "CAB011512, HPA043640, HPA046280" Uncertain Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 78: Testis - Spermatogenesis" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 11: Alveolar cells - Smell perception" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB011512: AB_444319, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.90e-4)" "unprognostic (6.87e-2)" 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.5 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC240274.1 ENSG00000271254 "Neuroblastoma breakpoint family member 1" Unmapped 4612-29626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Spermatocytes: 186.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Cytosol Microtubules "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " 12.0 29.1 16.1 10.4 19.5 9.4 10.9 19.5 17.7 12.7 14.0 21.1 17.0 18.1 13.3 9.6 18.6 12.4 7.9 14.7 18.3 14.9 8.2 12.8 6.6 22.2 19.7 29.6 5.7 18.0 14.6 21.7 11.6 21.8 13.8 11.2 9.2 10.9 11.8 25.0 16.4 18.3 12.9 8.5 40.6 20.5 6.8 12.0 6.8 7.4 8.5 23.5 25.6 33.3 36.9 26.2 12.1 13.2 8.4 37.6 22.7 34.4 28.8 12.2 9.7 20.0 2.9 34.8 11.9 14.0 14.3 7.0 46.2 13.4 29.2 5.4 19.6 16.7 16.4 17.5 11.4 8.7 10.0 19.6 15.6 22.3 9.8 32.6 24.4 6.7 13.5 35.0 21.5 7.5 5.8 3.6 79.2 38.4 23.5 2.9 8.3 14.0 27.3 44.2 37.2 31.0 16.0 10.8 28.1 5.2 13.3 21.2 21.5 53.0 17.1 7.8 28.3 16.1 5.2 26.3 7.6 1.5 0.8 1.1 0.6 0.8 1.1 0.6 0.4 0.4 0.3 0.9 0.6 0.7 0.7 2.3 0.6 0.5 0.0 0.4 16.1 19.5 19.5 17.7 14.7 18.3 22.2 19.7 21.7 18.3 20.5 23.5 2.5 22.4 11.6 0.0 1.4 0.0 1.6 0.0 6.8 2.0 4.3 4.8 0.0 1.5 4.3 0.0 4.2 9.5 0.7 12.9 1.9 2.5 46.1 2.1 3.6 4.4 0.0 5.2 0.0 2.7 12.8 6.4 3.6 1.6 15.2 14.3 2.5 2.7 6.9 0.0 0.0 4.3 0.0 4.2 0.0 11.0 16.8 5.2 0.0 0.0 4.0 2.4 2.1 0.0 0.0 2.8 3.4 18.4 0.6 0.9 5.7 1.6 10.9 1.4 6.6 6.1 2.3 186.6 46.2 5.9 0.0 2.6 1.6 33.3 3.6 0.9 AC242842.3 ENSG00000286185 "Novel protein, identical to neuroblastoma breakpoint family, member 19 NBPF19" 1 149390623-149556361 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACSF2 "ACSMW, FLJ20920" ENSG00000167107 "Acyl-CoA synthetase family member 2" Q96CM8 17 50426158-50474845 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 142.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 85.8;Proximal enterocytes: 78.2;Proximal tubular cells: 128.4;Syncytiotrophoblasts: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 97.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024693 Enhanced Uncertain Nucleoplasm,Microtubules,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 15: RT4 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Microtubules, Cytosol" "HPA024693: AB_2671654" "unprognostic (1.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (1.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.48e-2)" "unprognostic (1.14e-2)" "unprognostic (6.49e-2)" "unprognostic (7.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (2.45e-2)" "prognostic favorable (2.41e-4)" 24.8 71.9 7.6 5.7 8.5 3.3 21.0 7.7 10.1 18.9 8.6 26.9 22.1 6.7 15.8 7.7 9.7 10.8 25.9 7.1 7.0 142.1 36.4 17.8 8.5 8.5 7.3 19.3 6.8 9.9 2.9 15.4 8.0 15.0 17.5 1.1 15.8 16.0 41.3 22.5 20.2 5.4 8.2 8.4 18.8 4.9 7.9 5.6 42.5 25.8 8.2 17.8 13.4 7.7 24.8 8.1 6.6 15.8 68.1 12.1 38.1 5.9 8.6 12.6 24.5 32.1 47.2 15.7 12.6 7.3 11.5 14.7 4.7 29.2 15.3 19.5 11.2 27.3 3.9 58.5 11.4 3.3 24.3 54.9 44.4 15.8 2.1 45.4 17.4 20.3 3.2 8.8 13.7 31.3 8.8 11.1 1.1 47.5 11.9 20.6 4.8 41.2 4.2 97.2 21.6 11.3 11.8 17.3 12.3 13.7 15.5 22.8 12.7 22.5 6.8 3.5 1.9 15.4 3.1 8.2 9.3 17.1 1.4 0.0 2.9 15.3 2.0 7.7 1.7 8.6 1.5 2.1 16.1 2.0 0.7 0.9 0.5 1.6 7.0 6.3 5.5 2.7 7.6 8.5 7.7 10.1 7.1 7.0 8.5 7.3 8.0 8.2 7.9 7.7 3.2 28.9 24.3 27.1 7.3 6.0 23.3 17.0 25.0 0.0 20.8 16.0 25.9 11.5 19.9 3.7 0.0 85.8 1.7 59.5 11.7 13.5 0.4 4.9 3.5 4.9 10.2 1.3 0.3 4.3 11.7 6.5 21.9 7.7 22.2 24.5 4.2 44.4 21.9 0.0 0.3 20.6 2.0 9.8 11.0 1.6 26.8 11.0 3.6 17.8 12.7 6.1 5.2 3.5 0.5 5.7 53.1 14.3 2.6 3.5 78.2 128.4 14.6 0.2 0.0 2.7 5.9 0.2 2.2 5.4 7.0 81.0 4.1 12.1 25.8 14.0 ACTR1A "ARP1, Arp1A" ENSG00000138107 "Actin related protein 1A" P61163 10 102461881-102502712 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037193, HPA047443" Approved Approved Microtubules NA NA 560000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 1: Pancreatic cells - Digestion" Microtubules "CAB037193: AB_258253, HPA047443: AB_2680049" "unprognostic (9.64e-3)" "unprognostic (1.92e-2)" "unprognostic (8.34e-2)" "unprognostic (4.05e-2)" "unprognostic (2.57e-1)" "unprognostic (3.48e-1)" "unprognostic (2.20e-3)" "unprognostic (2.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.66e-2)" "unprognostic (7.77e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-1)" "unprognostic (3.10e-1)" "unprognostic (4.13e-1)" 59.4 58.8 98.3 39.4 100.6 36.8 51.5 101.9 108.4 50.9 78.4 90.0 37.8 61.8 37.5 61.6 47.4 36.1 93.0 101.9 108.0 49.0 40.4 58.5 33.7 116.3 105.9 36.9 41.9 56.5 54.7 45.3 116.9 53.0 41.7 41.9 46.4 51.9 174.3 65.1 49.1 69.0 97.4 48.7 56.2 40.4 104.0 56.8 41.2 127.0 42.2 74.8 51.2 104.4 80.5 95.8 113.5 117.1 138.0 109.2 45.5 100.3 177.3 154.4 142.4 52.7 63.3 54.4 75.2 149.5 76.2 78.3 109.9 123.7 106.5 70.7 75.8 72.9 53.4 77.9 99.6 56.9 65.0 112.4 89.6 141.2 100.7 155.7 201.6 88.7 60.5 53.5 154.6 67.1 103.5 97.9 45.4 62.5 86.2 78.5 146.0 35.0 125.2 43.9 40.5 88.8 60.1 35.4 75.1 98.3 130.0 38.9 147.0 74.7 71.5 83.6 102.1 54.0 58.8 63.3 78.7 98.3 45.9 32.2 40.7 44.3 31.1 51.8 25.5 18.8 22.0 30.4 40.6 17.6 18.0 20.7 31.2 23.9 57.0 20.8 33.6 39.2 98.3 100.6 101.9 108.4 101.9 108.0 116.3 105.9 116.9 97.4 104.0 104.4 40.0 57.7 41.0 10.1 23.4 33.8 24.0 42.3 13.1 26.6 22.1 17.1 51.6 14.3 34.8 27.6 16.7 54.9 23.8 52.4 54.8 75.5 53.0 15.3 21.0 45.2 39.6 45.9 14.9 77.5 63.3 36.9 23.4 19.3 32.3 27.3 34.6 24.1 73.9 26.9 15.5 24.4 46.8 37.6 38.2 53.9 33.2 44.5 51.6 5.6 70.3 31.5 38.1 10.1 15.3 92.0 36.8 36.1 30.0 26.7 40.9 45.6 26.5 24.5 46.0 17.1 48.5 61.9 14.0 27.3 32.4 104.7 28.2 32.9 24.2 26.6 ACTR1B "Arp1B, CTRN2" ENSG00000115073 "Actin related protein 1B" P42025 2 97655939-97664044 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047443 Approved Microtubules NA NA 49000 "Cluster 44: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Microtubules "HPA047443: AB_2680049" "unprognostic (5.26e-2)" "unprognostic (8.91e-3)" "unprognostic (2.83e-3)" "unprognostic (2.67e-1)" "unprognostic (2.96e-1)" "unprognostic (2.82e-1)" "unprognostic (3.68e-3)" "unprognostic (1.37e-2)" "unprognostic (1.60e-2)" "unprognostic (7.84e-2)" "unprognostic (8.21e-2)" "unprognostic (6.29e-2)" "unprognostic (3.42e-2)" "unprognostic (2.78e-1)" "unprognostic (2.89e-2)" "unprognostic (4.58e-2)" "prognostic favorable (4.69e-4)" 38.5 68.3 60.0 24.9 61.0 38.8 41.9 54.1 66.4 41.1 59.3 52.1 36.1 48.1 21.5 37.5 43.4 26.0 68.6 60.6 57.0 47.0 54.3 36.7 30.9 57.3 55.2 47.1 72.9 51.1 41.4 20.6 58.4 43.6 22.1 22.0 45.4 37.3 86.9 39.3 43.2 26.5 56.6 57.8 52.1 20.8 58.2 33.2 45.8 68.8 24.8 44.0 36.4 57.7 52.8 28.5 27.1 35.8 49.1 39.8 78.1 49.2 74.2 34.6 28.9 22.5 28.1 38.0 45.3 50.5 37.1 28.4 21.9 56.5 14.6 76.6 36.8 28.2 28.3 62.1 38.3 22.8 43.1 39.7 41.5 22.0 67.7 51.8 39.0 46.8 20.1 44.8 52.1 58.5 44.2 28.6 27.5 40.1 38.1 24.7 39.6 63.2 55.0 41.1 31.7 23.8 23.7 48.1 36.2 34.8 38.1 35.9 41.1 23.0 35.6 24.7 20.8 57.7 27.0 13.7 68.8 32.5 21.1 11.7 15.0 19.2 19.1 13.5 14.6 14.6 20.9 19.2 21.1 14.7 17.2 18.8 5.7 14.9 20.5 8.5 29.7 16.4 60.0 61.0 54.1 66.4 60.6 57.0 57.3 55.2 58.4 56.6 58.2 57.7 43.8 19.2 18.2 15.0 30.4 13.6 30.9 28.4 16.5 38.5 24.9 20.8 32.8 22.8 22.2 22.0 12.5 29.0 26.1 26.5 35.2 69.2 13.2 16.2 16.4 30.9 25.8 24.6 33.4 58.0 57.7 24.3 23.4 13.1 29.9 20.4 28.2 18.7 29.1 55.5 26.4 31.7 36.7 18.5 20.0 10.0 24.2 17.4 23.2 12.2 57.3 29.5 43.3 17.1 26.1 42.8 32.8 26.7 21.9 55.5 59.9 40.5 22.2 30.0 39.5 25.3 28.5 13.1 31.7 29.9 16.3 16.3 31.4 47.7 36.4 39.8 AGBL5 "CCP5, FLJ21839" ENSG00000084693 "ATP/GTP binding protein like 5" Q8NDL9 2 27042364-27070622 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "parathyroid gland: 49.9;testis: 192.9" "Group enriched" "Detected in many" 6 "Early spermatids: 302.7;Late spermatids: 338.0;Spermatocytes: 156.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030981 Uncertain Supported "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cluster 34: Basophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Cytokinetic bridge" "Microtubules, Cytosol" "HPA030981: AB_10611673" "unprognostic (1.29e-2)" "unprognostic (8.70e-2)" "unprognostic (2.26e-1)" "unprognostic (3.13e-3)" "unprognostic (1.95e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.86e-1)" "unprognostic (4.34e-1)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.20e-1)" "unprognostic (3.41e-2)" "unprognostic (5.56e-2)" "unprognostic (2.05e-1)" "unprognostic (1.69e-2)" "unprognostic (4.50e-2)" 8.8 16.7 8.4 8.0 7.4 13.6 12.4 7.8 8.2 14.4 9.5 16.2 8.8 14.0 26.0 18.3 20.8 14.3 12.7 7.3 11.3 22.5 7.2 11.2 10.7 8.3 7.8 14.4 15.0 49.9 12.5 11.2 8.9 15.2 11.5 16.3 21.2 16.5 7.1 20.5 9.9 14.6 6.1 8.5 11.8 192.9 9.1 15.6 28.5 6.5 8.6 14.9 7.3 7.5 55.0 34.7 55.4 37.2 11.6 23.0 62.9 10.9 23.5 30.9 31.9 30.2 40.5 30.3 34.0 18.9 43.4 24.6 44.8 49.4 33.9 25.9 66.8 44.5 42.0 65.7 23.6 21.6 14.4 24.4 36.7 27.1 22.0 46.9 32.8 43.5 38.9 23.8 30.3 21.5 63.2 32.3 39.4 39.4 23.7 64.5 62.9 48.0 31.9 13.6 37.1 53.6 21.5 16.7 35.0 53.9 24.9 16.3 16.4 28.6 39.2 13.8 23.9 47.7 27.2 62.4 31.8 24.4 26.1 8.8 1.8 4.5 3.3 1.1 2.5 4.6 4.1 4.6 4.1 2.3 3.6 2.2 1.1 8.5 0.7 2.3 2.8 3.8 8.4 7.4 7.8 8.2 7.3 11.3 8.3 7.8 8.9 6.1 9.1 7.5 3.6 0.0 10.1 5.2 6.3 3.3 8.3 7.2 13.6 5.7 8.6 6.7 6.7 10.0 6.8 9.2 0.0 14.7 1.8 5.9 19.6 8.3 302.7 13.0 3.9 4.9 2.4 11.6 7.9 6.0 7.9 6.4 5.6 5.8 1.3 14.1 6.4 4.1 5.2 0.0 9.1 8.4 6.1 3.1 3.5 338.0 10.5 8.0 7.2 6.5 4.9 6.8 0.0 10.1 10.1 5.0 7.6 11.3 17.1 6.0 6.3 25.0 10.7 10.0 0.0 4.2 7.0 156.8 41.2 16.3 2.7 8.3 5.0 9.4 8.6 10.5 AIDA "C1orf80, FLJ12806" ENSG00000186063 "Axin interactor, dorsalization associated" Q96BJ3 1 222668013-222713210 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027935 Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cluster 21: B-cells - Adaptive immune response" "Cluster 65: Brain - Ion transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 41: Macrophages - Immune response" Cytosol "Microtubules, Cytokinetic bridge" "HPA027935: AB_10602226" "unprognostic (2.33e-1)" "prognostic unfavorable (7.08e-5)" "unprognostic (1.37e-1)" "unprognostic (1.43e-2)" "unprognostic (2.63e-2)" "unprognostic (7.28e-2)" "unprognostic (2.58e-2)" "unprognostic (2.26e-2)" "unprognostic (2.73e-1)" "unprognostic (4.43e-2)" "unprognostic (2.09e-3)" "unprognostic (2.08e-1)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.28e-1)" "unprognostic (2.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.70e-2)" 72.3 36.1 53.6 39.1 63.8 21.9 40.2 57.1 66.5 47.8 47.1 50.0 25.3 36.1 56.1 45.2 31.3 40.8 45.8 51.7 62.0 39.3 49.0 46.2 51.2 63.0 58.4 40.6 32.5 32.5 21.4 47.8 62.8 35.1 36.1 19.4 28.0 42.1 28.4 26.6 28.9 54.2 58.9 37.4 28.2 44.3 58.5 33.8 37.5 49.7 52.9 47.2 31.2 69.6 74.3 56.2 65.5 70.4 181.2 169.9 71.4 135.7 145.0 95.1 87.0 64.3 62.0 39.5 67.2 161.7 73.4 44.8 81.4 89.9 115.4 59.6 30.0 50.4 64.2 61.9 95.2 62.5 28.4 104.0 78.9 113.4 108.9 102.4 117.8 49.6 77.1 54.3 180.8 27.6 40.9 38.4 163.6 83.9 118.8 43.8 183.9 57.9 110.9 49.7 43.1 72.1 91.0 53.4 83.8 100.3 43.5 38.5 94.1 127.4 62.9 124.9 162.7 40.3 80.4 35.2 118.1 38.7 128.0 5.7 2.8 2.9 5.7 4.4 4.8 14.2 7.2 6.2 2.5 13.8 7.4 5.8 1.6 3.5 5.0 7.2 10.2 4.1 53.6 63.8 57.1 66.5 51.7 62.0 63.0 58.4 62.8 58.9 58.5 69.6 80.2 22.4 49.9 6.5 57.9 32.5 36.2 19.8 20.5 18.8 20.8 18.0 8.6 27.1 18.7 33.1 33.3 20.6 46.5 19.0 29.4 38.6 20.4 27.1 48.9 52.4 36.1 46.7 8.9 37.9 55.0 52.6 12.8 46.6 3.8 32.4 43.9 36.9 31.5 23.5 11.1 22.4 22.4 37.8 40.2 23.8 60.3 42.5 37.4 30.9 58.9 32.1 38.1 10.6 10.0 51.1 19.8 50.8 32.1 61.2 24.4 54.4 32.8 13.8 32.9 66.1 43.9 35.3 17.9 26.6 30.3 9.0 28.0 32.0 17.8 33.7 AKNAD1 "C1orf62, MGC26989" ENSG00000162641 "AKNA domain containing 1" Q5T1N1 1 108815898-108963484 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 4.8" "Cell type enriched" "Detected in some" 4 "Early spermatids: 80.6" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.1;hTCEpi: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030270, HPA030271, HPA030272" Uncertain Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Cluster 78: Testis - Spermatogenesis" "Cluster 30: Epithelial cell lines - Translation" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "Microtubules, Cytokinetic bridge" "HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342" "unprognostic (4.93e-2)" "unprognostic (1.72e-1)" "unprognostic (5.52e-2)" "unprognostic (2.00e-3)" "unprognostic (7.22e-2)" "unprognostic (1.08e-1)" "unprognostic (1.09e-5)" "unprognostic (8.15e-2)" "unprognostic (5.95e-2)" "unprognostic (2.83e-2)" "unprognostic (1.89e-1)" "unprognostic (2.24e-1)" "unprognostic (3.00e-8)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "unprognostic (5.75e-2)" "unprognostic (8.22e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.7 0.0 0.0 1.6 0.0 1.5 0.1 0.0 1.8 2.5 0.5 0.9 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 80.6 0.3 5.1 1.4 0.0 0.0 1.0 0.2 0.8 3.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.7 0.0 0.0 0.3 17.8 2.5 0.1 1.8 0.0 0.0 0.4 0.0 3.5 3.1 0.2 0.0 1.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.9 0.6 1.4 0.1 0.1 0.7 0.1 0.7 0.5 0.0 AKT1 "AKT, PKB, PRKBA, RAC, RAC-alpha" ENSG00000142208 "AKT serine/threonine kinase 1" P31749 14 104769349-104795751 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 61.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 61.5" "Cell line enhanced" "Detected in all" "MCF7: 558.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002891, CAB003765" Supported Supported Nucleoplasm,Microtubules NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 30: Mammary glandular cells - Lactation" Nucleoplasm Microtubules "CAB003765: AB_562035, HPA002891: AB_1078123" "unprognostic (3.30e-2)" "unprognostic (4.27e-2)" "unprognostic (1.98e-1)" "unprognostic (1.84e-1)" "unprognostic (3.70e-1)" "unprognostic (9.17e-3)" "unprognostic (1.55e-3)" "unprognostic (1.21e-1)" "unprognostic (1.47e-1)" "prognostic favorable (4.83e-4)" "unprognostic (3.58e-2)" "unprognostic (1.90e-2)" "prognostic favorable (2.12e-4)" "unprognostic (7.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" 71.5 102.7 45.9 57.7 45.5 51.2 61.2 43.7 53.2 52.0 50.4 85.0 50.8 59.5 23.2 70.7 53.7 50.0 105.9 45.2 44.3 54.3 97.3 69.2 51.9 50.5 45.7 43.7 94.3 53.0 35.9 55.4 45.0 67.2 39.6 25.1 67.7 73.0 58.1 45.0 53.3 63.4 47.4 63.7 77.8 23.9 48.0 52.4 52.3 64.9 40.3 72.6 48.4 43.3 77.3 150.5 124.6 186.9 95.2 97.7 136.9 142.3 171.5 204.6 163.6 96.8 92.8 91.2 105.5 196.6 102.8 99.4 89.5 131.9 90.1 214.3 36.2 70.6 90.4 103.2 104.6 117.5 178.0 140.0 109.1 102.9 68.1 98.2 154.4 87.5 62.1 102.2 134.1 558.3 145.3 146.8 32.6 153.5 107.2 137.5 111.9 60.5 94.8 189.5 141.2 117.2 117.3 152.2 88.9 56.8 195.7 170.2 123.5 133.2 63.2 192.3 145.1 105.4 52.6 80.7 113.7 96.7 162.0 6.4 9.9 61.5 10.0 10.3 7.2 5.5 8.7 11.4 7.0 7.2 4.6 10.1 22.6 11.0 12.4 10.0 9.0 6.3 45.9 45.5 43.7 53.2 45.2 44.3 50.5 45.7 45.0 47.4 48.0 43.3 45.8 16.0 27.4 16.6 13.7 12.4 20.0 17.3 15.9 26.3 58.0 39.9 16.1 32.9 17.7 22.0 12.5 19.4 54.2 40.9 13.7 23.6 1.9 17.9 28.1 27.5 30.0 11.3 8.2 35.2 31.8 24.0 26.0 24.8 2.5 40.4 23.2 42.9 23.2 42.1 13.0 37.3 22.4 23.3 21.4 3.3 28.6 28.0 10.6 6.5 23.1 51.2 24.7 8.0 9.6 53.3 22.1 30.9 10.3 38.8 23.5 17.9 14.2 26.6 26.3 24.9 29.1 1.8 5.3 16.2 13.9 23.4 23.3 34.0 33.7 33.4 ANKRD24 KIAA1981 ENSG00000089847 "Ankyrin repeat domain 24" Q8TF21 19 4183354-4224814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3;testis: 14.0" "Cell type enhanced" "Detected in some" "Astrocytes: 12.1;Excitatory neurons: 24.7;Extravillous trophoblasts: 19.1;Inhibitory neurons: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.9;U-266/70: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041534, HPA048498" Uncertain Uncertain Microtubules,Cytosol NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Microtubules, Cytosol" "HPA041534: AB_2677537, HPA048498: AB_2680420" "unprognostic (3.70e-2)" "unprognostic (3.96e-3)" "unprognostic (5.23e-9)" "unprognostic (7.03e-2)" "unprognostic (5.01e-2)" "unprognostic (2.31e-1)" "prognostic favorable (9.13e-5)" "unprognostic (1.53e-1)" "unprognostic (3.52e-2)" "unprognostic (3.41e-2)" "unprognostic (1.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.27e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-4)" 1.1 3.7 6.8 0.3 11.0 0.5 0.9 4.2 20.3 1.3 0.0 1.3 0.8 0.8 0.8 0.5 1.4 0.5 0.6 10.9 4.1 3.1 10.7 1.0 0.4 2.6 4.0 2.0 3.9 0.6 6.5 0.8 2.4 4.1 0.3 2.7 0.9 0.6 1.2 0.6 1.4 0.2 1.5 1.5 1.8 14.0 5.8 0.4 2.8 0.4 0.1 1.0 0.7 10.8 0.1 0.2 0.0 0.1 2.7 0.2 2.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.4 0.2 0.1 0.1 0.4 0.0 2.2 0.3 0.0 0.1 0.1 1.5 0.1 0.3 1.5 0.1 0.2 0.7 0.4 0.1 1.7 0.1 4.9 0.0 0.7 0.0 0.1 2.1 0.6 0.6 0.3 0.0 0.4 0.0 0.2 0.8 0.1 0.1 0.1 0.3 0.5 0.6 0.4 0.0 0.1 1.0 0.8 0.0 16.2 1.5 0.1 0.7 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 11.0 4.2 20.3 10.9 4.1 2.6 4.0 2.4 1.5 5.8 10.8 0.1 0.0 1.9 12.1 0.5 0.0 0.2 0.1 0.0 1.2 0.4 0.4 0.9 1.5 1.4 0.0 4.2 0.3 0.0 0.3 0.0 0.1 0.4 0.6 0.2 0.2 3.6 0.0 24.7 0.0 19.1 0.2 1.5 0.4 0.0 0.2 0.7 0.9 0.4 0.0 14.4 0.7 0.0 0.8 0.0 1.7 0.0 0.3 0.0 1.0 0.0 0.9 0.0 3.5 4.4 0.0 0.3 0.0 0.2 0.2 0.5 0.8 0.3 1.2 0.0 0.4 0.2 1.0 2.9 0.2 0.0 1.1 0.2 0.4 0.2 0.2 ANKRD54 LIAR ENSG00000100124 "Ankyrin repeat domain 54" Q6NXT1 22 37830855-37849327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071287 Approved Approved Nucleoplasm,Microtubules,Midbody Yes No "Cluster 15: NK-cells - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "Microtubules, Midbody" Nucleoplasm "HPA071287: AB_2686380" "unprognostic (5.36e-2)" "prognostic favorable (2.06e-4)" "unprognostic (1.02e-1)" "prognostic favorable (7.38e-5)" "unprognostic (1.14e-1)" "unprognostic (1.50e-1)" "unprognostic (1.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.41e-2)" "prognostic favorable (6.16e-4)" "unprognostic (2.53e-1)" "unprognostic (6.33e-2)" "unprognostic (1.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-3)" 8.6 18.7 22.4 5.9 20.8 6.9 9.1 22.6 23.3 13.0 28.7 16.4 7.1 12.9 7.8 14.0 23.8 6.3 12.4 23.0 26.2 14.9 15.6 8.4 6.4 22.6 24.7 17.8 18.1 11.7 19.2 5.4 21.6 13.7 6.6 6.3 13.9 11.0 12.6 11.3 8.9 9.5 22.0 9.2 10.9 30.9 26.1 10.4 13.8 8.7 7.2 14.0 10.9 20.3 18.5 18.6 15.4 23.0 19.9 11.3 8.1 24.8 19.2 41.1 25.2 11.8 7.3 17.8 10.1 16.5 13.3 16.4 19.5 14.1 19.9 14.2 39.5 9.3 17.3 28.3 17.7 17.8 20.8 10.1 14.2 22.6 13.3 10.3 25.5 13.1 11.9 12.7 19.1 19.8 17.6 21.1 4.4 24.5 16.5 20.2 18.3 11.3 23.2 6.4 26.4 14.1 20.7 18.8 30.8 7.0 19.3 28.0 15.1 24.5 25.6 12.9 18.6 13.3 11.7 14.3 20.1 15.1 17.9 3.5 4.5 2.2 5.4 5.5 5.4 3.9 5.1 4.0 5.7 5.2 5.3 2.6 2.7 10.2 9.3 5.3 2.4 3.3 22.4 20.8 22.6 23.3 23.0 26.2 22.6 24.7 21.6 22.0 26.1 20.3 8.4 12.8 14.5 11.8 14.4 15.8 11.0 12.4 12.0 18.3 16.9 15.6 8.1 24.3 12.2 18.4 29.2 20.9 14.0 19.9 39.2 17.1 6.4 47.8 12.6 10.9 9.0 12.8 9.4 14.7 17.7 12.3 12.2 8.5 9.5 23.3 13.6 12.0 13.2 26.9 9.4 14.3 12.2 12.5 10.7 7.7 18.0 8.8 10.6 2.8 9.2 18.5 17.5 13.6 8.6 11.3 15.3 21.4 8.4 11.4 19.2 22.0 48.2 23.2 6.6 13.1 13.4 65.6 42.1 12.7 17.6 16.8 13.3 25.4 20.7 9.9 AP000812.4 ENSG00000284922 "Leucine rich transmembrane and O-methyltransferase domain containing" Q8WZ04 11 72080331-72110782 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Hearing, Neurotransmitter degradation" "Methyltransferase, Transferase" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 14.1;testis: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.9;HBEC3-KT: 2.9;MCF7: 3.0" HPA039949 Approved Uncertain Microtubules NA NA "Cluster 40: Non-specific - Basic cellular processes" Microtubules "HPA039949: AB_10960708" 0.1 0.0 0.4 0.0 0.5 0.0 0.2 0.6 1.8 0.0 0.1 0.0 0.0 0.9 0.0 0.0 14.1 0.0 0.0 0.3 0.6 0.4 0.2 0.6 0.0 0.4 0.4 0.2 0.0 0.5 0.0 0.4 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.2 0.2 0.3 0.2 0.0 9.5 0.4 0.0 0.1 0.0 0.0 0.1 0.6 0.2 0.1 0.0 0.2 0.7 0.2 0.1 0.4 0.5 0.3 1.2 0.2 0.2 0.0 0.1 2.9 0.5 0.6 0.4 2.9 0.3 1.2 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.8 0.0 1.3 0.4 0.1 0.1 0.6 0.0 0.0 0.4 3.0 0.0 0.0 0.1 1.0 0.0 0.6 0.5 0.2 0.9 0.5 0.3 0.1 0.4 0.3 0.0 0.0 0.9 0.1 0.0 0.2 0.2 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.6 1.8 0.3 0.6 0.4 0.4 0.4 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARC "Arg3.1, KIAA0278" ENSG00000198576 "Activity regulated cytoskeleton associated protein" Q7LC44 8 142611049-142614479 "Predicted intracellular proteins" "Endocytosis, Transport" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 122.9;pituitary gland: 67.6" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 57.0;Endometrial stromal cells: 47.8;Enteroendocrine cells: 164.2;Skeletal myocytes: 57.7" "Cancer enriched" "Detected in many" 12 "glioma: 36.1" "Group enriched" "Detected in all" 6 "cerebral cortex: 122.9;hippocampal formation: 34.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 8.1;HEK 293: 10.0;SCLC-21H: 23.6;U-2 OS: 11.5;U-87 MG: 12.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basal ganglia: 20.7;cerebral cortex: 75.1;hippocampal formation: 42.4;olfactory bulb: 22.9" "HPA056430, CAB079013" Supported Approved Vesicles,Microtubules NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 10: Brain - Neuronal signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 36: Stromal cells - Cell proliferation" "Vesicles, Microtubules" "CAB079013: , HPA056430: AB_2683130" "unprognostic (1.40e-3)" "unprognostic (2.95e-2)" "unprognostic (4.35e-3)" "unprognostic (4.87e-4)" "unprognostic (6.83e-2)" "unprognostic (8.12e-2)" "unprognostic (5.13e-2)" "unprognostic (1.77e-1)" "unprognostic (5.07e-2)" "unprognostic (9.43e-2)" "unprognostic (4.15e-3)" "unprognostic (1.40e-1)" "unprognostic (2.14e-2)" "unprognostic (1.01e-2)" "unprognostic (7.42e-2)" "unprognostic (1.54e-1)" "unprognostic (3.35e-2)" 14.2 10.2 6.6 0.4 8.2 0.2 1.2 4.5 122.9 3.3 2.7 1.6 0.2 0.9 0.9 1.6 1.9 2.0 2.1 34.2 14.1 4.0 0.3 8.1 0.0 6.4 4.0 0.6 4.0 0.0 67.6 0.9 4.8 0.8 0.1 0.8 0.8 3.8 0.4 10.9 1.1 0.3 3.6 0.7 8.7 0.6 8.9 0.1 1.0 0.4 0.1 0.7 4.5 13.4 0.0 0.1 0.4 8.1 0.1 0.8 0.0 1.7 0.0 0.4 0.2 0.2 0.0 0.0 1.1 0.3 0.3 0.1 0.5 0.0 0.0 0.0 10.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.1 0.0 0.0 0.1 3.5 0.0 0.0 3.7 1.4 1.8 0.0 0.8 0.0 0.0 0.0 23.6 5.5 0.6 0.0 0.3 0.0 0.1 0.1 0.0 1.3 11.5 0.9 0.2 2.2 0.1 0.0 12.8 0.0 3.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 8.2 4.5 122.9 34.2 14.1 6.4 4.0 4.8 3.6 8.9 13.4 19.7 0.0 3.0 1.6 1.9 5.1 16.6 2.6 1.2 8.4 33.2 57.0 4.5 4.3 0.8 0.0 0.0 0.1 5.8 6.0 0.0 1.6 0.1 9.2 47.8 9.8 164.2 0.0 17.0 0.0 0.4 24.1 21.9 10.3 0.0 0.5 7.5 0.0 1.6 3.3 0.8 6.2 4.1 0.8 7.0 0.0 0.3 8.2 7.2 1.0 0.1 15.2 0.0 3.5 0.8 0.1 0.0 1.9 1.1 10.3 0.3 0.0 0.3 2.8 0.0 57.7 27.0 0.2 0.6 4.7 6.5 0.1 4.2 0.5 4.1 2.7 ARHGAP39 "CrGAP, KIAA1688, Vilse" ENSG00000147799 "Rho GTPase activating protein 39" Q9C0H5 8 144529179-144605816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 21.8" "Cell type enhanced" "Detected in many" "Astrocytes: 34.3;Endometrial ciliated cells: 31.4;Excitatory neurons: 41.7;Inhibitory neurons: 33.1;Oligodendrocytes: 30.8;Respiratory ciliated cells: 27.6;Rod photoreceptor cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044491 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Nucleoplasm, Microtubules, Cytokinetic bridge" "HPA044491: AB_10794775" "unprognostic (3.42e-2)" "unprognostic (2.65e-2)" "unprognostic (9.85e-2)" "unprognostic (4.17e-1)" "unprognostic (1.53e-1)" "unprognostic (2.49e-1)" "unprognostic (1.74e-7)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (2.02e-1)" "unprognostic (6.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (1.26e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (9.97e-2)" 1.6 3.9 4.3 0.8 5.2 0.0 3.4 2.3 9.4 4.9 1.2 4.5 1.7 2.8 0.8 5.0 8.2 0.7 1.9 8.5 2.3 4.9 1.6 2.7 0.3 8.4 5.9 2.6 5.2 1.3 9.9 0.7 5.5 4.2 0.6 3.1 3.5 1.4 0.7 5.2 2.7 0.5 4.7 1.3 2.0 21.8 3.5 0.7 7.5 0.1 0.1 1.9 3.1 9.5 8.3 8.1 3.8 5.8 0.7 0.6 7.2 2.1 0.7 2.6 1.6 5.2 4.8 0.8 5.4 0.8 2.7 7.0 1.8 2.0 0.5 0.0 7.2 0.1 5.8 3.4 1.3 0.0 0.8 0.5 3.2 3.3 1.4 1.3 0.8 0.4 7.7 0.0 1.1 13.4 4.6 0.0 4.0 3.4 11.4 4.3 3.0 3.2 2.1 4.1 10.9 7.7 6.2 2.1 3.8 1.4 9.0 1.2 2.0 1.9 0.1 6.6 4.5 0.0 0.1 0.3 3.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 5.2 2.3 9.4 8.5 2.3 8.4 5.9 5.5 4.7 3.5 9.5 0.8 3.2 2.3 34.3 0.6 3.7 0.6 1.9 2.2 7.2 5.0 3.3 1.6 0.0 2.8 3.7 20.9 0.6 0.1 7.5 0.0 2.4 3.9 31.4 2.8 1.1 0.0 0.0 41.7 2.5 0.9 1.2 1.1 6.0 0.0 6.0 0.7 1.4 0.5 3.3 33.1 4.2 4.1 0.0 0.4 3.1 2.1 0.2 5.4 1.0 0.0 3.6 0.0 15.6 30.8 1.4 7.9 8.2 0.0 1.0 3.3 1.5 27.6 24.5 6.6 2.5 2.1 8.5 11.2 2.1 3.0 0.5 0.3 3.1 5.2 0.7 ARHGEF28 "p190RhoGEF, RGNEF, RIP2" ENSG00000214944 "Rho guanine nucleotide exchange factor 28" Q8N1W1 5 73626158-73941993 "Predicted intracellular proteins" Differentiation "Guanine-nucleotide releasing factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 31.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 73.1;Granulosa cells: 83.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 97.8;LHCN-M2: 92.2;TIME: 59.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037602 Enhanced Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" "Microtubules, Cytosol" "Plasma membrane" "HPA037602: AB_10672282" "unprognostic (1.97e-1)" "prognostic favorable (5.31e-4)" "unprognostic (7.66e-2)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (3.18e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (5.37e-1)" "unprognostic (3.63e-1)" "unprognostic (2.62e-1)" "unprognostic (3.04e-1)" "prognostic favorable (1.91e-6)" "unprognostic (1.07e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-2)" "prognostic favorable (8.98e-4)" 4.8 23.9 4.5 1.1 4.7 0.0 7.5 0.4 5.1 3.9 0.0 3.3 3.2 4.1 2.5 6.4 9.8 5.3 1.9 5.0 4.3 31.5 6.4 7.3 0.4 1.6 2.0 19.0 20.7 1.2 6.0 0.5 3.2 5.0 3.7 6.0 19.2 3.6 0.9 14.8 2.5 3.5 1.4 2.8 21.8 1.5 3.2 4.0 13.6 0.9 2.9 3.7 6.6 2.8 30.1 21.0 0.1 2.6 2.6 3.6 0.0 10.8 21.5 13.5 13.3 6.3 12.8 0.1 22.5 3.7 30.4 10.0 1.4 17.4 20.2 0.2 3.1 0.6 3.3 27.2 20.9 0.0 0.0 3.3 7.0 21.0 97.8 25.2 44.4 0.6 0.0 0.0 92.2 2.8 0.0 0.0 0.2 7.9 8.5 0.0 5.5 3.7 36.4 18.0 2.0 3.9 5.3 0.8 0.6 0.0 4.6 0.1 59.8 6.6 9.2 0.5 10.3 1.1 0.0 0.2 10.1 1.4 4.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.5 4.7 0.4 5.1 5.0 4.3 1.6 2.0 3.2 1.4 3.2 2.8 9.1 28.9 16.4 3.9 0.2 25.7 14.1 14.1 40.5 4.9 7.5 11.0 2.0 24.3 15.5 31.3 0.0 0.3 2.1 3.7 15.6 13.0 9.6 32.7 1.7 12.8 11.4 2.7 73.1 11.3 0.3 3.1 35.7 12.6 1.3 83.2 2.2 7.3 0.3 13.5 34.5 10.7 40.7 0.3 0.9 2.6 10.2 3.3 1.8 32.8 0.6 26.8 1.0 34.7 15.2 26.3 4.6 5.7 1.2 16.0 3.9 26.7 50.4 1.6 6.6 0.5 7.0 1.0 1.3 20.4 25.6 0.1 1.2 32.3 6.7 17.3 ARL13B "ARL2L1, DKFZp761H079, JBTS8" ENSG00000169379 "ADP ribosylation factor like GTPase 13B" Q3SXY8 3 93980139-94055678 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 18.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 93.0;Rod photoreceptor cells: 102.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048926 Approved Uncertain Microtubules,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 77: Retina - Visual perception" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 46: Photoreceptor cells - Phototransduction" Microtubules Cytosol "HPA048926: AB_2680559" "unprognostic (2.29e-2)" "unprognostic (2.35e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (1.94e-1)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-2)" "unprognostic (1.19e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (5.42e-3)" "unprognostic (8.86e-2)" "unprognostic (2.73e-1)" "unprognostic (5.41e-2)" "unprognostic (7.50e-2)" 3.4 2.5 1.3 2.9 1.6 0.8 2.3 1.2 2.5 4.1 8.7 1.9 0.8 4.6 1.0 3.3 4.1 4.0 2.0 1.2 1.1 3.6 2.6 4.1 2.1 1.5 1.8 3.2 1.5 3.6 2.0 2.7 1.6 2.0 1.4 18.2 1.5 2.6 0.7 1.4 1.9 4.2 1.5 2.9 1.6 3.5 1.2 2.5 4.3 1.7 1.7 3.1 1.7 2.0 8.3 12.5 7.9 4.3 13.3 3.5 3.6 7.8 4.8 11.8 15.9 8.0 4.4 5.9 11.3 6.9 7.1 5.1 7.2 5.3 16.2 10.5 6.4 12.7 5.6 5.4 6.0 15.2 6.9 5.2 2.1 12.3 19.0 4.5 4.0 8.7 12.5 7.3 6.7 3.1 12.3 1.2 2.9 4.3 7.5 7.2 25.8 2.0 5.7 1.2 18.0 4.6 15.9 0.9 9.4 2.9 2.1 3.5 7.7 11.6 11.0 6.8 9.6 1.8 2.0 11.7 8.5 8.8 8.5 6.4 3.4 2.9 3.7 4.2 3.8 3.9 3.3 3.0 3.0 3.4 3.3 3.1 2.0 4.3 4.8 4.8 2.9 1.8 1.3 1.6 1.2 2.5 1.2 1.1 1.5 1.8 1.6 1.5 1.2 2.0 27.2 93.0 39.6 31.6 11.3 46.8 28.1 8.6 10.2 19.0 11.0 16.8 8.1 12.8 19.7 1.8 41.7 1.9 7.1 1.3 15.6 17.1 14.8 30.1 25.2 31.7 22.1 6.5 58.4 11.8 6.3 48.5 10.2 11.2 45.6 9.2 17.5 7.7 12.1 15.2 41.5 3.1 12.2 7.0 21.6 6.4 23.9 10.7 16.0 38.4 6.0 26.9 6.2 29.7 49.8 11.4 3.8 25.6 8.0 13.9 1.8 18.7 71.9 102.0 6.6 59.4 33.8 43.1 14.5 12.7 58.7 0.8 13.2 16.5 3.1 10.6 ARL6 "BBS3, RP55" ENSG00000113966 "ADP ribosylation factor like GTPase 6" Q9H0F7 3 97764521-97801229 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 46.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 55.0;Inhibitory neurons: 51.5;Rod photoreceptor cells: 57.4;Spermatocytes: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SCLC-21H: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019361 Approved Approved Microtubules NA NA "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 46: Photoreceptor cells - Phototransduction" Microtubules "HPA019361: AB_1845028" "unprognostic (1.31e-1)" "unprognostic (2.82e-2)" "unprognostic (7.12e-2)" "unprognostic (4.66e-2)" "unprognostic (2.08e-1)" "unprognostic (1.02e-1)" "unprognostic (8.78e-3)" "unprognostic (2.88e-2)" "unprognostic (5.55e-3)" "unprognostic (9.43e-2)" "unprognostic (1.19e-1)" "unprognostic (3.31e-1)" "prognostic favorable (2.53e-7)" "unprognostic (9.49e-2)" "unprognostic (1.67e-1)" "unprognostic (2.16e-2)" "unprognostic (2.97e-1)" 3.6 5.2 4.1 2.2 4.8 0.8 3.3 4.2 5.2 3.4 3.8 2.4 1.5 4.4 3.9 3.0 7.2 3.7 3.6 5.7 4.9 7.5 2.6 5.0 2.5 3.5 3.7 3.5 2.9 12.8 4.1 2.8 3.7 3.9 2.5 46.3 5.8 3.5 1.6 3.1 1.8 4.2 3.9 3.0 2.8 6.6 3.8 2.3 5.5 2.2 2.2 3.2 2.1 3.7 10.1 5.2 4.9 4.1 11.5 7.6 1.3 6.2 5.5 5.6 6.7 2.2 3.6 5.8 6.1 3.1 8.5 4.6 6.1 6.8 10.4 6.3 3.7 1.5 3.9 2.2 5.4 7.6 3.5 4.1 4.9 7.4 1.7 4.5 6.1 7.0 1.8 1.1 8.1 3.1 4.1 3.2 6.1 4.9 7.5 1.9 5.9 4.0 6.5 2.8 26.0 14.4 5.4 3.4 11.2 3.1 4.3 2.4 5.3 5.2 4.7 4.5 8.7 4.2 5.3 6.4 9.5 4.0 6.4 0.2 0.2 0.1 1.0 0.4 2.1 0.8 0.9 1.1 0.4 1.6 1.6 1.3 0.0 1.8 0.5 0.4 1.7 0.7 4.1 4.8 4.2 5.2 5.7 4.9 3.5 3.7 3.7 3.9 3.8 3.7 3.2 3.2 3.6 31.6 2.2 3.2 3.2 4.8 5.2 12.7 3.2 3.0 2.4 1.5 5.0 9.2 27.1 1.2 0.8 0.6 3.9 3.4 25.7 20.3 4.4 3.7 2.4 2.1 55.0 2.5 2.3 5.1 4.6 2.2 0.0 2.4 4.6 2.9 1.8 5.0 51.5 1.0 6.1 1.3 1.1 5.6 4.1 1.5 1.8 15.0 0.4 8.2 2.1 15.1 27.6 1.7 2.0 4.1 3.7 1.3 0.2 10.1 27.2 57.4 6.6 3.3 4.6 39.6 6.7 4.4 2.0 0.7 2.7 4.6 1.3 2.0 ASRGL1 "ALP, ALP1, FLJ22316" ENSG00000162174 "Asparaginase and isoaspartyl peptidase 1" Q7L266 11 62337448-62393412 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 112.7;cervix: 121.7;testis: 100.5" "Cell type enhanced" "Detected in many" "Early spermatids: 372.5;Endometrial ciliated cells: 414.6;Glandular and luminal cells: 437.1;Late spermatids: 597.6;Proximal tubular cells: 214.1;Spermatocytes: 534.3" "Cancer enhanced" "Detected in all" "endometrial cancer: 53.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 277.9;eosinophil: 269.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 277.9" "Cell line enhanced" "Detected in many" "EFO-21: 85.2;HAP1: 83.9;SCLC-21H: 112.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029725, HPA055572, CAB070192" Enhanced Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes NA "Cluster 2: Granulocytes - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 44: Endometrium - Transcription" Microtubules "Nucleoplasm, Cytokinetic bridge" "CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854" "unprognostic (1.14e-1)" "unprognostic (8.38e-3)" "prognostic favorable (6.14e-4)" "prognostic favorable (1.56e-5)" "unprognostic (5.35e-2)" "unprognostic (8.19e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (8.67e-2)" "unprognostic (1.85e-1)" "unprognostic (3.54e-2)" "unprognostic (2.71e-1)" "unprognostic (4.44e-1)" "prognostic favorable (4.32e-7)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (5.43e-3)" "unprognostic (1.40e-1)" 13.8 3.7 94.2 6.5 95.4 14.4 12.0 92.5 103.5 121.7 71.7 14.2 6.8 26.4 3.1 2.1 68.1 11.2 6.2 87.1 93.3 42.5 10.2 25.8 5.6 87.5 102.7 1.8 13.4 2.3 21.2 3.2 87.6 23.8 17.1 17.8 13.2 7.2 7.3 2.9 9.5 4.4 83.4 4.7 15.1 100.5 112.7 10.3 6.7 3.0 4.7 4.3 2.0 90.0 2.4 19.5 20.9 27.2 0.1 0.0 16.4 2.3 0.8 3.6 3.5 32.0 8.5 1.9 85.2 0.3 9.3 1.8 83.9 0.7 4.2 2.6 34.4 1.2 28.1 23.5 0.6 24.0 30.8 0.8 0.2 1.6 0.4 1.3 39.4 47.8 24.5 21.5 0.9 37.5 65.3 15.9 28.5 13.6 15.2 26.1 12.5 11.8 73.3 5.9 112.3 16.1 16.4 28.2 14.4 21.2 15.0 12.1 2.0 0.4 15.4 1.2 9.5 32.8 33.6 3.0 0.8 12.3 9.7 277.9 68.6 269.5 2.8 50.8 1.9 2.4 1.0 3.3 39.7 1.5 2.3 3.4 16.3 11.5 38.5 7.2 0.8 24.2 94.2 95.4 92.5 103.5 87.1 93.3 87.5 102.7 87.6 83.4 112.7 90.0 29.2 6.4 27.8 56.8 5.2 3.4 2.5 2.2 0.6 24.4 13.8 6.6 2.4 42.9 4.1 22.0 33.3 2.3 3.2 14.0 133.1 30.3 372.5 414.6 39.9 31.2 47.2 14.1 13.9 22.3 2.4 4.0 19.9 437.1 80.9 16.6 49.2 3.7 25.0 16.8 18.6 67.4 6.1 11.4 6.4 597.6 8.7 26.9 1.8 9.4 10.5 80.8 4.1 15.1 22.0 7.8 7.5 7.2 13.9 35.4 2.9 214.1 5.4 37.1 13.1 7.7 6.1 534.3 48.6 0.1 1.3 0.8 7.8 10.8 36.0 15.9 ATG4A "APG4A, AUTL2" ENSG00000101844 "Autophagy related 4A cysteine peptidase" Q8WYN0 X 108091668-108154671 "Enzymes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 84.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036374, HPA064759" Uncertain Approved "Actin filaments,Microtubules" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 6: Erythroid cells - Oxygen transport" Microtubules "Actin filaments" "HPA036374: AB_10672354, HPA064759: AB_2685346" "prognostic unfavorable (1.36e-5)" "unprognostic (1.41e-2)" "unprognostic (3.65e-1)" "unprognostic (2.52e-1)" "unprognostic (1.28e-1)" "unprognostic (1.79e-1)" "unprognostic (1.18e-1)" "unprognostic (2.83e-3)" "unprognostic (2.23e-1)" "unprognostic (3.14e-1)" "unprognostic (2.62e-2)" "unprognostic (4.09e-1)" "unprognostic (1.03e-3)" "unprognostic (7.53e-2)" "unprognostic (2.98e-1)" "unprognostic (5.02e-3)" "unprognostic (1.20e-2)" 8.1 8.5 4.9 7.8 5.2 9.1 7.7 5.2 6.1 7.6 10.4 12.1 12.8 4.7 11.6 8.9 5.6 7.7 11.8 4.7 5.2 14.1 18.1 8.9 8.2 5.3 5.0 2.8 17.2 12.4 6.1 8.0 5.4 5.9 13.1 5.7 13.0 7.1 18.5 5.8 11.4 7.7 5.0 7.7 11.2 2.4 5.7 11.2 11.4 18.6 11.1 8.9 5.1 5.4 13.0 6.5 4.1 7.8 38.2 13.2 5.1 17.5 11.2 9.1 10.6 5.3 6.9 14.0 15.7 14.0 14.5 6.0 11.9 13.0 13.5 24.1 12.9 6.0 10.3 3.7 8.4 13.0 18.8 13.4 13.9 11.1 4.8 8.4 84.9 19.5 18.5 43.5 16.6 12.8 12.1 11.9 7.8 23.6 18.4 8.2 6.9 20.3 13.2 11.3 5.9 4.5 11.2 13.9 7.9 12.4 7.0 11.5 24.0 5.7 2.6 19.1 9.8 20.2 24.0 15.1 11.1 14.6 8.1 28.1 7.8 15.1 11.7 11.3 8.4 9.2 8.9 11.4 10.6 9.9 7.1 12.0 2.4 12.3 7.8 5.4 10.3 8.7 4.9 5.2 5.2 6.1 4.7 5.2 5.3 5.0 5.4 5.0 5.7 5.4 13.6 3.2 10.3 9.1 8.1 5.1 4.9 13.5 2.8 3.2 7.0 4.6 17.4 7.2 12.8 5.5 4.2 6.2 12.4 19.1 27.4 9.6 7.0 10.6 7.4 12.9 6.7 36.7 7.9 17.9 7.5 4.6 8.2 6.0 3.8 3.3 9.7 15.4 9.0 1.7 8.4 9.0 30.5 4.1 3.6 10.0 2.8 7.3 14.2 4.7 6.7 10.3 18.6 7.1 11.6 16.6 8.0 7.5 23.5 5.6 14.7 24.7 17.2 5.0 0.0 4.5 6.9 2.4 3.9 5.9 5.3 10.4 12.0 6.2 5.6 7.3 BRINP1 "DBC1, DBCCR1, FAM5A" ENSG00000078725 "BMP/retinoic acid inducible neural specific 1" O60477 9 119153458-119369435 "Predicted intracellular proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 43.5" "Group enriched" "Detected in some" 8 "Astrocytes: 178.9;Excitatory neurons: 285.7;Inhibitory neurons: 163.4;Oligodendrocyte precursor cells: 204.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 8.6;NTERA-2: 17.0;SCLC-21H: 7.4;SH-SY5Y: 3.2;SuSa: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038828 Approved Uncertain Microtubules "Intracellular and membrane" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 5: NTERA-2 - Transcription" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Microtubules "HPA038828: AB_10670909" "unprognostic (8.60e-5)" "unprognostic (2.31e-2)" "unprognostic (1.24e-1)" "unprognostic (5.09e-5)" "unprognostic (1.12e-1)" "unprognostic (1.14e-2)" "unprognostic (1.37e-1)" "unprognostic (2.98e-1)" "unprognostic (1.76e-1)" "unprognostic (1.02e-1)" "unprognostic (2.28e-4)" "unprognostic (1.51e-2)" "unprognostic (5.06e-3)" "unprognostic (1.39e-3)" "unprognostic (1.56e-1)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" 0.1 3.8 28.8 0.0 23.3 0.0 2.4 20.5 43.5 0.5 0.0 0.2 0.2 0.7 4.9 0.6 0.0 1.4 1.8 35.7 17.8 1.7 0.6 1.9 0.0 9.6 20.6 0.1 0.0 0.0 1.6 0.0 16.8 1.5 0.1 5.3 0.7 5.2 0.3 0.1 0.6 0.1 16.0 0.3 0.2 0.5 27.7 0.8 0.3 0.1 0.0 0.3 0.2 18.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 17.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 7.4 3.2 0.0 0.0 0.0 6.0 0.6 0.0 0.0 1.1 1.8 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 23.3 20.5 43.5 35.7 17.8 9.6 20.6 16.8 16.0 27.7 18.8 0.1 0.0 0.0 178.9 0.0 0.0 0.5 0.5 0.0 8.7 8.1 4.2 0.9 0.0 0.1 0.0 25.0 0.1 0.0 0.3 0.0 0.0 2.1 0.5 15.9 0.5 2.4 0.0 285.7 0.0 0.0 0.4 0.0 0.4 0.0 0.2 2.9 0.0 0.3 1.7 163.4 0.0 0.0 0.3 0.0 1.0 0.0 0.3 0.0 8.4 0.0 1.6 0.0 204.6 4.9 0.1 0.0 0.4 0.0 0.4 0.0 23.9 0.0 2.6 0.0 0.0 0.4 1.0 1.7 0.0 0.0 0.0 0.2 0.1 0.0 0.3 BUD31 "Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W" ENSG00000106245 "BUD31 homolog" P41223 7 99408641-99419616 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028943 Approved Approved Nucleoplasm,Microtubules,Centrosome NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Microtubules, Centrosome" "HPA028943: AB_10602396" "unprognostic (1.68e-1)" "unprognostic (2.73e-2)" "unprognostic (2.89e-2)" "unprognostic (2.63e-2)" "unprognostic (5.29e-2)" "unprognostic (2.38e-2)" "unprognostic (2.02e-3)" "unprognostic (2.16e-2)" "unprognostic (4.02e-2)" "unprognostic (1.46e-2)" "unprognostic (8.71e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (9.66e-4)" "unprognostic (1.42e-1)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (1.71e-1)" 48.2 47.1 51.3 32.6 51.0 91.7 45.9 54.5 59.7 37.8 52.3 46.4 32.0 38.1 35.4 49.6 39.9 32.2 39.6 51.9 51.8 65.5 42.9 43.4 45.5 51.4 51.3 39.0 33.9 41.1 54.0 33.9 51.6 42.3 25.7 14.8 37.9 30.8 31.6 40.8 35.2 29.2 51.5 40.9 44.0 68.4 55.0 41.1 41.2 25.1 35.8 40.3 40.7 53.2 111.2 123.9 67.5 153.9 67.3 75.0 67.0 103.7 96.7 113.4 124.1 148.5 104.5 83.7 122.7 98.3 123.8 65.5 76.0 92.9 93.8 102.3 106.9 61.1 83.1 98.2 139.4 106.0 78.2 73.8 112.1 104.1 195.1 66.4 89.8 87.6 151.7 182.3 106.2 283.9 143.3 281.2 152.2 114.6 156.8 73.2 69.5 145.7 100.7 85.6 120.3 145.8 101.8 114.9 216.8 43.8 72.2 129.0 74.8 108.1 138.5 216.8 163.6 115.0 207.2 220.9 94.9 153.6 199.4 390.7 206.8 516.9 175.8 232.0 164.7 226.1 165.5 171.2 175.9 223.9 140.0 145.7 451.2 203.7 252.6 171.2 215.7 360.5 51.3 51.0 54.5 59.7 51.9 51.8 51.4 51.3 51.6 51.5 55.0 53.2 103.2 83.3 81.2 3.6 88.1 192.7 142.3 192.7 103.6 32.8 94.8 134.1 12.8 68.6 110.5 92.0 10.4 169.9 118.5 157.7 238.7 169.9 173.1 137.3 91.7 98.1 146.8 85.2 5.7 187.1 163.0 97.9 65.2 111.9 91.2 79.6 86.0 84.3 151.5 16.8 5.6 187.2 111.9 89.2 125.1 121.3 82.0 90.8 136.9 5.6 148.5 103.5 116.4 5.0 6.8 248.1 153.8 74.1 68.4 153.9 155.4 242.3 171.2 40.1 59.2 77.4 144.3 298.2 135.7 99.1 183.8 182.4 112.0 86.9 132.3 174.8 C10orf67 "bA215C7.4, C10orf115, LINC01552, MGC46732" ENSG00000179133 "Chromosome 10 open reading frame 67" Q8IYJ2 10 23202696-23344845 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.1;fallopian tube: 4.8;testis: 12.4" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 38.5;Early spermatids: 40.2;Endometrial ciliated cells: 18.2;Late spermatids: 32.8;Proximal tubular cells: 17.9;Respiratory ciliated cells: 35.7;Spermatocytes: 70.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 3.0;SiHa: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA038131 Approved Approved Vesicles,Microtubules,Mitochondria NA No "Cluster 35: T-regs - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Vesicles, Microtubules, Mitochondria" "HPA038131: AB_10670658" "unprognostic (4.76e-4)" "unprognostic (2.38e-1)" "unprognostic (3.75e-2)" "unprognostic (2.92e-2)" "unprognostic (9.67e-3)" "unprognostic (1.91e-1)" "unprognostic (1.54e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (2.46e-3)" "unprognostic (3.98e-1)" "unprognostic (3.59e-2)" "unprognostic (3.84e-3)" "unprognostic (9.58e-2)" 0.0 0.2 1.5 0.2 1.4 0.3 0.1 0.9 1.6 0.1 5.1 0.1 0.5 0.2 1.4 0.1 4.8 0.2 0.7 1.7 1.3 3.5 0.4 2.9 0.3 2.0 2.2 0.5 0.2 0.4 1.2 0.1 1.5 0.0 0.0 0.9 0.1 0.1 0.5 1.3 0.3 0.0 1.3 0.2 0.1 12.4 1.9 0.0 0.6 0.1 0.1 0.0 0.0 2.0 0.7 0.1 0.9 0.1 0.0 0.2 0.3 0.1 0.0 0.9 0.8 0.2 1.3 0.1 0.1 0.8 0.1 3.0 0.1 0.3 0.8 0.3 0.2 0.3 0.7 0.2 0.5 0.1 0.2 0.2 1.0 0.3 0.4 0.1 0.0 0.1 0.3 0.5 0.0 0.3 0.1 0.2 0.5 0.0 0.1 0.1 0.1 0.1 0.7 0.2 0.5 0.2 3.9 0.1 0.0 0.1 0.2 0.2 0.2 0.2 0.8 0.2 0.1 0.5 0.1 0.0 1.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.3 0.2 0.0 0.3 0.2 0.2 0.0 0.2 0.1 0.2 1.2 0.0 1.5 1.4 0.9 1.6 1.7 1.3 2.0 2.2 1.5 1.3 1.9 2.0 0.0 38.5 2.4 0.3 0.0 2.8 0.1 1.9 0.0 0.4 0.0 0.0 1.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 1.9 0.2 40.2 18.2 0.2 0.1 0.0 0.0 4.7 0.2 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 32.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 2.2 0.2 0.0 0.7 0.0 0.0 0.0 17.9 35.7 1.6 6.6 0.0 0.1 70.1 5.2 0.0 1.3 0.0 0.3 0.5 0.1 0.0 C21orf91 "C21orf14, C21orf38, CSSG1, EURL, YG81" ENSG00000154642 "Chromosome 21 open reading frame 91" Q9NYK6 21 17788974-17819386 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.0" "Cell type enhanced" "Detected in many" "Early spermatids: 345.8;Late spermatids: 98.6;Oligodendrocytes: 103.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 111.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 107.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018288, HPA049030" Approved Approved "Microtubules,Cytokinetic bridge" Yes NA "Cluster 2: Granulocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 2: Karpas-707 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" Microtubules "Cytokinetic bridge" "HPA018288: AB_1845710, HPA049030: AB_2680605" "unprognostic (3.28e-1)" "unprognostic (3.41e-2)" "unprognostic (3.12e-2)" "unprognostic (4.51e-2)" "unprognostic (6.19e-2)" "unprognostic (1.11e-3)" "unprognostic (2.42e-1)" "unprognostic (8.81e-3)" "unprognostic (2.79e-1)" "unprognostic (1.97e-1)" "unprognostic (3.25e-1)" "unprognostic (5.49e-2)" "unprognostic (1.24e-2)" "unprognostic (6.80e-2)" "unprognostic (1.59e-1)" "unprognostic (6.49e-2)" "unprognostic (9.90e-3)" 6.3 4.8 11.5 9.8 26.7 8.2 8.2 22.0 16.3 6.2 4.4 4.7 5.1 9.2 4.3 8.3 6.7 6.0 5.4 13.3 15.5 5.3 8.7 7.9 15.4 26.0 21.2 8.0 2.8 4.9 2.7 13.5 26.6 5.3 5.2 5.7 5.0 3.6 2.7 18.9 5.5 7.6 20.9 9.8 6.3 24.4 20.7 19.2 5.7 5.5 13.0 8.3 4.1 59.0 7.2 1.2 15.6 0.1 3.9 7.3 6.9 10.4 18.6 10.1 8.9 6.5 3.7 25.2 5.1 4.2 14.1 5.7 17.1 13.4 8.7 27.5 9.2 16.9 13.2 4.1 8.8 20.6 9.2 5.3 14.6 13.3 21.5 7.1 2.8 10.3 12.1 107.9 7.7 4.5 28.8 6.1 16.4 1.7 5.7 21.9 29.9 10.2 6.8 12.0 6.2 14.4 13.1 10.1 47.2 7.0 6.1 11.6 4.8 44.2 13.8 0.2 6.8 28.6 37.7 21.5 3.5 18.9 17.3 111.1 11.2 56.8 20.9 11.9 29.8 14.0 19.3 22.7 13.9 11.7 14.9 19.7 24.9 20.7 12.2 3.5 36.9 12.0 11.5 26.7 22.0 16.3 13.3 15.5 26.0 21.2 26.6 20.9 20.7 59.0 20.2 19.2 11.1 1.6 26.4 27.9 10.1 57.9 63.2 12.6 14.4 10.4 7.4 4.3 27.1 5.5 16.7 17.3 18.8 4.4 1.9 4.8 345.8 14.5 13.8 21.3 10.7 5.5 0.8 6.9 12.2 12.0 9.2 14.4 39.9 11.3 7.5 6.8 5.8 15.2 0.8 5.0 18.3 7.2 14.0 98.6 23.6 9.7 21.4 3.7 30.7 3.5 48.4 7.5 103.4 4.4 5.9 17.0 27.6 11.0 3.4 6.4 19.3 13.0 6.6 20.1 12.1 38.7 24.1 21.4 27.6 80.2 38.9 22.1 3.8 7.7 C9orf16 "EST00098, FLJ12823, MGC4639" ENSG00000171159 "Chromosome 9 open reading frame 16" Q9BUW7 9 128160265-128163924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 325.2" "Cell type enhanced" "Detected in all" "Late spermatids: 869.5;Urothelial cells: 938.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020725 Uncertain Approved Microtubules NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Microtubules "HPA020725: AB_1845816" "unprognostic (8.85e-2)" "prognostic favorable (7.60e-4)" "prognostic unfavorable (9.91e-4)" "unprognostic (6.42e-3)" "unprognostic (3.98e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.13e-5)" "unprognostic (8.26e-2)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (7.04e-3)" "unprognostic (2.13e-1)" "unprognostic (3.09e-3)" "unprognostic (4.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.00e-3)" "unprognostic (2.48e-2)" 81.3 325.2 174.9 22.8 145.7 66.8 75.7 96.3 295.9 75.5 121.4 62.8 24.4 67.0 9.3 89.0 53.3 27.8 78.3 314.3 114.6 85.4 63.0 59.0 41.2 123.0 114.2 42.4 93.6 18.5 81.6 12.8 136.5 93.4 8.9 5.9 100.1 32.7 41.8 160.6 52.8 13.1 107.4 88.8 64.0 51.7 148.2 41.6 53.5 11.7 22.2 108.2 100.1 154.2 36.4 48.0 26.9 150.2 18.0 39.7 63.1 34.2 27.9 27.7 21.9 23.9 95.4 41.0 67.6 14.9 6.7 103.5 7.5 27.3 1.5 77.0 60.7 29.2 57.3 48.7 31.5 32.6 72.0 30.0 39.8 14.5 7.2 21.9 39.5 111.9 78.5 79.4 15.1 210.4 109.0 139.0 60.4 74.2 89.1 102.0 17.9 170.7 35.7 31.9 67.1 98.9 60.8 54.1 74.0 6.5 60.8 30.1 48.2 28.9 69.4 37.3 30.0 76.5 61.5 63.8 80.1 45.9 29.4 221.4 119.4 205.0 155.7 105.1 169.6 168.8 178.4 153.3 135.4 178.0 139.9 144.2 138.0 165.9 92.5 144.4 254.8 142.0 174.9 145.7 96.3 295.9 314.3 114.6 123.0 114.2 136.5 107.4 148.2 154.2 146.3 6.4 4.8 11.8 149.7 197.2 356.6 519.8 124.1 77.1 265.6 298.3 33.9 108.7 199.9 355.0 14.6 97.1 209.8 291.7 309.1 223.8 162.2 100.5 88.4 151.9 407.8 139.5 26.4 354.5 88.3 103.8 77.5 120.2 162.0 112.7 133.2 106.4 247.4 18.5 19.2 254.0 193.3 247.3 251.6 869.5 76.7 203.1 224.1 9.4 236.7 91.4 311.0 8.0 11.6 223.6 233.9 83.1 129.0 281.5 131.2 224.9 93.7 46.1 72.3 58.1 197.3 30.7 82.9 142.3 233.4 60.3 215.2 155.3 205.9 938.8 CA11 "CARP2, CARPX1" ENSG00000063180 "Carbonic anhydrase 11" O75493 19 48637946-48646187 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 330.0;choroid plexus: 146.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 46.1;hTERT-RPE1: 47.1;SCLC-21H: 32.6;U-266/84: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041778 Approved Vesicles,Microtubules "Secreted in brain" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 56: Bipolar cells - Visual perception" "Vesicles, Microtubules" "HPA041778: AB_10794525" "unprognostic (1.39e-1)" "prognostic favorable (4.33e-4)" "unprognostic (2.59e-3)" "unprognostic (5.72e-2)" "unprognostic (1.54e-1)" "unprognostic (9.80e-3)" "unprognostic (6.02e-2)" "prognostic favorable (2.11e-5)" "unprognostic (3.79e-2)" "unprognostic (2.98e-1)" "prognostic favorable (8.60e-5)" "unprognostic (4.88e-2)" "unprognostic (8.64e-3)" "unprognostic (1.21e-1)" "unprognostic (7.15e-2)" "unprognostic (4.09e-3)" "unprognostic (1.75e-1)" 13.1 17.3 240.8 3.2 256.9 1.6 8.5 215.4 330.0 15.9 146.2 19.4 8.4 33.0 28.2 8.0 21.4 5.5 10.7 266.6 167.0 14.7 1.7 5.8 5.0 170.3 169.2 48.8 5.9 58.0 37.2 1.1 172.2 14.0 2.5 30.0 8.9 13.5 9.2 14.3 9.3 18.2 163.8 6.1 13.0 6.4 180.5 6.6 12.1 7.4 5.3 9.2 12.2 231.9 2.0 12.7 22.9 46.1 3.1 1.2 0.6 1.5 14.9 1.5 3.3 3.1 15.7 7.5 1.7 1.7 4.2 4.9 9.4 4.6 1.3 1.6 13.5 3.3 7.2 0.2 3.0 0.3 9.8 5.4 9.2 1.4 2.0 47.1 1.8 19.8 6.1 20.5 0.7 5.0 4.1 1.4 9.9 7.5 4.7 2.6 0.9 16.1 10.1 0.4 32.6 18.2 1.7 1.6 2.7 6.1 6.3 0.8 0.2 3.9 14.2 0.1 0.4 18.9 33.9 1.3 5.7 4.3 2.0 0.0 0.4 0.0 1.5 0.5 1.5 1.0 1.2 1.2 0.7 1.3 1.5 1.3 0.0 1.3 0.0 1.9 1.5 0.7 240.8 256.9 215.4 330.0 266.6 167.0 170.3 169.2 172.2 163.8 180.5 231.9 5.1 3.2 8.1 11.1 9.3 7.1 9.1 13.2 12.5 81.0 15.5 12.1 5.4 21.5 9.6 31.3 16.7 0.7 9.8 3.9 25.4 11.5 15.0 6.7 6.3 6.7 13.1 3.6 47.0 10.0 0.4 11.6 5.6 7.9 6.3 3.1 8.9 47.5 6.0 28.6 18.1 6.4 16.2 20.4 26.4 7.9 22.1 6.8 8.8 5.6 5.6 50.4 12.3 7.1 6.8 3.4 2.9 26.7 4.3 4.3 20.7 38.7 7.5 30.8 6.6 4.2 8.9 1.3 4.9 5.9 10.9 0.4 6.9 8.7 5.2 6.4 CAPSL MGC26610 ENSG00000152611 "Calcyphosine like" Q8WWF8 5 35904288-35938779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "fallopian tube: 110.9" "Cell type enhanced" "Detected in some" "Early spermatids: 167.1;Endometrial ciliated cells: 400.1;Late spermatids: 148.9;Respiratory ciliated cells: 709.5" "Cancer enriched" "Detected in many" 4 "endometrial cancer: 14.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 7.3;BJ hTERT+ SV40 Large T+ RasG12V: 6.2;HBF TERT88: 4.7;REH: 8.0;U-698: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA046811, HPA058495" Enhanced Approved Nucleoplasm,Microtubules No No "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Microtubules" "HPA046811: AB_2679819, HPA058495: AB_2683735" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (2.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.20e-2)" "unprognostic (7.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-3)" "unprognostic (4.42e-1)" "unprognostic (3.62e-4)" "unprognostic (1.46e-1)" "unprognostic (1.36e-2)" "unprognostic (1.52e-1)" 0.0 0.0 3.3 0.0 2.8 0.2 0.1 1.9 2.1 2.5 25.4 0.0 0.0 2.0 8.4 0.0 110.9 0.0 0.0 2.1 3.6 0.8 0.0 7.7 0.0 9.9 10.2 0.1 0.5 1.2 13.6 0.0 7.5 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 8.0 0.0 0.1 9.9 4.0 6.6 5.4 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 7.3 6.2 0.0 0.0 2.2 0.0 1.0 0.1 0.0 0.1 0.0 4.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.0 0.0 1.2 2.1 0.0 0.5 0.0 0.0 19.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 2.8 1.9 2.1 2.1 3.6 9.9 10.2 7.5 8.0 4.0 7.6 0.0 3.2 7.3 0.3 0.0 0.0 0.1 58.0 0.0 0.0 0.2 0.0 0.0 0.0 66.2 1.8 0.0 0.0 0.0 0.0 1.9 0.1 167.1 400.1 2.4 0.5 0.0 0.0 0.4 0.0 0.0 0.8 0.0 4.7 1.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 65.1 0.0 0.0 148.9 0.9 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.5 0.0 1.6 709.5 0.0 0.0 0.0 19.2 21.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 CCDC117 FLJ33814 ENSG00000159873 "Coiled-coil domain containing 117" Q8IWD4 22 28772674-28789301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 104.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000826 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "Microtubules, Cytosol" "HPA000826: AB_1078417" "unprognostic (1.71e-1)" "unprognostic (2.04e-2)" "unprognostic (1.61e-3)" "unprognostic (9.07e-2)" "unprognostic (3.84e-2)" "unprognostic (1.26e-1)" "unprognostic (1.62e-1)" "unprognostic (1.35e-2)" "unprognostic (8.43e-2)" "unprognostic (7.74e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-3)" "unprognostic (8.25e-2)" 9.5 10.2 11.8 12.7 12.7 21.8 11.9 15.7 22.8 14.2 13.4 11.2 11.8 11.5 8.0 8.2 9.1 9.5 7.9 11.6 12.5 9.8 24.2 9.4 18.2 11.6 11.8 12.5 9.4 12.6 6.7 19.1 11.5 9.8 11.2 10.6 18.3 9.3 16.9 8.2 9.4 9.7 11.8 12.6 10.0 36.6 13.1 17.9 10.9 20.7 20.3 10.6 7.5 17.6 19.9 16.0 32.2 31.7 20.6 18.0 25.5 19.7 23.9 33.4 29.2 24.6 9.4 61.7 8.6 18.0 14.2 20.2 47.8 7.8 31.6 33.6 31.4 25.2 17.3 36.6 14.1 40.6 30.9 12.2 16.8 19.3 11.9 14.9 23.5 20.0 36.0 26.6 15.2 25.6 24.1 32.8 26.4 35.3 7.7 48.1 50.8 27.0 14.9 7.6 12.3 16.4 30.4 28.0 12.7 38.0 34.9 17.4 13.7 41.7 28.3 13.3 15.3 61.7 68.9 51.2 14.6 21.9 18.1 13.5 14.6 15.3 10.0 13.2 10.2 10.0 8.3 9.8 14.6 12.4 14.5 11.8 6.7 25.3 12.9 12.7 11.6 14.9 11.8 12.7 15.7 22.8 11.6 12.5 11.6 11.8 11.5 11.8 13.1 17.6 11.1 22.4 14.3 4.2 18.3 10.6 14.4 4.3 6.2 7.7 21.9 14.2 10.4 15.7 8.5 14.7 14.6 16.5 20.4 13.2 7.9 9.9 104.0 20.7 32.5 15.5 20.4 17.4 6.6 10.0 17.8 14.3 6.6 31.0 17.2 11.9 10.8 42.3 9.3 3.3 7.1 12.3 4.1 18.9 19.0 38.2 12.8 15.4 17.8 7.5 14.7 6.2 21.6 4.5 12.8 9.7 8.9 7.9 26.4 22.6 9.0 12.5 13.8 15.2 0.0 9.6 16.1 49.5 48.5 9.5 10.9 24.6 14.7 9.0 12.4 22.3 CCDC40 "CFAP172, CILD15, FAP172, FLJ20753, FLJ32021, KIAA1640" ENSG00000141519 "Coiled-coil domain containing 40" Q4G0X9 17 80036632-80100613 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 31.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 58.5;Respiratory ciliated cells: 92.9;Rod photoreceptor cells: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.1;SH-SY5Y: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA022974 Enhanced Approved Microtubules NA NA "Cluster 11: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Microtubules "HPA022974: AB_1848791" "unprognostic (5.89e-3)" "unprognostic (2.30e-1)" "unprognostic (8.76e-3)" "prognostic favorable (2.95e-4)" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "unprognostic (1.44e-2)" "unprognostic (1.53e-2)" "unprognostic (2.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.04e-5)" "unprognostic (7.38e-2)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.86e-1)" "unprognostic (2.84e-1)" "unprognostic (1.91e-3)" "unprognostic (4.26e-2)" 2.0 2.3 2.3 0.9 2.2 0.3 2.2 1.8 2.3 2.6 31.4 2.3 0.5 3.2 2.5 0.7 14.8 2.1 3.1 2.2 4.1 7.5 1.7 3.2 0.7 7.4 10.8 1.7 2.6 1.8 6.9 0.6 3.7 3.2 0.5 5.7 2.3 1.6 0.8 1.1 1.6 1.0 4.6 1.2 1.8 8.4 4.8 0.3 4.9 0.5 0.5 1.7 1.2 2.2 2.2 7.0 6.2 6.9 0.8 0.9 1.6 2.0 1.4 1.7 1.8 0.7 3.0 0.3 0.9 1.4 2.9 0.6 1.6 1.5 0.4 0.1 1.3 0.1 3.9 3.5 1.4 0.1 2.2 1.6 2.1 2.1 0.2 3.0 0.9 1.3 0.8 0.0 1.4 2.5 0.1 0.4 2.8 3.0 2.3 1.8 3.3 0.0 3.5 1.4 12.1 8.7 3.1 1.5 1.4 3.3 2.8 0.2 1.1 3.8 2.3 2.5 0.4 2.0 0.7 0.3 0.8 0.2 1.9 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.3 2.2 1.8 2.3 2.2 4.1 7.4 10.8 3.7 4.6 4.8 2.2 0.8 12.8 5.2 16.6 0.6 0.6 2.4 2.5 0.6 4.2 2.9 3.0 3.6 0.0 10.0 7.3 14.6 0.4 0.1 0.3 1.9 2.9 13.6 58.5 4.0 1.4 3.0 0.0 10.7 1.5 1.0 2.3 1.5 4.7 0.0 1.8 1.8 1.2 1.4 11.8 11.7 1.7 8.2 4.3 1.4 7.9 1.2 1.5 0.0 10.3 0.3 4.7 0.0 8.0 1.9 0.9 1.1 3.4 0.1 1.5 0.3 2.1 92.9 28.6 0.0 3.3 3.2 16.0 5.3 0.5 0.3 0.3 0.5 2.4 0.7 1.1 CCDC57 "FLJ00130, FLJ23754" ENSG00000176155 "Coiled-coil domain containing 57" Q2TAC2 17 82101460-82212830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "Late spermatids: 729.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 3.7;naive CD8 T-cell: 7.6" "Lineage enriched" "Detected in many" 6 "T-cells: 7.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA023315, HPA023326, HPA023342, HPA023344" Approved Approved "Microtubules,Centriolar satellite,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 20: HeLa - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" Microtubules "Centriolar satellite, Cytosol" "HPA023315: AB_1846159, HPA023326: AB_1846160, HPA023342: AB_2275460, HPA023344: AB_1846162" "unprognostic (2.51e-3)" "unprognostic (8.22e-2)" "unprognostic (1.41e-1)" "unprognostic (9.92e-3)" "unprognostic (1.25e-1)" "unprognostic (2.11e-3)" "unprognostic (1.33e-1)" "unprognostic (1.56e-2)" "unprognostic (3.19e-2)" "unprognostic (2.16e-1)" "prognostic favorable (5.55e-5)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.28e-6)" "unprognostic (5.19e-2)" "unprognostic (1.53e-1)" "unprognostic (2.04e-1)" "unprognostic (3.80e-3)" 5.3 8.4 3.3 5.8 5.1 8.3 8.3 6.1 8.2 13.0 6.4 8.7 7.2 9.4 6.4 3.5 11.0 6.6 4.3 3.7 1.5 12.4 7.4 8.1 5.3 2.1 1.4 12.3 10.5 7.9 16.9 3.4 1.3 14.4 3.0 9.0 9.1 5.8 4.0 5.6 6.6 3.6 0.1 6.2 7.7 12.2 1.8 8.1 17.7 1.1 2.8 6.9 6.5 3.1 5.2 10.4 5.4 6.9 3.1 5.8 6.0 3.9 3.9 2.8 2.5 3.0 7.9 2.7 3.7 3.2 2.9 12.0 1.6 7.2 1.6 2.8 10.6 4.5 20.3 6.7 4.0 4.5 5.6 5.9 5.5 5.3 6.9 6.5 3.4 3.9 5.8 1.5 2.0 7.5 8.8 8.5 1.7 3.0 4.1 4.7 2.4 3.8 5.5 6.2 18.5 11.3 3.4 17.3 6.7 3.4 9.9 5.3 3.7 11.0 10.0 4.8 8.2 11.0 1.2 0.9 8.5 5.1 4.5 0.5 0.4 0.5 0.6 0.1 0.2 0.4 0.5 0.8 0.4 0.3 3.7 7.6 1.3 0.3 0.1 1.2 0.2 1.0 3.3 5.1 6.1 8.2 3.7 1.5 2.1 1.4 1.3 0.1 1.8 3.1 5.9 25.6 62.7 19.6 35.8 11.7 22.7 23.7 19.4 22.5 82.3 66.2 5.3 17.2 41.9 29.5 41.7 36.2 45.4 27.6 9.8 15.8 116.1 44.9 15.9 6.9 42.7 14.1 72.8 17.1 34.2 9.8 36.2 19.2 34.9 33.2 7.1 101.0 29.9 25.2 54.4 46.9 30.5 42.1 35.8 729.3 8.1 28.7 33.8 13.1 39.6 10.0 48.4 16.1 10.6 18.1 26.9 10.1 36.5 20.4 31.6 13.2 52.3 66.3 6.6 14.3 9.9 13.6 6.9 21.2 18.3 12.4 40.2 10.5 37.2 23.1 CDC42 "CDC42Hs, G25K" ENSG00000070831 "Cell division cycle 42" P60953 1 22025511-22101360 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004360, HPA069590" Approved Supported "Microtubules,Cytokinetic bridge" Yes No 2700000 "Cluster 49: Eosinophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 10: Non-specific - Unknown function" "Microtubules, Cytokinetic bridge" "CAB004360: AB_627233, HPA069590: AB_2732138" "unprognostic (9.40e-2)" "unprognostic (1.37e-1)" "unprognostic (9.45e-3)" "unprognostic (5.11e-2)" "unprognostic (1.73e-1)" "unprognostic (9.72e-2)" "prognostic unfavorable (5.28e-5)" "unprognostic (1.09e-1)" "unprognostic (7.92e-3)" "unprognostic (1.86e-2)" "unprognostic (3.90e-2)" "unprognostic (9.41e-2)" "unprognostic (9.72e-3)" "unprognostic (2.71e-1)" "unprognostic (3.88e-2)" "unprognostic (6.38e-2)" "unprognostic (2.09e-1)" 177.4 116.1 91.7 160.2 96.5 402.9 142.7 100.1 113.8 128.6 98.4 198.2 142.3 131.3 99.8 162.3 124.8 131.7 117.0 95.2 108.8 158.8 153.5 154.1 167.9 115.5 103.7 105.9 82.5 128.4 59.6 170.3 108.4 108.3 185.4 95.9 103.8 107.5 119.9 132.0 156.9 175.0 107.4 157.5 159.9 64.2 102.2 157.7 110.6 120.9 216.8 194.8 114.9 127.1 341.9 146.4 272.2 222.0 295.0 306.4 274.2 347.3 318.8 365.5 336.2 178.0 374.5 253.1 272.8 416.7 136.2 210.7 241.1 369.3 431.1 332.4 180.1 438.1 184.5 225.4 259.1 388.5 350.5 285.6 396.6 341.0 195.2 234.7 535.6 157.8 250.8 273.4 430.2 135.6 242.9 307.5 170.2 242.9 179.3 199.6 297.6 243.3 316.2 301.3 183.4 175.8 293.4 228.7 263.4 296.3 242.3 219.1 466.3 265.3 265.2 349.3 207.8 148.6 355.9 305.8 234.5 419.3 277.6 244.3 200.6 255.1 142.4 282.3 144.3 108.0 152.0 146.7 162.3 103.4 109.5 143.5 308.3 145.0 352.2 107.2 157.4 244.8 91.7 96.5 100.1 113.8 95.2 108.8 115.5 103.7 108.4 107.4 102.2 127.1 502.1 60.9 51.8 20.9 301.0 450.6 385.5 266.0 136.1 119.1 281.1 179.6 86.9 231.6 168.0 312.6 18.8 349.6 470.1 434.9 375.6 441.3 38.0 350.5 356.5 307.7 300.4 243.0 58.5 441.9 499.6 225.2 152.4 425.8 163.6 138.2 277.0 230.9 439.2 106.0 71.0 315.4 187.2 585.4 875.2 41.3 157.8 443.4 423.4 53.4 654.9 102.5 286.3 41.7 72.9 570.5 369.7 177.1 192.9 323.1 283.1 578.2 176.2 65.2 236.7 174.2 308.3 155.3 116.2 176.6 556.6 551.6 379.2 178.6 286.7 469.6 CDC42EP2 "BORG1, CEP2" ENSG00000149798 "CDC42 effector protein 2" O14613 11 65314866-65322417 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 50.5;Langerhans cells: 77.7;Pancreatic endocrine cells: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "classical monocyte: 50.4;intermediate monocyte: 118.8;neutrophil: 171.5;non-classical monocyte: 88.5" "Group enriched" "Detected in many" 15 "granulocytes: 171.5;monocytes: 118.8" "Cell line enhanced" "Detected in many" "HHSteC: 51.5;PC-3: 61.0;U-2197: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038562 Approved Supported Microtubules,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 41: Macrophages - Immune response" "Microtubules, Cytosol" "HPA038562: AB_10671745" "unprognostic (1.69e-1)" "unprognostic (2.40e-2)" "unprognostic (9.91e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (4.73e-3)" "prognostic unfavorable (2.89e-5)" "prognostic unfavorable (6.66e-4)" "unprognostic (1.01e-1)" "unprognostic (5.36e-2)" "unprognostic (8.57e-3)" "unprognostic (3.81e-1)" "unprognostic (1.68e-1)" "unprognostic (2.66e-2)" "unprognostic (3.67e-2)" "unprognostic (2.89e-2)" "unprognostic (1.89e-2)" 42.1 5.7 15.4 7.7 25.1 0.4 23.1 20.7 20.0 13.9 5.8 15.4 9.1 16.6 1.7 7.7 15.3 15.2 22.4 15.7 17.0 15.3 4.1 19.1 1.8 24.9 23.6 10.8 5.8 0.6 5.0 11.6 22.3 10.2 1.6 1.9 4.9 4.5 6.6 5.6 13.0 6.8 17.5 18.4 14.5 2.1 21.4 0.4 16.8 5.6 1.2 18.6 9.4 44.3 7.1 6.6 0.9 4.3 14.6 26.4 1.3 7.4 28.8 5.5 6.2 19.8 16.7 0.5 20.9 19.9 2.0 8.9 2.5 26.0 1.2 1.0 3.8 1.3 12.8 14.8 51.5 0.4 0.5 11.5 2.7 20.3 28.8 4.5 22.4 1.0 2.6 4.3 7.1 10.7 0.8 1.6 3.7 18.5 61.0 0.8 0.7 0.5 19.5 4.9 0.5 1.7 18.0 14.7 1.1 0.7 2.5 0.4 30.6 6.7 5.6 55.9 3.1 0.1 1.7 0.6 11.2 0.3 2.7 0.0 50.4 2.1 0.1 118.8 0.1 1.2 0.0 0.1 9.9 0.0 0.1 0.0 171.5 0.0 88.5 0.4 0.0 17.8 15.4 25.1 20.7 20.0 15.7 17.0 24.9 23.6 22.3 17.5 21.4 44.3 25.8 0.0 0.0 0.0 1.5 12.7 11.0 25.8 6.8 15.3 12.1 6.3 6.3 2.8 17.0 12.9 0.0 0.5 1.6 10.0 3.9 50.5 0.5 6.0 11.6 36.4 1.8 2.7 0.6 40.3 3.5 32.3 9.7 11.1 5.7 1.5 26.7 0.9 1.3 3.3 0.4 8.0 8.2 18.7 77.7 1.9 18.6 33.3 12.4 1.0 18.3 1.0 0.0 0.0 10.6 65.1 15.6 13.5 1.8 7.4 21.2 3.7 6.3 5.3 39.5 16.6 16.2 1.7 3.4 4.8 10.1 1.6 1.4 1.8 8.4 36.4 CDC42EP4 "BORG4, CEP4, KAIA1777, MGC17125, MGC3740" ENSG00000179604 "CDC42 effector protein 4" Q9H3Q1 17 73283624-73312005 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Horizontal cells: 753.7;Muller glia cells: 570.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 20.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023335, HPA024797" Approved Supported Supported "Plasma membrane,Actin filaments,Microtubules" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" "Actin filaments, Microtubules" "Plasma membrane" "HPA023335: AB_10603783, HPA024797: AB_10600696" "unprognostic (8.76e-2)" "unprognostic (4.38e-3)" "unprognostic (1.49e-2)" "unprognostic (5.43e-3)" "unprognostic (6.29e-2)" "unprognostic (9.01e-3)" "unprognostic (2.44e-3)" "unprognostic (1.08e-1)" "unprognostic (8.00e-2)" "unprognostic (2.41e-1)" "unprognostic (4.16e-2)" "unprognostic (6.73e-2)" "unprognostic (3.97e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (1.10e-1)" "unprognostic (1.94e-1)" 94.5 54.9 84.9 15.3 84.7 14.9 74.5 90.6 76.3 47.4 75.0 55.6 35.7 52.7 60.1 33.3 69.4 19.1 50.5 82.2 103.1 28.6 32.2 38.6 16.1 141.9 104.5 70.7 77.5 20.5 45.0 22.9 83.7 38.7 17.4 98.1 41.5 43.1 28.8 40.6 36.0 25.5 103.5 24.1 42.4 20.5 105.9 20.2 45.4 18.8 27.6 33.8 39.5 109.5 30.1 70.1 24.7 20.9 48.8 40.5 65.0 26.2 32.6 24.3 17.9 14.8 42.1 0.1 22.9 31.6 27.6 20.6 17.2 18.0 14.6 1.4 17.0 6.7 35.2 34.7 24.3 1.1 7.3 51.4 14.9 21.2 10.5 19.2 27.9 0.6 18.9 1.4 14.9 23.2 1.2 8.6 13.5 87.8 48.4 0.8 11.0 3.1 28.8 34.3 16.4 24.8 19.7 53.1 18.4 19.0 64.3 9.8 28.7 22.7 47.6 18.1 18.9 1.4 1.2 0.2 37.3 4.7 60.7 3.3 3.2 5.9 0.1 8.5 0.2 0.1 0.0 0.0 4.3 0.0 0.2 0.0 5.4 0.3 20.1 0.1 0.0 2.1 84.9 84.7 90.6 76.3 82.2 103.1 141.9 104.5 83.7 103.5 105.9 109.5 117.1 12.8 15.6 54.9 2.8 48.7 58.5 54.9 97.9 11.5 45.8 37.1 10.8 31.5 29.1 12.9 6.2 32.1 2.5 47.3 11.7 29.4 0.6 29.7 47.6 43.8 31.2 9.1 1.0 43.6 35.0 46.1 31.1 41.2 13.3 19.6 42.8 27.7 6.1 753.7 1.3 41.3 14.2 5.5 30.1 2.7 18.3 9.1 30.2 6.5 11.1 570.4 0.0 2.5 2.5 30.4 33.5 15.4 2.5 42.6 53.1 8.0 18.0 26.2 131.5 98.0 69.9 1.1 2.0 83.2 44.9 84.3 6.0 13.6 30.2 124.1 CDH26 VR20 ENSG00000124215 "Cadherin 26" Q8IXH8 20 59958423-60034011 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 8.0" "Cell type enhanced" "Detected in many" "Astrocytes: 17.9;Club cells: 18.7;Oligodendrocytes: 14.9;Respiratory ciliated cells: 39.6;Syncytiotrophoblasts: 14.9" "Group enriched" "Detected in some" 6 "cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 36.4" "Low region specificity" "Detected in some" "HPA015722, HPA047578" Uncertain Supported "Plasma membrane,Microtubules" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane" Microtubules "HPA015722: AB_2077659, HPA047578: AB_2680091" "unprognostic (2.42e-1)" "prognostic favorable (7.62e-4)" "unprognostic (4.71e-4)" "unprognostic (8.17e-2)" "unprognostic (9.40e-2)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "prognostic favorable (3.75e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (3.26e-4)" "unprognostic (8.24e-3)" "unprognostic (9.96e-7)" "unprognostic (1.85e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" 0.9 0.4 1.0 0.3 1.5 1.0 0.8 1.2 2.0 2.0 0.3 0.7 0.4 0.6 0.4 3.4 2.0 0.4 0.7 0.9 1.8 0.5 0.3 2.1 0.4 1.6 1.7 0.3 0.5 0.3 1.7 0.4 1.5 8.0 0.3 0.4 2.0 0.5 1.0 0.6 0.8 0.4 0.6 0.8 1.2 0.7 1.9 0.9 0.6 0.3 3.0 2.7 1.3 2.6 0.0 0.7 0.2 0.0 0.6 0.2 0.4 0.2 0.0 0.1 0.0 0.8 0.8 0.1 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.1 7.9 0.1 0.1 0.0 0.3 0.3 0.1 1.1 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.3 0.3 0.4 0.4 0.0 0.1 0.0 0.0 0.7 0.1 36.4 0.8 0.1 0.4 0.2 0.1 0.4 0.2 0.4 0.2 0.0 0.0 1.0 0.0 0.3 0.2 0.0 0.0 1.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.5 1.2 2.0 0.9 1.8 1.6 1.7 1.5 0.6 1.9 2.6 4.3 6.4 6.1 17.9 0.1 0.1 1.2 6.6 0.0 0.5 1.6 0.5 0.7 0.0 18.7 0.0 0.0 1.7 0.0 0.2 0.0 0.0 3.2 2.1 0.4 2.1 0.0 2.5 9.3 0.0 0.0 0.3 0.0 0.4 1.3 0.0 0.7 0.1 0.6 0.0 8.4 0.0 6.1 1.3 0.4 1.7 0.0 1.4 0.0 7.5 0.6 0.2 1.0 7.1 14.9 0.0 0.0 0.0 0.4 10.9 0.2 0.1 39.6 0.0 0.0 0.5 2.4 0.9 0.2 0.2 0.0 14.9 0.2 0.1 0.2 7.4 CDK16 "FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1" ENSG00000102225 "Cyclin dependent kinase 16" Q00536 X 47217860-47229997 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 217.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000974, HPA001366, CAB016535" Approved Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Microtubules, Cytosol" "Plasma membrane" "CAB016535: AB_785112, HPA000974: AB_2666162, HPA001366: AB_1079584" "unprognostic (2.37e-3)" "unprognostic (6.93e-2)" "unprognostic (2.96e-2)" "unprognostic (1.16e-3)" "unprognostic (8.80e-2)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.02e-6)" "unprognostic (2.85e-1)" "unprognostic (5.59e-2)" "unprognostic (7.62e-3)" "unprognostic (1.20e-1)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (1.59e-2)" "unprognostic (1.83e-1)" "unprognostic (3.89e-3)" "unprognostic (2.55e-1)" 48.2 61.3 59.0 30.4 63.6 65.7 38.6 63.8 75.0 37.9 35.7 41.4 34.2 37.5 19.7 60.7 37.6 23.8 113.3 64.3 46.5 62.7 35.0 41.6 24.3 57.2 52.4 45.3 43.1 50.6 41.7 37.9 54.9 37.2 29.6 33.6 43.9 30.4 217.6 41.9 36.3 37.7 39.6 34.0 39.1 55.2 74.3 29.9 50.3 180.4 26.5 34.2 36.8 60.6 177.6 132.5 124.8 185.0 89.5 76.2 124.2 82.4 100.7 122.3 90.5 150.2 83.3 42.1 51.2 148.1 225.7 97.7 134.3 174.7 81.8 50.9 212.6 46.0 193.8 118.8 115.7 48.7 103.0 95.5 109.6 173.8 207.4 101.7 111.0 43.7 69.6 69.7 108.4 153.1 42.7 111.1 97.9 66.3 141.8 44.9 98.8 74.4 91.7 137.7 105.0 79.4 223.2 169.9 86.5 144.4 152.0 59.3 112.9 81.1 131.4 125.4 99.8 54.6 58.2 41.8 71.4 223.0 93.1 2.6 7.8 7.5 3.7 9.3 4.9 3.4 5.0 6.0 9.7 9.8 4.3 4.6 3.2 5.5 8.4 11.3 5.5 6.1 59.0 63.6 63.8 75.0 64.3 46.5 57.2 52.4 54.9 39.6 74.3 60.6 18.8 0.0 6.1 7.2 20.2 32.5 33.0 30.6 33.6 23.5 38.2 26.8 43.3 21.5 22.1 31.3 4.2 25.7 20.1 67.2 54.8 33.7 26.5 41.2 24.5 21.8 28.1 20.6 12.5 37.0 45.2 24.0 46.4 57.7 5.7 27.8 19.2 16.7 25.3 30.3 15.8 34.3 32.6 19.5 30.8 94.8 17.1 23.5 33.8 2.8 12.6 17.1 9.2 3.5 7.8 48.4 46.1 13.2 31.9 48.3 45.1 34.7 17.9 14.6 0.0 19.1 22.6 27.6 17.5 64.2 34.7 26.0 21.5 30.0 48.6 63.3 CENPE "KIF10, PPP1R61" ENSG00000138778 "Centromere protein E" Q02224 4 103105349-103198445 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein, Motor protein" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 10.0;lymphoid tissue: 9.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 75.1;Extravillous trophoblasts: 28.4;Granulosa cells: 32.0;Spermatocytes: 75.3;Spermatogonia: 51.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011110, HPA042294" Enhanced Enhanced "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes Yes "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA011110: , HPA042294: AB_10797386" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "unprognostic (5.64e-3)" "unprognostic (2.55e-2)" "unprognostic (1.65e-1)" "unprognostic (3.44e-2)" "unprognostic (2.40e-8)" "unprognostic (2.49e-3)" "unprognostic (1.59e-2)" "unprognostic (3.38e-1)" "unprognostic (4.88e-5)" "unprognostic (1.15e-2)" "unprognostic (0.00e+0)" "unprognostic (9.95e-3)" "unprognostic (2.49e-1)" "unprognostic (1.05e-1)" "unprognostic (2.37e-1)" 0.4 0.2 0.4 2.7 0.4 10.0 0.6 0.3 0.5 0.4 0.4 1.8 1.5 0.6 0.0 2.0 0.2 0.8 0.2 0.3 0.6 0.2 0.5 0.8 5.6 0.5 0.5 0.1 0.1 0.3 0.0 1.4 0.9 0.3 2.0 0.4 0.3 0.2 0.0 2.0 1.7 1.1 0.3 1.2 1.1 4.1 0.5 9.2 0.2 0.6 4.9 0.8 0.6 0.5 42.6 11.8 42.2 20.5 2.7 6.2 8.4 36.7 18.2 26.9 17.9 19.6 22.2 28.6 9.2 13.7 19.2 18.2 30.3 15.1 42.2 35.9 11.3 33.5 26.8 13.6 0.4 39.9 18.6 1.8 1.1 21.7 18.0 6.0 22.9 25.2 34.4 32.5 34.8 15.6 31.5 18.9 13.8 17.0 17.9 20.9 38.5 9.3 8.0 8.4 19.3 11.5 32.9 22.9 9.0 16.0 12.9 13.9 26.1 25.8 27.2 27.2 38.6 15.9 28.6 28.8 14.2 21.7 27.8 2.9 0.0 0.3 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.3 1.5 0.2 0.6 0.0 0.4 0.4 0.3 0.5 0.3 0.6 0.5 0.5 0.9 0.3 0.5 0.5 1.4 3.2 2.2 1.0 6.6 3.6 1.5 2.9 0.0 7.6 1.8 2.7 1.9 0.0 1.3 0.0 8.4 12.7 3.9 4.7 0.0 0.5 7.7 3.5 5.7 4.2 1.2 75.1 2.0 0.0 28.4 6.5 4.6 6.9 7.0 32.0 4.2 0.9 14.1 0.0 1.9 4.3 4.1 10.4 5.7 3.5 0.9 9.6 0.0 0.0 6.0 1.3 2.1 0.5 3.1 1.8 1.4 2.6 16.0 1.4 0.8 0.3 0.3 2.6 0.0 5.7 7.4 75.3 51.0 8.3 2.8 3.6 6.6 7.0 11.6 1.9 CEP131 "AZ1, AZI1, KIAA1118" ENSG00000141577 "Centrosomal protein 131" Q9UPN4 17 81189593-81222999 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatogonia: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024019 Approved Supported "Microtubules,Cytokinetic bridge,Centriolar satellite" Yes No "Cluster 14: Monocytes - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 20: HeLa - Mitochondria" "Cluster 43: Cardiomyocytes - Nuclear processes" Microtubules "Cytokinetic bridge, Centriolar satellite" "HPA024019: AB_1845227" "unprognostic (1.56e-2)" "unprognostic (1.09e-2)" "unprognostic (2.41e-1)" "unprognostic (2.31e-1)" "unprognostic (2.80e-1)" "unprognostic (3.26e-2)" "prognostic unfavorable (9.68e-5)" "unprognostic (3.43e-1)" "unprognostic (7.62e-2)" "unprognostic (2.43e-1)" "unprognostic (1.33e-3)" "unprognostic (7.04e-2)" "unprognostic (8.82e-3)" "unprognostic (1.36e-2)" "unprognostic (8.48e-2)" "unprognostic (2.66e-1)" "unprognostic (7.32e-3)" 9.1 8.6 6.7 5.2 6.4 10.2 10.3 7.8 10.0 14.7 7.5 9.8 4.6 11.4 0.9 9.1 11.5 2.0 16.8 6.5 5.8 11.7 6.8 10.7 7.9 6.8 6.2 12.8 10.1 2.2 15.4 4.1 6.2 12.0 0.8 1.8 9.3 2.1 11.1 10.5 10.3 1.6 5.7 19.0 9.9 28.2 6.7 3.5 10.3 2.0 2.2 10.4 10.7 6.8 21.1 20.0 10.6 19.4 1.7 2.7 33.6 14.4 2.5 10.3 7.9 23.8 10.5 14.8 8.0 3.5 6.3 14.9 3.1 7.0 2.5 6.2 26.8 14.3 32.7 41.3 2.9 12.5 30.6 2.3 4.6 7.5 2.1 3.3 7.3 15.6 10.6 8.5 2.7 23.5 29.0 24.3 9.5 6.1 17.7 29.0 12.1 6.1 3.9 18.4 24.2 27.2 18.5 11.4 18.0 3.9 17.2 12.3 10.0 18.6 32.1 16.7 19.2 22.0 4.0 11.3 9.6 10.7 13.5 2.1 0.8 0.5 1.2 2.3 0.3 2.9 0.7 1.1 1.8 1.7 1.1 0.8 1.3 1.0 4.6 2.0 0.1 0.8 6.7 6.4 7.8 10.0 6.5 5.8 6.8 6.2 6.2 5.7 6.7 6.8 6.5 0.0 4.4 5.5 6.6 0.0 3.4 0.0 3.4 5.8 3.3 4.4 13.4 2.8 1.3 3.7 6.2 8.7 4.8 5.6 0.0 4.5 14.0 8.4 3.5 6.0 6.7 5.7 2.1 3.7 7.2 6.9 6.6 2.8 15.9 9.3 2.5 1.7 5.2 5.0 2.9 5.1 0.0 1.9 0.0 17.9 9.6 3.6 0.0 1.0 1.3 6.0 7.2 2.5 2.8 5.2 0.8 3.0 4.4 1.2 1.8 1.4 3.6 6.9 0.0 4.3 5.7 14.7 20.5 3.7 0.0 6.0 3.5 8.4 7.9 2.7 CEP170B "Cep170R, FAM68C, KIAA0284" ENSG00000099814 "Centrosomal protein 170B" Q9Y4F5 14 104865268-104896770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 229.4;Distal enterocytes: 81.2;Rod photoreceptor cells: 112.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000871, HPA059017" Enhanced Approved Microtubules,Centrosome,Cytosol NA NA "Cluster 18: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol "Microtubules, Centrosome" "HPA000871: AB_2666124, HPA059017: AB_2683883" "unprognostic (1.09e-1)" "unprognostic (1.60e-2)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" "unprognostic (2.38e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (5.40e-2)" "unprognostic (1.84e-1)" "unprognostic (4.96e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (4.41e-4)" "prognostic favorable (3.26e-4)" "unprognostic (1.62e-1)" "unprognostic (1.00e-1)" "unprognostic (8.17e-2)" "unprognostic (1.17e-2)" 13.0 12.8 13.0 4.9 14.1 0.2 13.2 0.0 27.6 11.9 0.0 27.8 17.9 14.8 2.6 31.3 14.7 6.0 9.9 16.6 1.7 29.2 20.2 14.9 0.8 12.3 4.4 6.3 27.7 6.1 21.1 2.7 10.6 19.5 5.7 10.2 18.5 7.7 6.5 36.2 21.1 4.1 0.0 4.5 24.3 15.4 5.1 1.0 20.7 1.4 1.9 16.1 16.4 10.3 23.4 19.1 1.4 17.8 7.4 5.3 41.3 18.0 7.0 8.9 5.9 20.3 14.0 0.0 21.5 13.8 6.1 50.7 4.2 21.1 2.3 8.6 8.8 0.0 22.9 13.4 14.9 0.1 18.2 5.2 26.2 9.3 13.5 7.0 9.0 0.1 6.0 0.2 7.7 49.4 0.1 0.3 5.9 33.2 16.3 7.7 0.1 5.6 8.9 39.1 4.8 5.0 26.7 15.5 24.2 3.0 27.1 3.4 20.0 14.0 15.3 39.0 12.3 0.8 0.1 0.1 11.1 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 14.1 0.0 27.6 16.6 1.7 12.3 4.4 10.6 0.0 5.1 10.3 1.7 9.6 15.3 5.2 0.8 23.8 12.6 12.8 10.2 18.0 15.2 11.4 3.7 22.8 10.0 18.4 229.4 3.6 0.2 81.2 1.9 12.2 0.8 16.2 6.3 4.4 22.1 0.0 17.7 24.0 7.6 5.4 48.4 18.2 5.7 5.7 8.6 12.8 1.4 40.4 14.9 41.0 8.2 0.8 5.2 1.7 3.7 1.3 8.8 2.8 1.0 11.1 0.0 5.5 5.9 31.8 42.9 8.6 0.7 30.3 27.5 5.0 20.1 112.6 6.6 6.8 7.8 1.7 5.2 13.9 24.6 6.7 1.9 0.0 35.6 24.5 CEP57 "KIAA0092, Translokin, TSP57" ENSG00000166037 "Centrosomal protein 57" Q86XR8 11 95789965-95832693 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 462.9;Late spermatids: 372.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA018315 Approved Approved Microtubules,Cytosol "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 34: Spermatids - Unknown function" Microtubules Cytosol "HPA018315: AB_1846537" "unprognostic (1.64e-1)" "unprognostic (2.30e-1)" "unprognostic (1.45e-2)" "unprognostic (2.66e-1)" "prognostic favorable (7.24e-4)" "unprognostic (1.69e-1)" "unprognostic (2.25e-2)" "unprognostic (8.10e-2)" "unprognostic (9.04e-3)" "unprognostic (7.93e-2)" "unprognostic (2.38e-3)" "unprognostic (7.81e-2)" "unprognostic (1.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.35e-1)" "unprognostic (6.69e-3)" "unprognostic (3.25e-1)" 16.6 14.0 10.6 19.2 11.4 29.0 21.6 15.0 13.3 19.0 12.6 17.7 32.4 21.8 19.8 15.0 17.7 27.3 15.6 10.4 11.2 15.7 44.6 16.9 30.1 12.2 11.2 31.2 22.8 12.2 14.9 16.1 10.8 16.2 18.6 25.9 14.1 17.3 12.8 17.8 21.9 15.5 10.9 20.5 17.8 27.9 11.7 34.2 22.7 14.3 30.6 14.0 15.1 12.4 26.7 13.1 42.0 32.7 19.4 38.6 34.4 29.8 48.6 41.4 46.1 47.5 55.1 47.1 39.6 22.4 24.2 43.8 34.7 29.5 43.8 38.1 21.8 66.4 36.9 38.4 33.9 67.0 37.2 25.9 42.5 43.2 80.4 39.3 33.4 49.6 43.8 25.3 33.8 13.1 74.7 89.1 23.3 30.2 29.2 43.8 53.2 40.7 34.8 27.8 21.5 28.9 36.1 34.4 38.3 29.7 35.1 44.0 17.2 35.2 28.3 52.0 28.2 16.9 38.1 51.7 14.6 74.4 31.0 19.0 11.8 24.3 19.5 14.4 25.9 23.6 25.7 22.7 15.6 21.7 24.8 23.5 11.6 26.0 13.2 21.1 33.7 17.5 10.6 11.4 15.0 13.3 10.4 11.2 12.2 11.2 10.8 10.9 11.7 12.4 43.7 54.5 51.1 35.9 58.5 36.3 30.6 35.7 51.2 72.3 30.6 42.7 41.3 85.8 41.7 29.5 35.5 44.1 42.8 16.2 54.8 34.2 462.9 52.2 33.0 38.2 28.8 88.1 68.0 25.7 50.8 41.1 18.3 33.0 27.3 58.4 30.7 71.5 33.1 57.2 78.3 34.0 16.2 35.0 37.3 372.7 33.8 33.2 17.8 27.2 37.6 29.6 44.3 57.8 60.9 26.2 23.9 35.7 57.8 28.8 45.2 40.2 52.6 59.0 65.7 34.4 37.8 75.8 46.1 42.0 32.0 38.4 59.1 53.0 47.2 27.6 CFAP54 "C12orf55, C12orf63, FLJ31514, FLJ44112" ENSG00000188596 "Cilia and flagella associated protein 54" Q96N23 12 96489571-96875555 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7;choroid plexus: 30.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 70.5;Alveolar cells type 2: 80.1;Club cells: 42.7;Endometrial ciliated cells: 65.8;granulocytes: 37.8;Oligodendrocytes: 47.7;Respiratory ciliated cells: 106.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 7.7;TIME: 9.4" "Low region specificity" "Detected in many" HPA039897 Enhanced Approved Microtubules,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 49: Ciliated cells - Cilium organization" Microtubules Cytosol "HPA039897: AB_10674427" "unprognostic (1.87e-4)" "unprognostic (3.63e-2)" "unprognostic (8.07e-2)" "unprognostic (7.89e-2)" "unprognostic (4.66e-2)" "unprognostic (5.55e-2)" "unprognostic (2.75e-2)" "unprognostic (2.91e-2)" "unprognostic (6.16e-2)" "unprognostic (8.40e-2)" "unprognostic (2.86e-1)" "unprognostic (2.36e-1)" "unprognostic (3.55e-5)" "unprognostic (2.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.26e-2)" "unprognostic (8.00e-2)" 0.8 0.7 5.6 1.3 8.1 2.7 0.9 9.2 10.3 0.6 30.7 0.7 1.8 1.6 1.6 0.7 5.0 0.8 0.5 7.0 4.6 0.9 0.9 1.4 1.2 14.6 14.7 1.0 0.2 0.6 1.0 0.7 7.3 0.9 1.1 6.2 0.8 0.6 1.3 1.6 1.2 0.6 8.5 1.5 1.0 5.4 7.0 0.5 1.3 0.2 1.1 0.4 0.1 12.4 1.4 0.6 0.8 1.1 0.4 0.6 0.9 0.7 0.2 0.2 0.4 0.6 1.9 1.0 1.6 0.4 0.9 1.0 0.3 0.3 0.3 2.0 0.6 0.9 2.3 0.7 0.1 1.5 1.5 0.2 0.3 1.1 0.5 1.8 7.7 0.9 0.6 3.5 0.8 0.7 1.2 1.5 1.7 0.6 1.0 1.2 1.1 1.3 2.2 1.3 1.6 1.2 0.8 0.7 1.0 0.9 2.1 0.7 9.4 1.7 2.2 1.8 1.5 4.2 2.1 0.6 1.3 0.9 1.3 2.4 0.7 0.6 0.7 0.6 0.5 0.7 0.5 0.6 0.3 1.1 0.6 0.6 1.3 0.7 0.7 0.6 0.4 0.1 5.6 8.1 9.2 10.3 7.0 4.6 14.6 14.7 7.3 8.5 7.0 12.4 2.1 70.5 80.1 27.1 2.6 0.0 0.3 0.0 0.0 3.9 0.3 0.6 1.0 1.5 42.7 0.0 22.9 0.3 2.2 0.0 0.0 0.2 33.2 65.8 2.9 6.8 1.2 1.3 21.9 0.0 0.3 6.4 0.5 1.9 37.8 0.6 0.4 0.0 0.2 0.0 3.9 0.0 0.0 0.8 0.0 15.4 0.3 3.2 0.0 1.9 0.1 8.1 0.0 4.0 47.7 0.3 0.1 0.0 5.0 0.5 0.0 0.3 106.4 7.8 0.0 1.7 0.5 16.8 7.0 0.0 0.0 0.0 4.2 1.9 0.1 0.3 CFAP99 ENSG00000206113 "Cilia and flagella associated protein 99" 4 2418974-2462942 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.8;choroid plexus: 5.8;fallopian tube: 3.9;retina: 1.5;testis: 5.3" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Early spermatids: 11.6;Endometrial ciliated cells: 13.6;Late spermatids: 11.2;Rod photoreceptor cells: 5.5;Spermatocytes: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA071642 Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA071642: " "unprognostic (7.54e-3)" "unprognostic (6.46e-3)" "unprognostic (1.12e-1)" "unprognostic (2.31e-3)" "unprognostic (2.68e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-2)" "unprognostic (5.22e-2)" "unprognostic (1.89e-1)" "unprognostic (8.14e-2)" "unprognostic (7.93e-5)" "unprognostic (1.15e-1)" "unprognostic (5.97e-3)" "unprognostic (1.92e-2)" "unprognostic (1.36e-1)" "unprognostic (6.94e-2)" "unprognostic (3.49e-1)" 0.0 0.8 0.5 0.0 0.5 0.0 0.0 0.8 0.3 0.2 5.8 0.0 0.0 0.2 0.1 0.0 3.9 0.0 0.0 0.9 0.8 0.2 0.1 0.6 0.0 3.2 4.8 0.0 0.3 0.0 0.8 0.0 1.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 5.3 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.8 0.3 0.9 0.8 3.2 4.8 1.8 2.0 1.0 0.6 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 0.0 1.8 3.7 4.2 0.0 0.0 0.0 0.0 0.2 11.6 13.6 0.2 0.1 0.0 0.0 1.2 0.6 0.1 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 11.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 1.5 2.9 5.5 0.0 0.0 0.0 14.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 CHFR "FLJ10796, RNF196" ENSG00000072609 "Checkpoint with forkhead and ring finger domains" Q96EP1 12 132822187-132956304 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 93.8;Late spermatids: 89.1;Rod photoreceptor cells: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045768, HPA073826" Approved Uncertain "Nuclear bodies,Microtubules" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 15: RT4 - Unknown function" "Cluster 9: Photoreceptor cells - Phototransduction" "Nuclear bodies, Microtubules" "HPA045768: , HPA073826: AB_2732242" "unprognostic (1.46e-1)" "unprognostic (2.11e-2)" "unprognostic (1.41e-1)" "unprognostic (3.86e-2)" "unprognostic (2.08e-1)" "unprognostic (2.14e-3)" "unprognostic (6.56e-4)" "unprognostic (1.94e-2)" "unprognostic (2.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.00e-2)" "unprognostic (3.98e-3)" "prognostic unfavorable (4.21e-9)" "unprognostic (5.03e-1)" "unprognostic (8.46e-2)" "unprognostic (6.71e-2)" "unprognostic (1.11e-2)" 9.8 8.1 7.8 15.6 7.9 22.0 9.1 7.1 9.1 9.8 6.0 12.4 15.9 10.7 3.3 15.6 8.7 9.9 10.7 6.9 7.0 8.6 9.0 12.2 20.9 7.9 7.3 6.2 11.9 7.6 9.4 17.7 7.9 9.9 8.5 6.3 9.4 9.6 8.0 12.3 15.0 12.6 6.0 17.5 12.9 15.4 8.6 25.2 9.1 9.2 13.8 14.4 10.8 9.1 11.0 24.1 19.3 1.6 16.8 21.3 41.0 23.4 17.9 23.7 22.7 20.6 8.7 0.2 21.6 25.3 16.7 18.6 2.1 21.5 12.2 1.3 21.0 36.5 16.7 24.4 42.0 1.2 67.5 32.4 20.0 19.6 13.5 15.5 30.1 2.8 15.9 0.0 16.7 40.4 24.5 25.3 27.4 20.9 19.8 2.9 2.5 11.4 15.3 49.4 20.8 28.2 18.2 20.0 17.8 22.5 34.4 36.2 33.3 1.2 4.7 11.8 7.7 37.0 0.1 4.2 0.0 6.8 21.7 38.3 25.5 35.5 16.7 29.6 15.8 10.5 13.2 17.8 20.7 6.4 12.0 13.3 34.8 23.2 31.5 10.6 21.5 19.3 7.8 7.9 7.1 9.1 6.9 7.0 7.9 7.3 7.9 6.0 8.6 9.1 11.2 12.8 19.5 20.5 17.2 6.1 7.9 6.0 4.6 22.1 8.2 5.7 9.9 4.3 15.3 7.3 93.8 12.3 29.4 17.9 9.8 10.2 53.0 11.1 14.3 13.1 21.1 13.0 33.4 13.8 15.7 10.8 28.1 12.2 66.4 14.4 11.4 7.7 19.4 21.9 32.0 10.2 14.2 21.7 9.3 89.1 7.5 22.0 10.6 24.4 29.4 8.8 40.2 18.1 31.3 16.9 11.4 8.6 24.2 11.2 11.7 4.4 10.8 117.9 19.7 9.2 10.7 19.0 24.6 11.1 9.7 23.7 24.2 16.1 8.6 13.8 CHMP4C "MGC22825, Shax3, VPS32C" ENSG00000164695 "Charged multivesicular body protein 4C" Q96CF2 8 81732448-81759515 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.8" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 71.6;Pancreatic endocrine cells: 78.7;Proximal enterocytes: 80.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 37.2;CAPAN-2: 41.5;hTCEpi: 51.4;hTERT-HME1: 41.6;OE19: 73.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA023763, HPA023799" Enhanced Approved "Microtubules,Cytokinetic bridge" Yes NA "Cluster 48: NK-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "Microtubules, Cytokinetic bridge" "HPA023763: , HPA023799: AB_1846670" "unprognostic (3.98e-2)" "unprognostic (6.75e-3)" "unprognostic (1.58e-1)" "unprognostic (5.19e-2)" "unprognostic (3.12e-2)" "unprognostic (2.45e-2)" "unprognostic (5.75e-2)" "prognostic unfavorable (9.33e-5)" "unprognostic (7.54e-2)" "unprognostic (8.08e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.99e-2)" "prognostic favorable (1.96e-6)" "unprognostic (3.29e-3)" "unprognostic (4.95e-1)" "unprognostic (2.67e-1)" "prognostic favorable (6.45e-4)" 1.7 5.8 1.2 2.1 1.3 1.2 16.6 1.6 1.3 7.5 2.8 16.2 41.8 2.3 5.8 22.6 8.7 8.0 3.6 1.1 1.0 13.9 7.7 7.2 0.5 1.5 1.4 0.5 20.1 15.8 10.1 5.8 1.5 10.0 14.8 0.2 28.1 7.6 0.2 29.1 31.7 0.8 1.1 8.5 23.7 1.1 1.4 1.9 17.5 0.5 5.2 9.7 14.2 2.0 37.2 7.6 0.0 0.2 0.0 0.0 16.6 1.9 2.2 0.1 0.0 14.3 41.5 0.1 28.8 0.0 6.4 22.1 0.2 15.7 0.0 0.0 17.9 0.7 9.9 13.6 0.8 0.1 0.1 0.0 51.4 0.0 41.6 15.3 0.0 0.0 10.0 12.4 0.0 18.4 0.1 0.3 0.1 73.1 14.9 0.1 0.0 8.3 36.3 22.0 7.9 0.1 9.9 16.3 0.1 8.5 23.9 0.2 0.0 0.1 8.9 0.1 0.2 6.5 4.3 0.2 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.9 0.0 0.1 0.0 0.1 1.2 1.3 1.6 1.3 1.1 1.0 1.5 1.4 1.5 1.1 1.4 2.0 5.3 25.6 21.5 0.0 3.2 4.6 35.4 17.1 18.2 0.0 27.2 29.3 4.1 21.5 22.4 5.5 0.0 40.2 0.6 42.0 25.4 47.4 0.4 18.6 2.9 4.0 9.1 1.7 0.1 71.6 38.9 1.0 25.5 31.0 1.3 6.5 4.2 7.6 4.4 0.0 0.1 36.4 12.2 0.3 0.7 1.3 0.0 0.9 8.8 1.0 0.0 0.0 1.0 0.0 0.1 78.7 52.8 0.0 5.7 28.9 80.4 22.6 19.1 0.0 0.0 0.2 7.0 0.3 0.7 25.0 17.5 44.5 1.3 0.1 34.4 33.6 CHMP5 "C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60" ENSG00000086065 "Charged multivesicular body protein 5" Q9NZZ3 9 33264879-33282070 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033874, HPA042883, HPA056437" Enhanced Supported Microtubules,Midbody,Cytosol Yes No 22000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Microtubules, Cytosol" Midbody "CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (9.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.32e-1)" "unprognostic (4.56e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-2)" "unprognostic (4.71e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.66e-1)" "prognostic favorable (2.87e-7)" "unprognostic (2.22e-1)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (7.31e-2)" 54.6 54.6 48.3 36.7 49.2 30.5 49.6 50.4 63.8 56.4 50.0 55.7 55.2 41.3 48.1 64.6 43.8 42.1 50.8 49.0 50.3 77.8 56.3 53.5 41.6 50.4 49.7 42.9 32.7 63.9 49.7 63.8 50.7 54.8 55.9 53.8 43.7 39.4 48.2 47.0 59.2 33.9 52.7 43.5 54.6 36.2 49.4 44.9 55.8 44.3 38.1 49.7 56.5 56.9 92.2 66.5 67.0 43.5 99.0 89.0 61.9 90.1 99.7 138.3 152.6 50.9 56.9 49.0 96.3 84.3 95.9 39.2 70.5 72.8 111.1 102.5 49.3 41.5 129.7 55.8 85.9 53.4 78.8 95.6 131.3 93.6 86.4 114.5 73.3 68.3 44.9 63.6 110.5 41.3 56.1 164.1 61.8 70.1 80.6 34.0 59.2 32.9 115.2 48.7 32.7 83.6 91.0 53.4 87.2 77.8 54.2 82.7 74.4 69.5 73.0 60.2 80.8 42.3 87.6 57.0 100.5 36.0 45.6 98.6 50.3 106.3 25.3 56.5 27.6 31.0 33.7 33.8 46.5 26.4 30.6 29.4 129.4 47.4 67.3 71.2 43.4 51.3 48.3 49.2 50.4 63.8 49.0 50.3 50.4 49.7 50.7 52.7 49.4 56.9 182.7 89.8 59.0 14.0 52.9 188.1 156.2 372.5 71.7 63.7 85.2 75.1 64.7 94.4 228.6 110.3 27.1 172.0 77.4 241.0 285.7 141.7 245.2 228.0 90.6 133.8 80.2 90.1 19.6 86.1 186.1 104.4 56.1 167.0 58.4 66.5 97.5 70.5 154.9 26.9 19.0 137.9 246.2 100.9 103.2 35.9 93.2 95.3 117.4 15.0 166.3 156.2 38.1 14.6 26.8 151.9 247.9 104.6 45.2 182.4 226.3 355.2 328.9 68.2 85.5 97.0 130.0 99.5 68.7 70.1 236.3 259.0 68.5 71.4 78.5 246.0 CISH "CIS, CIS-1, G18, SOCS" ENSG00000114737 "Cytokine inducible SH2 containing protein" Q9NSE2 3 50606489-50611774 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 60.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 38.5;Distal tubular cells: 58.7;Proximal tubular cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "HDLM-2: 316.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034039, HPA040812" Approved Approved "Microtubules,Cytokinetic bridge" Yes No "Cluster 32: T-cells - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Microtubules "Cytokinetic bridge" "CAB034039: AB_2080282, HPA040812: AB_2677148" "unprognostic (2.36e-3)" "unprognostic (7.60e-3)" "unprognostic (2.89e-2)" "prognostic favorable (1.13e-5)" "unprognostic (8.54e-2)" "unprognostic (9.38e-2)" "prognostic favorable (6.98e-4)" "unprognostic (6.97e-3)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "prognostic favorable (9.65e-4)" "unprognostic (1.30e-2)" "prognostic favorable (3.53e-12)" "unprognostic (2.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-2)" 19.0 4.8 1.0 8.7 1.0 7.6 24.5 1.1 1.3 10.0 1.9 9.9 10.2 9.4 3.1 9.6 9.8 4.5 26.5 0.9 1.4 47.6 60.7 28.0 8.5 2.8 1.9 14.5 20.2 22.1 14.3 23.2 2.2 7.5 8.9 0.3 13.1 8.9 40.0 13.3 8.8 4.9 1.7 9.9 10.4 2.3 1.6 9.7 36.4 5.2 6.7 5.9 10.0 1.5 2.4 0.8 2.8 5.9 0.7 3.4 2.5 0.6 0.6 0.3 0.4 2.3 0.6 0.0 2.0 0.9 1.3 2.8 4.7 3.8 0.3 316.3 0.8 18.7 1.8 2.5 2.1 2.5 22.0 14.2 1.6 0.7 1.3 0.2 0.6 2.0 75.6 0.6 0.6 14.8 4.1 17.4 2.7 8.7 2.9 1.8 1.2 19.4 6.3 2.7 1.4 4.7 1.0 37.7 0.7 0.8 20.9 15.4 0.5 0.8 2.2 2.8 1.4 0.3 0.4 0.0 0.5 22.7 0.4 21.3 10.2 13.7 33.8 6.2 51.1 0.9 54.0 41.6 7.0 0.4 40.5 40.6 8.6 2.0 3.9 4.6 35.3 19.6 1.0 1.0 1.1 1.3 0.9 1.4 2.8 1.9 2.2 1.7 1.6 1.5 7.1 3.2 38.5 0.0 1.8 8.0 7.4 1.9 10.2 0.7 18.3 12.1 14.3 0.0 6.7 18.4 0.0 9.1 14.1 8.9 58.7 11.7 2.6 6.6 4.3 3.5 2.4 11.6 0.1 16.4 4.0 11.6 3.6 8.5 1.3 16.9 2.2 7.0 12.7 0.0 0.0 9.6 2.0 8.4 10.0 0.6 8.4 12.8 1.8 1.0 17.3 0.1 14.4 0.0 0.0 7.2 6.7 3.8 4.0 3.0 6.5 58.2 0.8 0.2 13.1 7.6 8.8 1.0 1.3 7.3 8.9 15.9 31.0 3.4 12.1 3.6 CKAP2 "FLJ10749, LB1, se20-10, TMAP" ENSG00000136108 "Cytoskeleton associated protein 2" Q8WWK9 13 52455429-52476628 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 67.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 122.9;Granulosa cells: 88.6;Spermatocytes: 151.7;Spermatogonia: 87.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA008410, HPA027821" Enhanced Enhanced "Microtubules,Mitotic spindle,Centrosome" Yes Yes "Cluster 6: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Microtubules, Mitotic spindle" Centrosome "HPA008410: AB_1846832, HPA027821: AB_10602208" "unprognostic (1.85e-1)" "unprognostic (2.09e-3)" "unprognostic (2.44e-2)" "unprognostic (4.07e-3)" "unprognostic (1.39e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (3.26e-5)" "unprognostic (3.38e-2)" "unprognostic (4.24e-2)" "unprognostic (1.69e-2)" "unprognostic (8.30e-2)" "unprognostic (6.60e-3)" "prognostic unfavorable (1.90e-5)" "unprognostic (2.01e-2)" "unprognostic (5.20e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" 6.0 6.4 3.7 10.0 3.8 67.8 5.7 10.8 5.3 3.2 1.3 8.9 12.1 5.1 4.4 10.4 3.5 4.1 6.0 3.2 4.1 5.1 4.0 5.3 19.4 4.8 3.8 3.2 1.5 4.3 4.5 10.6 5.2 5.6 9.5 7.7 4.6 4.2 2.9 13.9 9.5 8.5 3.3 9.4 5.4 32.5 3.7 33.7 6.3 3.4 20.2 7.2 5.0 3.1 77.6 40.0 155.7 76.4 19.7 19.5 39.6 124.7 70.7 137.4 87.2 59.7 92.3 142.5 19.3 89.2 65.7 86.2 107.6 61.7 188.8 103.0 90.4 129.8 42.6 41.4 8.6 129.7 50.4 14.5 24.6 64.5 83.3 41.2 84.0 62.0 55.3 58.1 152.8 36.0 91.2 64.8 92.2 116.6 42.4 86.2 88.6 62.6 42.1 40.9 47.6 62.4 68.9 49.0 37.1 78.7 54.4 61.7 56.7 38.7 60.9 62.0 124.1 33.4 56.3 173.9 27.3 67.3 105.7 86.0 14.1 22.0 10.3 21.0 9.3 25.3 15.7 12.8 15.8 33.0 12.0 10.4 4.3 5.8 28.7 32.8 33.6 10.0 3.7 3.8 10.8 5.3 3.2 4.1 4.8 3.8 5.2 3.3 3.7 3.1 6.7 6.4 2.8 5.2 41.2 15.0 4.5 32.8 22.2 13.1 11.2 13.2 10.8 2.8 11.4 1.8 6.2 44.3 30.9 7.5 9.8 4.9 41.3 19.4 16.1 12.7 7.2 122.9 10.3 6.0 38.1 12.1 10.7 10.1 16.5 88.6 17.5 5.5 31.8 1.7 12.4 13.6 20.3 24.5 13.7 51.7 7.5 18.5 0.0 6.5 22.9 12.9 5.2 3.5 2.0 2.6 4.6 17.0 30.8 3.7 6.3 9.4 3.7 6.6 6.6 7.6 12.1 151.7 87.5 41.3 15.3 10.0 27.1 29.6 17.9 3.9 CKAP2L "FLJ40629, radmis" ENSG00000169607 "Cytoskeleton associated protein 2 like" Q8IYA6 2 112736349-112764664 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 13.1;lymphoid tissue: 12.1;testis: 4.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 25.2;Granulosa cells: 12.5;Spermatocytes: 33.0;Spermatogonia: 35.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039407, HPA040057, HPA070737" Uncertain Supported "Microtubules,Mitotic spindle,Cytosol" Yes Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Microtubules, Mitotic spindle" Cytosol "HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (4.69e-3)" "unprognostic (1.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.59e-2)" "unprognostic (5.75e-5)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.49e-3)" "unprognostic (1.91e-1)" "unprognostic (9.57e-6)" "unprognostic (2.42e-1)" "unprognostic (0.00e+0)" "unprognostic (7.37e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" 0.4 0.1 0.2 2.6 0.2 13.1 0.4 0.4 0.3 0.4 0.0 1.6 1.5 0.3 0.1 2.3 0.1 0.3 0.0 0.2 0.1 0.1 0.3 0.3 5.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.1 2.2 0.2 0.3 0.0 0.0 1.5 1.1 1.1 0.0 0.9 1.0 4.5 0.2 12.1 0.2 0.0 5.2 0.8 0.6 0.2 47.9 9.6 35.4 16.2 2.0 3.3 7.2 38.5 32.2 37.9 36.1 8.7 13.3 32.0 15.5 15.1 48.3 18.0 20.4 19.6 64.1 44.8 8.9 53.6 12.7 7.7 0.1 25.2 30.9 0.9 1.9 47.4 27.2 10.1 17.5 22.8 14.3 44.9 31.2 6.9 31.0 10.6 15.4 20.0 29.5 22.3 37.0 8.4 6.9 18.7 19.7 12.7 15.2 12.8 13.3 13.2 12.4 11.8 12.9 42.7 33.7 34.5 28.5 9.9 20.1 26.6 18.5 18.1 69.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.2 0.2 0.4 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 3.2 0.6 0.0 1.2 3.3 2.1 2.7 0.6 0.0 0.5 0.8 0.5 1.5 0.4 0.0 0.0 11.1 1.3 1.3 0.0 0.4 2.4 1.1 1.6 1.1 0.0 25.2 0.3 0.4 10.6 2.0 1.5 2.1 0.0 12.5 2.9 0.1 6.6 0.0 0.2 3.1 2.0 1.9 1.4 2.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 5.6 1.1 0.1 0.1 0.4 0.0 0.0 0.4 2.8 33.0 35.7 9.5 1.7 1.0 2.5 0.7 3.8 1.1 CLNS1A "CLCI, ICln" ENSG00000074201 "Chloride nucleotide-sensitive channel 1A" P54105 11 77514936-77637794 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017840, HPA031707, HPA031708, HPA032045" Approved Supported Nucleoplasm,Microtubules,Cytosol No No 17000 "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 32: Non-specific - Translation" Cytosol "Nucleoplasm, Microtubules" "CAB017840: , HPA031707: AB_2674002, HPA031708: AB_2674003, HPA032045: AB_2674123" "unprognostic (1.30e-1)" "unprognostic (3.26e-1)" "unprognostic (5.16e-2)" "unprognostic (1.30e-2)" "unprognostic (5.12e-3)" "unprognostic (5.09e-2)" "unprognostic (9.63e-2)" "unprognostic (5.56e-2)" "unprognostic (2.06e-3)" "unprognostic (5.56e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.05e-1)" "unprognostic (9.19e-2)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" 53.1 88.7 86.1 63.1 91.8 72.3 79.9 89.3 92.7 62.2 82.0 72.7 49.7 63.5 99.6 85.3 74.8 53.2 76.4 79.9 94.1 59.6 105.6 45.7 99.5 88.0 86.6 103.3 90.0 60.2 54.0 65.6 89.8 61.2 77.5 97.0 58.2 57.5 98.4 54.0 53.6 56.8 90.5 61.9 65.7 45.7 87.9 102.8 79.0 100.7 105.4 74.6 61.0 94.8 138.4 134.7 216.6 160.7 157.1 224.8 86.8 119.1 181.3 189.0 168.9 326.5 190.0 308.6 194.5 144.6 148.1 162.8 263.0 245.6 227.2 178.6 160.1 301.9 161.7 188.8 132.5 451.8 134.1 182.9 278.9 165.9 311.7 185.5 217.4 187.1 404.8 91.9 186.6 205.0 299.2 364.5 205.7 458.8 243.9 161.5 419.8 332.7 136.7 191.9 219.0 250.1 158.2 177.7 112.1 155.2 241.8 195.8 144.4 138.7 171.2 274.4 116.8 184.3 276.6 330.1 55.0 166.9 114.4 48.1 100.6 39.1 61.1 107.1 68.9 96.5 76.1 66.3 138.7 99.5 91.1 77.8 7.1 101.2 93.6 85.3 72.8 105.7 86.1 91.8 89.3 92.7 79.9 94.1 88.0 86.6 89.8 90.5 87.9 94.8 47.9 16.0 20.3 14.7 91.6 82.7 107.0 248.2 116.7 67.2 75.4 78.6 71.6 71.4 102.6 58.8 50.1 132.9 70.0 27.4 84.1 76.4 17.0 45.1 57.4 53.1 31.8 123.6 21.7 87.5 145.9 72.5 43.8 34.5 78.0 117.0 57.5 62.2 91.1 58.9 24.3 65.3 87.5 108.7 99.3 13.6 87.7 74.9 76.5 10.3 153.8 221.9 57.7 17.6 24.9 65.4 54.3 68.4 64.8 108.2 79.3 97.6 71.6 60.3 52.6 61.8 54.5 116.0 109.4 128.0 86.1 80.6 69.2 126.7 112.5 103.9 CNFN PLAC8L2 ENSG00000105427 Cornifelin Q9BYD5 19 42387019-42390297 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 952.0;esophagus: 3093.3;vagina: 1442.7" "Cell type enhanced" "Detected in many" "Breast glandular cells: 57.9;Breast myoepithelial cells: 51.6;Squamous epithelial cells: 71.8" "Cancer enhanced" "Detected in all" "head and neck cancer: 367.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "memory B-cell: 61.2;naive B-cell: 70.2" "Lineage enriched" "Detected in many" 12 "B-cells: 70.2" "Cell line enhanced" "Detected in many" "A549: 18.1;HEK 293: 25.7;MCF7: 12.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA049073, HPA053997" Enhanced Approved "Microtubules,Cytokinetic bridge" Yes No "Cluster 19: B-cells - Humoral immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 61: Squamous epithelial cells - Keratinization" Microtubules "Cytokinetic bridge" "HPA049073: AB_2680620, HPA053997: AB_2682337" "unprognostic (5.08e-2)" "unprognostic (4.21e-3)" "unprognostic (2.52e-1)" "unprognostic (7.22e-2)" "unprognostic (3.15e-2)" "unprognostic (8.35e-3)" "unprognostic (6.04e-2)" "unprognostic (2.06e-3)" "unprognostic (3.52e-1)" "unprognostic (9.44e-2)" "unprognostic (1.39e-1)" "unprognostic (8.37e-2)" "unprognostic (8.42e-2)" "unprognostic (4.83e-2)" "unprognostic (7.77e-3)" "prognostic favorable (4.02e-5)" "unprognostic (2.45e-1)" 4.3 5.3 1.8 0.4 4.2 0.6 12.9 1.9 2.2 952.0 1.3 3.2 0.4 1.5 7.3 3093.3 1.6 0.1 1.9 1.9 2.8 2.3 1.4 0.9 0.7 2.1 1.9 1.0 3.3 1.6 2.2 0.1 1.7 8.6 1.3 0.1 661.6 1.1 1.7 555.6 3.5 0.5 1.7 3.3 3.3 2.4 2.9 2.8 1.8 0.0 276.8 2.4 1442.7 1.6 6.0 18.1 0.4 1.6 0.8 0.9 0.2 1.0 0.3 0.4 0.4 1.0 1.6 5.1 8.0 0.2 1.2 2.4 1.5 2.3 0.1 0.0 25.7 0.4 6.9 1.9 0.0 0.0 0.1 1.8 4.0 1.0 0.0 0.1 0.0 4.7 1.1 0.2 0.0 12.6 0.1 0.1 6.6 8.1 5.4 2.2 0.3 2.9 1.6 2.3 2.7 7.7 3.4 5.1 2.5 2.7 6.2 2.6 0.0 0.0 5.3 0.2 0.1 5.8 7.6 3.6 0.1 2.2 0.3 0.1 4.6 0.1 1.7 3.9 0.4 61.2 1.3 1.2 5.9 70.2 0.6 0.9 1.3 0.0 0.9 1.3 0.1 2.2 1.8 4.2 1.9 2.2 1.9 2.8 2.1 1.9 1.7 1.7 2.9 1.6 32.7 3.2 2.2 0.0 24.6 4.6 16.8 28.5 14.8 0.1 57.9 51.6 0.8 2.8 20.2 33.1 0.0 0.2 2.1 24.5 7.9 13.1 1.5 20.6 3.9 9.3 32.5 3.6 0.1 2.5 0.3 2.3 4.6 23.9 4.5 7.2 3.9 0.7 5.7 0.0 0.2 33.4 14.2 3.8 7.7 3.9 5.3 6.3 3.6 0.0 6.4 0.3 7.2 0.0 0.1 2.4 39.4 4.5 0.5 11.5 43.8 12.3 10.5 0.1 0.0 0.9 8.0 0.4 17.4 71.8 12.9 0.3 1.3 1.1 41.8 27.0 CORO7-PAM16 ENSG00000103426 "CORO7-PAM16 readthrough" 16 4340251-4420494 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Club cells: 2.5;Oligodendrocytes: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041657, HPA053586, HPA062721" Uncertain Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Mitochondria" Microtubules "HPA041657: AB_10796351, HPA053586: AB_2682201, HPA062721: AB_2684849" "unprognostic (2.95e-2)" "unprognostic (2.46e-1)" "unprognostic (1.44e-1)" "unprognostic (2.46e-1)" "unprognostic (2.11e-1)" "unprognostic (1.24e-2)" "unprognostic (2.11e-4)" "unprognostic (4.39e-2)" "unprognostic (9.83e-3)" "unprognostic (1.20e-1)" "unprognostic (8.75e-3)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.59e-2)" "unprognostic (2.19e-1)" "unprognostic (3.85e-1)" 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.3 0.2 0.5 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRACDL "C2orf55, KIAA1211L, MGC42367" ENSG00000196872 "CRACD like" Q6NV74 2 98793846-98936259 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;epididymis: 31.6" "Cell type enriched" "Detected in some" 9 "Adipocytes: 35.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 6 "amygdala: 12.8;basal ganglia: 20.0;cerebral cortex: 30.8;hippocampal formation: 29.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 41.0;HDLM-2: 61.7;Karpas-707: 17.4;MCF7: 16.3;SiHa: 17.3;SK-BR-3: 22.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 16 "amygdala: 19.1;basal ganglia: 45.5;cerebral cortex: 36.9;hippocampal formation: 54.9;olfactory bulb: 15.9" "HPA051082, HPA061678" Enhanced Approved "Microtubules,Cytokinetic bridge,Centrosome" Yes No "Cluster 68: Epididymis - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Microtubules, Centrosome" "Cytokinetic bridge" "HPA051082: AB_2681337, HPA061678: AB_2684584" "unprognostic (3.56e-3)" "unprognostic (1.23e-3)" "unprognostic (5.88e-2)" "unprognostic (6.43e-2)" "unprognostic (1.34e-1)" "unprognostic (1.24e-1)" "unprognostic (3.67e-3)" "unprognostic (2.12e-1)" "unprognostic (5.10e-2)" "unprognostic (7.65e-2)" "unprognostic (3.23e-2)" "unprognostic (3.61e-2)" "prognostic favorable (1.13e-5)" "unprognostic (1.22e-1)" "unprognostic (3.34e-1)" "prognostic favorable (1.33e-5)" "unprognostic (2.22e-2)" 5.0 0.9 12.8 1.5 20.0 0.5 5.1 0.0 30.8 5.1 0.0 5.9 8.0 2.1 31.6 11.2 22.6 2.9 3.4 29.7 0.0 4.1 0.3 6.0 0.8 0.0 0.0 0.6 4.7 7.7 6.6 4.5 0.0 2.3 4.6 0.1 11.0 4.6 1.7 6.4 7.5 2.3 0.0 1.3 8.3 6.2 0.0 1.0 5.0 1.5 1.8 2.2 5.5 3.6 8.4 0.4 0.2 3.2 0.0 0.0 41.0 0.0 0.0 0.0 0.0 0.4 4.9 0.0 10.4 0.0 0.2 7.4 0.3 0.4 0.0 61.7 1.2 0.0 0.5 0.5 0.0 0.0 0.1 0.3 2.3 0.1 1.2 0.1 2.5 0.0 0.0 17.4 0.0 16.3 0.2 1.3 0.1 8.3 0.9 0.0 0.0 0.8 3.2 6.5 5.8 0.9 17.3 22.5 0.1 0.0 8.7 1.4 10.7 0.0 1.3 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.8 20.0 0.0 30.8 29.7 0.0 0.0 0.0 0.0 0.0 0.0 3.6 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 CREG1 CREG ENSG00000143162 "Cellular repressor of E1A stimulated genes 1" O75629 1 167529117-167553805 "Predicted secreted proteins" "Growth regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 545.7;Kupffer cells: 559.7;monocytes: 322.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 55.4;classical monocyte: 128.4;eosinophil: 75.7;intermediate monocyte: 75.7;myeloid DC: 89.9;neutrophil: 43.7;non-classical monocyte: 72.3" "Group enriched" "Detected in all" 6 "dendritic cells: 89.9;granulocytes: 75.7;monocytes: 128.4" "Cell line enhanced" "Detected in all" "RPMI-8226: 1237.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056390 Approved Vesicles,Microtubules "Secreted to blood" NA NA 520000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 25: RPMI-8226 - Immune response" "Cluster 4: Macrophages - Innate immune response" Microtubules Vesicles "HPA056390: AB_2683113" "unprognostic (3.25e-1)" "unprognostic (2.00e-1)" "unprognostic (1.91e-1)" "unprognostic (9.65e-3)" "unprognostic (4.64e-2)" "unprognostic (2.35e-2)" "unprognostic (1.55e-1)" "unprognostic (5.02e-2)" "unprognostic (2.07e-3)" "unprognostic (8.54e-2)" "unprognostic (8.65e-2)" "unprognostic (1.21e-1)" "unprognostic (8.24e-3)" "unprognostic (2.99e-1)" "unprognostic (4.63e-2)" "unprognostic (3.78e-3)" "unprognostic (3.16e-1)" 130.5 127.7 37.5 79.0 41.1 125.9 109.7 39.0 45.9 76.8 47.8 77.1 60.3 61.8 109.7 91.7 70.9 128.2 82.2 36.5 40.4 132.1 295.2 99.1 98.9 46.0 39.1 84.2 70.7 75.4 64.8 110.8 44.4 62.9 82.7 80.0 104.5 74.6 71.4 109.8 63.0 77.9 45.7 136.9 61.4 50.1 49.3 35.5 125.8 78.2 63.5 116.3 63.3 61.2 93.5 41.5 21.1 43.5 325.8 89.8 53.0 39.2 17.8 30.7 39.8 67.8 104.4 101.7 112.2 43.6 57.2 143.3 24.3 84.9 20.9 140.3 82.3 41.5 31.1 37.9 111.5 93.6 295.2 94.5 250.5 35.6 38.7 42.7 10.3 35.9 218.5 405.0 42.6 39.2 19.6 95.9 22.8 214.0 63.9 32.5 58.8 1237.2 54.7 64.9 14.0 25.7 98.1 132.8 112.8 70.1 175.5 252.7 19.1 8.0 39.6 126.2 25.9 79.4 168.4 67.7 131.6 96.0 16.3 55.4 128.4 75.7 5.1 75.7 8.0 4.3 7.5 6.5 89.9 2.1 16.6 8.8 43.7 11.0 72.3 6.2 3.9 57.6 37.5 41.1 39.0 45.9 36.5 40.4 46.0 39.1 44.4 45.7 49.3 61.2 44.7 35.3 90.1 5.9 15.3 44.1 49.1 23.1 56.9 17.9 61.7 63.8 55.7 65.8 32.2 55.2 89.6 91.5 18.3 15.6 23.5 36.0 27.6 33.9 19.3 34.2 29.3 124.8 24.7 39.7 41.7 78.4 21.9 64.1 29.9 62.0 48.2 90.3 545.7 15.2 22.1 44.5 14.2 559.7 57.6 27.4 43.5 213.8 24.9 26.2 322.8 30.5 6.2 10.1 14.6 21.0 31.5 28.6 27.8 34.0 46.3 60.6 18.5 31.5 13.1 43.2 40.8 65.5 42.0 86.3 51.1 126.7 17.3 38.9 50.4 44.0 CRY1 PHLL1 ENSG00000008405 "Cryptochrome circadian regulator 1" Q16526 12 106991364-107093549 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation" "Photoreceptor protein, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 108.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018762 Approved Supported "Nucleoplasm,Nuclear membrane,Microtubules" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nuclear membrane, Microtubules" "CAB018762: AB_2083970" "unprognostic (1.21e-3)" "unprognostic (4.74e-2)" "unprognostic (6.50e-2)" "unprognostic (9.03e-2)" "unprognostic (1.79e-1)" "unprognostic (2.84e-1)" "unprognostic (3.48e-2)" "unprognostic (3.61e-1)" "unprognostic (4.29e-3)" "unprognostic (1.34e-2)" "unprognostic (6.85e-3)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.82e-2)" "unprognostic (5.08e-1)" "unprognostic (1.85e-1)" "unprognostic (2.25e-1)" 13.3 12.4 8.5 7.6 9.8 12.4 11.2 16.2 10.9 11.1 16.7 12.6 11.5 14.2 6.4 11.0 16.4 16.7 11.7 8.4 9.0 13.7 13.6 19.3 5.8 9.8 10.1 9.0 13.5 8.8 8.4 12.1 9.9 11.3 8.6 21.3 9.0 11.5 10.9 9.0 12.7 16.8 9.7 8.7 16.2 37.3 9.9 19.0 17.0 11.0 6.7 15.6 8.6 12.5 17.3 16.9 20.6 23.0 14.6 9.1 36.9 17.9 19.1 36.0 24.2 19.9 10.1 0.0 11.1 16.7 22.7 11.6 26.8 9.3 39.6 17.3 16.6 16.9 15.3 13.8 18.6 17.3 14.2 8.6 9.6 26.4 24.9 17.8 30.5 31.4 19.3 14.6 22.7 12.1 39.2 19.7 25.1 16.5 24.6 34.5 52.3 6.1 25.3 20.2 37.1 19.2 33.6 22.1 10.9 20.0 15.6 9.6 13.5 20.9 22.2 14.6 16.2 26.6 26.6 7.8 10.2 16.3 17.5 12.0 3.2 5.8 12.8 4.7 16.1 1.9 9.6 8.2 4.3 1.9 8.9 8.8 1.4 6.4 8.9 2.8 13.5 5.7 8.5 9.8 16.2 10.9 8.4 9.0 9.8 10.1 9.9 9.7 9.9 12.5 16.3 16.0 16.2 20.5 9.7 69.2 47.9 4.3 55.2 16.8 30.4 14.7 11.1 11.5 6.1 11.0 20.9 8.3 29.1 12.7 17.6 11.4 12.8 27.3 19.3 20.1 19.6 11.2 22.4 16.3 13.4 24.5 45.9 33.2 5.1 6.2 12.1 20.2 6.3 26.9 38.4 9.7 6.1 7.3 21.0 4.8 11.5 8.8 16.0 13.1 16.3 22.8 19.6 35.2 32.8 21.5 7.0 17.3 15.3 29.7 7.7 16.1 18.7 13.7 6.6 24.3 19.2 108.0 32.4 24.3 59.5 15.1 29.7 5.7 6.8 27.0 CRYBB3 CRYB3 ENSG00000100053 "Crystallin beta B3" P26998 22 25199858-25207359 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Distal enterocytes: 2.6;Distal tubular cells: 1.9;granulocytes: 4.5;Muller glia cells: 4.3;Proximal tubular cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.4;HEK 293: 1.4;HeLa: 1.8;hTERT-HME1: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA055840 Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 81: Kidney & Liver - Metabolism" "Cluster 20: HeLa - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA055840: AB_2682939" "unprognostic (1.36e-2)" "unprognostic (6.27e-4)" "unprognostic (6.30e-3)" "unprognostic (5.34e-2)" "unprognostic (8.76e-2)" "unprognostic (3.15e-2)" "unprognostic (6.45e-2)" "unprognostic (2.07e-2)" "unprognostic (4.15e-2)" "unprognostic (8.28e-2)" "unprognostic (2.40e-1)" "unprognostic (2.68e-2)" "unprognostic (1.03e-2)" "unprognostic (2.01e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (1.20e-3)" 0.2 0.5 0.9 0.1 0.6 0.0 0.7 0.0 1.0 0.5 0.0 0.6 0.3 0.3 0.2 0.6 0.4 0.4 0.5 0.9 0.0 2.0 2.0 0.3 0.1 0.0 0.1 0.1 0.3 0.0 0.3 0.1 0.0 0.8 0.4 0.7 1.0 0.4 0.7 0.9 0.7 0.1 0.0 0.1 0.5 0.2 0.5 0.2 1.3 0.1 0.3 0.1 0.4 0.0 0.6 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.2 1.4 0.8 0.6 0.0 0.0 1.4 0.0 1.8 1.0 0.0 0.0 0.0 0.0 0.7 0.4 1.2 0.2 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.6 0.5 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 1.0 0.9 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.6 0.3 0.4 1.5 0.1 0.0 0.0 0.0 0.0 2.6 1.9 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 4.5 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 1.3 10.5 0.4 0.3 0.0 0.0 0.1 0.1 0.7 0.0 0.3 0.0 0.1 0.0 0.3 0.1 CRYBG1 "AIM1, ST4" ENSG00000112297 "Crystallin beta-gamma domain containing 1" 6 106360717-106572017 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 61.9;placenta: 72.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 219.4;dendritic cells: 153.6;Plasma cells: 89.9;Syncytiotrophoblasts: 600.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 93.7;HBEC3-KT: 124.1;hTERT-HME1: 95.8" "Region enriched" "Detected in single" 5 "olfactory bulb: 4.2" "Low region specificity" "Detected in many" "CAB026378, HPA030948, HPA030949" Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA "Cluster 13: T-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Microtubules, Cytosol" "CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671" "unprognostic (1.66e-1)" "unprognostic (3.44e-2)" "unprognostic (9.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-1)" "unprognostic (1.40e-1)" "unprognostic (2.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (3.69e-3)" "unprognostic (5.61e-2)" "unprognostic (8.97e-2)" "unprognostic (3.53e-2)" "unprognostic (8.89e-2)" "unprognostic (8.60e-2)" "unprognostic (3.25e-2)" 17.0 1.2 0.6 21.9 0.5 24.1 17.3 0.7 0.8 6.8 40.3 25.0 25.4 2.4 6.2 61.9 6.7 8.1 1.0 1.9 0.4 15.3 11.8 9.8 20.4 0.8 0.7 2.3 4.9 5.8 0.4 72.0 0.6 25.2 19.2 0.8 9.3 5.4 1.1 42.1 23.7 4.8 0.5 12.6 10.3 5.1 1.5 9.7 2.6 1.2 33.5 19.0 14.0 0.4 34.7 0.2 0.0 0.1 25.5 93.7 9.9 4.9 33.5 10.8 10.0 2.4 11.5 54.0 2.3 21.7 14.6 54.5 0.2 124.1 5.3 74.0 2.3 0.0 1.5 16.9 12.1 33.4 0.2 44.9 66.7 19.7 95.8 0.1 46.5 41.9 1.7 7.3 28.5 3.5 9.7 10.7 0.4 0.2 21.2 16.4 0.4 0.4 14.9 80.0 2.2 0.2 20.3 31.9 0.3 3.0 16.4 24.3 13.5 11.6 1.5 0.2 34.4 5.7 4.7 57.7 56.0 39.3 26.3 0.3 3.4 0.4 7.4 3.6 10.1 6.6 9.8 8.5 8.6 2.9 5.8 5.7 2.4 4.8 4.1 1.0 9.9 4.0 0.6 0.5 0.7 0.8 1.9 0.4 0.8 0.7 0.6 0.5 1.5 0.4 13.4 12.8 11.9 0.0 24.2 0.0 0.0 0.0 0.0 0.0 31.2 14.1 0.0 0.0 13.0 33.1 0.0 219.4 153.6 0.0 3.9 10.9 0.0 20.2 2.7 4.4 0.0 0.0 0.0 12.5 15.3 2.5 0.0 31.6 1.3 0.1 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.8 0.0 0.0 5.7 0.0 0.0 0.0 0.0 26.4 0.0 0.0 89.9 0.0 0.0 15.0 8.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 600.1 76.7 0.1 0.0 0.0 CXCR2 "CD182, CMKAR2, IL8RB" ENSG00000180871 "C-X-C motif chemokine receptor 2" P25025 2 218125289-218137251 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 27.2;lymphoid tissue: 40.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 10.5;dendritic cells: 12.9;granulocytes: 6.3;NK-cells: 40.2;Squamous epithelial cells: 11.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 52 "neutrophil: 3273.9" "Lineage enriched" "Detected in many" 111 "granulocytes: 3273.9" "Group enriched" "Detected in some" 11 "BEWO: 14.5;HL-60: 8.2;HMC-1: 16.5;THP-1: 15.3;U-937: 15.1" "Low region specificity" "Detected in all" "CAB016268, HPA031999, HPA032017" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle" Yes NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "Nucleoplasm, Microtubules, Mitotic spindle" "CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112" "unprognostic (4.89e-2)" "unprognostic (2.01e-1)" "unprognostic (5.63e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (3.13e-1)" "unprognostic (1.33e-1)" "unprognostic (2.13e-1)" "unprognostic (5.96e-2)" "unprognostic (1.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-1)" "unprognostic (7.54e-2)" "unprognostic (1.04e-1)" "unprognostic (7.23e-2)" "unprognostic (8.18e-2)" "unprognostic (5.48e-2)" 13.8 1.5 0.3 40.0 0.6 7.3 0.8 0.2 2.6 4.5 0.1 0.9 0.2 0.4 1.3 27.2 2.9 7.8 1.0 0.3 0.1 0.4 2.4 6.5 0.7 0.6 0.5 0.4 2.9 0.4 0.2 4.6 1.4 0.6 0.7 0.0 3.0 3.8 0.5 4.8 1.2 2.4 0.3 27.3 0.7 0.2 0.5 2.8 0.6 11.6 3.0 7.8 7.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 16.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 1.3 0.2 0.0 0.0 0.4 0.0 1.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 15.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 15.1 0.0 63.5 29.5 50.3 28.8 7.4 0.4 0.2 1.3 7.3 13.5 0.2 1.1 9.9 3273.9 6.8 3.6 25.0 0.5 17.4 0.3 0.6 0.2 2.6 0.3 0.1 0.6 0.5 1.4 0.3 0.5 0.4 0.0 0.0 10.5 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.4 0.2 0.0 1.9 0.0 0.0 0.7 12.9 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.5 1.2 0.0 0.0 6.3 3.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.2 1.6 0.0 0.0 2.8 0.0 1.0 3.7 0.0 40.2 0.0 0.1 0.0 2.2 0.0 1.4 0.1 0.0 0.1 0.3 0.0 0.0 0.4 0.4 0.0 0.0 11.6 0.1 0.3 4.1 0.1 0.1 1.9 DAPL1 ENSG00000163331 "Death associated protein like 1" A0PJW8 2 158795317-158862781 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 196.9;esophagus: 242.0;skin 1: 301.0" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 212.9;Muller glia cells: 913.0;Squamous epithelial cells: 736.5" "Cancer enhanced" "Detected in all" "ovarian cancer: 62.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 4.0;hTCEpi: 23.2;SCLC-21H: 5.9;U-87 MG: 8.4" "HPA046937, HPA058635" Enhanced Approved "Nucleoplasm,Nuclear bodies,Microtubules" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Nuclear bodies, Microtubules" "HPA046937: AB_2679870, HPA058635: AB_2732625" "unprognostic (3.95e-5)" "prognostic favorable (8.43e-4)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (4.63e-2)" "unprognostic (8.59e-2)" "unprognostic (5.24e-2)" "unprognostic (4.59e-2)" "unprognostic (2.44e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-3)" "unprognostic (4.09e-2)" "unprognostic (6.68e-2)" "unprognostic (3.00e-2)" "unprognostic (2.30e-3)" 1.9 56.0 1.6 0.1 1.8 0.8 28.7 1.6 6.6 47.6 1.2 2.9 0.5 0.6 196.9 242.0 80.5 0.6 0.5 1.3 9.3 3.6 0.2 1.6 0.6 1.5 5.3 1.0 22.8 0.0 24.4 0.1 2.4 9.2 0.7 115.6 30.2 1.1 1.0 301.0 1.0 0.5 1.3 0.3 1.5 1.5 4.3 4.8 34.3 0.0 25.0 8.6 108.1 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.0 0.1 0.2 23.2 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.4 5.9 0.0 0.0 0.0 0.6 0.0 0.7 1.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 8.4 0.0 0.0 1.2 0.8 0.5 0.1 0.6 0.2 0.4 0.2 0.1 0.3 0.4 0.1 0.1 0.5 0.7 0.1 1.2 0.4 0.1 1.6 1.8 1.6 6.6 1.3 9.3 1.5 5.3 2.4 1.3 4.3 1.2 0.6 0.0 0.0 0.0 4.1 106.9 51.8 74.8 212.9 7.2 15.0 19.6 0.1 2.8 29.8 9.2 6.2 6.0 4.9 2.0 3.9 7.6 13.8 5.6 2.2 2.0 3.0 0.0 0.2 6.0 12.8 2.4 0.0 5.4 4.5 148.1 0.7 14.3 14.7 3.3 0.4 2.0 14.2 9.1 9.3 56.1 4.1 5.0 12.4 0.0 5.4 913.0 2.1 1.0 0.1 5.8 7.1 2.2 3.4 11.8 5.9 13.3 4.8 23.8 0.0 1.9 10.9 10.8 4.2 736.5 126.6 4.5 3.1 1.7 2.3 67.4 DCDC2 "DCDC2A, DFNB66, KIAA1154, NPHP19, RU2" ENSG00000146038 "Doublecortin domain containing 2" Q9UHG0 6 24171755-24358059 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Neurogenesis" "Ciliopathy, Deafness, Disease variant, Nephronophthisis, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 15.1;kidney: 23.2;pancreas: 26.2" "Cell type enhanced" "Detected in many" "Cholangiocytes: 62.9;Collecting duct cells: 79.1;Distal tubular cells: 56.7;Ductal cells: 135.9;Endometrial ciliated cells: 160.3;Glandular and luminal cells: 102.4;Proximal tubular cells: 54.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 71.8;EFO-21: 48.3;Hep G2: 82.3;RPTEC TERT1: 254.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031582, HPA031583, HPA031584" Enhanced Supported "Microtubules,Mitotic spindle,Centriolar satellite,Cytosol" Yes NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" Cytosol "Microtubules, Mitotic spindle, Centriolar satellite" "HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945" "unprognostic (8.65e-2)" "unprognostic (2.07e-2)" "unprognostic (1.66e-1)" "unprognostic (6.70e-2)" "unprognostic (1.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.09e-1)" "unprognostic (2.67e-2)" "unprognostic (5.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.99e-2)" 0.0 1.3 0.8 0.0 1.2 0.1 4.4 0.3 0.8 1.6 15.1 0.7 0.6 4.4 5.3 0.0 7.6 3.9 0.0 0.8 1.0 23.2 2.2 3.4 0.0 2.2 2.7 0.2 26.2 8.2 1.2 0.6 1.7 1.2 0.6 1.4 0.4 2.3 0.3 0.1 0.1 0.1 2.0 0.1 1.8 3.7 1.1 0.1 8.2 0.2 0.0 0.4 0.0 1.6 0.0 8.8 0.5 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 71.8 0.2 0.0 48.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 8.2 0.0 0.0 82.3 0.0 0.0 0.0 0.0 0.0 9.7 0.0 1.4 0.0 0.2 0.1 0.0 0.3 10.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 254.5 0.3 5.2 0.5 0.0 1.3 0.0 0.2 12.3 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.5 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 1.2 0.3 0.8 0.8 1.0 2.2 2.7 1.7 2.0 1.1 1.6 0.2 19.2 14.4 3.9 1.4 0.1 0.6 0.3 0.0 0.0 20.3 11.7 0.3 62.9 6.1 79.1 0.0 0.4 0.0 1.2 56.7 135.9 40.1 160.3 5.3 0.4 3.6 0.0 11.3 8.4 0.0 1.3 3.6 102.4 0.0 4.1 0.0 1.0 0.5 0.0 8.3 2.9 0.0 0.0 0.0 14.6 0.3 1.0 0.0 1.0 2.0 2.3 0.0 1.0 0.5 27.9 4.1 0.4 0.0 1.3 0.0 54.3 37.1 0.1 0.0 0.0 2.4 32.3 2.6 0.0 0.1 0.1 1.1 5.6 2.7 0.9 DCTN1 ENSG00000204843 "Dynactin subunit 1" Q14203 2 74361154-74392087 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009108, HPA034635, HPA071875" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes No 250000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB009108: AB_2090601, HPA034635: AB_2674256, HPA071875: " "unprognostic (1.14e-1)" "unprognostic (7.19e-2)" "unprognostic (1.33e-3)" "unprognostic (4.08e-2)" "unprognostic (1.20e-1)" "unprognostic (2.67e-1)" "unprognostic (4.61e-3)" "unprognostic (2.11e-2)" "unprognostic (2.79e-1)" "unprognostic (3.73e-3)" "unprognostic (1.87e-1)" "unprognostic (2.26e-1)" "prognostic favorable (2.34e-7)" "unprognostic (5.41e-2)" "unprognostic (3.11e-1)" "unprognostic (7.86e-3)" "unprognostic (1.12e-3)" 43.3 40.0 90.5 27.0 94.7 23.7 37.4 76.4 113.2 44.3 20.8 51.3 22.2 51.4 17.0 42.6 38.7 28.2 82.6 99.9 80.1 27.6 18.2 36.0 22.8 110.9 85.1 39.2 28.6 118.0 61.2 32.6 112.6 30.0 25.5 43.5 56.3 38.0 87.6 44.2 32.2 49.9 76.0 26.5 39.5 51.3 101.9 34.7 31.3 63.4 24.6 47.6 39.0 116.2 65.0 74.7 68.4 71.9 122.5 90.7 55.2 102.0 105.2 127.0 89.9 99.9 48.6 88.8 40.8 213.0 70.1 63.5 84.3 129.5 96.1 111.2 85.0 92.5 55.6 84.7 94.4 50.7 109.3 109.6 62.0 138.3 82.3 86.9 110.3 79.4 40.3 61.4 97.3 55.6 92.8 52.5 74.0 78.6 78.3 82.3 120.1 63.8 70.2 39.6 83.3 74.1 57.1 67.7 60.6 59.0 43.5 36.5 84.3 115.0 82.7 50.0 77.2 37.8 32.7 78.9 107.6 81.4 82.5 8.3 11.3 12.7 14.4 13.0 11.7 10.1 8.2 10.8 11.2 6.8 5.6 6.3 9.2 9.2 15.6 8.8 7.7 16.5 90.5 94.7 76.4 113.2 99.9 80.1 110.9 85.1 112.6 76.0 101.9 116.2 28.6 32.1 25.4 9.8 23.2 10.1 10.3 19.1 25.6 27.2 19.6 17.8 56.4 18.6 20.0 29.5 25.0 29.8 19.4 41.0 19.6 22.5 7.3 21.5 32.8 26.6 16.7 27.3 28.4 19.9 27.1 25.1 49.5 27.8 29.2 30.8 29.6 19.9 28.8 90.9 26.7 31.8 24.4 21.0 11.3 9.3 44.7 21.2 16.0 8.4 27.3 14.9 23.7 12.1 29.7 26.6 33.6 51.9 24.7 9.6 34.2 19.6 19.4 45.5 19.7 28.3 30.0 40.6 38.5 29.0 11.8 25.2 20.0 33.9 24.9 10.7 DCXR "DCR, HCR2, KIDCR, P34H, SDR20C1" ENSG00000169738 "Dicarbonyl and L-xylulose reductase" Q7Z4W1 17 82035136-82037709 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Xylose metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "liver: 1851.6" "Cell type enhanced" "Detected in all" "Distal tubular cells: 812.0;Hepatocytes: 3510.3;Proximal tubular cells: 2919.4" "Group enriched" "Detected in all" 5 "liver cancer: 305.9;prostate cancer: 163.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 365.2;MCF7: 446.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023371, HPA023863" Enhanced Uncertain Nucleoli,Microtubules NA NA 4000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoli, Microtubules" "HPA023371: AB_1847530, HPA023863: AB_1847531" "unprognostic (3.33e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-1)" "unprognostic (1.16e-2)" "unprognostic (1.19e-1)" "unprognostic (8.43e-2)" "unprognostic (4.54e-3)" "unprognostic (1.86e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-2)" "prognostic favorable (4.70e-4)" "unprognostic (1.72e-1)" "prognostic favorable (2.13e-4)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.10e-2)" 106.7 43.9 93.1 15.2 95.3 25.3 107.6 102.5 111.1 52.0 84.4 49.6 29.2 39.5 281.3 96.6 59.2 10.8 132.7 87.6 100.7 239.9 1851.6 61.0 16.6 102.4 98.0 70.0 71.6 46.1 63.9 20.2 105.9 138.0 20.9 9.7 103.4 33.6 187.3 87.6 44.4 10.4 91.8 35.8 167.0 44.8 105.9 26.1 60.7 80.6 19.6 48.9 62.1 94.9 50.3 68.2 32.8 56.4 123.2 31.8 80.4 25.0 33.9 68.5 48.4 122.0 21.3 100.3 47.4 35.9 9.4 57.4 59.6 52.6 24.1 21.4 145.9 96.9 48.8 365.2 143.2 75.6 114.5 44.6 62.2 22.7 79.8 16.0 41.1 61.1 112.4 76.3 36.5 446.2 63.7 184.1 35.0 242.9 71.3 57.9 42.0 135.3 53.3 71.9 85.5 51.0 35.5 287.5 46.0 19.7 213.4 74.5 20.5 36.6 45.0 48.9 48.2 73.7 56.2 50.2 31.4 83.0 26.7 49.5 92.6 77.9 66.5 92.0 64.1 86.8 83.0 64.7 151.3 99.2 117.7 85.4 47.2 108.9 88.1 121.6 98.9 110.1 93.1 95.3 102.5 111.1 87.6 100.7 102.4 98.0 105.9 91.8 105.9 94.9 29.0 51.3 198.2 16.6 133.6 58.5 200.3 113.5 109.8 16.0 301.8 269.2 120.7 183.0 123.4 178.4 18.8 372.1 116.6 152.9 812.0 41.4 6.0 67.0 50.9 44.6 54.7 335.7 4.7 42.6 450.6 65.0 151.4 102.3 64.7 62.7 138.5 3510.3 164.7 21.9 9.0 170.4 189.2 165.7 65.6 22.6 70.8 82.3 179.7 1.9 52.8 145.1 78.2 5.5 10.5 30.4 135.7 47.4 98.6 215.2 158.9 2919.4 55.4 26.5 19.7 40.6 79.6 10.3 48.2 219.9 73.2 342.6 135.7 118.6 154.6 178.8 DECR2 "PDCR, SDR17C1" ENSG00000242612 "2,4-dienoyl-CoA reductase 2" Q9NUI1 16 401858-412487 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 165.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 129.2;Proximal enterocytes: 81.3;Proximal tubular cells: 159.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Hep G2: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047631 Approved Peroxisomes,Microtubules NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Peroxisomes Microtubules "HPA047631: " "unprognostic (2.74e-2)" "unprognostic (3.84e-1)" "unprognostic (1.83e-1)" "unprognostic (4.44e-3)" "unprognostic (1.77e-1)" "unprognostic (7.45e-2)" "unprognostic (2.38e-2)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (3.02e-2)" "unprognostic (3.11e-2)" "unprognostic (3.38e-1)" "unprognostic (1.12e-1)" "unprognostic (3.40e-1)" "unprognostic (2.21e-1)" "unprognostic (1.94e-1)" "unprognostic (4.22e-3)" 13.0 34.8 5.5 1.6 5.7 5.8 11.8 5.5 8.1 9.6 5.4 18.5 20.6 10.0 2.0 12.0 9.2 2.1 12.4 6.0 6.6 35.8 165.1 6.8 1.2 5.6 5.5 8.6 21.2 1.7 8.4 2.4 5.5 11.9 2.8 0.5 9.5 7.1 32.3 10.5 17.4 1.5 5.5 6.8 13.8 11.4 6.1 1.8 6.3 7.2 1.0 10.7 8.1 6.1 2.4 22.5 3.4 14.7 4.1 6.3 7.7 7.0 5.7 6.0 6.7 16.2 16.2 6.1 12.2 7.5 3.7 3.5 2.1 6.4 1.3 12.4 5.7 2.3 10.3 37.6 17.7 4.9 11.1 9.1 4.8 4.2 5.5 6.1 6.9 9.5 4.3 7.9 5.5 27.7 3.2 10.2 8.0 9.0 7.5 5.8 1.3 12.2 6.9 6.3 4.3 8.5 11.3 15.9 8.8 1.3 21.9 10.1 10.8 5.1 5.8 7.5 5.6 6.7 7.1 2.6 7.0 10.2 16.1 0.0 3.8 0.1 2.7 5.1 1.5 1.8 1.1 1.5 5.1 1.7 2.6 1.5 0.2 2.9 2.5 7.8 0.9 2.6 5.5 5.7 5.5 8.1 6.0 6.6 5.6 5.5 5.5 5.5 6.1 6.1 9.6 12.8 16.2 5.2 4.3 3.8 7.3 5.6 10.2 2.0 14.9 15.6 8.3 20.0 7.4 20.2 0.0 34.3 5.7 53.8 39.2 37.3 2.6 7.1 8.1 9.4 12.5 29.5 2.3 38.9 7.1 9.9 38.7 9.6 12.7 15.8 7.5 129.2 12.9 3.3 2.7 30.6 6.1 7.3 5.7 6.3 6.5 6.0 5.4 0.0 10.0 7.0 5.2 3.0 2.8 25.3 37.2 6.8 3.8 6.4 81.3 159.1 7.7 3.0 0.0 7.7 8.3 3.8 6.3 12.6 6.0 12.6 3.5 25.8 38.8 5.1 DENND5B MGC24039 ENSG00000170456 "DENN domain containing 5B" Q6ZUT9 12 31382226-31591136 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 152.8;Excitatory neurons: 217.3;Inhibitory neurons: 246.4;Oligodendrocyte precursor cells: 144.3;Oligodendrocytes: 121.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.4;naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SuSa: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038865 Approved Approved Nucleoli,Microtubules NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Microtubules Nucleoli "HPA038865: AB_2676245" "unprognostic (5.41e-2)" "unprognostic (2.23e-2)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "unprognostic (1.24e-1)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (7.23e-2)" "unprognostic (2.13e-1)" "unprognostic (1.16e-2)" "unprognostic (4.96e-2)" "unprognostic (3.14e-1)" "unprognostic (8.27e-2)" "unprognostic (5.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.26e-1)" "unprognostic (2.60e-2)" 4.0 6.4 6.3 5.4 7.8 2.1 3.2 20.1 12.3 4.8 2.9 4.2 9.2 6.9 2.0 2.4 3.9 4.2 10.9 6.1 8.4 7.6 12.5 2.6 7.3 7.7 5.2 21.7 5.7 2.7 4.7 4.9 7.7 2.9 4.3 15.9 2.0 3.1 7.1 1.3 10.4 7.2 2.0 6.7 5.0 16.1 7.1 2.4 2.9 13.1 8.4 3.7 3.1 6.1 2.8 27.9 20.1 7.7 7.1 8.8 3.0 6.8 7.4 16.9 12.1 18.9 11.1 10.4 11.1 14.8 18.5 0.8 4.0 1.9 16.7 0.0 8.5 0.1 21.2 11.3 6.5 9.6 0.2 5.5 6.0 11.3 18.5 15.5 15.7 5.7 4.0 20.6 10.6 2.6 5.7 10.0 20.4 6.5 4.9 5.4 27.8 0.2 14.2 3.6 6.4 9.5 17.0 1.9 15.0 57.3 2.8 5.2 16.5 6.3 16.0 11.4 14.4 10.9 13.0 10.5 10.7 1.1 10.7 0.1 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.2 1.6 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.1 6.3 7.8 20.1 12.3 6.1 8.4 7.7 5.2 7.7 2.0 7.1 6.1 6.7 3.2 0.5 152.8 43.9 2.9 3.5 0.9 2.8 42.4 5.3 4.1 44.0 17.2 2.1 7.3 31.3 0.6 7.0 13.3 3.9 1.8 19.6 6.1 10.1 7.4 8.4 6.3 217.3 9.3 2.9 13.0 4.6 4.4 0.0 45.0 25.0 34.2 4.5 28.6 246.4 3.1 2.0 4.5 5.8 8.3 8.4 3.8 23.2 74.9 2.5 12.9 1.0 144.3 121.0 7.9 3.6 10.5 72.6 2.4 33.2 12.0 2.2 26.8 6.6 12.9 10.0 32.0 18.2 0.2 1.4 0.7 2.3 15.5 4.4 1.2 DEPDC4 "DEP.4, FLJ33505" ENSG00000166153 "DEP domain containing 4" Q8N2C3 12 100203669-100267079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 3.9" "Cell type enhanced" "Detected in many" "Early spermatids: 13.7;Late spermatids: 19.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039323 Uncertain Approved Microtubules NA NA "Cluster 24: B-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Microtubules "HPA039323: AB_10674283" "unprognostic (8.89e-2)" "unprognostic (2.29e-1)" "unprognostic (1.09e-1)" "unprognostic (4.33e-2)" "unprognostic (3.62e-1)" "unprognostic (7.96e-2)" "unprognostic (1.59e-1)" "unprognostic (1.53e-1)" "unprognostic (9.09e-4)" "unprognostic (5.02e-2)" "unprognostic (1.05e-2)" "unprognostic (3.35e-1)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-2)" 0.2 0.3 0.2 0.3 0.2 0.6 0.8 0.2 0.6 0.3 0.0 0.6 1.2 0.4 0.5 0.7 0.4 0.4 0.3 0.2 0.6 1.7 1.3 0.3 0.3 0.3 0.2 0.7 0.7 0.5 0.5 0.7 0.2 0.7 0.8 0.4 0.7 1.0 0.2 0.4 0.5 0.2 0.3 0.2 0.6 3.9 0.2 0.6 0.5 0.2 0.3 0.3 0.3 0.3 1.3 1.8 3.4 0.9 0.1 0.4 2.1 1.8 1.2 3.7 2.2 2.9 0.7 1.4 1.1 0.9 1.1 2.0 2.9 1.5 4.0 1.5 3.2 4.9 0.8 3.3 0.4 1.6 1.9 0.3 0.9 1.3 0.3 0.7 0.9 2.5 2.9 0.6 1.7 1.3 1.0 2.9 1.6 1.6 1.9 2.0 3.4 3.3 1.7 0.8 0.9 2.0 1.0 1.4 1.1 2.0 2.8 1.7 0.2 2.5 1.0 1.0 1.4 1.5 1.7 3.0 0.7 1.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.2 0.6 0.3 0.2 0.2 0.3 0.2 0.3 0.5 0.0 4.4 6.2 0.7 0.9 1.4 1.8 3.4 2.1 1.0 1.5 0.9 0.0 2.2 5.5 4.2 3.5 0.2 0.5 5.9 0.6 13.7 0.9 0.9 0.7 0.0 2.1 3.3 1.3 2.0 3.6 0.0 0.9 0.0 1.1 0.4 1.1 1.1 0.0 3.4 0.5 0.0 0.3 1.1 19.2 1.2 0.5 1.8 1.0 0.1 1.3 0.0 3.5 6.5 0.5 0.3 0.0 0.2 0.6 1.4 5.3 1.8 4.8 0.0 1.4 1.2 8.0 6.2 0.7 0.3 1.2 0.7 2.4 1.5 0.9 DET1 FLJ10103 ENSG00000140543 "DET1 partner of COP1 E3 ubiquitin ligase" Q7L5Y6 15 88494440-88546681 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA048873 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Cluster 7: Monocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA048873: AB_2680541" "unprognostic (9.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (3.17e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (6.64e-2)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (2.82e-3)" "unprognostic (2.62e-2)" "unprognostic (1.20e-1)" "unprognostic (8.69e-2)" "unprognostic (4.67e-2)" 3.7 5.2 2.5 2.0 2.8 1.2 3.6 2.7 2.7 6.0 3.2 4.2 3.5 6.7 5.4 2.2 5.6 3.0 5.6 2.5 2.6 3.2 2.7 2.1 2.9 2.7 2.5 10.3 3.6 3.7 3.7 3.5 2.8 4.1 3.2 5.0 4.1 3.8 9.7 2.6 3.2 5.5 2.4 2.5 3.4 1.5 2.6 5.6 4.1 11.7 3.0 4.5 3.3 3.2 1.7 6.2 8.6 6.0 3.4 6.0 1.1 5.4 6.1 4.5 5.1 1.0 4.8 3.3 4.1 7.3 4.5 2.4 8.7 1.3 3.9 0.2 5.9 6.9 3.1 1.5 6.7 2.5 1.1 5.0 5.9 1.9 6.9 4.4 3.8 2.9 8.5 3.8 6.7 2.6 3.2 2.8 3.6 2.6 1.8 4.2 6.9 3.8 2.4 5.3 3.0 4.9 6.5 2.0 14.9 5.6 2.9 5.2 3.0 5.1 3.7 4.8 5.4 2.3 1.4 2.1 5.4 4.3 4.5 0.0 2.3 1.6 2.2 3.4 1.4 1.8 1.7 1.9 3.7 2.2 2.6 1.9 0.3 1.4 2.3 1.9 2.4 1.3 2.5 2.8 2.7 2.7 2.5 2.6 2.7 2.5 2.8 2.4 2.6 3.2 3.5 3.2 2.7 6.8 3.5 0.6 2.0 3.7 4.6 11.5 4.3 3.8 2.3 1.5 2.1 3.7 10.4 7.2 1.7 2.1 1.9 3.4 1.2 3.4 6.1 2.3 3.0 5.5 5.7 3.9 6.3 4.9 2.0 2.4 0.0 10.6 2.2 2.8 4.4 6.7 6.8 2.7 2.0 1.6 2.2 0.6 4.4 2.5 3.6 3.7 4.7 7.1 2.1 6.0 9.5 3.1 1.0 3.8 1.6 1.5 3.1 2.6 3.1 7.9 0.0 5.6 4.5 8.1 9.9 1.5 1.3 4.1 2.7 8.4 3.3 1.4 DHX57 DDX57 ENSG00000163214 "DExH-box helicase 57" Q6P158 2 38797729-38875934 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 136.3;Late spermatids: 352.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036160 Uncertain Approved "Nucleoli,Intermediate filaments,Microtubules,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 25: Spermatids - Spermatogenesis" "Intermediate filaments, Microtubules" "Nucleoli, Cytosol" "HPA036160: AB_10670711" "unprognostic (6.78e-2)" "unprognostic (3.08e-1)" "unprognostic (3.49e-2)" "unprognostic (2.03e-3)" "unprognostic (3.25e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (3.32e-6)" "unprognostic (1.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.45e-1)" "unprognostic (7.35e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (3.88e-2)" "unprognostic (7.03e-3)" "unprognostic (1.77e-1)" 6.1 9.2 6.6 5.2 6.9 4.8 6.5 6.4 8.8 8.1 6.9 7.1 2.2 7.7 10.3 5.4 6.6 4.2 5.3 7.1 7.2 6.8 5.3 4.9 6.2 5.8 6.5 7.8 7.0 9.7 10.0 5.8 6.0 6.2 5.5 8.5 5.6 6.3 9.1 7.1 5.2 7.3 6.0 5.9 5.7 23.4 6.6 6.7 7.2 5.5 6.3 7.4 6.2 6.5 23.4 19.3 21.0 15.8 13.5 16.6 16.2 15.5 15.9 15.2 14.7 15.7 7.2 7.1 15.6 16.9 17.1 11.8 23.6 18.2 24.9 28.0 18.4 13.3 11.5 21.3 12.2 14.5 7.3 16.0 10.8 20.0 12.5 10.8 20.7 5.2 17.8 9.5 16.7 17.7 14.7 12.9 25.1 10.1 11.4 7.0 27.7 13.9 14.2 8.6 16.8 24.8 15.8 16.4 17.4 14.7 11.7 8.0 15.4 15.1 16.5 10.9 17.7 9.3 12.2 2.8 11.4 10.1 10.2 1.6 6.3 1.2 2.8 4.5 3.6 3.8 2.3 2.1 3.2 4.6 2.9 1.7 0.4 2.3 5.6 1.2 2.5 2.9 6.6 6.9 6.4 8.8 7.1 7.2 5.8 6.5 6.0 6.0 6.6 6.5 6.2 3.2 10.9 24.2 8.8 2.7 2.7 5.9 6.2 24.7 5.2 7.6 6.2 10.0 10.9 23.9 56.3 7.2 4.7 2.5 0.0 7.7 136.3 18.0 13.4 6.3 11.9 8.2 36.7 7.6 6.7 9.3 7.1 6.2 10.8 19.4 9.7 6.2 7.0 18.5 38.0 5.7 4.1 11.7 3.8 352.8 15.8 8.5 1.8 25.3 23.9 9.5 8.2 33.2 20.9 8.5 3.1 13.9 8.1 2.0 2.1 6.0 27.3 27.7 0.0 8.8 6.0 19.3 9.8 5.3 2.6 2.9 7.9 14.7 5.0 2.2 DIAPH3 "AN, AUNA1, DRF3, FLJ34705, NSDAN" ENSG00000139734 "Diaphanous related formin 3" Q9NSV4 13 59665583-60163928 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.1;testis: 18.9" "Cell type enriched" "Detected in many" 5 "Early spermatids: 414.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA032151 Supported "Plasma membrane,Microtubules" NA Yes "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 29: Early spermatids - Spermatogenesis" "Plasma membrane, Microtubules" "HPA032151: AB_2674181" "unprognostic (3.78e-2)" "unprognostic (1.28e-2)" "prognostic favorable (9.04e-4)" "prognostic unfavorable (4.18e-4)" "unprognostic (2.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.27e-4)" "prognostic unfavorable (3.72e-4)" "unprognostic (1.74e-2)" "unprognostic (2.19e-1)" "unprognostic (5.22e-5)" "unprognostic (3.59e-3)" "unprognostic (5.31e-5)" "unprognostic (4.30e-2)" "unprognostic (2.37e-1)" "unprognostic (4.07e-1)" "unprognostic (2.74e-3)" 0.4 0.1 0.1 1.7 0.2 7.1 0.8 0.3 0.3 0.3 0.2 1.9 1.9 0.6 0.0 2.1 0.1 0.4 0.1 0.1 0.2 0.8 0.2 1.2 2.4 0.2 0.3 0.1 0.2 0.1 0.0 3.5 0.2 0.1 2.1 0.0 0.5 0.0 0.0 1.3 1.6 2.6 0.1 0.5 1.6 18.9 0.3 5.4 0.1 0.0 2.4 0.6 0.7 0.2 47.7 15.6 15.8 9.1 2.7 7.1 26.9 65.0 28.7 64.2 55.6 41.7 31.4 15.9 5.2 33.4 16.7 31.7 26.0 25.5 96.9 18.0 17.9 22.7 37.6 9.5 4.1 31.2 17.4 2.8 0.6 39.2 26.3 16.3 29.2 14.0 17.8 21.9 61.8 6.9 28.0 10.2 14.7 22.5 8.9 18.8 38.9 12.9 19.9 9.6 8.3 14.3 33.2 22.8 9.5 33.8 16.7 16.8 29.3 40.5 25.9 13.7 54.5 14.7 17.1 24.4 10.9 15.2 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.3 0.3 0.1 0.2 0.2 0.3 0.2 0.1 0.3 0.2 0.6 54.5 3.4 39.8 1.9 3.7 0.8 2.1 2.8 0.0 3.9 1.5 1.0 2.8 1.8 0.0 0.0 21.1 1.1 3.8 5.9 1.3 414.4 2.5 3.5 2.1 0.0 26.7 5.6 4.0 30.7 5.8 9.7 9.3 0.0 78.8 1.8 0.4 6.1 0.0 3.3 2.6 2.0 1.0 1.2 56.0 0.6 1.5 0.0 5.6 0.1 3.5 2.1 19.1 1.8 1.5 0.2 0.0 18.9 0.4 1.1 5.4 0.2 0.0 0.0 0.0 7.9 39.2 17.8 11.6 1.1 7.3 2.2 2.8 5.6 1.5 DNAH2 "DNHD3, FLJ46675, KIAA1503" ENSG00000183914 "Dynein axonemal heavy chain 2" Q9P225 17 7717354-7833744 "Predicted intracellular proteins, Predicted membrane proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 13.1;parathyroid gland: 10.5;retina: 21.1" "Group enriched" "Detected in many" 4 "Respiratory ciliated cells: 43.0;Rod photoreceptor cells: 123.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.6;CACO-2: 4.0;CAPAN-2: 2.4;OE19: 1.8;SCLC-21H: 2.3;SiHa: 2.3" "Low region specificity" "Detected in some" HPA067103 Enhanced Approved Microtubules NA NA "Cluster 77: Retina - Visual perception" "Cluster 39: CACO-2 - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" Microtubules "HPA067103: AB_2685778" "unprognostic (2.03e-2)" "unprognostic (1.79e-2)" "unprognostic (2.23e-2)" "unprognostic (1.25e-1)" "unprognostic (3.92e-2)" "unprognostic (2.51e-1)" "unprognostic (1.35e-1)" "unprognostic (7.50e-3)" "unprognostic (1.29e-2)" "unprognostic (8.28e-2)" "unprognostic (2.51e-3)" "unprognostic (1.74e-1)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (8.74e-3)" "unprognostic (4.60e-2)" 0.4 0.1 1.5 0.1 2.4 0.5 0.5 1.0 1.1 1.2 7.1 0.2 0.2 0.5 1.6 0.1 13.1 0.4 0.1 1.8 1.1 0.1 0.4 1.9 0.1 5.6 6.8 2.5 0.5 10.5 0.4 1.7 2.8 0.3 0.2 21.1 0.1 0.0 0.1 0.2 0.1 0.2 3.5 0.2 0.2 6.5 1.1 0.3 0.3 0.0 0.1 0.2 0.1 1.8 2.6 0.1 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 4.0 2.4 0.1 1.1 0.0 0.0 0.2 0.0 0.6 0.0 0.1 0.1 0.0 0.3 0.1 0.6 0.1 0.1 0.2 0.0 0.4 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.5 0.1 0.2 0.2 1.8 0.8 0.1 0.2 0.0 0.0 0.7 2.3 0.1 2.3 0.0 1.2 0.2 0.2 0.1 0.1 0.2 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.6 0.1 0.0 0.1 0.0 0.0 1.5 2.4 1.0 1.1 1.8 1.1 5.6 6.8 2.8 3.5 1.1 1.8 1.1 0.0 1.1 1.3 0.7 0.3 1.0 1.7 0.0 2.7 0.6 1.0 1.9 0.0 3.6 0.0 2.1 0.0 0.0 0.0 0.0 0.4 6.2 20.2 0.6 1.2 6.7 0.0 6.1 0.0 0.0 0.8 0.0 0.8 0.0 2.3 0.4 0.1 0.1 1.7 4.9 0.5 8.2 0.3 0.7 2.3 0.3 0.2 0.0 1.0 0.0 4.6 0.0 3.0 2.1 0.1 1.1 0.0 0.0 0.7 0.0 0.4 43.0 123.9 0.0 1.0 1.0 9.6 2.6 0.0 0.1 0.0 0.2 0.5 0.2 0.9 DNAJA1 "dj-2, hdj-2, HSJ2, HSPF4, NEDD7" ENSG00000086061 "DnaJ heat shock protein family (Hsp40) member A1" P31689 9 33025273-33039907 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 438.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001306, CAB033665" Approved Supported Microtubules,Cytosol NA Yes 160000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 65: Brain - Ion transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Cytosol Microtubules "CAB033665: AB_2094242, HPA001306: AB_1079043" "unprognostic (3.11e-2)" "unprognostic (5.05e-2)" "unprognostic (5.14e-2)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (9.80e-2)" "unprognostic (3.17e-2)" "unprognostic (2.88e-2)" "unprognostic (5.58e-2)" "prognostic favorable (5.39e-4)" "unprognostic (1.69e-2)" "unprognostic (1.05e-1)" "prognostic favorable (3.40e-4)" "unprognostic (3.27e-1)" "unprognostic (2.65e-1)" "unprognostic (1.25e-1)" "unprognostic (4.70e-2)" 102.6 134.7 143.9 83.9 154.7 148.8 65.8 147.4 438.9 83.7 142.7 61.9 44.5 81.0 80.4 51.7 102.7 83.6 72.9 154.1 159.8 114.6 216.9 94.4 80.6 147.7 152.8 83.5 59.7 105.2 80.7 108.3 160.9 85.8 63.5 78.2 61.0 64.7 47.3 43.8 50.1 87.2 155.3 72.0 67.7 135.0 164.6 95.7 66.0 61.5 89.1 130.7 57.3 174.0 255.6 447.5 353.7 123.6 240.2 155.1 202.4 256.5 205.9 451.2 348.2 299.2 115.0 259.5 191.6 175.4 254.9 113.1 515.7 154.7 386.1 368.2 150.2 208.3 537.3 382.7 115.1 242.5 234.2 96.1 156.1 170.4 53.9 218.4 273.6 110.9 330.5 109.7 262.0 208.6 407.7 530.3 345.3 254.2 308.2 294.7 126.6 132.9 254.1 148.8 223.8 243.5 345.4 220.6 120.0 262.5 103.5 231.5 236.1 160.0 273.1 184.6 346.2 69.9 233.3 271.7 209.9 208.3 140.9 154.1 140.8 160.9 93.3 202.0 111.1 127.5 116.8 105.7 127.8 119.7 119.6 113.4 176.2 117.8 268.3 213.4 110.4 209.9 143.9 154.7 147.4 438.9 154.1 159.8 147.7 152.8 160.9 155.3 164.6 174.0 1110.8 214.7 154.9 7.8 368.7 264.6 942.8 245.3 327.8 209.3 307.8 513.5 187.7 95.8 257.7 82.8 208.5 274.0 619.1 287.9 172.1 247.7 536.4 549.2 348.2 427.8 391.1 198.9 16.2 181.1 341.6 392.8 188.6 526.1 424.7 127.6 133.2 129.6 231.1 121.1 16.7 327.3 213.6 156.0 497.4 222.2 99.1 402.3 284.6 22.5 243.7 150.5 91.6 8.0 22.5 189.8 334.7 94.8 195.8 393.8 134.7 178.1 417.8 161.7 105.2 391.1 476.0 492.7 209.4 238.5 265.4 464.9 678.9 179.2 273.3 636.8 DPY19L3 ENSG00000178904 "Dpy-19 like C-mannosyltransferase 3" Q6ZPD9 19 32405543-32485895 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 71.5;Horizontal cells: 79.1;Oligodendrocyte precursor cells: 97.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008325 Approved Approved Microtubules NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 68: Oligodendrocytes - Mixed function" Microtubules "HPA008325: AB_1847853" "unprognostic (9.58e-3)" "unprognostic (3.89e-1)" "unprognostic (2.24e-1)" "unprognostic (3.60e-1)" "unprognostic (5.21e-2)" "prognostic favorable (5.55e-4)" "unprognostic (2.00e-2)" "unprognostic (3.76e-2)" "unprognostic (1.28e-3)" "unprognostic (3.27e-1)" "prognostic favorable (1.70e-4)" "unprognostic (3.26e-1)" "unprognostic (1.02e-2)" "unprognostic (6.34e-2)" "unprognostic (1.87e-1)" "unprognostic (1.75e-1)" "unprognostic (9.72e-3)" 5.9 7.3 10.9 5.2 12.6 8.9 6.9 12.1 11.2 8.1 13.5 4.4 2.9 7.2 6.1 4.2 6.0 6.9 3.6 14.4 13.1 5.7 5.2 5.3 4.7 10.7 11.4 13.0 5.0 8.2 6.4 8.3 9.9 10.8 4.6 9.2 7.9 5.6 1.9 3.0 4.2 5.3 8.7 6.6 6.8 8.9 10.5 5.6 10.4 3.0 4.6 5.3 3.5 10.5 4.6 8.7 32.9 15.0 32.9 16.8 16.4 14.2 10.1 5.8 10.5 10.5 5.4 18.6 8.7 10.5 4.2 2.4 13.8 6.5 11.2 9.1 8.6 24.5 9.1 9.6 21.6 13.0 13.9 17.6 3.4 7.1 6.9 11.0 13.9 8.6 17.7 5.9 15.1 7.8 3.4 6.4 13.7 9.0 3.5 9.1 13.1 5.7 10.9 11.4 7.3 19.4 7.0 6.7 7.8 18.1 5.3 15.1 15.4 11.9 8.3 7.1 15.1 8.6 19.0 12.5 16.5 15.3 19.5 5.3 1.6 5.2 1.1 1.3 0.6 1.3 1.0 1.1 1.4 1.7 0.8 0.9 5.8 0.9 1.9 1.0 1.6 0.6 10.9 12.6 12.1 11.2 14.4 13.1 10.7 11.4 9.9 8.7 10.5 10.5 8.1 6.4 15.1 71.5 4.8 2.0 3.8 2.7 5.2 15.2 8.3 5.5 3.3 4.3 5.2 14.7 10.4 6.8 4.7 4.3 1.9 2.4 2.1 13.0 16.6 8.4 3.6 6.1 30.1 3.9 5.5 11.9 9.2 17.1 1.3 21.1 20.3 5.8 5.8 79.1 35.6 8.9 6.1 19.5 3.4 2.7 10.8 4.7 1.8 25.3 4.1 22.1 9.2 97.5 24.8 2.6 5.4 11.7 6.4 11.9 5.5 3.0 6.5 13.3 0.0 12.5 6.7 11.5 18.7 4.5 3.0 14.9 2.9 11.5 3.5 3.5 DST "BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2" ENSG00000151914 Dystonin Q03001 6 56457987-56954830 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 2368.6;Basal prostatic cells: 1651.4;Basal squamous epithelial cells: 3008.4;Cone photoreceptor cells: 1401.1;Oligodendrocytes: 1410.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 488.1;hTERT-HME1: 371.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030200 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA 16000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 57: Non-specific - Angiogenesis" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Microtubules" Cytosol "HPA030200: AB_10601901" "unprognostic (4.87e-3)" "unprognostic (1.29e-1)" "unprognostic (3.40e-1)" "unprognostic (1.54e-1)" "unprognostic (1.25e-2)" "unprognostic (3.60e-2)" "unprognostic (5.78e-2)" "unprognostic (2.35e-2)" "unprognostic (1.09e-1)" "unprognostic (2.75e-2)" "unprognostic (1.13e-1)" "unprognostic (3.69e-1)" "unprognostic (4.39e-2)" "unprognostic (5.13e-3)" "unprognostic (1.46e-1)" "unprognostic (2.66e-1)" "unprognostic (7.62e-2)" 60.9 86.2 206.5 16.2 275.8 3.3 117.3 240.6 221.9 158.8 143.3 173.2 25.4 167.1 38.2 66.1 103.9 32.6 166.0 194.6 230.7 52.2 80.8 108.0 11.3 258.1 250.4 78.2 39.8 36.7 78.8 28.7 263.4 84.5 32.4 87.4 100.3 48.7 143.1 166.2 64.2 106.0 209.1 36.7 68.9 28.4 243.3 31.4 29.8 104.1 15.2 90.4 113.2 325.4 62.4 26.6 41.2 20.8 79.5 103.5 24.6 82.2 89.7 37.8 42.1 17.1 15.5 10.4 32.2 220.7 35.6 46.7 34.4 161.2 73.0 52.3 45.2 17.8 49.5 31.4 65.9 15.0 0.4 58.3 488.1 92.5 371.6 69.1 73.3 9.5 12.6 38.2 113.9 20.2 5.1 6.8 27.7 35.6 21.9 0.1 28.8 16.5 118.8 83.0 47.2 37.8 32.7 11.7 64.1 67.7 18.6 27.2 176.5 77.3 55.9 37.0 68.9 39.6 28.6 5.0 55.8 8.8 40.3 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.9 0.3 1.3 0.0 0.1 206.5 275.8 240.6 221.9 194.6 230.7 258.1 250.4 263.4 209.1 243.3 325.4 193.2 336.5 11.8 1048.7 5.6 2368.6 1651.4 250.1 3008.4 673.1 81.0 301.5 862.8 77.2 161.7 55.2 1401.1 61.5 7.8 357.8 7.9 204.3 53.6 133.8 218.4 122.7 44.9 12.4 550.4 66.3 11.6 212.5 71.9 166.8 17.1 478.7 60.7 80.3 21.8 307.9 591.7 100.3 118.0 74.2 124.6 15.5 133.3 56.6 215.3 215.5 46.6 200.8 2.1 630.3 1410.3 194.1 283.0 152.4 27.2 229.8 124.2 10.3 52.0 122.6 65.7 381.8 196.6 20.0 13.7 298.2 857.2 26.5 19.7 30.5 48.1 142.8 DTNBP1 "BLOC1S8, DBND, Dysbindin, HPS7, My031" ENSG00000047579 "Dystrobrevin binding protein 1" Q96EV8 6 15522807-15663058 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction" "Albinism, Hermansky-Pudlak syndrome, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 127.0" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 173.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028053, HPA029615, HPA029616" Approved Enhanced Microtubules,Midbody Yes No "Cluster 48: NK-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" Microtubules Midbody "HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413" "unprognostic (2.83e-1)" "prognostic favorable (2.82e-4)" "unprognostic (1.62e-1)" "unprognostic (1.20e-1)" "unprognostic (4.93e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.72e-4)" "prognostic favorable (6.34e-5)" "unprognostic (1.36e-1)" "unprognostic (4.28e-3)" "unprognostic (2.21e-3)" "unprognostic (2.08e-1)" "unprognostic (1.88e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.81e-3)" "unprognostic (1.09e-2)" 16.2 9.3 40.8 17.6 60.1 16.7 14.8 35.1 46.6 13.2 32.5 26.0 11.8 13.5 18.3 11.3 11.6 12.6 21.5 42.8 45.7 18.0 8.6 14.7 29.3 40.2 41.9 11.0 11.9 21.0 11.5 14.9 40.8 13.8 16.4 127.0 13.7 14.8 26.8 13.6 17.4 17.8 38.0 22.1 17.1 12.0 44.3 21.4 13.2 16.0 30.9 19.8 12.5 37.8 30.6 12.9 10.9 23.7 15.5 17.8 16.6 15.3 20.0 36.0 32.4 17.6 13.7 42.9 40.5 21.8 29.6 10.4 21.8 16.3 32.6 27.3 28.9 30.2 15.4 25.7 27.3 30.6 24.8 16.9 24.7 18.5 26.8 16.6 32.2 29.0 29.3 10.2 22.1 35.9 31.9 48.7 7.7 25.4 18.6 37.7 21.2 33.4 33.7 31.7 22.1 9.5 12.1 28.4 36.4 25.1 20.6 19.4 15.2 20.5 13.4 21.2 28.6 27.7 57.3 30.9 9.5 27.1 39.5 11.1 10.1 14.4 19.5 12.4 13.1 24.8 16.5 17.2 11.0 31.3 15.5 12.6 11.6 49.3 9.0 30.8 12.1 11.5 40.8 60.1 35.1 46.6 42.8 45.7 40.2 41.9 40.8 38.0 44.3 37.8 23.2 12.8 11.3 35.3 42.6 29.1 16.5 12.5 11.4 47.2 14.3 13.1 29.3 15.7 11.4 14.7 58.4 41.4 29.6 18.6 37.2 37.5 50.5 16.3 9.8 31.7 13.8 5.5 36.3 35.8 17.9 16.9 14.3 14.5 54.6 54.1 20.0 6.0 54.8 25.2 38.6 17.5 8.2 18.5 32.4 26.6 10.2 22.1 37.4 39.4 29.8 55.2 64.9 26.7 36.3 26.5 12.1 15.4 20.2 12.9 27.2 81.6 13.0 173.4 6.6 12.3 20.8 22.3 18.3 8.6 22.0 16.7 29.1 11.0 19.2 12.0 DYNC1I2 "DIC74, DNCI2" ENSG00000077380 "Dynein cytoplasmic 1 intermediate chain 2" Q13409 2 171687409-171750158 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transport" "Motor protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033836, HPA040619, HPA053987" Supported Supported "Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol" NA NA 82000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum, Cytosol" "Nucleoli, Microtubules" "CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334" "unprognostic (3.01e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-2)" "unprognostic (8.15e-2)" "unprognostic (8.90e-2)" "unprognostic (1.37e-3)" "unprognostic (2.51e-3)" "unprognostic (6.30e-3)" "unprognostic (1.23e-1)" "unprognostic (1.89e-2)" "unprognostic (1.40e-2)" "unprognostic (4.19e-1)" "prognostic favorable (8.04e-4)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (1.35e-3)" "unprognostic (6.42e-2)" 65.1 58.5 89.2 44.4 121.1 23.1 65.3 122.6 185.9 62.3 70.4 62.3 54.3 74.5 51.0 68.3 47.1 58.6 65.9 89.2 101.4 80.0 41.3 51.7 38.7 130.5 116.2 71.7 38.7 68.2 29.4 76.2 124.1 59.9 64.7 63.5 46.7 60.3 51.0 48.8 51.0 80.4 104.0 41.4 49.3 55.9 112.9 60.0 56.3 57.7 47.4 72.3 53.3 155.5 87.5 55.0 167.0 61.9 151.2 144.0 94.2 149.2 115.7 122.9 133.7 96.5 84.4 79.2 127.7 178.8 168.0 86.2 132.5 143.5 159.8 30.1 59.7 69.3 65.7 109.6 75.5 80.0 71.7 113.0 133.4 152.3 97.3 171.7 219.1 76.5 112.1 21.3 246.1 54.4 68.9 65.7 77.0 127.0 55.5 68.7 149.8 58.3 163.3 138.0 105.8 116.6 82.7 65.6 90.6 126.0 64.1 77.3 238.3 185.9 91.9 75.2 90.9 26.3 54.0 64.5 126.8 64.2 139.2 209.6 93.9 49.2 50.7 98.0 54.3 77.2 58.1 59.4 68.7 71.1 51.7 49.5 5.8 64.4 100.1 111.8 66.2 39.6 89.2 121.1 122.6 185.9 89.2 101.4 130.5 116.2 124.1 104.0 112.9 155.5 146.2 198.7 60.6 30.3 49.2 50.6 59.2 138.5 19.9 73.1 101.7 87.1 75.4 158.7 124.8 169.2 64.6 101.9 46.3 169.5 131.0 207.6 129.5 118.2 147.3 117.1 84.3 95.2 102.4 161.5 107.5 91.2 42.8 172.6 102.3 69.3 174.9 150.7 101.1 80.8 104.9 140.0 116.0 148.1 39.8 48.0 128.6 75.9 35.6 45.9 156.2 91.3 70.0 35.7 182.4 189.2 126.9 138.0 22.7 44.7 139.2 270.3 108.0 128.9 111.7 61.4 111.0 248.4 95.2 43.2 60.0 115.6 46.7 60.6 123.9 58.5 DZIP1L "DZIP2, FLJ32844" ENSG00000158163 "DAZ interacting zinc finger protein 1 like" Q8IYY4 3 138061990-138115818 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 58.8;Respiratory ciliated cells: 74.0;Rod photoreceptor cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030404 Approved Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Cluster 45: Eosinophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA030404: AB_10601548" "unprognostic (3.65e-2)" "unprognostic (8.37e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-2)" "unprognostic (6.50e-2)" "unprognostic (6.47e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-2)" "unprognostic (3.13e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (1.51e-2)" "unprognostic (2.35e-3)" "unprognostic (2.72e-1)" "unprognostic (9.98e-2)" "unprognostic (2.77e-2)" 4.9 1.4 1.7 2.2 2.2 8.8 4.7 5.9 2.1 8.6 15.3 5.0 2.2 8.1 1.9 2.5 12.8 5.7 3.3 2.2 2.3 5.6 1.0 5.7 0.9 5.7 7.4 7.0 6.3 2.7 2.1 2.0 4.2 4.1 1.5 4.6 2.1 3.3 1.0 7.8 2.1 4.6 4.3 2.6 7.2 4.1 2.6 0.4 3.6 0.9 0.7 6.1 5.3 2.2 5.4 3.1 6.1 5.1 3.8 5.1 1.4 8.6 5.1 5.0 6.3 2.0 0.4 0.0 4.3 8.0 7.0 1.7 4.5 2.0 2.4 1.2 4.4 2.4 7.5 0.3 3.1 1.8 4.0 5.4 2.0 5.5 2.6 5.1 2.8 1.4 1.8 0.0 6.9 0.3 0.0 0.8 7.4 0.0 1.1 0.0 7.1 0.0 2.3 8.5 2.1 4.8 8.9 0.0 4.3 3.4 2.3 3.7 2.2 12.3 5.6 6.0 4.5 0.0 0.0 0.1 4.9 2.6 4.8 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 2.2 5.9 2.1 2.2 2.3 5.7 7.4 4.2 4.3 2.6 2.2 1.4 3.2 2.0 4.2 0.0 3.6 0.6 1.9 7.4 8.6 0.2 2.5 2.9 7.2 7.7 1.8 8.4 0.1 0.0 0.0 5.9 3.8 17.4 58.8 8.5 2.6 0.0 1.3 4.0 1.2 0.1 6.5 7.1 1.1 0.0 7.4 0.0 0.0 1.4 3.3 2.9 0.0 2.0 3.2 2.6 1.8 6.2 3.5 0.0 3.7 0.6 2.7 0.0 2.5 0.2 5.9 0.0 4.1 0.0 0.4 0.0 0.8 74.0 19.4 0.0 7.2 9.8 0.6 2.3 1.7 4.3 0.0 0.5 1.7 0.0 0.1 EMILIN3 "C20orf130, dJ620E11.4, EMILIN5" ENSG00000183798 "Elastin microfibril interfacer 3" Q9NT22 20 41359962-41366818 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 53.6" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 17.7;Granulosa cells: 7.6;Microglial cells: 4.7;Oligodendrocyte precursor cells: 3.5;Peritubular cells: 4.9;Skeletal myocytes: 3.2" "Group enriched" "Detected in many" 5 "glioma: 10.8;testis cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.3;HAP1: 11.1;NTERA-2: 7.0;SCLC-21H: 13.0" "Region enriched" "Detected in single" 30 "cerebellum: 3.3" "Region enriched" "Detected in single" 4 "spinal cord: 4.1" "HPA044034, HPA059912, HPA078559" Enhanced Approved "Golgi apparatus,Microtubules,Cytokinetic bridge" "Secreted to extracellular matrix" Yes NA 1200000 "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus" "Microtubules, Cytokinetic bridge" "HPA044034: AB_2678783, HPA059912: AB_2684158, HPA078559: " "unprognostic (1.66e-4)" "unprognostic (1.85e-2)" "unprognostic (2.50e-2)" "unprognostic (2.14e-1)" "unprognostic (2.65e-1)" "unprognostic (2.15e-2)" "unprognostic (1.71e-1)" "unprognostic (7.66e-2)" "unprognostic (2.18e-3)" "unprognostic (2.57e-1)" "unprognostic (6.54e-2)" "unprognostic (7.66e-2)" "unprognostic (3.13e-7)" "unprognostic (2.64e-2)" "unprognostic (1.05e-1)" "unprognostic (1.97e-1)" "unprognostic (9.62e-2)" 0.6 1.4 2.5 0.1 2.4 0.0 3.5 2.3 3.8 8.6 1.8 4.9 0.6 2.3 53.6 0.8 4.2 0.3 7.8 2.1 2.2 1.0 0.6 0.3 0.1 3.7 2.7 8.9 0.2 0.1 1.8 0.0 3.0 6.7 0.3 0.0 1.0 9.9 0.9 3.9 1.7 0.9 2.5 0.1 2.0 1.7 2.6 0.5 0.3 2.6 0.2 2.3 4.7 3.0 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 11.1 0.0 0.2 0.0 1.3 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.0 1.3 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.4 2.3 3.8 2.1 2.2 3.7 2.7 3.0 2.5 2.6 3.0 0.6 0.0 0.0 0.7 0.0 0.9 0.2 0.0 0.0 0.3 1.2 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 17.7 0.4 0.0 0.0 1.1 0.0 0.0 0.8 0.0 0.7 0.0 7.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 1.8 0.1 0.0 4.7 0.0 0.1 0.0 3.5 0.1 0.0 1.2 4.9 0.0 0.2 0.3 0.1 0.0 0.0 0.0 3.2 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 EML4 "C2orf2, ELP120, ROPP120" ENSG00000143924 "EMAP like 4" Q9HC35 2 42169353-42332548 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 186.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036687, HPA036688, HPA065337" Enhanced Supported Microtubules,Cytosol NA NA 25000 "Cluster 13: T-cells - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 24: Non-specific - Transcription regulation" Microtubules Cytosol "HPA036687: AB_2675251, HPA036688: AB_10671968, HPA065337: AB_2685474" "unprognostic (1.70e-1)" "unprognostic (1.38e-1)" "unprognostic (8.17e-2)" "unprognostic (3.53e-3)" "unprognostic (1.79e-2)" "unprognostic (9.19e-2)" "unprognostic (8.61e-3)" "unprognostic (1.61e-2)" "unprognostic (2.96e-3)" "unprognostic (6.80e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-2)" "unprognostic (1.86e-2)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" 11.2 13.7 1.5 32.4 2.5 41.1 14.1 1.0 1.4 11.7 3.9 23.6 38.8 11.1 4.6 11.1 9.9 19.9 4.6 1.6 1.0 19.4 38.1 24.3 28.3 2.2 1.6 8.9 24.3 13.8 4.3 35.6 1.6 9.7 23.7 10.3 21.0 8.0 2.4 18.3 36.5 14.1 2.0 28.3 20.9 20.4 3.7 14.9 21.5 3.9 30.0 27.3 5.7 2.8 45.1 76.7 43.7 34.9 15.6 25.4 47.7 27.3 21.4 29.7 28.5 80.8 55.1 41.1 18.5 26.9 45.6 22.7 38.0 26.3 51.3 80.8 31.8 37.7 23.5 186.3 19.7 28.8 37.1 27.9 9.8 39.4 26.5 14.4 20.9 14.0 37.9 40.3 32.5 26.4 27.3 7.7 44.8 57.8 21.9 27.8 69.2 24.3 24.2 64.3 42.9 86.3 26.9 27.7 20.8 39.6 14.4 11.4 24.6 30.1 39.9 24.3 24.9 44.9 33.3 34.6 26.3 27.0 21.6 5.6 4.7 9.9 9.0 13.7 19.0 13.9 15.0 14.8 4.1 9.1 12.8 9.6 12.3 11.9 14.6 5.3 22.3 7.6 1.5 2.5 1.0 1.4 1.6 1.0 2.2 1.6 1.6 2.0 3.7 2.8 47.0 60.9 107.3 37.9 137.6 67.3 74.3 60.5 75.1 35.1 53.5 45.7 7.0 51.5 60.9 40.5 47.9 143.0 120.8 57.0 17.6 34.0 33.1 33.4 50.1 50.8 102.3 20.8 54.2 75.4 47.5 55.3 76.0 86.6 48.1 80.7 43.9 61.9 65.6 16.8 60.0 69.3 34.6 40.3 56.6 31.0 23.9 74.8 16.0 119.9 38.4 35.1 47.4 62.8 32.9 38.1 58.9 23.0 139.5 65.4 51.3 41.3 28.6 47.3 6.6 25.0 47.6 46.5 39.4 73.4 79.7 118.9 223.8 42.0 85.0 96.4 ENSA "ARPP-19e, MGC4319, MGC78563, MGC8394" ENSG00000143420 "Endosulfine alpha" O43768 1 150600851-150629612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 11 "U-698: 8664.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051294 Uncertain Approved Nucleoplasm,Nucleoli,Microtubules,Cytosol NA NA 700000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 3: Monocytes - Immune response regulation" "Nucleoplasm, Nucleoli" "Microtubules, Cytosol" "HPA051294: AB_2681425" "unprognostic (6.27e-2)" "prognostic favorable (8.24e-4)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (2.58e-1)" "unprognostic (8.24e-2)" "unprognostic (1.94e-3)" "unprognostic (1.82e-1)" "unprognostic (2.02e-1)" "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (5.40e-2)" "unprognostic (2.21e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-1)" "unprognostic (7.64e-2)" "unprognostic (8.07e-3)" 140.5 106.6 151.2 115.1 156.7 219.8 154.9 133.6 188.2 145.2 132.6 135.9 133.6 117.8 183.3 288.0 100.5 94.9 120.2 161.6 144.1 118.8 148.8 124.0 128.4 137.2 135.6 102.4 108.5 173.0 92.0 103.7 134.2 97.7 123.9 121.8 122.9 94.6 301.0 241.3 132.7 105.8 136.9 99.7 124.1 45.2 147.4 157.8 134.4 212.3 146.7 147.0 165.6 157.0 287.1 170.8 236.9 206.9 149.7 126.8 220.7 141.0 148.4 199.9 171.7 207.3 216.6 288.9 196.8 122.1 125.1 238.3 198.5 325.4 160.1 415.1 277.4 434.3 239.6 158.2 108.3 372.1 462.6 100.5 202.0 214.1 293.6 118.8 206.2 224.8 321.7 551.8 140.9 775.5 302.3 272.6 431.2 386.2 211.1 298.6 199.9 328.0 299.2 306.0 303.8 193.3 201.6 385.6 222.1 200.8 533.9 442.9 208.2 143.9 261.9 171.8 340.3 309.4 441.4 8664.2 197.1 357.6 191.8 67.3 54.4 94.3 55.6 62.9 52.2 64.3 46.3 57.5 70.7 55.3 37.7 56.0 53.0 68.8 64.3 58.3 58.2 75.1 151.2 156.7 133.6 188.2 161.6 144.1 137.2 135.6 134.2 136.9 147.4 157.0 103.1 41.7 166.1 20.9 132.9 190.3 225.1 303.9 124.7 59.7 152.7 117.1 102.6 98.7 172.9 82.8 45.9 286.5 148.9 170.7 254.3 160.3 9.7 109.1 68.5 114.2 130.8 178.2 44.7 152.4 184.2 85.9 71.9 93.7 224.3 51.1 80.3 86.9 203.3 67.3 29.3 169.1 211.6 101.1 171.4 17.7 86.0 123.3 103.2 19.7 409.7 83.6 184.4 21.6 19.3 91.5 146.8 104.2 135.6 128.0 187.2 186.0 128.8 50.0 72.3 85.5 94.4 27.6 25.0 269.7 286.8 382.8 140.4 87.9 163.9 253.7 ENTPD1 "ATPDase, CD39, NTPDase-1, SPG64" ENSG00000138185 "Ectonucleoside triphosphate diphosphohydrolase 1" P49961 10 95711779-95877266 "CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" Hydrolase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 74.1;Kupffer cells: 110.4;Langerhans cells: 161.3;Microglial cells: 217.4;monocytes: 112.2;Plasma cells: 80.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 17.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 102.2" "Group enriched" "Detected in all" 4 "dendritic cells: 31.9;granulocytes: 102.2;monocytes: 41.0" "Group enriched" "Detected in many" 7 "HDLM-2: 147.5;Karpas-707: 135.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002494, HPA014067, CAB079986" Enhanced Uncertain Microtubules NA NA 19000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 2: Karpas-707 - Immune response" "Cluster 41: Macrophages - Immune response" Microtubules "CAB002494: AB_563557, CAB079986: , HPA014067: AB_1848178" "unprognostic (1.14e-1)" "unprognostic (1.01e-2)" "unprognostic (3.11e-1)" "unprognostic (5.67e-2)" "unprognostic (9.68e-3)" "unprognostic (3.45e-3)" "unprognostic (6.31e-2)" "unprognostic (5.26e-3)" "unprognostic (2.73e-1)" "unprognostic (1.28e-2)" "unprognostic (6.40e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.33e-5)" "unprognostic (9.79e-2)" "unprognostic (2.30e-1)" "prognostic favorable (7.89e-4)" "unprognostic (5.09e-2)" 11.8 8.3 5.9 24.7 5.5 27.5 10.8 5.0 6.3 17.5 5.0 14.3 9.3 28.0 19.3 19.2 14.0 27.7 8.5 5.3 6.3 7.6 5.4 16.1 20.2 7.1 6.5 5.5 2.8 3.4 3.9 11.4 7.7 11.2 12.8 6.8 6.0 18.1 4.0 6.3 11.7 49.7 6.2 21.5 7.3 4.5 7.5 6.8 20.0 8.7 25.6 30.6 11.0 6.3 1.4 2.7 5.4 7.1 0.1 0.1 5.0 4.5 1.2 0.0 0.0 4.0 1.6 8.2 3.1 0.0 5.3 2.2 0.0 0.0 0.0 147.5 5.2 7.2 4.0 4.3 0.0 12.5 4.1 0.1 0.0 0.6 0.0 2.4 18.2 2.0 5.3 135.4 0.1 4.4 4.7 5.8 5.9 3.6 2.8 15.3 2.4 4.4 1.7 2.2 5.1 6.2 3.6 3.7 3.9 3.6 5.5 5.9 3.9 3.9 2.8 3.8 5.3 21.6 7.2 0.6 4.3 13.9 2.7 0.7 41.0 102.2 0.6 27.2 1.1 13.7 1.6 1.1 31.9 11.4 0.6 0.6 49.4 1.5 6.7 2.1 13.1 15.5 5.9 5.5 5.0 6.3 5.3 6.3 7.1 6.5 7.7 6.2 7.5 6.3 19.6 0.0 1.1 74.1 40.9 8.9 0.3 0.0 0.6 1.4 0.8 1.5 10.1 0.0 0.7 1.8 2.1 0.6 3.7 0.3 1.9 0.0 10.3 0.6 3.6 60.6 0.0 4.4 2.8 2.0 1.9 15.7 6.1 0.6 3.8 0.3 31.4 0.8 26.6 0.0 5.2 0.1 0.0 110.4 161.3 7.3 0.6 62.1 16.0 217.4 112.2 0.4 0.0 20.6 5.0 0.2 1.2 3.0 80.1 0.5 0.1 0.3 0.8 0.8 6.6 1.0 22.7 10.1 4.4 0.8 11.2 15.7 26.9 15.1 1.0 0.5 ERI1 "3'HEXO, THEX1" ENSG00000104626 "Exoribonuclease 1" Q8IV48 8 9002147-9116746 "Predicted intracellular proteins" "RNA-mediated gene silencing, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033838, HPA055548, HPA056074" Uncertain Approved Vesicles,Microtubules NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Microtubules Vesicles "CAB033838: AB_2098575, HPA055548: AB_2682845, HPA056074: AB_2683029" "unprognostic (2.49e-1)" "unprognostic (1.13e-1)" "prognostic favorable (8.05e-5)" "unprognostic (1.96e-2)" "unprognostic (2.79e-2)" "unprognostic (2.61e-3)" "unprognostic (1.08e-3)" "unprognostic (2.90e-1)" "unprognostic (5.50e-2)" "unprognostic (1.49e-1)" "unprognostic (1.25e-3)" "unprognostic (4.23e-1)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.27e-2)" "unprognostic (3.57e-1)" "unprognostic (8.75e-2)" "unprognostic (2.36e-2)" 5.3 3.1 3.1 6.5 3.8 13.0 4.8 3.7 4.1 4.3 3.5 3.8 4.7 4.7 2.5 4.3 3.9 3.9 2.8 3.0 3.5 4.2 4.4 5.1 7.4 4.5 3.9 4.2 3.0 4.2 2.5 6.7 3.7 3.2 4.6 11.3 3.8 3.2 2.4 3.2 3.8 5.1 3.8 5.0 3.6 9.1 3.8 6.9 2.9 2.7 7.4 6.2 3.5 4.1 32.3 19.9 17.2 13.1 13.4 21.7 23.5 27.4 14.4 19.6 24.1 14.8 14.4 36.7 7.0 15.7 32.7 11.2 15.1 18.5 27.3 15.1 10.8 20.3 15.8 11.5 13.7 15.6 28.6 12.9 6.1 16.3 14.4 10.9 26.8 21.6 23.3 22.6 22.8 10.5 47.2 19.3 20.0 24.2 12.1 20.1 25.1 13.7 25.2 45.6 2.4 18.8 16.4 12.5 13.8 12.1 9.3 13.9 23.2 20.7 21.4 39.5 21.6 4.9 18.1 31.9 15.3 22.2 16.5 6.4 4.6 3.4 4.2 5.1 4.3 5.3 4.9 4.4 3.9 3.9 3.8 3.6 3.3 6.0 3.5 2.9 9.8 3.5 3.1 3.8 3.7 4.1 3.0 3.5 4.5 3.9 3.7 3.8 3.8 4.1 9.2 3.2 8.1 17.6 9.7 18.2 9.6 6.7 3.4 17.4 8.6 5.0 5.7 2.8 10.1 3.7 14.6 25.3 11.3 7.4 3.9 9.0 46.9 14.8 14.4 8.6 3.6 18.7 11.4 12.0 27.6 9.1 8.6 23.3 8.2 7.7 11.4 4.8 13.5 5.0 9.7 5.2 8.2 9.7 15.9 16.7 6.5 12.9 10.6 9.4 11.9 8.0 6.2 9.5 16.7 11.2 5.6 9.1 11.2 6.3 4.3 8.2 9.1 21.6 13.1 7.8 7.5 43.6 45.6 6.1 10.1 20.8 11.7 5.9 6.8 3.8 ERP29 "C12orf8, ERp28, ERp31, PDI-DB, PDIA9" ENSG00000089248 "Endoplasmic reticulum protein 29" P30040 12 112013348-112023449 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039363, HPA039456" Enhanced Uncertain Nucleoplasm,Microtubules "Intracellular and membrane" NA NA 900000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Microtubules Nucleoplasm "HPA039363: AB_10673422, HPA039456: AB_10672963" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (1.96e-1)" "prognostic favorable (7.43e-5)" "unprognostic (1.13e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (1.21e-1)" "unprognostic (5.10e-3)" "unprognostic (2.58e-1)" "unprognostic (3.21e-1)" "unprognostic (2.74e-3)" "unprognostic (3.34e-1)" "unprognostic (1.76e-1)" "unprognostic (6.26e-2)" 62.7 100.9 56.9 77.9 58.0 202.3 84.0 65.1 62.0 78.4 91.1 94.5 100.7 60.5 109.8 91.5 74.8 64.1 59.0 56.0 68.7 93.0 179.9 78.8 123.8 61.1 62.6 78.9 174.6 123.6 99.1 73.0 64.2 93.4 91.3 68.3 122.7 87.4 34.3 113.3 96.1 47.1 57.8 118.3 131.4 57.6 60.8 107.6 90.4 34.3 111.2 75.9 71.0 61.6 145.4 137.2 98.8 194.2 367.4 143.7 211.3 139.2 163.7 108.5 139.3 215.2 164.4 152.7 106.4 244.5 117.8 175.4 187.8 181.2 89.3 133.7 104.2 174.3 150.1 239.2 246.8 432.1 164.0 207.5 227.6 178.4 201.6 287.4 156.1 157.9 203.2 277.3 84.7 166.6 140.9 765.7 161.5 513.1 102.5 114.2 120.9 501.2 229.8 213.5 88.6 119.8 173.6 140.1 426.1 187.4 177.1 575.7 116.5 92.6 142.7 88.8 103.3 303.4 379.8 128.0 157.8 268.5 73.2 96.2 241.4 346.2 131.6 178.8 140.4 259.1 170.7 164.1 229.7 264.1 186.5 154.9 47.5 86.5 170.9 455.8 179.6 307.4 56.9 58.0 65.1 62.0 56.0 68.7 61.1 62.6 64.2 57.8 60.8 61.6 102.6 83.3 183.4 13.7 324.8 141.4 205.5 249.3 132.6 125.3 207.8 199.9 91.6 198.8 178.0 185.8 110.5 497.7 396.6 210.1 93.9 239.5 7.7 142.1 84.9 114.9 197.9 134.4 14.4 211.8 405.3 118.3 131.5 149.9 88.8 164.4 146.3 346.6 373.1 80.8 20.6 280.6 343.8 306.9 192.6 16.6 128.9 230.4 168.9 12.2 269.0 152.8 160.6 11.6 22.8 128.7 288.0 106.8 350.1 195.4 355.5 274.6 187.0 164.9 52.6 79.2 112.2 100.3 195.3 143.1 161.0 441.6 221.7 252.4 285.2 219.8 ESRRA "ERR1, ERRa, ERRalpha, ESRL1, NR3B1" ENSG00000173153 "Estrogen related receptor alpha" P11474 11 64305497-64316743 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.3" "Cell type enhanced" "Detected in all" "Distal enterocytes: 159.2;Hepatocytes: 266.3;Proximal enterocytes: 199.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053785, HPA077297" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge" Yes No "Cluster 8: Neutrophils - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 2: Hepatocytes - Metabolism" "Nucleoplasm, Nucleoli fibrillar center, Microtubules" "Cytokinetic bridge" "HPA053785: AB_2682260, HPA077297: " "unprognostic (7.63e-2)" "unprognostic (1.51e-1)" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (3.08e-1)" "unprognostic (7.24e-2)" "unprognostic (1.07e-1)" "unprognostic (2.97e-1)" "unprognostic (2.98e-1)" "unprognostic (3.52e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.34e-7)" "unprognostic (3.43e-3)" "unprognostic (3.19e-2)" "unprognostic (2.38e-2)" "unprognostic (7.20e-2)" 27.3 35.5 25.5 15.8 29.8 16.3 23.6 36.4 31.4 17.5 33.6 67.6 81.8 15.5 4.7 62.7 14.6 10.2 154.9 23.5 31.6 70.3 91.5 30.9 11.0 30.9 31.7 8.1 56.3 23.9 15.9 15.4 29.8 26.4 22.9 5.1 48.5 12.6 195.3 35.9 65.4 7.1 26.6 32.0 52.4 8.4 37.5 8.4 28.3 88.8 12.4 31.0 28.8 23.7 25.9 40.2 9.8 23.6 13.0 12.7 54.2 25.0 11.9 9.2 9.0 37.4 30.3 34.9 45.1 12.8 23.7 66.0 16.9 33.0 3.5 23.0 21.0 22.9 51.7 30.1 18.0 39.3 55.3 17.4 49.8 20.7 27.0 12.8 12.8 18.1 37.9 18.7 15.3 57.9 19.4 55.9 27.9 30.4 74.4 20.4 19.7 79.6 31.1 52.4 20.6 26.2 12.8 81.2 83.8 5.5 25.8 38.2 28.9 16.6 20.4 47.4 25.6 28.6 25.5 23.6 26.9 38.2 13.4 0.2 2.9 4.8 2.7 5.4 2.6 1.7 2.3 1.9 2.7 2.3 2.3 3.3 5.3 1.8 5.1 2.1 3.6 1.7 25.5 29.8 36.4 31.4 23.5 31.6 30.9 31.7 29.8 26.6 37.5 23.7 20.8 9.6 22.7 21.2 14.7 18.6 41.0 29.7 18.8 28.8 30.9 24.3 9.2 100.1 21.3 20.2 33.3 103.8 20.9 159.2 54.8 51.3 3.4 18.7 17.4 15.3 37.8 19.4 13.6 80.2 61.3 12.4 39.8 20.3 7.6 9.3 35.0 266.3 33.6 33.7 16.6 82.5 28.5 82.7 11.7 1.1 6.5 22.2 17.8 11.2 28.8 20.1 27.8 9.0 6.4 81.1 103.1 12.0 8.2 42.8 199.7 82.2 19.8 20.4 13.1 18.7 21.7 3.5 7.1 26.3 18.5 134.2 14.5 22.2 113.7 65.0 EVC2 LBN ENSG00000173040 "EvC ciliary complex subunit 2" Q86UK5 4 5542772-5709548 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Ciliopathy, Disease variant, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 17.6;Basal squamous epithelial cells: 12.0;Fibroblasts: 8.9;Leydig cells: 11.5;Skeletal myocytes: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 9.7;HHSteC: 13.0;hTERT-HME1: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040910, HPA048122" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" "Microtubules, Cytokinetic bridge" "Nucleoplasm, Cytosol" "HPA040910: AB_2677195, HPA048122: AB_2680272" "unprognostic (6.56e-2)" "unprognostic (6.74e-2)" "unprognostic (5.10e-2)" "unprognostic (2.25e-1)" "unprognostic (8.23e-3)" "unprognostic (2.80e-1)" "unprognostic (2.05e-2)" "unprognostic (1.22e-2)" "unprognostic (1.71e-1)" "unprognostic (1.28e-1)" "unprognostic (8.57e-2)" "unprognostic (9.37e-2)" "prognostic favorable (1.58e-4)" "unprognostic (2.51e-2)" "unprognostic (3.14e-1)" "unprognostic (5.61e-2)" "unprognostic (6.29e-5)" 4.8 0.7 1.3 1.5 1.4 0.1 3.6 1.2 1.1 6.0 2.3 3.7 0.6 4.7 1.7 2.2 4.7 2.7 3.1 1.3 1.4 2.6 0.7 2.1 1.9 1.6 1.5 7.8 1.7 3.1 1.1 1.3 1.2 3.2 0.6 0.3 2.8 2.0 1.1 3.8 2.0 2.3 1.4 1.0 2.1 1.6 1.5 1.0 3.8 1.9 1.7 4.1 4.4 1.3 0.0 2.7 0.0 6.6 8.4 9.3 0.0 4.1 9.7 3.6 6.0 0.0 0.0 5.2 0.0 3.3 2.0 2.8 0.0 1.7 3.4 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 5.9 4.6 4.6 10.6 0.0 3.9 0.0 0.0 0.2 5.3 0.0 0.0 0.0 3.9 0.0 0.0 8.6 8.2 0.0 0.4 0.0 0.4 0.6 0.0 0.0 0.0 1.6 0.0 0.5 6.7 0.0 0.0 2.4 0.0 4.1 4.7 1.2 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 1.4 1.2 1.1 1.3 1.4 1.6 1.5 1.2 1.4 1.5 1.3 0.6 0.0 0.5 17.6 0.8 2.2 4.9 2.3 12.0 0.0 0.9 2.2 1.0 1.5 1.3 0.0 0.0 8.3 1.7 0.0 0.0 1.9 2.2 0.7 5.6 1.2 0.0 0.4 0.3 0.5 0.3 8.9 0.5 1.7 2.5 4.7 1.4 0.1 0.5 0.0 0.3 0.0 0.0 0.3 1.2 0.9 11.5 0.8 0.0 6.5 0.0 1.9 1.0 1.0 0.3 0.6 0.0 7.9 1.7 2.8 0.0 0.9 1.0 0.1 0.0 14.7 3.2 1.8 2.1 4.4 0.9 1.4 2.8 3.4 0.0 1.4 EXOC1 "BM-102, FLJ10893, SEC3, SEC3L1, Sec3p" ENSG00000090989 "Exocyst complex component 1" Q9NV70 4 55853648-55905086 "Predicted intracellular proteins, Transporters" "Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037706, HPA044873" Uncertain Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane" "Microtubules, Cytosol" "HPA037706: AB_10670525, HPA044873: AB_2679125" "unprognostic (7.10e-3)" "unprognostic (4.48e-2)" "unprognostic (8.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.81e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (2.63e-4)" "unprognostic (2.84e-3)" "unprognostic (4.65e-2)" "unprognostic (2.04e-2)" "unprognostic (4.03e-3)" "unprognostic (1.55e-1)" "unprognostic (1.94e-1)" "unprognostic (3.11e-1)" "unprognostic (2.93e-2)" "unprognostic (6.24e-2)" "prognostic favorable (5.50e-5)" 19.7 16.5 18.1 17.3 20.4 12.7 20.0 20.4 20.0 18.9 18.7 18.0 16.8 16.6 20.4 29.3 16.5 15.5 16.5 18.3 20.0 15.9 10.2 17.4 18.3 21.1 19.2 15.1 12.9 20.5 14.5 20.8 20.3 14.3 19.1 18.5 17.4 12.8 13.6 28.1 16.2 15.7 20.4 20.8 15.6 16.9 20.1 13.9 16.3 13.5 20.0 16.2 20.1 25.1 21.8 12.4 21.9 25.3 36.9 45.9 14.6 30.2 30.1 24.1 25.1 8.6 37.1 20.9 20.6 32.6 29.1 25.4 18.0 23.9 34.5 11.1 12.4 19.4 14.8 10.1 34.7 21.3 26.4 37.4 32.1 25.1 27.6 31.2 39.9 16.0 28.3 20.1 53.0 13.8 15.6 21.5 13.9 31.2 23.4 18.0 16.4 17.1 26.9 23.6 16.2 28.7 18.0 29.2 25.5 18.5 18.6 22.6 48.5 29.7 24.2 25.8 26.3 23.9 12.7 18.4 38.6 23.4 28.8 21.3 14.6 13.1 6.5 19.0 8.8 8.4 9.2 9.5 14.3 8.3 8.3 6.0 19.5 12.5 23.6 6.4 11.6 7.9 18.1 20.4 20.4 20.0 18.3 20.0 21.1 19.2 20.3 20.4 20.1 25.1 44.7 41.7 38.0 77.4 24.5 34.8 14.8 34.0 22.2 48.8 26.4 21.2 29.1 17.2 35.6 22.0 31.3 60.8 21.4 38.3 19.6 23.6 45.3 41.0 47.5 39.0 22.2 19.6 72.6 20.0 31.6 28.9 22.4 37.2 36.7 35.5 40.0 12.3 40.9 28.6 86.5 28.8 24.4 37.7 47.4 16.7 21.5 37.8 40.9 56.2 38.7 40.3 22.6 73.4 138.0 36.2 32.4 23.7 19.0 17.4 37.6 21.9 44.7 32.5 32.9 25.9 27.9 47.6 31.6 42.5 39.9 51.2 27.8 44.6 28.7 26.8 F11R "CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1" ENSG00000158769 "F11 receptor" Q9Y624 1 160995211-161021343 "CD markers, Plasma proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 253.2;Urothelial cells: 242.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "eosinophil: 165.5;neutrophil: 113.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 165.5" "Cell line enhanced" "Detected in many" "HaCaT: 205.4;OE19: 202.4;SuSa: 232.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004671, HPA043616, HPA061700" Enhanced Supported "Cell Junctions,Microtubules" NA NA 1900000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Microtubules "Cell Junctions" "CAB004671: AB_425964, HPA043616: , HPA061700: AB_2684589" "unprognostic (1.60e-2)" "unprognostic (5.78e-3)" "unprognostic (1.78e-3)" "unprognostic (2.24e-1)" "unprognostic (4.99e-2)" "unprognostic (4.89e-2)" "unprognostic (2.28e-1)" "unprognostic (2.55e-1)" "unprognostic (6.35e-2)" "unprognostic (1.98e-3)" "unprognostic (1.87e-2)" "unprognostic (1.24e-1)" "unprognostic (1.78e-1)" "unprognostic (2.50e-1)" "unprognostic (1.59e-1)" "unprognostic (9.72e-3)" "unprognostic (5.01e-2)" 21.1 24.5 6.6 20.8 6.3 21.3 26.8 6.0 8.2 24.2 9.6 52.6 55.9 11.9 21.1 85.5 33.1 28.7 12.8 6.3 6.5 40.4 73.6 67.1 13.2 7.8 7.5 14.0 41.7 36.3 18.8 50.7 7.5 28.7 51.7 2.2 49.4 21.2 6.1 48.2 64.0 9.0 7.2 21.5 52.6 13.0 8.6 16.5 39.2 6.3 32.0 52.2 44.1 7.1 122.9 15.5 4.7 1.4 3.3 0.2 95.5 0.6 0.1 4.0 4.1 113.5 155.9 8.9 78.6 0.2 22.6 205.4 25.3 105.2 6.4 6.9 17.8 25.8 6.2 52.3 4.8 24.2 72.6 1.4 132.5 0.6 32.7 24.1 98.6 18.8 35.6 2.5 0.6 53.5 7.6 13.6 80.1 202.4 21.9 11.3 0.0 39.2 67.2 94.4 34.3 8.8 29.2 123.4 26.2 232.8 132.6 41.7 58.8 0.3 3.0 0.4 1.2 28.2 59.3 3.1 18.0 23.4 7.5 34.6 31.0 165.5 12.6 16.3 6.7 4.7 11.7 8.0 24.6 2.9 11.1 8.8 113.4 8.2 13.0 18.7 5.7 25.1 6.6 6.3 6.0 8.2 6.3 6.5 7.8 7.5 7.5 7.2 8.6 7.1 27.7 253.2 137.2 0.0 9.8 35.2 119.7 86.2 64.3 0.9 35.0 15.5 3.3 67.2 136.2 77.3 2.1 78.6 10.2 154.9 7.9 76.8 7.2 120.8 13.9 41.5 62.2 10.3 2.7 71.0 176.2 9.1 66.8 150.9 18.3 13.7 34.2 68.8 31.0 0.0 1.1 71.5 46.8 14.4 25.5 2.1 2.1 24.7 8.8 7.5 48.7 1.5 13.4 3.0 0.4 91.4 114.1 0.7 10.8 135.3 82.5 12.6 178.8 2.4 0.0 5.1 6.2 13.4 2.9 102.3 50.6 63.1 12.3 8.1 50.7 242.0 FAM83D "C20orf129, CHICA, dJ616B8.3" ENSG00000101447 "Family with sequence similarity 83 member D" Q9H4H8 20 38926312-38953106 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 84.7;intestine: 83.1;smooth muscle: 95.3" "Group enriched" "Detected in many" 4 "Basal squamous epithelial cells: 44.9;Erythroid cells: 72.6;Extravillous trophoblasts: 67.5;Squamous epithelial cells: 71.7;Syncytiotrophoblasts: 152.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.1;NK-cells: 1.1;T-cells: 2.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049333, HPA060854" Supported "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Cluster 26: Non-specific - Mitochondria" "Cluster 37: Intestine - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 61: Squamous epithelial cells - Keratinization" "Mitotic spindle" "Microtubules, Cytokinetic bridge, Cytosol" "HPA049333: AB_2680717, HPA060854: " "unprognostic (7.90e-3)" "unprognostic (4.34e-2)" "unprognostic (6.41e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (5.44e-6)" "prognostic unfavorable (9.69e-4)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.73e-5)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.81e-14)" "unprognostic (2.57e-3)" "unprognostic (5.74e-2)" "unprognostic (2.82e-1)" "unprognostic (4.87e-2)" 1.6 1.8 0.8 7.2 1.6 23.3 1.1 0.9 1.4 4.1 0.2 83.1 8.4 1.0 1.6 84.7 1.0 13.6 1.0 0.9 0.5 5.7 3.7 5.2 4.5 0.5 0.4 0.5 0.4 0.2 0.4 3.4 0.5 16.2 8.6 0.2 7.8 1.7 0.2 10.2 34.7 95.3 0.5 1.9 44.9 5.0 0.5 6.6 1.0 0.2 12.2 27.0 17.1 0.9 112.2 67.3 52.0 44.0 5.8 6.5 93.6 49.3 30.2 94.7 57.4 103.4 49.7 28.3 47.6 32.1 73.4 93.1 71.8 83.9 87.9 9.4 28.6 32.6 50.7 75.2 4.7 14.6 16.5 3.3 4.2 54.6 31.4 11.4 52.7 12.3 29.6 39.5 54.4 59.7 22.7 21.3 43.2 64.4 85.1 21.8 96.0 15.6 27.6 28.0 24.3 40.2 143.0 117.4 20.6 48.1 73.6 14.9 25.4 62.4 76.4 71.6 110.1 12.0 19.6 29.0 28.1 21.2 46.7 0.0 0.0 0.0 0.2 0.1 0.9 0.6 1.0 1.1 0.0 1.1 1.1 1.4 0.0 1.1 0.1 0.0 2.0 0.5 0.8 1.6 0.9 1.4 0.9 0.5 0.5 0.4 0.5 0.5 0.5 0.9 3.9 0.0 1.3 0.3 2.3 2.3 5.8 7.0 44.9 0.0 2.8 9.0 0.8 1.5 18.0 0.0 0.0 17.3 6.3 6.5 0.0 0.1 0.5 1.1 1.6 2.2 1.8 72.6 3.7 0.0 67.5 2.7 18.3 2.1 0.0 8.2 1.8 5.7 4.8 0.0 1.2 6.0 4.1 1.6 0.5 0.6 0.3 2.6 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 6.0 0.0 12.5 1.6 1.7 8.3 4.5 0.0 19.7 0.3 4.0 15.7 18.3 71.7 1.8 152.6 5.2 0.3 10.2 4.1 FAM91A1 FLJ23790 ENSG00000176853 "Family with sequence similarity 91 member A1" Q658Y4 8 123768439-123815452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027978 Approved Approved Nucleoplasm,Microtubules NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Microtubules" "HPA027978: AB_10600004" "unprognostic (2.21e-2)" "unprognostic (6.13e-2)" "unprognostic (2.95e-2)" "unprognostic (4.56e-3)" "unprognostic (2.39e-1)" "unprognostic (3.80e-2)" "unprognostic (4.42e-3)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (8.55e-2)" "unprognostic (2.30e-2)" "unprognostic (1.16e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (2.58e-1)" "unprognostic (5.40e-2)" "unprognostic (6.19e-2)" 12.9 11.7 6.8 15.9 7.9 42.9 14.0 8.4 8.2 12.8 12.2 13.0 14.5 13.8 11.9 13.1 10.3 16.0 7.1 7.0 9.0 18.4 26.6 13.1 18.7 9.1 8.2 12.8 14.0 21.0 9.3 20.2 8.6 11.6 14.8 11.7 11.4 11.0 6.1 11.6 14.2 11.7 8.7 19.6 13.9 10.9 8.5 14.3 18.3 6.2 17.0 17.1 10.6 11.6 63.9 42.4 12.9 22.4 24.4 26.3 20.8 36.2 39.4 33.7 42.5 21.3 25.8 29.9 39.2 29.9 26.7 30.4 30.8 39.2 60.0 57.5 29.8 47.2 21.9 25.6 38.0 21.7 58.9 25.0 31.1 44.1 54.3 23.0 31.0 18.4 17.1 41.3 30.7 75.8 37.7 14.4 12.7 51.8 37.3 20.4 21.5 22.4 28.4 64.7 15.5 21.6 48.1 102.4 49.8 18.8 31.5 22.9 31.5 32.0 57.4 35.7 53.1 31.9 65.8 28.4 50.2 38.7 39.9 7.0 8.0 11.3 3.2 9.5 2.9 5.1 3.2 2.7 8.2 4.2 2.7 3.7 10.1 5.9 8.5 3.1 3.1 4.3 6.8 7.9 8.4 8.2 7.0 9.0 9.1 8.2 8.6 8.7 8.5 11.6 31.9 25.6 13.2 17.6 30.6 39.6 21.9 19.0 20.5 15.0 24.0 17.7 8.4 22.8 19.3 25.8 22.9 10.4 25.3 21.3 5.9 12.1 22.4 20.8 22.9 27.5 27.5 10.3 21.0 15.5 12.7 19.3 26.5 33.0 8.8 18.2 18.5 59.3 27.1 23.5 22.0 22.0 16.2 73.6 43.5 26.0 14.0 45.9 21.4 24.4 40.1 17.6 19.6 23.6 45.8 35.1 21.7 14.7 25.8 34.8 18.7 20.8 16.5 21.7 13.1 26.5 22.4 14.2 10.7 27.0 46.7 19.2 19.6 16.0 14.5 45.3 FBXL20 "Fbl2, Fbl20, MGC15482" ENSG00000108306 "F-box and leucine rich repeat protein 20" Q96IG2 17 39252663-39402523 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 122.6;Inhibitory neurons: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "SK-BR-3: 65.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044748, HPA050397" Uncertain Supported Microtubules NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Microtubules "HPA044748: AB_2679072, HPA050397: AB_2681112" "unprognostic (7.21e-2)" "unprognostic (1.00e-1)" "unprognostic (2.23e-1)" "unprognostic (1.01e-1)" "unprognostic (1.33e-1)" "unprognostic (7.55e-2)" "unprognostic (5.10e-2)" "unprognostic (1.32e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (9.54e-4)" "unprognostic (1.65e-1)" "unprognostic (3.29e-1)" "unprognostic (9.95e-2)" "unprognostic (2.19e-1)" "unprognostic (2.60e-1)" "unprognostic (2.04e-2)" "unprognostic (1.90e-2)" 4.1 5.4 7.8 3.4 8.2 8.2 4.5 6.8 11.4 4.6 1.0 4.1 3.5 4.4 3.4 4.1 4.0 3.7 3.5 8.8 9.7 4.1 4.7 4.0 3.6 3.3 4.8 4.7 4.3 4.6 3.5 5.5 5.0 3.7 4.1 8.3 3.7 3.5 3.6 6.5 4.2 5.0 2.3 4.4 3.8 12.7 8.8 7.5 3.9 5.2 4.0 3.9 4.3 5.2 4.0 8.2 8.0 8.5 10.1 7.2 4.6 5.6 7.5 6.3 7.7 2.6 9.3 6.3 12.3 7.3 12.6 9.3 9.4 6.5 9.1 12.1 12.5 6.7 7.2 7.9 7.3 9.5 8.1 6.0 7.5 6.2 7.2 8.9 7.7 8.0 13.4 4.5 6.1 5.9 9.4 6.7 2.1 8.1 3.5 4.6 15.9 4.2 3.2 6.2 5.1 4.0 10.6 65.7 7.1 10.4 10.3 9.0 6.3 7.0 6.9 5.3 5.3 7.9 8.9 5.2 8.7 4.3 5.5 30.2 5.5 18.3 4.2 4.5 3.9 4.0 3.9 3.9 4.1 6.2 3.6 3.5 26.9 8.2 6.7 5.3 8.3 2.4 7.8 8.2 6.8 11.4 8.8 9.7 3.3 4.8 5.0 2.3 8.8 5.2 13.5 19.2 20.4 61.4 15.4 4.0 7.1 2.6 10.2 31.4 13.0 10.9 6.5 11.5 6.7 12.9 58.4 14.4 23.9 18.4 1.9 11.2 14.1 28.3 16.3 12.5 9.6 34.9 122.6 6.1 8.2 14.4 5.1 25.6 8.8 23.7 22.5 12.0 10.5 20.2 126.8 10.0 12.2 25.2 3.8 15.6 18.0 16.1 1.8 71.2 24.0 12.0 32.0 74.9 79.6 13.8 10.0 11.3 14.2 15.9 26.5 6.3 8.8 39.2 6.6 15.3 14.3 51.2 39.9 10.5 5.5 24.2 18.1 11.7 10.6 15.3 FBXO30 "Fbx30, MGC21674" ENSG00000118496 "F-box protein 30" Q8TB52 6 145793502-145814795 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "basophil: 9.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012583 Approved Approved Microtubules NA NA "Cluster 38: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 40: Granulosa cells - Unknown function" Microtubules "HPA012583: AB_2668686" "unprognostic (8.69e-2)" "unprognostic (3.35e-3)" "unprognostic (2.92e-2)" "unprognostic (4.29e-2)" "unprognostic (5.47e-3)" "unprognostic (8.36e-2)" "unprognostic (7.61e-7)" "unprognostic (5.79e-2)" "unprognostic (1.63e-1)" "unprognostic (6.32e-2)" "unprognostic (1.18e-2)" "unprognostic (9.25e-2)" "unprognostic (2.35e-1)" "unprognostic (3.28e-2)" "unprognostic (5.72e-2)" "unprognostic (1.68e-1)" "unprognostic (1.78e-1)" 4.5 4.0 3.8 4.2 5.0 7.2 4.0 4.6 3.9 4.1 2.7 9.7 4.1 6.7 3.1 9.6 3.2 5.6 7.2 3.1 6.0 4.1 3.4 3.2 4.3 4.5 5.5 5.9 3.8 4.0 1.6 4.8 4.7 6.0 4.7 5.3 4.4 6.8 11.5 2.6 3.5 8.0 4.2 3.7 3.7 6.5 5.1 2.9 8.0 9.1 4.1 5.7 2.9 5.3 3.7 6.9 9.7 13.2 9.9 8.8 9.9 10.3 9.6 6.9 6.8 8.7 3.3 17.0 7.8 11.8 12.6 5.7 8.4 7.5 10.4 10.0 5.8 10.8 9.1 8.8 17.8 14.1 10.8 14.6 8.3 8.6 11.4 9.0 10.1 4.1 12.6 11.9 13.6 2.9 6.4 7.5 11.2 2.4 5.1 8.2 21.7 5.9 7.2 3.8 4.3 6.9 12.6 6.5 6.1 9.6 3.0 13.8 13.4 7.1 6.0 9.1 10.4 8.8 7.2 6.8 11.4 6.0 7.7 9.3 1.3 1.6 0.4 1.1 0.3 0.6 0.4 0.8 1.6 1.3 0.6 0.6 1.2 0.5 0.9 0.5 0.3 0.6 3.8 5.0 4.6 3.9 3.1 6.0 4.5 5.5 4.7 4.2 5.1 5.3 11.1 3.2 5.9 7.2 5.4 14.3 5.3 4.2 12.5 8.8 10.5 8.3 22.9 10.0 4.7 3.7 4.2 5.8 5.7 4.9 11.7 4.7 10.9 4.1 13.7 13.8 6.0 36.7 5.3 3.2 3.4 15.4 7.1 6.2 12.0 37.1 11.4 9.7 7.5 26.9 6.4 5.0 2.0 11.9 20.8 4.4 11.1 10.2 7.2 7.5 7.5 12.0 0.0 5.0 7.6 5.1 3.2 10.1 11.1 7.1 4.3 8.2 2.8 8.7 0.0 26.5 18.4 19.7 10.5 12.4 17.3 5.6 6.2 7.2 5.0 5.0 FEZ1 UNC-76 ENSG00000149557 "Fasciculation and elongation protein zeta 1" Q99689 11 125442881-125592568 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 176.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 109.8;Horizontal cells: 166.5;Oligodendrocytes: 246.6" "Cancer enriched" "Detected in all" 10 "glioma: 68.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 23.4;MAIT T-cell: 15.5" "Lineage enriched" "Detected in many" 23 "T-cells: 23.4" "Cell line enhanced" "Detected in many" "AF22: 48.3;HBEC3-KT: 66.0;NTERA-2: 68.6;SCLC-21H: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038490, HPA076844" Approved Approved Microtubules,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 5: NTERA-2 - Transcription" "Cluster 62: Horizontal cells - Visual perception" "Microtubules, Cytosol" "HPA038490: AB_10672647, HPA076844: " "unprognostic (5.68e-2)" "prognostic unfavorable (9.06e-5)" "unprognostic (7.40e-2)" "unprognostic (3.73e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-1)" "unprognostic (2.06e-1)" "unprognostic (8.30e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-1)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (2.14e-2)" "unprognostic (2.68e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" 16.9 5.4 96.8 2.9 144.0 0.9 11.3 145.5 120.6 21.8 53.1 39.3 1.7 23.5 2.3 6.2 14.7 6.9 37.4 95.5 120.4 6.8 5.5 34.2 1.9 145.6 136.9 12.7 2.5 1.9 17.6 3.8 138.9 15.4 3.3 18.7 6.4 7.6 5.9 7.9 12.6 8.3 134.8 8.8 15.9 12.7 126.7 0.5 10.2 3.0 1.4 26.5 16.9 176.6 0.3 0.0 48.3 0.2 39.2 25.3 0.0 10.3 14.6 3.8 0.6 0.2 0.3 0.1 16.3 21.1 11.4 0.5 31.2 66.0 2.4 2.3 0.5 37.6 0.1 0.0 25.3 0.0 0.6 23.1 17.6 11.5 29.3 0.4 32.0 0.0 4.5 0.6 3.8 1.5 0.2 0.0 68.6 0.5 1.2 0.0 0.1 0.2 0.0 30.3 54.3 5.5 0.3 0.1 1.4 27.3 4.9 26.4 19.3 0.4 2.4 0.2 11.1 0.6 0.5 0.1 7.9 0.0 26.6 0.2 0.8 0.0 23.4 0.1 15.5 0.1 0.9 5.1 0.4 0.0 0.6 5.5 0.2 1.0 0.0 0.1 0.0 4.4 96.8 144.0 145.5 120.6 95.5 120.4 145.6 136.9 138.9 134.8 126.7 176.6 4.9 0.0 5.2 53.2 0.8 8.0 4.9 96.9 6.2 23.1 0.5 10.3 109.8 2.8 9.6 0.0 2.1 8.0 23.3 0.1 27.4 2.8 68.6 0.8 14.2 13.9 5.4 0.0 41.0 0.4 1.2 43.0 0.5 0.5 0.0 11.1 58.9 1.0 91.6 166.5 48.7 0.0 16.2 24.9 15.5 65.9 25.4 2.3 78.2 12.2 1.9 97.1 74.2 32.2 246.6 0.3 0.0 35.3 0.9 12.7 0.0 2.1 3.8 17.8 19.7 25.4 35.6 28.8 7.7 0.2 5.5 4.2 7.8 5.5 0.1 3.5 FRYL "AF4p12, DKFZp686E205, KIAA0826, MOR2" ENSG00000075539 "FRY like transcription coactivator" O94915 4 48497357-48780322 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.5" "Cell type enriched" "Detected in all" 5 "Oligodendrocytes: 1148.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 13.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 13.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031106, HPA031107" Supported Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cluster 38: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "Microtubules, Cytokinetic bridge" "HPA031106: AB_10600660, HPA031107: AB_10600536" "unprognostic (7.50e-2)" "unprognostic (9.72e-3)" "unprognostic (6.68e-3)" "unprognostic (3.22e-2)" "unprognostic (5.37e-2)" "unprognostic (2.03e-2)" "unprognostic (3.59e-2)" "unprognostic (4.80e-2)" "unprognostic (4.67e-2)" "unprognostic (2.08e-1)" "unprognostic (2.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.62e-2)" "unprognostic (3.32e-2)" "unprognostic (1.66e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-2)" 8.8 5.4 12.2 13.2 43.5 15.0 7.9 26.6 22.6 8.4 0.8 37.9 10.4 8.4 3.7 6.6 6.1 8.3 8.6 12.1 19.9 8.4 5.7 9.7 13.4 34.8 23.4 7.9 5.6 20.3 2.7 10.5 31.2 6.5 36.7 29.2 6.8 6.6 4.5 10.2 12.8 9.2 22.2 10.8 10.7 6.3 25.7 16.7 7.9 12.0 13.1 10.2 3.4 81.5 19.7 11.6 26.8 16.4 11.3 16.1 14.5 18.1 17.4 17.6 21.2 9.4 14.7 25.0 14.3 19.3 32.9 11.8 17.8 28.1 37.9 14.3 6.1 45.6 11.3 4.3 7.0 31.6 16.8 11.6 10.5 24.0 24.9 16.4 26.4 21.3 14.8 9.2 22.9 9.6 34.5 10.9 4.6 8.9 9.8 25.4 35.0 4.7 15.7 20.8 23.1 9.9 17.7 5.2 9.9 12.8 6.8 19.6 40.3 19.8 25.5 10.1 35.3 12.4 17.5 22.1 16.6 20.6 19.8 13.5 0.9 1.8 2.0 1.4 1.6 1.5 1.8 1.7 1.0 1.2 2.0 1.9 2.8 2.7 1.0 1.7 1.3 0.7 12.2 43.5 26.6 22.6 12.1 19.9 34.8 23.4 31.2 22.2 25.7 81.5 87.1 38.5 33.1 92.1 50.1 47.3 24.3 32.0 38.7 45.3 23.7 17.0 33.5 18.6 28.9 16.5 135.5 23.6 59.9 122.8 3.9 13.8 11.6 48.2 29.0 74.8 79.5 80.6 110.1 11.6 21.5 23.7 128.4 56.8 46.9 25.6 48.9 15.2 19.4 47.1 172.5 195.1 38.7 30.1 34.0 3.9 17.1 40.1 26.6 214.5 35.1 32.8 63.8 146.8 1148.7 28.8 87.3 18.4 38.6 43.4 50.4 8.4 21.0 105.6 19.7 31.2 37.3 12.8 10.9 37.3 49.3 10.8 54.4 15.6 93.9 53.3 FSIP2 FLJ34780 ENSG00000188738 "Fibrous sheath interacting protein 2" Q5CZC0 2 185738804-185833290 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 18.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 137.8;Alveolar cells type 2: 93.8;Early spermatids: 289.6;Gastric mucus-secreting cells: 68.3;Spermatocytes: 124.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA036139 Approved Microtubules,Mitochondria NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 15: RT4 - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" Microtubules Mitochondria "HPA036139: AB_10602134" "unprognostic (5.28e-2)" "unprognostic (1.20e-2)" "unprognostic (4.17e-1)" "unprognostic (5.81e-2)" "unprognostic (1.67e-1)" "unprognostic (2.95e-1)" "unprognostic (6.31e-2)" "unprognostic (2.76e-3)" "unprognostic (1.55e-1)" "unprognostic (5.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.79e-3)" "unprognostic (4.89e-3)" "unprognostic (1.28e-1)" "unprognostic (7.52e-2)" "unprognostic (5.17e-2)" "unprognostic (4.64e-5)" 0.1 0.2 0.3 0.2 0.5 0.0 0.2 0.3 0.3 0.2 0.0 1.5 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.5 0.4 0.2 0.2 0.2 0.4 0.1 0.6 0.2 0.9 0.6 0.2 0.0 0.0 0.2 0.2 0.0 0.6 0.0 2.6 18.3 0.3 0.1 0.2 0.0 0.0 0.2 0.1 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.3 0.2 0.3 0.5 0.4 0.6 0.6 0.3 0.9 1.7 137.8 93.8 5.2 2.6 0.5 0.1 1.4 1.8 16.3 3.0 1.7 3.9 0.0 31.5 0.0 10.4 0.3 1.0 26.0 0.0 0.7 289.6 3.3 3.3 5.6 7.7 0.0 4.5 0.2 0.1 7.3 68.3 2.1 40.4 2.7 1.8 0.1 0.4 18.5 5.4 19.7 0.0 0.8 1.0 50.8 2.1 5.9 1.8 3.7 0.7 3.9 2.1 23.6 14.0 5.4 5.5 3.8 1.3 0.2 0.5 0.2 46.0 7.2 0.0 4.0 0.8 124.4 5.4 0.2 0.3 0.3 6.0 2.6 5.2 0.2 FUT9 Fuc-TIX ENSG00000172461 "Fucosyltransferase 9" Q9Y231 6 96015974-96215612 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 18.9;stomach 1: 23.2" "Cell type enhanced" "Detected in some" "Astrocytes: 776.4;Excitatory neurons: 333.5;Inhibitory neurons: 238.2;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 224.7" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.9;OE19: 2.8;RT4: 6.5;SCLC-21H: 6.3;SK-BR-3: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070923 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cluster 22: Non-specific - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA070923: AB_2686323" "unprognostic (1.60e-1)" "unprognostic (2.48e-1)" "unprognostic (5.99e-3)" "unprognostic (1.33e-1)" "unprognostic (2.40e-1)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (6.43e-3)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" 0.0 0.4 10.5 0.0 12.6 0.0 0.6 14.5 11.7 0.0 0.0 0.1 2.1 0.2 0.0 0.0 0.2 0.0 0.0 11.8 13.6 0.2 0.0 0.0 0.0 3.4 18.9 0.0 4.8 0.0 0.4 0.4 3.2 0.2 0.0 0.5 0.0 0.2 0.1 0.1 0.0 0.0 5.5 0.0 23.2 0.0 15.3 0.0 0.1 0.0 0.0 0.9 0.0 6.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 1.4 2.8 0.0 0.0 0.0 0.0 0.0 6.5 6.3 0.1 0.0 3.6 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 12.6 14.5 11.7 11.8 13.6 3.4 18.9 3.2 5.5 15.3 6.4 0.0 0.0 0.0 776.4 0.2 0.0 0.6 0.0 0.0 4.2 1.4 1.7 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.5 0.1 1.3 0.0 0.0 333.5 2.0 0.0 0.1 56.1 1.4 0.0 0.4 0.0 0.0 0.1 0.0 238.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.2 0.0 168.9 224.7 0.5 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.2 GAN "GAN1, GIG, KLHL16" ENSG00000261609 Gigaxonin Q9H2C0 16 81314944-81390809 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 24.8" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 130.4;Urothelial cells: 188.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011825, HPA049473" Approved Supported Microtubules NA NA "Cluster 15: NK-cells - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 22: Epithelial cell types - Mixed function" Microtubules "CAB011825: AB_732515, HPA049473: AB_2680782" "unprognostic (1.78e-1)" "unprognostic (1.55e-1)" "unprognostic (8.23e-2)" "unprognostic (2.51e-2)" "unprognostic (8.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.42e-4)" "unprognostic (1.90e-1)" "unprognostic (3.86e-1)" "unprognostic (1.20e-1)" "unprognostic (1.22e-3)" "unprognostic (5.91e-3)" "unprognostic (3.12e-3)" "unprognostic (5.93e-2)" "unprognostic (9.98e-2)" "unprognostic (1.46e-2)" "unprognostic (5.86e-2)" 1.3 0.9 7.3 0.7 5.7 0.7 2.4 6.6 4.7 2.6 1.0 2.3 0.8 1.3 1.1 5.4 1.3 0.6 1.5 6.9 8.8 1.0 1.1 1.7 0.7 9.3 8.6 1.4 1.2 0.8 1.4 0.8 5.5 2.0 1.2 3.2 2.3 0.7 1.5 24.8 1.4 0.9 8.7 0.9 1.8 0.9 8.7 0.9 1.1 1.4 1.3 1.5 4.3 9.2 1.6 2.0 1.5 2.1 1.9 1.0 10.4 1.2 0.7 0.8 0.3 5.1 1.8 2.5 1.4 1.6 0.4 3.1 2.7 1.3 1.8 0.6 1.4 2.2 1.8 4.1 2.0 2.1 2.4 1.1 3.8 1.3 3.5 1.1 1.7 2.1 2.8 1.1 1.1 9.1 1.9 2.9 4.0 2.2 0.6 3.7 1.4 1.0 1.6 5.0 1.5 1.0 4.3 4.2 1.4 3.6 2.9 2.0 2.5 2.3 2.1 0.8 1.9 2.2 2.7 5.8 1.2 2.4 1.7 0.7 0.4 0.2 0.8 0.4 0.7 0.4 0.8 0.6 0.2 0.5 0.7 0.9 0.3 0.9 0.3 0.9 0.6 0.2 7.3 5.7 6.6 4.7 6.9 8.8 9.3 8.6 5.5 8.7 8.7 9.2 12.2 12.8 8.2 69.5 9.9 91.3 66.8 15.0 34.1 28.4 15.4 18.5 12.5 7.2 29.5 5.5 89.6 19.3 17.4 27.5 0.0 9.4 2.3 11.6 19.3 14.7 5.4 12.6 21.2 6.7 15.4 14.1 17.3 14.0 1.3 7.2 12.1 6.7 5.6 23.5 29.5 15.1 10.2 6.8 30.9 4.6 9.6 8.6 37.4 14.0 7.5 14.0 9.2 22.1 18.3 18.6 16.8 12.8 11.0 75.0 14.8 3.8 30.1 43.8 6.6 20.2 17.6 11.9 16.4 67.1 130.4 21.3 16.1 5.3 15.6 188.7 GIGYF1 "GYF1, PERQ1" ENSG00000146830 "GRB10 interacting GYF protein 1" O75420 7 100679507-100694250 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 100.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020999, HPA023995" Enhanced Approved Vesicles,Microtubules NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Vesicles Microtubules "HPA020999: AB_2111744, HPA023995: AB_1855221" "unprognostic (3.82e-3)" "unprognostic (1.58e-1)" "unprognostic (2.56e-2)" "unprognostic (2.67e-2)" "unprognostic (7.46e-2)" "prognostic favorable (7.42e-4)" "prognostic unfavorable (2.30e-4)" "unprognostic (1.43e-2)" "unprognostic (8.06e-2)" "unprognostic (1.65e-2)" "prognostic favorable (1.35e-5)" "unprognostic (3.66e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (1.89e-1)" "unprognostic (2.79e-1)" "unprognostic (2.67e-3)" 25.7 25.9 21.1 15.6 21.1 30.5 26.9 27.7 24.1 36.1 21.3 26.5 15.8 34.9 11.0 19.1 30.2 10.4 22.4 19.5 17.3 27.3 23.1 22.6 18.9 20.9 18.8 43.4 36.1 13.5 41.9 11.4 18.7 28.5 8.0 8.8 29.6 13.7 26.5 33.5 30.7 11.2 16.2 39.1 25.1 32.2 21.4 17.2 32.8 16.7 11.3 23.5 23.6 24.0 16.5 16.8 26.1 38.2 12.3 9.6 46.6 15.3 12.4 9.4 10.8 9.8 27.6 22.9 19.2 11.1 19.0 19.4 12.9 15.3 5.8 24.4 26.4 15.9 48.5 14.3 12.2 18.1 26.1 15.1 12.2 12.0 17.0 15.3 9.5 26.4 44.8 21.9 8.7 37.5 32.1 100.1 32.0 6.5 20.1 51.2 13.9 23.1 6.9 14.8 23.3 36.7 19.8 31.2 18.2 17.6 14.2 30.2 14.7 26.8 32.9 44.7 14.2 17.8 8.4 12.3 15.6 35.9 16.2 2.2 1.3 1.2 2.4 1.2 1.8 1.3 1.6 1.5 0.5 1.9 1.4 1.5 4.5 1.3 1.3 2.0 0.9 0.5 21.1 21.1 27.7 24.1 19.5 17.3 20.9 18.8 18.7 16.2 21.4 24.0 26.5 3.2 7.8 19.9 18.1 31.7 11.0 5.8 8.0 25.5 25.5 20.6 8.3 32.9 5.8 18.4 18.8 12.0 31.2 19.5 15.6 11.5 1.0 12.2 24.3 17.5 18.6 9.9 18.1 9.4 10.7 17.8 18.8 17.5 5.7 26.5 22.5 19.0 11.4 52.2 17.7 22.8 6.1 25.5 19.8 3.8 24.5 15.6 17.8 29.0 12.5 15.3 20.6 14.6 22.6 11.8 18.0 18.0 10.5 16.7 20.4 9.9 5.0 28.0 32.9 33.2 19.6 16.4 36.0 6.8 22.4 16.3 20.5 12.9 16.1 10.2 GIT2 "KIAA0148, PKL" ENSG00000139436 "GIT ArfGAP 2" Q14161 12 109929802-109996389 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB004681 Approved Approved Microtubules NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Microtubules "CAB004681: AB_425820" "unprognostic (1.07e-1)" "unprognostic (2.61e-1)" "unprognostic (3.67e-3)" "unprognostic (3.44e-2)" "unprognostic (1.36e-1)" "unprognostic (4.50e-3)" "unprognostic (3.87e-2)" "unprognostic (1.50e-1)" "unprognostic (1.87e-1)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (3.18e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" "unprognostic (8.71e-2)" "unprognostic (2.41e-2)" 16.6 18.0 12.1 25.5 18.1 60.2 13.0 20.3 17.0 14.0 9.8 15.0 11.2 14.1 10.8 11.5 12.1 15.4 17.4 16.4 12.1 11.7 11.8 16.9 33.1 16.2 13.9 17.8 17.2 14.1 13.8 22.9 16.5 12.8 13.8 9.1 13.5 12.8 14.7 13.1 19.0 19.8 12.1 36.0 10.7 13.9 15.3 37.0 16.4 15.6 32.1 16.3 12.8 16.2 20.6 24.6 16.6 18.4 28.6 26.3 11.9 42.1 41.3 37.0 23.2 12.5 10.8 49.8 16.3 51.7 14.6 14.9 14.5 18.8 38.1 42.1 14.3 32.7 15.0 14.6 18.1 47.7 49.6 22.0 17.4 34.9 18.7 34.0 39.5 28.5 17.2 12.4 46.0 13.1 42.0 66.4 11.7 11.7 17.7 34.5 41.7 27.9 18.2 17.1 10.1 14.9 27.1 12.5 16.6 17.0 17.9 39.3 37.3 25.0 12.6 20.0 22.0 25.0 22.8 49.3 21.5 34.9 21.2 85.6 76.4 172.9 42.7 72.0 41.6 42.4 42.3 43.9 74.7 49.4 36.0 32.2 165.1 49.3 71.3 30.6 46.5 63.7 12.1 18.1 20.3 17.0 16.4 12.1 16.2 13.9 16.5 12.1 15.3 16.2 26.3 19.2 15.3 24.8 44.8 9.6 6.4 11.3 11.4 24.7 10.8 10.0 7.8 14.3 12.2 27.6 8.4 13.1 37.7 9.9 3.9 16.0 6.5 7.6 16.9 24.0 7.8 19.4 73.2 14.0 11.3 15.3 14.8 11.1 14.5 36.1 24.7 13.7 35.1 33.7 82.2 6.7 8.2 65.5 32.0 5.2 18.6 45.1 14.2 66.5 64.5 9.3 61.8 28.6 39.8 18.4 8.6 19.9 26.1 4.3 22.8 7.2 12.4 18.7 13.1 29.4 14.5 36.1 20.1 11.8 11.4 6.2 36.5 19.1 9.9 7.4 GLIPR2 "C9orf19, GAPR-1" ENSG00000122694 "GLI pathogenesis related 2" Q9H4G4 9 36136536-36163913 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 188.5;Langerhans cells: 203.6;Macrophages: 117.6;monocytes: 203.0;NK-cells: 180.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 71.6;HDLM-2: 72.9;TIME: 127.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029478 Approved Uncertain Vesicles,Microtubules NA NA 19000000 "Cluster 5: Granulocytes - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 4: Macrophages - Innate immune response" Vesicles Microtubules "HPA029478: AB_10670038" "unprognostic (1.57e-2)" "unprognostic (5.70e-3)" "unprognostic (1.54e-1)" "unprognostic (1.28e-1)" "unprognostic (1.46e-2)" "unprognostic (1.33e-2)" "unprognostic (9.90e-2)" "unprognostic (2.50e-1)" "unprognostic (1.84e-2)" "unprognostic (4.26e-2)" "unprognostic (3.21e-1)" "unprognostic (5.87e-2)" "prognostic unfavorable (6.54e-7)" "unprognostic (6.57e-3)" "unprognostic (4.94e-1)" "unprognostic (1.02e-1)" "unprognostic (2.43e-2)" 38.5 20.9 17.6 52.7 22.8 73.8 32.4 21.0 22.6 45.9 14.1 73.7 14.7 77.8 15.1 18.6 36.9 24.1 24.2 17.2 19.3 8.8 6.9 62.6 29.9 24.8 22.1 13.3 5.6 2.5 4.9 8.8 22.3 38.3 33.1 2.7 15.3 39.3 7.7 12.2 32.2 63.8 22.8 41.3 25.3 3.4 26.7 18.7 15.8 11.1 19.2 38.8 27.4 27.6 3.7 2.9 20.9 22.3 71.6 33.3 2.4 32.9 20.0 7.8 14.1 1.3 0.3 0.2 10.2 30.9 19.7 0.2 7.9 1.1 4.7 72.9 6.4 8.8 6.2 0.4 27.9 5.7 28.3 23.4 1.0 44.5 7.8 14.0 62.5 22.6 0.4 5.0 17.4 7.9 27.9 15.2 20.1 0.3 10.7 18.9 44.1 1.0 1.6 1.8 5.6 11.3 4.4 2.2 3.6 42.2 2.3 24.0 127.3 10.7 24.8 9.6 28.0 7.8 2.2 12.7 11.0 35.0 2.5 268.6 360.9 540.3 168.4 162.5 89.1 24.4 114.3 108.2 208.3 24.5 47.0 74.7 657.0 125.5 124.9 18.5 132.2 414.0 17.6 22.8 21.0 22.6 17.2 19.3 24.8 22.1 22.3 22.8 26.7 27.6 11.9 3.2 25.4 4.6 22.3 13.4 2.5 14.7 1.8 0.3 46.9 19.0 2.6 2.8 30.9 5.5 0.0 3.8 66.9 14.7 0.0 21.2 0.7 1.8 33.9 13.3 8.4 58.7 1.1 1.3 3.3 54.3 11.7 2.1 52.6 1.9 16.1 0.9 188.5 0.0 0.8 42.4 14.2 83.2 203.6 2.3 18.0 117.6 62.2 2.8 203.0 21.4 180.2 3.0 28.6 5.2 16.1 25.9 22.8 16.0 4.0 1.1 64.3 0.5 46.0 44.7 43.2 0.9 6.4 0.9 10.2 3.4 75.5 10.9 45.3 3.3 GPRIN2 "KIAA0514, MGC15171" ENSG00000204175 "G protein regulated inducer of neurite outgrowth 2" O60269 10 46549044-46555530 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 10.5;skin 1: 17.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Distal enterocytes: 30.4;Exocrine glandular cells: 20.2;Intestinal goblet cells: 30.8;Late spermatids: 20.6;Proximal enterocytes: 21.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 10.2;A549: 13.1;SiHa: 3.7;SK-BR-3: 12.0" "Low region specificity" "Detected in many" "HPA038129, HPA070760" Approved Approved "Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Plasma membrane, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA038129: AB_2675846, HPA070760: " "unprognostic (1.00e-2)" "unprognostic (1.91e-1)" "unprognostic (1.77e-2)" "prognostic unfavorable (8.60e-8)" "unprognostic (5.77e-2)" "prognostic favorable (3.47e-4)" "unprognostic (2.23e-1)" "unprognostic (2.67e-2)" "unprognostic (2.54e-1)" "unprognostic (1.27e-1)" "unprognostic (1.52e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.98e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.67e-3)" 0.1 0.0 1.7 0.6 1.6 0.0 0.9 5.9 2.1 0.9 0.4 6.2 3.6 0.0 0.0 4.4 0.3 0.2 0.0 0.6 6.7 5.7 0.3 10.5 0.0 5.5 4.9 0.1 5.7 2.1 4.2 0.0 5.7 1.9 3.4 0.1 2.8 1.1 0.1 17.4 8.0 0.1 1.8 0.0 5.1 3.0 9.7 0.0 3.4 0.0 0.5 0.6 2.0 1.0 10.2 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.2 0.0 0.7 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.0 0.0 1.7 0.3 0.3 0.1 3.7 12.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 5.9 2.1 0.6 6.7 5.5 4.9 5.7 1.8 9.7 1.0 0.0 19.2 3.7 0.0 0.0 1.7 2.8 1.9 2.8 0.3 1.4 1.0 0.2 7.2 2.1 3.7 0.0 0.0 0.0 30.4 0.0 11.3 9.3 0.0 0.0 0.1 6.6 0.0 0.7 20.2 0.0 0.1 3.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.9 30.8 0.0 0.0 0.3 20.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 13.1 0.4 0.0 2.1 21.7 4.0 1.8 0.1 0.0 0.0 0.2 2.9 0.8 2.4 6.1 0.0 0.1 0.0 7.3 1.3 GTF2F2 "BTF4, RAP30, TFIIF" ENSG00000188342 "General transcription factor IIF subunit 2" P13984 13 45120510-45284893 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006912 Supported Supported Nucleoplasm,Microtubules NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Microtubules "HPA006912: AB_1080256" "unprognostic (3.39e-1)" "unprognostic (2.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.29e-1)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.65e-5)" "unprognostic (3.67e-2)" "unprognostic (3.17e-1)" "unprognostic (3.36e-2)" "unprognostic (2.53e-3)" "unprognostic (2.31e-2)" "unprognostic (4.76e-2)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (6.53e-3)" "unprognostic (3.94e-2)" "unprognostic (6.44e-3)" 10.9 16.6 12.4 11.0 13.2 18.3 12.9 12.4 14.9 13.5 18.1 18.3 10.4 11.6 15.4 16.5 10.0 8.4 20.0 13.1 13.2 15.0 11.3 9.6 13.4 12.3 13.0 12.1 10.7 14.1 12.9 11.0 12.4 10.7 14.2 9.9 12.2 13.0 25.0 24.9 10.0 12.9 13.5 10.2 11.3 13.3 13.0 14.8 11.4 15.8 14.4 15.5 14.8 15.6 43.2 15.9 29.3 21.8 17.6 25.8 24.3 46.2 30.2 46.1 44.9 26.8 65.7 42.9 25.4 33.9 44.8 46.9 44.3 37.1 66.7 32.6 38.4 50.8 20.7 35.2 28.1 57.0 27.9 21.8 55.9 34.4 57.8 52.0 29.9 32.9 36.6 15.8 125.6 24.2 42.0 65.2 34.8 68.6 38.3 39.0 22.2 24.8 101.4 15.0 15.6 26.0 23.5 22.9 39.8 27.5 18.6 45.9 23.7 38.6 33.1 30.8 79.9 10.0 14.6 42.7 44.9 36.1 41.2 16.2 15.9 29.9 10.3 16.7 12.4 17.3 12.1 12.4 18.8 17.8 13.5 13.5 22.5 18.9 18.9 14.7 14.7 10.1 12.4 13.2 12.4 14.9 13.1 13.2 12.3 13.0 12.4 13.5 13.0 15.6 21.6 41.7 32.1 41.1 36.0 75.1 82.8 80.2 35.9 19.2 27.3 30.2 79.4 10.0 41.6 11.0 4.2 33.0 25.7 29.0 49.0 49.7 93.0 34.9 37.5 27.6 28.2 32.6 23.7 33.6 49.4 28.9 13.7 56.8 39.3 25.6 18.2 21.4 49.1 8.4 35.1 26.4 50.8 27.1 38.2 82.3 24.2 32.0 76.5 36.5 38.2 36.8 27.8 57.8 48.9 48.5 30.3 31.6 30.4 88.3 22.6 42.7 29.4 21.5 6.6 35.6 32.3 68.6 83.9 34.5 72.7 33.8 28.8 33.5 40.7 75.1 GYS1 "GSY, GYS" ENSG00000104812 "Glycogen synthase 1" P13807 19 48968130-48993310 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Allosteric enzyme, Glycosyltransferase, Transferase" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 118.5;skeletal muscle: 319.4;tongue: 201.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007793, HPA041598" Enhanced Approved Microtubules,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Microtubules, Cytosol" "CAB007793: AB_562291, HPA041598: AB_2677571" "unprognostic (3.37e-1)" "unprognostic (3.07e-1)" "unprognostic (1.02e-1)" "unprognostic (1.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.04e-2)" "unprognostic (6.83e-3)" "unprognostic (2.41e-2)" "unprognostic (1.12e-1)" "unprognostic (3.30e-2)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.46e-4)" "unprognostic (4.04e-2)" "unprognostic (6.76e-2)" "unprognostic (5.87e-3)" "unprognostic (3.81e-2)" 32.4 26.3 17.9 16.2 18.8 46.0 23.7 26.4 23.3 17.1 22.2 21.7 15.3 18.8 8.9 38.2 18.7 10.1 118.5 19.7 17.6 21.8 14.9 16.0 15.5 22.2 20.9 19.7 13.6 15.7 15.5 11.3 19.6 27.4 14.7 19.2 22.2 15.5 319.4 20.7 19.9 16.7 16.4 18.5 23.2 6.1 20.2 14.7 15.9 201.6 14.4 24.3 23.2 18.3 67.3 26.3 19.0 26.3 43.2 16.9 37.6 45.5 31.7 46.8 54.3 25.8 21.3 28.0 27.0 44.7 12.4 46.6 32.0 57.7 40.6 17.4 46.5 23.1 33.3 23.1 24.3 25.4 15.9 41.8 27.2 30.2 25.4 40.5 39.8 28.8 16.4 36.1 59.4 25.4 31.8 21.9 10.2 29.0 29.8 26.6 33.2 27.5 46.7 70.6 11.8 16.4 40.5 52.1 10.4 25.2 27.7 26.1 31.0 57.1 22.0 26.1 50.5 29.8 33.1 13.5 58.3 22.2 13.1 7.7 9.4 6.6 7.0 5.3 8.6 5.2 6.0 6.5 13.4 3.9 4.7 4.4 3.7 10.6 8.0 7.2 8.6 7.1 17.9 18.8 26.4 23.3 19.7 17.6 22.2 20.9 19.6 16.4 20.2 18.3 3.5 0.0 14.2 21.9 5.9 5.1 3.7 11.7 11.4 4.2 7.3 5.5 67.9 2.8 5.8 0.0 16.7 7.6 6.8 13.2 0.0 8.1 0.3 6.9 8.9 7.1 7.2 4.8 14.7 6.9 31.7 5.0 12.8 11.9 4.5 6.7 9.7 5.2 8.3 0.0 16.6 9.2 4.1 7.0 5.7 0.7 5.3 7.2 7.2 4.7 9.8 3.3 10.3 8.5 6.9 11.8 8.2 5.7 9.7 5.4 9.2 6.0 6.2 11.7 0.0 5.0 7.3 1.3 2.9 15.3 4.1 4.0 5.2 3.8 11.7 3.3 HAS3 ENSG00000103044 "Hyaluronan synthase 3" O00219 16 69105653-69118719 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 33.5;urinary bladder: 92.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 162.3;Basal prostatic cells: 51.6;Basal respiratory cells: 107.1;Suprabasal keratinocytes: 158.6;Urothelial cells: 115.5" "Group enriched" "Detected in many" 8 "cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 52.5;PC-3: 270.5;RT4: 111.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA031554, CAB033850" Supported Approved Microtubules NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 28: Keratinocytes - Keratinization" Microtubules "CAB033850: AB_2116418, HPA031554: AB_10670703" "unprognostic (3.26e-2)" "unprognostic (1.22e-1)" "unprognostic (5.12e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (7.59e-3)" "unprognostic (2.86e-3)" "unprognostic (1.84e-1)" "unprognostic (3.70e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (2.46e-1)" "unprognostic (3.27e-3)" "unprognostic (3.25e-2)" "unprognostic (1.32e-1)" "unprognostic (2.21e-2)" "unprognostic (3.40e-3)" 0.8 0.5 0.9 0.7 1.2 0.9 7.5 1.3 1.3 4.6 0.9 5.3 2.9 0.9 1.1 33.5 1.2 4.8 0.7 0.6 1.1 1.1 1.3 20.1 0.4 1.0 1.3 1.4 1.3 0.4 1.7 3.4 1.1 3.7 3.1 0.8 5.4 1.5 1.2 9.7 2.2 0.6 0.4 0.8 12.8 3.5 1.0 0.5 5.9 0.9 2.8 92.8 10.3 1.0 3.5 17.1 1.0 0.9 0.3 0.4 6.6 1.1 0.4 1.0 0.4 3.4 9.0 0.7 2.0 0.4 4.0 52.5 2.9 31.5 1.0 0.2 1.3 0.0 0.2 0.6 0.1 0.3 0.9 0.5 8.6 1.0 3.0 4.0 0.7 0.6 0.1 0.4 0.3 1.8 1.2 0.7 15.5 18.7 270.5 2.0 0.1 0.2 28.3 111.6 19.2 0.8 1.8 0.1 0.3 3.1 0.6 0.8 0.3 0.9 0.9 29.9 1.8 1.0 0.9 0.2 1.0 0.0 0.6 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.9 1.2 1.3 1.3 0.6 1.1 1.0 1.3 1.1 0.4 1.0 1.0 4.2 0.0 30.8 0.7 0.2 162.3 51.6 107.1 8.6 1.1 1.6 6.1 1.4 0.0 12.2 0.0 2.1 1.0 0.1 16.4 0.0 4.5 10.2 0.7 0.3 2.4 0.0 0.4 1.0 3.6 0.9 1.1 5.1 2.7 0.0 0.4 1.1 0.2 0.3 0.0 2.1 0.7 2.0 0.0 6.5 22.7 1.2 0.5 3.6 0.0 0.0 0.1 0.0 0.5 0.8 2.4 0.2 0.4 0.6 18.4 0.1 0.7 3.0 1.0 0.0 0.9 1.9 0.5 0.7 25.6 158.6 0.3 1.1 0.1 2.2 115.5 HAUS3 "C4orf15, dgt3, IT1, MGC4701" ENSG00000214367 "HAUS augmin like complex subunit 3" Q68CZ6 4 2078998-2242276 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040649, HPA048190" Approved Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Mitochondria "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA040649: AB_2677060, HPA048190: AB_2680308" "unprognostic (4.22e-2)" "unprognostic (1.50e-1)" "unprognostic (6.30e-2)" "unprognostic (2.87e-1)" "unprognostic (2.26e-1)" "unprognostic (2.57e-3)" "unprognostic (7.63e-3)" "unprognostic (2.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (3.81e-3)" "unprognostic (2.79e-2)" "unprognostic (2.15e-2)" "unprognostic (2.79e-1)" "unprognostic (4.40e-2)" "prognostic favorable (4.78e-5)" 9.6 8.6 3.5 7.5 3.5 27.5 8.9 9.0 4.6 8.1 1.9 8.3 6.5 7.3 4.9 8.0 7.2 4.2 5.8 3.4 3.2 6.2 7.4 9.0 10.2 3.4 3.4 7.3 10.5 4.0 5.6 6.5 3.3 8.5 5.3 5.8 8.5 4.5 7.4 8.9 9.2 4.7 2.3 12.0 9.0 10.7 3.4 8.6 7.4 4.6 8.3 7.1 7.7 4.3 9.8 4.7 14.2 13.0 5.5 8.5 12.8 14.3 6.0 12.7 10.6 9.5 12.5 18.9 6.5 5.7 14.3 9.3 11.9 7.2 15.9 6.8 6.9 12.5 13.1 7.0 4.5 11.6 11.2 4.3 10.2 11.0 5.8 6.6 10.3 8.8 22.0 21.2 12.5 5.4 19.6 19.5 11.2 8.5 12.3 13.9 12.4 10.4 6.3 6.7 18.4 10.0 10.1 7.6 8.4 10.5 15.7 7.8 8.5 18.1 7.8 11.1 17.0 11.2 10.6 16.9 8.8 16.8 12.0 9.6 4.2 12.2 7.9 5.8 10.1 5.5 8.2 8.9 3.8 9.1 9.5 8.9 4.7 10.7 6.9 6.8 12.0 6.6 3.5 3.5 9.0 4.6 3.4 3.2 3.4 3.4 3.3 2.3 3.4 4.3 15.5 3.2 4.8 0.0 15.8 12.6 5.0 6.4 15.4 11.9 9.3 8.8 5.8 7.2 10.3 3.7 12.5 7.3 24.0 3.9 1.9 7.4 11.8 8.9 11.8 9.4 7.2 23.1 0.0 5.7 11.7 9.6 4.6 8.3 13.3 12.1 6.8 3.7 7.2 25.2 0.0 6.4 12.2 5.4 9.3 6.4 9.9 10.4 12.4 0.0 7.9 6.5 16.5 0.0 0.0 5.3 1.8 8.6 22.5 5.1 5.8 2.6 5.4 12.5 0.0 12.3 17.7 34.4 25.3 10.5 7.7 5.1 26.5 10.1 5.8 3.0 HIGD1B "CLST11240, CLST11240-15" ENSG00000131097 "HIG1 hypoxia inducible domain family member 1B" Q9P298 17 44846353-44850476 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 114.6;choroid plexus: 65.0;placenta: 105.2" "Group enriched" "Detected in some" 5 "Sertoli cells: 762.6;Smooth muscle cells: 209.3" "Cancer enhanced" "Detected in all" "glioma: 9.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA079501 Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 10: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 3: HMC-1 - Innate immune response" "Cluster 48: Smooth muscle cells - ECM organization" "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA079501: " "unprognostic (6.85e-2)" "unprognostic (9.41e-2)" "unprognostic (3.80e-3)" "unprognostic (2.07e-1)" "unprognostic (8.46e-2)" "unprognostic (2.37e-2)" "unprognostic (4.98e-3)" "unprognostic (3.61e-1)" "unprognostic (1.18e-2)" "unprognostic (3.98e-1)" "unprognostic (6.19e-2)" "unprognostic (3.56e-1)" "unprognostic (1.61e-3)" "unprognostic (5.23e-3)" "unprognostic (8.72e-2)" "unprognostic (1.79e-2)" "unprognostic (1.52e-2)" 11.7 0.5 71.0 0.7 71.0 0.5 8.8 70.3 114.6 8.3 65.0 3.7 2.1 9.9 11.6 5.0 5.3 11.3 46.4 68.8 71.4 11.5 0.6 38.6 2.6 71.4 70.9 2.9 3.1 8.0 1.4 105.2 72.4 9.5 1.1 2.3 1.4 6.4 14.5 2.0 4.3 11.3 68.9 0.1 3.7 1.5 73.0 1.8 5.0 30.8 1.4 4.3 4.4 69.1 0.2 0.6 0.0 0.7 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.3 0.2 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.7 0.1 0.8 0.5 0.0 0.9 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.7 0.5 0.0 0.3 0.7 0.7 0.4 0.3 0.3 0.8 0.4 1.0 0.0 0.5 0.7 0.3 0.2 0.0 0.1 0.0 0.3 0.3 0.0 0.6 0.2 0.4 0.5 0.4 1.2 0.6 0.5 1.1 0.7 1.7 0.6 0.2 1.2 1.0 0.4 0.2 0.7 0.9 1.2 0.3 0.9 0.7 0.0 0.7 0.1 0.3 0.8 0.5 71.0 71.0 70.3 114.6 68.8 71.4 71.4 70.9 72.4 68.9 73.0 69.1 88.9 0.0 0.5 0.0 0.3 3.4 0.6 0.3 0.0 0.5 1.2 2.8 11.0 0.0 1.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.2 0.7 70.2 0.0 0.0 0.7 0.0 0.2 4.4 0.0 0.3 0.0 0.0 0.7 0.1 0.8 1.7 0.6 0.0 0.0 0.0 3.9 0.6 0.3 1.6 0.0 2.8 0.0 1.0 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.9 762.6 9.5 209.3 0.0 0.3 0.7 2.4 0.3 0.8 32.3 0.0 0.7 HMMR "CD168, RHAMM" ENSG00000072571 "Hyaluronan mediated motility receptor" O75330 5 163460203-163491941 "CD markers, FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.6;lymphoid tissue: 27.3;testis: 27.5" "Cell type enhanced" "Detected in many" "Early spermatids: 86.2;Erythroid cells: 133.3;Extravillous trophoblasts: 55.1;Late spermatids: 60.9;Spermatocytes: 100.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB002433, HPA040025, HPA043926, HPA061524" Enhanced Enhanced Microtubules,Centrosome,Cytosol Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Microtubules "Centrosome, Cytosol" "CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551" "unprognostic (3.53e-3)" "unprognostic (1.01e-1)" "unprognostic (3.38e-3)" "unprognostic (8.88e-3)" "unprognostic (2.12e-1)" "prognostic unfavorable (5.52e-4)" "prognostic unfavorable (1.93e-7)" "prognostic unfavorable (1.09e-4)" "unprognostic (5.68e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.71e-5)" "unprognostic (1.02e-1)" "unprognostic (0.00e+0)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.77e-2)" 0.8 0.7 0.2 10.1 0.3 20.6 2.1 0.3 0.4 1.1 0.1 6.6 7.4 0.8 0.2 4.0 0.5 0.9 0.8 0.2 0.2 0.7 1.7 0.9 18.1 0.5 0.3 0.2 0.3 0.9 0.2 6.2 0.4 0.5 8.8 0.8 0.8 0.2 1.2 4.2 6.5 2.9 0.3 2.9 3.6 27.5 0.7 27.3 0.7 0.4 17.7 2.2 1.4 0.5 77.0 47.2 94.5 50.8 5.0 9.0 70.3 71.4 34.9 88.0 78.9 96.8 145.1 127.5 66.0 22.2 118.5 86.3 112.4 69.0 148.6 116.1 34.4 76.7 32.3 48.4 1.4 68.7 67.3 2.4 4.1 82.8 64.0 14.7 50.6 85.7 73.2 101.0 93.2 28.5 72.3 38.8 81.9 51.2 51.6 78.0 126.3 63.9 34.8 20.4 78.8 43.8 106.3 32.8 38.6 45.1 97.3 54.5 32.9 63.2 52.4 50.6 97.2 53.7 96.3 102.4 41.4 104.2 61.1 0.2 0.2 0.0 0.1 0.1 0.3 0.3 0.3 0.1 0.2 0.2 0.1 0.2 0.1 0.5 0.0 0.6 1.5 0.2 0.2 0.3 0.3 0.4 0.2 0.2 0.5 0.3 0.4 0.3 0.7 0.5 0.4 0.0 1.1 1.3 6.0 2.5 1.8 4.5 2.8 0.6 3.2 3.7 2.5 4.3 3.2 0.0 0.0 37.3 2.3 5.3 0.0 0.8 86.2 3.8 3.1 3.1 1.2 133.3 0.6 0.2 55.1 4.6 11.7 5.7 0.0 21.6 5.3 3.8 22.2 0.0 0.4 7.8 6.1 8.8 2.7 60.9 2.1 7.6 0.0 0.0 2.3 0.1 1.0 0.5 1.2 0.2 0.3 0.7 22.9 1.5 1.3 2.6 2.8 1.0 6.6 0.6 3.8 100.9 23.3 14.1 1.4 4.5 5.2 1.6 15.6 3.0 HOXC8 "HOX3, HOX3A" ENSG00000037965 "Homeobox C8" P31273 12 54008985-54012769 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 15.4;skeletal muscle: 16.8" "Cell type enhanced" "Detected in some" "Fibroblasts: 12.2;Granulosa cells: 11.0;Melanocytes: 10.6;Peritubular cells: 7.9;Proximal tubular cells: 7.4;Skeletal myocytes: 17.9;Smooth muscle cells: 7.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 41.6;ASC TERT1: 27.6;fHDF/TERT166: 49.8;HSkMC: 33.2;LHCN-M2: 38.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "spinal cord: 10.5" "HPA028911, CAB037020" Uncertain Supported Nucleoplasm,Microtubules NA NA "Cluster 52: Non-specific - Ribosome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" Nucleoplasm Microtubules "CAB037020: AB_1840935, HPA028911: AB_10602236" "unprognostic (1.03e-1)" "unprognostic (5.90e-2)" "unprognostic (6.26e-6)" "unprognostic (4.89e-2)" "unprognostic (5.20e-4)" "unprognostic (5.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (1.45e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.47e-5)" "unprognostic (2.47e-1)" "unprognostic (1.84e-2)" "unprognostic (4.68e-2)" "unprognostic (1.14e-2)" 5.2 5.2 0.0 0.7 0.0 0.0 5.6 0.0 0.0 0.4 0.0 0.4 0.0 0.4 15.4 0.2 7.9 0.0 0.0 0.0 0.0 4.9 0.0 0.1 1.8 0.1 0.0 4.5 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.3 0.0 0.1 16.8 3.1 5.7 7.6 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.0 1.0 2.7 0.0 15.0 41.6 27.6 0.2 2.8 0.1 4.9 3.1 4.4 2.4 0.0 0.3 49.8 0.8 2.0 3.9 1.2 5.4 5.3 5.3 0.9 2.1 0.0 4.9 0.0 5.8 33.2 3.9 15.7 9.0 0.5 0.4 0.8 0.6 0.0 38.7 1.2 0.0 0.4 0.0 0.3 0.7 0.0 0.0 0.0 6.1 0.0 0.0 2.0 5.4 1.0 13.8 3.6 1.6 0.0 0.0 1.0 8.0 6.8 1.7 0.1 0.0 0.0 0.9 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 4.6 0.1 0.0 1.2 0.0 1.5 2.9 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.2 1.9 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 12.2 0.0 0.0 0.0 11.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.2 6.2 0.2 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.1 0.3 7.4 0.0 1.3 6.6 17.9 7.6 5.6 3.1 0.2 4.3 0.3 0.3 3.2 0.1 0.1 HPF1 "C4orf27, FLJ20534" ENSG00000056050 "Histone PARylation factor 1" Q9NWY4 4 169729470-169757944 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 71.0;Distal tubular cells: 92.0;Extravillous trophoblasts: 61.2;Granulosa cells: 56.4;Hofbauer cells: 56.3;Proximal tubular cells: 63.9;Theca cells: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043467 Uncertain Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cluster 44: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "Microtubules, Cytokinetic bridge" "HPA043467: AB_10793949" "unprognostic (1.09e-1)" "unprognostic (1.15e-2)" "unprognostic (1.72e-2)" "unprognostic (1.47e-1)" "unprognostic (2.70e-1)" "unprognostic (1.09e-1)" "unprognostic (8.68e-3)" "unprognostic (2.74e-2)" "prognostic unfavorable (5.63e-4)" "prognostic favorable (7.47e-4)" "unprognostic (6.34e-2)" "unprognostic (4.55e-1)" "unprognostic (3.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.32e-1)" "unprognostic (5.51e-2)" "unprognostic (1.09e-1)" 19.3 18.6 18.6 16.4 19.9 16.8 21.2 19.6 26.0 19.6 22.0 22.0 12.2 23.3 24.8 15.7 17.1 13.1 22.5 19.2 19.7 18.1 22.1 14.3 21.1 20.2 19.3 22.7 14.4 16.0 19.5 16.8 20.9 17.3 17.7 21.3 13.2 15.7 21.3 19.6 12.8 24.8 19.6 17.5 15.8 14.1 19.6 26.9 18.8 20.9 21.1 16.8 16.8 22.2 33.7 21.0 71.2 37.7 42.6 52.4 30.3 59.9 58.8 72.8 76.7 14.3 35.5 17.5 15.7 39.2 53.3 14.7 49.5 43.6 76.7 55.1 33.7 57.0 30.0 20.5 29.9 48.7 20.1 34.1 43.2 47.1 14.5 44.1 64.1 59.1 43.7 66.2 64.4 27.3 102.7 42.4 29.2 32.2 27.0 44.7 33.8 21.2 41.9 21.9 17.2 63.1 39.7 17.2 56.3 49.1 34.0 43.1 31.3 24.8 39.2 58.4 54.3 31.3 49.8 52.4 68.3 47.0 40.3 19.3 20.0 22.4 28.7 24.0 34.6 22.0 33.0 35.1 26.1 18.1 32.1 33.3 5.3 25.4 23.7 17.9 38.1 21.9 18.6 19.9 19.6 26.0 19.2 19.7 20.2 19.3 20.9 19.6 19.6 22.2 41.6 44.8 26.4 0.0 5.7 0.0 0.0 0.0 0.0 0.0 19.9 29.6 0.0 0.0 17.3 27.6 0.0 71.0 14.3 0.0 92.0 45.7 0.0 31.9 36.9 20.1 0.0 0.0 0.0 46.3 61.2 26.1 0.0 21.9 17.7 56.4 0.0 0.0 56.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 31.1 0.0 0.0 1.6 0.0 0.0 63.9 15.3 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 16.3 10.5 56.0 0.0 0.0 HS3ST3A1 "30ST3A1, 3OST3A1" ENSG00000153976 "Heparan sulfate-glucosamine 3-sulfotransferase 3A1" Q9Y663 17 13494032-13601929 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 8.1" "Cell type enhanced" "Detected in some" "Astrocytes: 9.8;Granulosa cells: 11.6;Hepatic stellate cells: 7.1;Horizontal cells: 26.9;Leydig cells: 13.7;Squamous epithelial cells: 9.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "medulla oblongata: 5.9" "Immune cell enhanced" "Detected in some" "T-reg: 2.2" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;T-cells: 2.2" "Group enriched" "Detected in many" 4 "PC-3: 40.9;U-251 MG: 123.0;U-87 MG: 73.2" "Region enhanced" "Detected in many" "olfactory bulb: 5.0" "Region enhanced" "Detected in some" "olfactory bulb: 5.3" "HPA062518, HPA071530" Uncertain Approved Microtubules NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 64: Macrophages - Immune response" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 40: Granulosa cells - Unknown function" Microtubules "HPA062518: AB_2684789, HPA071530: AB_2686411" "unprognostic (2.88e-3)" "unprognostic (4.21e-2)" "unprognostic (8.35e-2)" "unprognostic (3.50e-2)" "unprognostic (1.48e-3)" "unprognostic (4.44e-2)" "unprognostic (2.01e-1)" "unprognostic (4.46e-3)" "unprognostic (2.12e-4)" "unprognostic (1.12e-2)" "unprognostic (8.52e-2)" "unprognostic (1.55e-1)" "unprognostic (1.85e-9)" "unprognostic (1.83e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-3)" "unprognostic (4.70e-3)" 0.4 2.0 0.1 1.9 1.0 1.0 0.4 0.0 0.6 4.5 3.2 1.2 1.4 0.7 0.1 4.6 1.3 0.3 2.5 0.2 0.0 1.4 1.9 1.2 2.6 5.9 1.4 8.1 0.3 0.0 0.7 2.7 1.1 3.1 0.3 1.3 2.0 4.9 0.1 0.7 1.2 0.2 3.5 6.4 0.6 2.3 0.1 0.3 0.3 0.0 1.6 0.5 3.4 0.5 0.1 0.3 3.3 0.0 2.7 6.8 5.1 18.2 4.4 3.2 2.0 0.0 0.6 0.0 2.6 11.2 0.0 0.0 0.1 0.0 3.1 1.1 18.3 4.9 1.5 2.0 1.6 0.0 1.2 4.9 0.1 8.5 2.2 5.5 0.0 0.2 19.2 0.0 3.8 2.5 0.1 3.3 3.5 0.0 40.9 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 2.0 0.1 0.6 0.2 3.1 0.4 0.1 123.0 0.0 0.0 0.0 73.2 0.0 9.1 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.4 0.5 0.0 0.0 0.5 0.5 0.2 0.3 0.0 1.7 2.2 0.3 0.1 1.0 0.0 0.6 0.2 0.0 5.9 1.4 1.1 3.5 0.1 0.5 0.2 0.0 0.0 9.8 0.0 0.6 0.0 0.0 5.7 0.3 0.0 0.3 0.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.4 0.3 1.1 0.0 0.0 1.8 0.2 0.0 4.7 0.0 0.2 0.0 11.6 7.1 0.0 1.6 26.9 4.1 0.0 0.0 0.8 0.3 0.1 13.7 0.0 0.0 1.9 0.0 2.4 0.0 0.5 0.2 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.8 4.0 0.3 0.4 9.3 0.6 0.1 0.1 0.0 0.0 0.0 HYPK "C15orf63, FLJ20431, HSPC136" ENSG00000242028 "Huntingtin interacting protein K" Q9NX55 15 43796142-43804427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 54.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055252 Uncertain Supported Nucleoplasm,Microtubules NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Microtubules "HPA055252: AB_2682759" "unprognostic (2.89e-2)" "unprognostic (5.82e-2)" "unprognostic (2.14e-2)" "unprognostic (7.58e-3)" "unprognostic (1.15e-1)" "unprognostic (1.08e-3)" "unprognostic (3.55e-1)" "unprognostic (1.48e-1)" "unprognostic (4.41e-2)" "unprognostic (1.04e-1)" "unprognostic (5.36e-3)" "unprognostic (2.39e-3)" "unprognostic (6.52e-7)" "unprognostic (2.05e-1)" "unprognostic (8.89e-2)" "unprognostic (2.61e-1)" "unprognostic (2.78e-4)" 8.9 9.8 13.8 5.9 13.8 4.9 6.5 16.6 22.0 5.0 13.8 5.0 3.7 4.3 5.1 4.2 6.0 2.9 8.5 13.8 15.0 6.5 14.2 7.6 6.5 14.7 15.2 6.2 9.4 6.2 5.6 3.6 14.7 6.8 3.8 8.6 5.5 4.3 19.2 6.1 5.1 4.9 13.4 5.5 5.8 7.9 14.2 6.1 5.2 14.7 7.7 8.3 4.3 15.4 13.5 36.8 17.3 19.5 11.6 11.5 6.5 21.8 13.1 18.9 12.6 23.7 7.4 19.8 25.9 16.7 17.8 23.1 30.3 24.9 14.3 17.3 37.3 26.4 64.6 34.0 17.8 30.4 16.3 10.1 24.2 21.3 18.1 9.3 14.7 20.9 40.5 16.9 17.2 33.5 19.2 33.9 19.5 48.6 40.9 15.4 12.6 22.4 17.7 26.5 33.9 24.7 20.7 31.1 13.3 10.6 23.7 19.5 13.3 22.6 11.8 24.2 55.8 20.5 40.6 46.2 15.1 33.1 26.8 16.8 25.7 22.1 25.0 37.7 26.4 30.0 26.8 26.7 23.5 31.4 29.9 27.9 9.4 26.7 47.7 39.8 27.5 23.5 13.8 13.8 16.6 22.0 13.8 15.0 14.7 15.2 14.7 13.4 14.2 15.4 11.3 6.4 14.5 0.0 11.1 30.0 15.0 8.1 13.6 11.2 14.4 11.9 0.7 8.6 12.1 7.3 54.2 6.6 8.2 6.4 9.8 6.5 2.4 7.2 9.6 10.7 10.7 9.5 0.0 8.4 4.4 12.5 26.0 7.7 8.8 4.5 6.4 6.5 3.9 13.5 0.0 11.6 8.2 4.4 26.2 1.1 5.0 9.1 23.2 0.0 4.7 4.9 6.2 0.0 0.0 6.8 4.7 2.2 11.3 14.8 7.2 10.4 15.4 28.5 0.0 23.2 11.8 3.9 4.7 19.4 37.4 4.9 10.4 9.1 9.4 11.1 IFT20 ENSG00000109083 "Intraflagellar transport 20" Q8IY31 17 28328325-28335489 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021376 Approved Approved Microtubules NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 10: Non-specific - Unknown function" Microtubules "HPA021376: AB_1851460" "unprognostic (1.29e-1)" "unprognostic (2.35e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (8.65e-4)" "unprognostic (1.13e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (8.02e-2)" "unprognostic (4.86e-3)" "unprognostic (2.42e-1)" "unprognostic (2.48e-2)" "unprognostic (6.19e-3)" "prognostic unfavorable (5.09e-7)" "unprognostic (1.67e-1)" "unprognostic (2.29e-1)" "unprognostic (2.59e-2)" "unprognostic (4.71e-3)" 24.9 32.9 26.6 14.7 26.9 77.0 26.8 27.0 46.1 23.4 29.1 37.0 28.8 20.9 39.2 18.8 22.6 22.2 19.7 26.9 28.3 33.5 41.4 22.3 20.7 27.7 27.6 21.6 116.1 25.5 45.2 24.1 27.0 29.9 20.0 26.7 41.2 20.5 9.5 17.6 28.0 20.0 27.5 24.9 42.4 50.1 27.0 22.8 29.2 7.5 19.9 27.9 19.6 27.9 27.3 39.0 25.2 20.7 74.2 75.2 24.2 47.2 58.0 28.9 45.5 59.6 12.7 13.4 24.8 59.8 17.5 29.1 16.9 35.1 41.8 55.0 72.5 8.0 39.7 26.7 72.7 34.1 16.0 57.6 46.4 24.8 39.9 48.2 46.1 26.6 24.2 32.8 23.0 38.2 30.7 26.8 16.9 82.4 21.8 14.4 32.6 35.4 46.2 26.7 31.7 46.2 31.3 64.3 74.8 43.6 41.0 38.2 51.3 16.9 25.8 25.3 25.9 49.6 44.8 17.1 61.6 24.6 25.1 53.7 67.7 52.6 38.6 50.6 44.8 43.2 39.2 38.6 78.1 51.6 39.8 34.7 71.1 36.8 49.0 56.1 45.8 53.7 26.6 26.9 27.0 46.1 26.9 28.3 27.7 27.6 27.0 27.5 27.0 27.9 42.1 38.5 55.8 17.9 36.7 37.0 38.0 63.0 34.7 63.3 74.6 68.3 6.1 47.1 51.5 51.5 60.5 73.0 47.4 30.7 140.8 60.8 245.4 79.8 40.3 47.3 62.6 25.7 31.3 113.2 82.6 47.4 32.1 39.5 23.5 34.2 38.2 48.6 54.2 57.2 36.5 69.5 40.7 47.8 69.4 53.4 60.3 49.6 32.0 7.5 72.8 37.4 42.2 24.6 30.7 68.0 29.9 57.6 57.8 45.9 127.8 98.0 102.6 78.3 78.9 33.5 67.0 164.8 53.0 25.7 42.8 81.4 35.9 59.6 43.1 49.5 IFT22 "DKFZp761N0823, FAP9, FLJ13225, FLJ14117, RABL5" ENSG00000128581 "Intraflagellar transport 22" Q9H7X7 7 101310914-101321823 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 577.5;Late spermatids: 1478.7;Spermatocytes: 357.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 92.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042930 Approved Approved Microtubules,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" "Microtubules, Cytosol" "HPA042930: AB_10794537" "unprognostic (1.55e-2)" "unprognostic (7.22e-2)" "unprognostic (1.29e-1)" "unprognostic (2.23e-2)" "unprognostic (6.70e-3)" "unprognostic (1.03e-1)" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (9.99e-2)" "unprognostic (1.73e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-2)" "unprognostic (2.23e-2)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-1)" 12.4 22.1 20.2 3.7 21.4 2.8 14.3 19.1 25.7 18.6 27.2 22.1 2.8 21.1 22.9 8.5 27.8 12.1 24.0 21.4 21.7 35.5 7.8 13.1 4.0 20.0 21.1 19.5 18.4 29.9 31.1 2.8 20.2 18.0 3.4 41.4 14.7 6.4 26.3 10.1 7.5 5.8 20.7 4.7 14.9 76.4 21.2 10.1 24.4 19.6 3.6 17.2 11.5 19.9 26.1 38.6 20.7 47.9 17.1 14.5 4.6 8.6 4.8 10.6 7.9 15.4 19.3 3.1 22.1 17.8 41.1 16.6 12.2 12.7 8.2 6.2 16.4 0.6 16.4 15.8 12.6 8.7 4.9 14.9 10.9 25.2 5.9 36.5 10.4 18.2 11.2 3.4 12.6 92.5 15.6 16.3 21.6 19.5 17.4 14.4 13.1 5.3 20.1 15.8 22.3 37.0 25.3 21.0 13.7 33.5 16.3 6.6 10.6 33.1 24.6 64.0 18.0 3.1 10.3 7.5 21.7 2.5 17.3 1.4 0.8 0.9 4.0 1.7 3.8 7.5 4.8 3.6 1.6 5.9 4.3 4.4 1.1 5.8 3.3 4.7 2.0 2.3 20.2 21.4 19.1 25.7 21.4 21.7 20.0 21.1 20.2 20.7 21.2 19.9 12.0 25.6 14.3 6.5 11.9 0.0 25.1 0.0 22.2 26.6 35.5 54.4 42.9 55.8 19.2 49.7 54.2 19.7 2.3 4.0 138.9 73.9 577.5 176.0 32.1 17.0 18.5 17.4 7.2 36.9 17.3 28.3 12.8 28.0 9.5 37.9 21.8 10.7 17.7 32.0 5.3 13.1 0.0 2.7 0.0 1478.7 37.9 6.9 0.0 2.8 2.9 76.2 3.1 3.0 2.4 29.9 13.5 41.3 4.8 17.1 2.9 170.2 102.7 103.9 13.1 21.8 22.6 357.7 71.5 15.0 0.0 6.6 7.3 36.0 8.0 20.4 IFT43 "C14orf179, FLJ32173, MGC16028" ENSG00000119650 "Intraflagellar transport 43" Q96FT9 14 75902136-76084585 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Ectodermal dysplasia, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 305.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003438 Approved Supported "Microtubules,Centriolar satellite" NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" Microtubules "Centriolar satellite" "HPA003438: AB_1078327" "unprognostic (1.64e-2)" "unprognostic (5.75e-3)" "unprognostic (2.10e-1)" "unprognostic (1.81e-3)" "unprognostic (1.48e-1)" "unprognostic (8.73e-2)" "unprognostic (1.53e-2)" "unprognostic (5.27e-2)" "unprognostic (8.87e-2)" "unprognostic (1.26e-2)" "unprognostic (2.32e-2)" "unprognostic (9.78e-2)" "unprognostic (4.43e-2)" "unprognostic (2.51e-1)" "unprognostic (2.70e-2)" "unprognostic (1.75e-1)" "unprognostic (1.07e-2)" 21.5 24.0 29.2 12.2 29.5 5.4 25.1 28.9 31.4 24.6 38.7 27.5 23.0 24.6 49.6 18.0 64.5 18.2 43.2 28.7 29.7 38.9 41.5 20.6 11.6 29.5 31.2 16.2 22.6 27.1 32.8 21.5 30.9 26.9 19.4 25.1 16.1 30.5 13.9 15.4 19.3 27.7 29.8 15.5 21.6 40.5 29.4 15.9 33.0 8.8 17.0 25.5 18.4 29.8 34.8 38.2 27.5 42.7 33.9 54.3 19.5 22.3 42.7 33.6 33.5 14.6 34.9 3.9 23.8 39.5 30.4 36.2 26.7 41.3 37.6 18.3 25.6 1.8 22.3 0.1 94.9 3.8 8.0 48.6 44.4 37.1 48.3 48.6 52.1 38.5 9.6 15.2 40.8 69.7 14.3 6.0 14.2 42.7 48.9 9.1 22.2 10.9 77.0 30.0 26.7 31.9 43.9 29.8 31.5 36.9 77.4 10.2 24.3 19.7 24.7 28.9 19.6 20.1 18.8 4.4 76.9 1.6 20.6 34.5 11.6 19.7 13.8 16.4 17.6 33.8 14.9 14.4 15.7 23.1 24.3 23.4 5.8 15.4 16.4 20.2 19.6 13.4 29.2 29.5 28.9 31.4 28.7 29.7 29.5 31.2 30.9 29.8 29.4 29.8 40.9 12.8 27.4 50.3 14.8 18.6 44.1 103.7 38.1 27.8 36.0 45.6 43.8 42.9 66.1 64.4 66.7 41.9 8.7 24.7 64.6 53.8 147.5 171.0 54.5 35.3 15.7 5.9 46.4 38.7 14.7 39.4 38.2 33.2 26.6 28.7 38.6 32.9 22.4 10.1 55.0 30.2 61.1 7.6 20.0 33.2 33.8 11.5 26.6 14.0 32.0 49.8 14.4 38.2 38.5 33.5 18.7 35.0 13.7 25.8 45.1 160.2 305.8 87.7 32.9 31.2 63.5 124.4 37.2 24.6 21.6 41.9 16.2 32.8 26.1 34.5 IQCB1 "KIAA0036, NPHP5, SLSN5" ENSG00000173226 "IQ motif containing B1" Q15051 3 121769761-121835079 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Calmodulin-binding "Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 155.3;Spermatogonia: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 131.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042028 Approved Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 43: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA042028: AB_2677806" "unprognostic (3.82e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.16e-1)" "unprognostic (4.10e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (3.08e-5)" "prognostic favorable (3.67e-4)" "unprognostic (1.42e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "unprognostic (6.78e-3)" "unprognostic (1.50e-3)" "unprognostic (2.59e-3)" "unprognostic (2.75e-1)" "unprognostic (1.67e-1)" "unprognostic (4.75e-3)" 11.6 11.2 9.6 14.7 10.0 20.4 23.1 11.0 10.5 15.7 10.8 13.0 12.0 15.5 19.7 12.5 16.6 12.1 9.7 10.1 10.1 12.2 8.9 12.3 24.3 9.7 9.5 17.9 18.3 13.9 15.3 11.5 9.5 15.9 16.2 18.9 15.6 15.5 11.4 15.5 14.1 11.8 9.7 18.3 12.3 28.9 10.4 22.1 10.5 5.7 25.7 14.2 13.7 11.0 38.3 10.1 48.9 55.5 7.5 11.6 57.2 17.4 10.8 19.7 23.8 33.6 18.1 76.8 23.9 10.1 30.2 28.7 30.5 14.5 29.3 15.1 23.8 51.2 22.2 28.7 20.0 64.1 14.8 7.4 27.2 13.7 30.3 10.2 15.2 32.4 31.0 27.9 22.3 19.3 41.7 44.5 40.1 22.6 18.1 40.4 23.4 24.9 11.4 16.9 26.0 20.9 17.3 12.2 31.3 16.0 10.8 49.4 12.9 18.5 22.4 9.1 23.4 66.4 44.9 131.2 17.9 29.0 17.1 3.2 6.6 11.7 7.2 12.3 10.5 22.8 9.8 9.0 9.6 21.6 11.5 7.2 2.8 12.2 14.1 8.7 11.7 6.4 9.6 10.0 11.0 10.5 10.1 10.1 9.7 9.5 9.5 9.7 10.4 11.0 15.8 6.4 15.0 48.3 28.4 18.9 19.2 20.0 19.9 15.2 19.6 17.3 8.4 11.5 26.5 11.0 27.1 26.6 21.9 7.7 3.9 11.1 3.7 31.1 12.7 11.2 7.2 21.5 60.1 12.9 8.2 15.4 11.7 12.6 8.8 21.9 6.8 6.2 10.5 13.5 66.8 8.6 20.3 9.8 14.1 7.4 15.5 11.3 14.2 51.5 15.8 12.8 17.5 49.3 59.5 13.9 8.2 13.5 45.2 15.7 7.9 7.5 69.2 27.7 13.1 17.8 15.9 155.3 96.5 16.2 20.6 14.1 19.9 8.4 11.9 16.3 IRAK4 NY-REN-64 ENSG00000198001 "Interleukin 1 receptor associated kinase 4" Q9NWZ3 12 43758944-43789543 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 56.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016685, CAB022077" Uncertain Approved Nucleoli,Microtubules,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Microtubules "Nucleoli, Cytosol" "CAB016685: AB_1618505, CAB022077: " "unprognostic (2.76e-2)" "unprognostic (5.63e-2)" "unprognostic (1.47e-2)" "prognostic favorable (3.46e-5)" "unprognostic (6.15e-2)" "unprognostic (3.50e-3)" "unprognostic (1.44e-2)" "unprognostic (8.49e-2)" "unprognostic (6.44e-3)" "unprognostic (7.50e-2)" "unprognostic (4.00e-3)" "unprognostic (6.29e-2)" "unprognostic (4.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.31e-1)" "unprognostic (1.84e-1)" "prognostic favorable (4.42e-5)" 8.6 6.5 4.0 13.6 4.6 10.0 8.9 4.5 5.1 7.9 5.1 7.9 9.1 6.8 7.0 10.5 7.0 8.8 5.4 3.9 4.6 8.0 9.2 8.5 17.5 5.5 4.7 5.6 15.1 6.9 6.2 8.3 5.4 7.5 8.4 12.3 8.4 7.0 3.0 13.3 11.9 7.2 4.8 18.6 10.5 5.8 4.9 18.5 10.9 3.2 16.3 7.8 7.9 5.3 9.3 6.8 4.7 6.2 16.5 27.6 6.7 12.9 9.1 10.0 9.1 5.8 8.7 15.8 12.4 10.7 6.6 7.5 5.3 8.3 14.2 22.8 4.9 15.2 5.2 3.7 9.4 21.2 17.7 14.7 12.7 12.7 7.4 17.4 15.0 15.1 14.4 11.6 27.8 5.1 18.6 11.7 1.7 0.0 7.9 12.2 5.8 8.4 7.8 8.8 3.4 3.3 6.3 7.9 6.2 6.4 9.9 18.5 13.4 12.2 2.3 15.1 9.0 14.0 19.4 13.7 12.7 56.2 6.9 20.8 4.0 8.7 6.1 4.6 6.3 3.3 4.9 5.3 3.7 4.4 4.4 4.8 7.9 7.9 5.9 5.1 6.7 4.6 4.0 4.6 4.5 5.1 3.9 4.6 5.5 4.7 5.4 4.8 4.9 5.3 24.1 19.2 15.6 5.2 36.5 10.8 11.3 10.7 17.1 5.8 15.2 11.2 4.5 17.2 11.3 33.1 20.9 14.9 52.1 15.7 21.5 12.7 18.4 14.1 12.4 17.3 3.6 12.0 2.9 17.8 8.4 13.7 33.6 15.2 22.1 10.7 16.1 8.7 16.9 8.4 3.4 11.9 14.2 24.7 20.2 23.2 12.5 25.1 10.6 20.6 28.2 9.9 60.8 2.5 14.7 13.3 7.2 11.3 33.2 8.9 18.6 13.8 9.5 27.2 6.6 9.5 11.0 28.2 12.5 17.2 11.8 27.9 41.1 15.0 9.2 13.5 IRX5 IRX-2a ENSG00000176842 "Iroquois homeobox 5" P78411 16 54930865-54934485 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Vision" DNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 14.0;skin 1: 16.9" "Cell type enhanced" "Detected in many" "Breast glandular cells: 40.3;Breast myoepithelial cells: 55.5;Granulosa cells: 43.8;Muller glia cells: 43.1;Squamous epithelial cells: 33.9" "Cancer enhanced" "Detected in many" "breast cancer: 20.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 27.1;T-47d: 36.6;THP-1: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047130 Approved "Nuclear speckles,Microtubules,Cytosol" No NA "Cluster 31: Skin - Epidermis development" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles" "Microtubules, Cytosol" "HPA047130: AB_10962983" "unprognostic (2.63e-1)" "unprognostic (4.49e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-2)" "unprognostic (1.42e-2)" "unprognostic (3.89e-2)" "unprognostic (5.38e-3)" "prognostic favorable (4.59e-4)" "unprognostic (8.52e-2)" "unprognostic (1.02e-1)" "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (1.17e-3)" "unprognostic (3.34e-2)" "unprognostic (8.90e-2)" "unprognostic (1.77e-3)" "unprognostic (4.28e-2)" 1.7 0.6 1.3 0.0 1.5 0.0 14.0 4.1 0.4 1.8 0.3 0.2 0.0 0.1 0.0 7.2 0.2 0.1 9.8 0.3 1.9 6.9 0.0 6.4 0.0 3.6 4.1 0.3 0.1 0.3 0.4 0.0 3.1 3.4 0.0 1.3 10.2 0.2 1.4 16.9 0.0 0.0 3.6 0.0 2.6 0.7 4.6 0.3 0.1 1.1 0.0 0.6 5.9 3.5 0.8 0.5 8.6 3.2 3.1 0.6 0.4 3.3 8.2 1.1 0.8 1.9 0.8 0.0 0.7 4.5 0.3 8.4 3.0 3.6 0.6 6.0 4.1 0.9 3.4 0.0 0.1 2.0 3.3 0.8 15.1 5.4 2.3 1.5 0.0 4.8 0.5 0.0 6.2 3.3 9.6 12.3 0.1 1.3 2.4 5.0 4.4 0.5 27.1 0.2 2.9 3.0 1.4 7.3 3.9 0.0 36.6 20.2 0.5 5.9 0.2 4.2 1.3 3.6 2.3 2.9 9.6 3.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.5 4.1 0.4 0.3 1.9 3.6 4.1 3.1 3.6 4.6 3.5 2.4 9.6 21.9 0.0 0.1 8.3 9.7 6.7 15.9 8.6 40.3 55.5 11.1 0.0 15.4 0.0 0.0 0.2 1.0 0.2 0.0 0.3 1.0 9.6 1.2 1.6 0.0 0.0 0.0 0.6 0.0 5.3 7.7 12.2 0.0 43.8 0.0 0.0 0.2 1.7 0.0 0.8 4.1 0.0 2.7 2.4 0.0 0.6 5.4 0.0 0.0 43.1 0.0 0.0 0.0 2.9 0.3 0.0 0.3 4.8 0.0 1.5 13.0 1.9 0.0 8.3 5.2 0.7 2.8 33.9 8.0 0.0 0.4 0.0 0.5 8.5 KANK4 "ANKRD38, KIAA0172" ENSG00000132854 "KN motif and ankyrin repeat domains 4" Q5T7N3 1 62236165-62319434 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.6;pancreas: 15.2" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 31.8;Exocrine glandular cells: 8.0;Extravillous trophoblasts: 19.0;Oligodendrocytes: 34.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 31.8;Hep G2: 13.4;SCLC-21H: 6.2;SuSa: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014030 Uncertain Uncertain Microtubules,Cytosol NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol Microtubules "HPA014030: AB_2128155" "unprognostic (1.66e-2)" "unprognostic (1.90e-3)" "unprognostic (2.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-2)" "unprognostic (6.31e-2)" "unprognostic (1.66e-2)" "unprognostic (3.58e-2)" "unprognostic (1.54e-1)" "unprognostic (3.85e-3)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (9.06e-2)" "unprognostic (1.97e-1)" "unprognostic (3.31e-2)" "unprognostic (7.74e-6)" 10.7 0.5 1.0 0.5 5.8 0.0 2.6 10.1 3.2 0.3 0.1 1.0 0.3 0.2 0.7 0.2 0.3 0.5 0.3 0.8 4.6 1.4 3.0 2.5 0.0 19.2 13.8 0.3 15.2 5.6 0.1 10.8 22.6 1.5 1.0 1.0 8.4 0.6 0.2 0.5 0.3 0.2 5.3 0.8 2.0 0.9 7.6 0.8 0.3 0.8 0.0 0.2 0.5 8.9 0.0 0.0 1.1 0.0 0.0 0.0 31.8 0.1 0.0 0.1 0.0 4.8 0.0 0.0 0.1 1.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 2.4 13.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.2 0.0 1.0 0.6 0.0 27.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 5.8 10.1 3.2 0.8 4.6 19.2 13.8 22.6 5.3 7.6 8.9 0.1 0.0 0.0 1.3 0.0 0.0 2.4 0.4 0.6 0.3 0.5 7.0 0.9 0.0 0.0 0.0 0.0 31.8 0.0 0.5 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 2.3 8.0 19.0 0.9 0.0 0.1 0.0 0.1 0.4 1.5 2.3 0.0 2.3 1.4 0.0 0.0 0.0 0.3 0.0 0.4 1.8 1.0 0.0 0.1 0.0 0.5 34.3 0.4 0.2 3.8 0.0 0.0 0.0 0.8 0.0 0.5 0.0 1.2 4.2 0.0 1.0 0.2 0.0 5.5 0.1 0.0 1.0 0.1 KATNB1 ENSG00000140854 "Katanin regulatory subunit B1" Q9BVA0 16 57735739-57757244 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease variant, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041165, HPA041839" Enhanced Supported "Plasma membrane,Microtubules,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Cytosol" Microtubules "HPA041165: AB_10795584, HPA041839: AB_10795598" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (1.56e-1)" "prognostic favorable (9.24e-4)" "unprognostic (2.54e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.42e-1)" "unprognostic (2.92e-1)" "unprognostic (1.75e-1)" "prognostic favorable (8.44e-4)" "unprognostic (2.89e-2)" "unprognostic (1.03e-3)" "unprognostic (2.20e-1)" "unprognostic (1.29e-1)" "unprognostic (6.88e-2)" "unprognostic (1.54e-1)" 9.9 13.3 16.0 10.8 18.4 23.0 10.6 5.5 24.7 10.1 11.8 9.9 10.6 11.2 4.1 15.9 19.2 6.2 11.7 18.2 11.7 10.3 9.5 11.9 10.5 10.4 9.1 9.6 14.0 10.7 13.7 7.2 10.1 10.2 5.5 5.9 13.1 7.7 10.4 29.0 10.1 6.5 6.6 12.9 10.3 37.1 13.2 12.8 11.0 7.9 8.2 8.7 11.9 16.3 20.8 35.7 19.2 25.0 10.4 9.2 35.2 13.9 18.5 35.2 19.6 30.2 18.3 16.1 28.0 8.8 13.2 27.0 25.8 27.9 16.2 11.1 74.8 21.0 20.4 42.5 11.5 47.6 77.6 9.5 17.3 28.7 16.1 14.8 21.2 58.8 42.8 8.2 15.0 21.6 67.6 60.1 34.0 14.7 61.4 53.7 23.8 59.6 10.6 9.9 97.0 29.2 23.8 27.1 16.8 7.6 10.2 23.9 16.0 24.5 21.9 22.9 31.0 18.5 16.1 19.9 35.2 36.6 15.7 50.8 18.9 46.1 21.0 20.8 20.4 9.3 17.5 16.3 17.8 9.3 16.0 15.5 27.9 16.1 22.7 11.9 20.1 21.7 16.0 18.4 5.5 24.7 18.2 11.7 10.4 9.1 10.1 6.6 13.2 16.3 5.5 3.2 5.5 3.3 5.2 9.1 8.0 11.5 9.6 10.2 8.4 7.1 2.6 4.3 7.7 5.5 6.2 17.3 8.5 13.2 11.7 13.7 115.4 18.8 4.4 6.0 4.8 8.8 14.8 13.6 11.7 6.6 12.8 4.7 5.1 7.6 6.8 4.7 9.9 18.5 11.2 9.2 6.1 5.1 2.5 36.6 7.8 7.6 7.2 3.7 6.1 10.0 11.3 2.5 4.9 10.1 5.1 4.9 13.3 7.3 10.5 8.0 26.2 10.9 6.6 4.9 6.3 41.8 8.3 11.9 13.8 7.7 10.9 8.2 11.8 7.8 KCNE4 MiRP3 ENSG00000152049 "Potassium voltage-gated channel subfamily E regulatory subunit 4" Q8WWG9 2 223051814-223198399 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 37.5" "Cell type enhanced" "Detected in many" "Fibroblasts: 32.3;Melanocytes: 32.0;Sertoli cells: 118.3;Smooth muscle cells: 128.3" "Cancer enhanced" "Detected in all" "breast cancer: 20.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AN3-CA: 164.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA011420 Approved Approved "Nuclear bodies,Microtubules" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 48: Smooth muscle cells - ECM organization" Microtubules "Nuclear bodies" "HPA011420: AB_1079170" "unprognostic (1.23e-1)" "unprognostic (2.02e-3)" "prognostic unfavorable (9.42e-5)" "unprognostic (2.17e-2)" "unprognostic (7.56e-2)" "unprognostic (2.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (7.89e-2)" "prognostic unfavorable (2.02e-7)" "unprognostic (4.70e-3)" "unprognostic (1.20e-1)" "unprognostic (6.24e-3)" "unprognostic (9.08e-3)" 13.3 3.4 7.7 11.0 6.9 0.5 6.9 6.0 11.2 5.0 5.8 8.0 1.3 30.7 2.3 5.1 7.9 20.3 13.5 8.0 6.9 7.5 5.1 3.1 5.7 9.5 8.1 12.3 10.3 1.8 10.3 6.7 9.3 4.4 2.0 3.3 2.7 5.5 5.4 3.2 3.6 37.5 6.9 4.5 12.5 1.1 7.5 0.7 9.4 3.2 1.1 10.7 3.8 8.0 0.0 0.8 0.0 164.3 36.6 3.7 0.2 4.0 3.8 0.8 1.8 0.0 0.2 0.0 0.0 2.5 5.8 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 4.5 0.0 0.1 6.3 0.0 5.5 0.0 0.0 0.0 0.1 0.0 0.2 6.7 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.1 0.1 0.4 6.4 0.1 12.1 0.7 0.1 0.0 0.0 3.8 0.1 3.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.7 6.9 6.0 11.2 8.0 6.9 9.5 8.1 9.3 6.9 7.5 8.0 8.2 0.0 2.2 4.2 0.0 3.8 0.4 0.2 0.0 0.1 1.8 0.4 4.9 0.0 1.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.8 16.3 19.8 4.8 0.0 0.0 0.0 0.2 32.3 9.2 0.6 3.8 0.4 3.9 0.2 0.1 3.3 0.3 0.0 2.0 0.0 5.8 0.3 21.1 1.0 32.0 5.6 0.0 6.1 0.0 1.0 0.0 0.4 0.1 17.0 0.4 1.4 0.0 0.0 3.7 0.7 118.3 1.7 128.3 0.1 0.2 0.4 3.1 0.3 0.6 0.1 0.2 1.8 KIAA1671 ENSG00000197077 KIAA1671 Q9BY89 22 24952730-25197448 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 74.4;Excitatory neurons: 67.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 1.8" "Lineage enriched" "Detected in single" 4 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "OE19: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018135 Approved Approved Microtubules NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Microtubules "HPA018135: AB_1859551" "unprognostic (1.67e-1)" "unprognostic (1.65e-3)" "unprognostic (1.14e-2)" "unprognostic (1.46e-2)" "unprognostic (7.34e-2)" "unprognostic (3.52e-2)" "unprognostic (8.71e-3)" "unprognostic (1.26e-2)" "unprognostic (1.21e-1)" "unprognostic (2.47e-1)" "unprognostic (2.66e-2)" "unprognostic (7.68e-2)" "prognostic favorable (3.19e-6)" "unprognostic (6.72e-2)" "unprognostic (1.14e-1)" "unprognostic (7.54e-2)" "unprognostic (7.87e-2)" 10.7 13.7 12.4 5.1 13.2 0.8 22.5 2.8 17.9 10.3 8.6 16.0 14.4 6.6 5.2 25.9 20.0 14.8 11.3 20.0 7.7 11.0 34.1 12.2 5.5 6.7 8.3 8.5 10.1 10.3 11.2 4.1 3.9 13.2 14.2 15.5 25.9 15.5 25.1 28.0 16.8 6.8 6.5 3.8 12.4 4.9 13.5 15.6 26.6 22.1 8.9 8.9 18.7 5.6 25.2 15.7 3.3 5.9 0.1 0.1 2.6 0.1 0.1 1.4 0.1 12.6 9.0 0.1 11.7 1.1 6.9 29.8 25.5 25.2 1.0 0.2 10.6 0.1 16.7 16.9 3.3 0.1 1.3 0.6 22.4 7.9 24.3 16.6 28.9 0.5 0.3 0.1 3.4 11.6 0.1 0.1 5.2 39.9 8.3 1.1 26.6 4.9 16.3 10.8 8.0 6.7 20.3 14.0 1.3 10.8 7.6 0.2 19.5 1.4 27.0 16.6 4.5 0.1 0.4 0.1 10.0 0.0 4.3 0.2 0.0 0.0 1.8 0.0 0.2 0.0 0.5 1.3 0.0 0.1 0.2 0.8 0.2 0.4 0.0 0.1 0.1 0.3 12.4 13.2 2.8 17.9 20.0 7.7 6.7 8.3 3.9 6.5 13.5 5.6 27.7 12.8 21.9 74.4 1.1 10.8 21.1 16.2 18.2 4.2 25.4 16.5 11.9 25.8 19.2 5.5 22.9 0.2 3.0 62.9 0.0 18.9 2.6 31.2 3.5 28.5 7.2 5.3 67.8 18.9 0.1 4.9 22.4 30.2 1.3 4.2 29.6 47.8 2.4 16.8 22.9 12.3 6.1 1.9 5.9 3.5 7.2 1.6 10.6 43.1 0.6 21.6 0.0 12.5 3.4 21.4 34.1 9.1 0.6 18.2 34.1 8.8 32.0 17.6 0.0 11.0 9.3 6.8 8.8 27.3 14.5 1.0 6.6 6.6 20.1 29.2 KIF18A "DKFZP434G2226, PPP1R99" ENSG00000121621 "Kinesin family member 18A" Q8NI77 11 28020619-28108156 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 8.2;lymphoid tissue: 9.6;testis: 13.7" "Cell type enhanced" "Detected in many" "Early spermatids: 43.1;Spermatocytes: 78.7;Spermatogonia: 28.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 4.1;memory B-cell: 1.0;NK-cell: 1.4;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA039312, HPA039484" Approved Supported "Microtubules,Cytokinetic bridge" Yes Yes "Cluster 41: Basophils - Cellular respiration" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Microtubules, Cytokinetic bridge" "HPA039312: AB_10794087, HPA039484: AB_10795252" "unprognostic (3.79e-1)" "unprognostic (2.63e-1)" "unprognostic (7.09e-3)" "unprognostic (3.80e-2)" "unprognostic (6.56e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-7)" "unprognostic (2.43e-3)" "unprognostic (2.04e-3)" "unprognostic (1.23e-2)" "unprognostic (1.72e-4)" "unprognostic (4.41e-2)" "unprognostic (0.00e+0)" "unprognostic (7.88e-3)" "unprognostic (1.67e-1)" "unprognostic (1.43e-1)" "unprognostic (2.50e-1)" 0.2 0.1 0.0 1.9 0.1 8.2 0.7 0.0 0.1 0.7 0.1 1.6 1.5 0.5 0.3 1.4 0.3 0.5 0.0 0.1 0.1 0.3 0.3 1.0 4.7 0.1 0.1 0.1 0.1 0.1 0.1 1.5 0.1 0.3 2.0 0.6 0.3 0.4 0.2 1.2 1.4 0.8 0.1 0.7 0.6 13.7 0.2 9.6 1.1 0.1 4.6 0.7 0.5 0.1 27.9 27.4 27.2 19.0 0.9 3.7 9.1 28.3 13.2 44.2 46.0 9.2 11.0 23.3 10.0 14.7 24.1 27.2 23.4 11.1 61.4 23.4 14.2 15.2 17.8 11.8 2.1 22.6 13.4 6.8 1.4 15.5 18.1 7.8 17.2 19.0 24.6 20.0 25.2 14.8 23.1 16.7 13.4 18.0 11.1 17.8 65.0 11.6 12.5 8.0 16.3 12.6 23.7 11.1 7.8 16.5 23.8 6.9 10.1 35.0 27.2 33.2 37.4 7.9 19.8 23.4 21.0 16.5 25.2 4.1 0.0 0.3 0.1 0.2 0.3 1.0 0.4 0.2 0.3 0.4 0.3 0.1 0.0 1.4 0.0 0.3 1.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 1.2 3.2 0.0 0.0 4.7 2.3 1.3 1.4 1.2 0.3 1.3 2.9 0.5 0.0 2.2 0.0 6.2 4.6 2.8 1.9 0.0 0.6 43.1 3.4 2.5 1.1 1.8 15.4 0.2 0.9 7.1 5.4 1.5 3.4 4.5 9.7 1.4 0.0 2.2 0.0 0.1 1.9 0.0 1.6 1.4 8.7 0.6 1.4 0.0 1.0 1.1 0.7 1.0 0.5 0.9 0.5 0.1 0.4 5.1 0.2 0.2 0.6 1.7 1.9 0.0 2.5 1.9 78.7 28.3 4.3 1.0 1.6 3.9 2.7 3.6 0.5 KIF1B "CMT2, CMT2A, HMSNII, KIAA0591, KLP" ENSG00000054523 "Kinesin family member 1B" O60333 1 10210570-10381603 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Motor protein" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 103.6;retina: 127.4;skeletal muscle: 202.3;tongue: 150.9" "Cell type enhanced" "Detected in many" "Astrocytes: 413.9;Cone photoreceptor cells: 579.6;Excitatory neurons: 297.4;Inhibitory neurons: 281.6;Oligodendrocytes: 521.3;Rod photoreceptor cells: 389.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 5.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015177 Approved Approved "Nucleoli fibrillar center,Microtubules" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 12: NES - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Microtubules "Nucleoli fibrillar center" "CAB015177: AB_2296564" "unprognostic (1.30e-1)" "unprognostic (6.88e-2)" "unprognostic (4.96e-2)" "unprognostic (9.82e-3)" "unprognostic (7.15e-2)" "unprognostic (1.37e-1)" "unprognostic (1.66e-2)" "unprognostic (1.13e-1)" "unprognostic (2.67e-1)" "unprognostic (8.72e-2)" "unprognostic (3.26e-2)" "unprognostic (1.20e-1)" "prognostic favorable (2.91e-6)" "unprognostic (1.51e-1)" "unprognostic (3.46e-2)" "unprognostic (1.10e-1)" "unprognostic (9.33e-3)" 11.1 14.8 64.1 8.2 73.5 16.0 12.4 68.4 67.0 11.0 0.0 16.7 9.5 15.5 6.8 18.3 10.5 10.3 29.7 65.9 58.2 14.6 12.1 11.0 4.2 74.7 61.6 15.7 13.2 20.5 12.6 10.2 78.1 11.9 9.2 127.4 12.8 9.3 202.3 14.2 10.6 15.2 44.0 7.3 9.4 19.7 60.4 4.8 10.9 150.9 5.0 11.6 12.5 103.6 25.0 17.7 81.3 31.8 22.0 24.6 7.0 24.0 16.6 24.8 25.0 19.5 12.2 3.6 23.4 38.9 13.2 17.7 58.9 18.8 34.2 35.1 19.3 14.7 25.8 23.0 17.6 5.2 4.5 19.0 18.8 42.3 26.7 18.0 31.1 15.4 16.6 14.4 27.7 7.5 5.9 5.2 17.9 10.9 13.0 24.6 47.2 6.6 10.3 12.2 55.3 27.0 33.8 16.1 32.9 33.5 11.5 7.0 36.4 29.1 18.4 33.0 23.1 7.8 13.9 7.7 25.1 15.8 14.9 2.3 1.0 5.5 0.6 0.9 0.3 0.5 0.6 0.7 0.7 0.5 0.4 0.4 4.7 0.6 1.2 0.5 0.8 0.5 64.1 73.5 68.4 67.0 65.9 58.2 74.7 61.6 78.1 44.0 60.4 103.6 38.3 60.9 21.6 413.9 9.3 50.9 24.5 15.2 25.0 248.2 33.6 26.5 120.0 14.3 18.1 22.0 579.6 6.9 17.5 26.4 0.0 18.8 85.8 34.6 41.8 39.8 28.8 4.2 297.4 18.1 6.1 42.6 22.4 63.1 7.0 104.6 20.3 37.6 22.1 139.7 281.6 17.7 20.3 22.0 43.5 48.4 18.6 36.8 51.6 75.9 19.5 56.1 6.2 238.8 521.3 23.8 23.4 20.7 21.1 25.8 31.7 14.2 19.9 389.3 19.7 85.4 42.3 37.3 37.7 40.8 59.1 6.7 14.4 63.0 21.3 20.8 KIF26B FLJ10157 ENSG00000162849 "Kinesin family member 26B" Q2KJY2 1 245154985-245709432 "Predicted intracellular proteins" "Developmental protein, Motor protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.2" "Group enriched" "Detected in many" 4 "Inhibitory neurons: 282.0;Oligodendrocyte precursor cells: 378.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 18 "plasmacytoid DC: 1.8" "Lineage enriched" "Detected in single" 18 "dendritic cells: 1.8" "Cell line enhanced" "Detected in some" "HSkMC: 16.5;REH: 15.2;SH-SY5Y: 14.4;U-937: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027709, HPA028478, HPA028561, HPA028562" Enhanced Approved "Plasma membrane,Microtubules" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane, Microtubules" "HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417" "unprognostic (3.66e-1)" "unprognostic (5.67e-2)" "unprognostic (7.90e-3)" "unprognostic (4.50e-3)" "unprognostic (3.23e-2)" "unprognostic (1.49e-1)" "unprognostic (4.17e-2)" "unprognostic (1.61e-1)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (8.30e-3)" "unprognostic (3.63e-1)" "unprognostic (1.38e-1)" "unprognostic (1.13e-2)" "unprognostic (5.77e-2)" "unprognostic (1.17e-4)" "unprognostic (7.22e-3)" 0.1 0.7 2.4 0.3 2.1 0.0 0.4 4.1 3.3 1.1 0.0 0.7 0.1 0.7 0.2 0.2 0.4 0.8 0.5 2.1 3.7 1.0 0.2 1.1 0.2 2.8 6.2 0.1 0.2 0.4 0.4 1.7 3.1 0.8 0.0 0.1 0.4 0.8 0.0 1.2 0.3 0.5 3.2 0.3 0.5 0.5 2.6 0.3 1.0 0.0 0.2 0.4 0.2 1.8 0.0 0.0 2.2 3.9 1.1 1.3 1.5 1.9 2.4 0.1 0.0 2.2 0.0 0.0 3.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 2.0 0.1 0.3 16.5 0.7 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 15.2 0.2 0.0 2.0 0.0 4.0 14.4 0.0 0.0 0.0 2.8 0.0 0.9 0.2 3.3 0.0 0.0 1.1 0.0 0.0 0.0 0.7 7.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 2.4 2.1 4.1 3.3 2.1 3.7 2.8 6.2 3.1 3.2 2.6 1.8 0.1 0.0 0.5 9.8 0.0 0.9 0.1 0.8 0.6 1.0 0.8 1.7 2.3 0.0 1.1 7.3 4.2 2.4 2.8 0.0 0.0 2.0 2.1 4.3 17.7 0.6 0.0 0.0 34.6 4.8 2.8 2.1 1.5 1.1 0.0 1.4 0.0 0.0 0.8 0.0 282.0 0.0 0.0 0.0 0.4 5.6 0.6 0.6 3.6 66.5 0.8 0.5 0.0 378.0 9.8 9.2 0.0 0.0 0.0 0.2 0.2 0.5 2.0 0.4 0.0 0.8 1.5 1.1 2.0 0.5 1.3 2.5 0.3 0.1 0.5 0.0 KIF2B ENSG00000141200 "Kinesin family member 2B" Q8N4N8 17 53822927-53825193 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 508 "testis: 75.3" "Group enriched" "Detected in some" 68 "Early spermatids: 744.0;Late spermatids: 623.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023081, HPA023103, HPA024795" Uncertain Supported "Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 74: Testis - Spermatogenesis" "Cluster 34: Spermatids - Unknown function" "Microtubules, Cytokinetic bridge, Mitotic spindle" Nucleoli "HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 744.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 623.2 6.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 10.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KIFAP3 "FLA3, KAP-1, KAP3, SMAP" ENSG00000075945 "Kinesin associated protein 3" Q92845 1 169921326-170085208 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 193.9;Excitatory neurons: 190.5;Inhibitory neurons: 192.4;Late spermatids: 200.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023738, HPA023742" Supported Approved Microtubules NA NA "Cluster 44: Non-specific - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Microtubules "HPA023738: AB_1857285, HPA023742: AB_1857286" "unprognostic (5.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (6.05e-2)" "unprognostic (4.64e-2)" "unprognostic (1.47e-1)" "unprognostic (7.17e-3)" "unprognostic (7.74e-2)" "unprognostic (1.02e-2)" "unprognostic (3.64e-1)" "unprognostic (1.15e-1)" "unprognostic (4.00e-2)" "unprognostic (3.08e-3)" "unprognostic (4.39e-3)" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (2.22e-2)" 17.8 34.8 46.8 11.9 50.0 6.9 16.4 37.4 60.0 18.8 27.7 19.9 11.6 17.3 23.3 12.6 19.4 15.4 51.1 50.8 55.7 23.5 16.6 15.4 13.1 50.0 43.3 19.2 14.0 27.1 29.1 14.5 52.0 14.4 15.9 56.4 13.0 16.2 22.4 14.1 14.5 15.6 39.2 10.8 10.0 35.1 44.2 18.8 16.7 23.1 13.9 13.5 18.1 49.9 13.0 11.8 17.6 19.0 41.0 43.2 9.9 16.1 19.9 19.7 24.2 5.8 20.5 23.2 23.1 33.3 9.1 27.6 37.7 22.6 18.5 49.3 19.9 56.3 13.8 5.3 20.4 16.6 9.4 30.5 30.3 34.7 30.1 23.3 22.6 29.5 47.7 17.1 24.9 3.5 31.2 9.8 3.8 33.7 10.7 12.3 15.5 14.8 37.2 4.8 20.8 32.0 22.1 17.9 25.1 40.5 16.7 10.4 24.1 42.0 9.7 26.7 19.5 33.0 23.9 21.2 19.6 6.0 27.3 16.8 3.8 14.8 13.0 10.6 15.0 7.5 13.2 14.9 8.8 7.6 14.9 15.3 1.4 22.3 19.3 7.6 18.6 8.4 46.8 50.0 37.4 60.0 50.8 55.7 50.0 43.3 52.0 39.2 44.2 49.9 33.2 32.1 27.8 64.6 14.4 9.1 11.9 12.3 12.0 56.5 13.8 18.2 37.3 28.6 27.6 29.5 43.8 14.2 22.8 14.5 9.8 25.9 193.9 51.5 35.4 20.9 32.2 25.9 190.5 8.2 16.0 32.4 9.2 25.5 31.0 15.5 12.8 13.6 9.8 48.8 192.4 12.5 24.4 13.4 5.9 200.7 38.5 17.1 10.6 51.5 8.6 42.7 29.9 84.4 65.0 12.0 9.4 21.8 27.8 4.9 13.2 37.3 64.3 70.7 0.0 34.5 31.1 77.8 64.0 14.6 10.7 8.8 20.3 17.4 17.0 9.9 KLHL22 "FLJ14360, KELCHL" ENSG00000099910 "Kelch like family member 22" Q53GT1 22 20441519-20495844 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 41.1;Excitatory neurons: 42.9;Inhibitory neurons: 51.1;Oligodendrocyte precursor cells: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040766 Supported "Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes No "Cluster 2: Granulocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Vesicles, Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA040766: AB_2732488" "unprognostic (4.15e-1)" "unprognostic (9.34e-3)" "unprognostic (5.37e-2)" "prognostic favorable (4.88e-6)" "unprognostic (1.17e-1)" "unprognostic (2.30e-3)" "unprognostic (1.00e-2)" "unprognostic (1.19e-3)" "unprognostic (2.20e-1)" "unprognostic (8.99e-2)" "prognostic favorable (3.85e-6)" "unprognostic (3.94e-2)" "prognostic favorable (1.34e-8)" "unprognostic (3.94e-2)" "unprognostic (3.10e-1)" "unprognostic (4.64e-2)" "unprognostic (1.08e-2)" 13.7 14.2 24.1 10.2 23.0 11.3 11.9 25.9 25.1 20.5 18.2 16.6 7.7 20.4 17.2 8.0 17.9 13.6 14.2 22.9 21.4 15.6 10.8 11.8 17.6 18.0 18.1 22.3 16.5 22.9 19.6 11.6 18.7 18.7 10.6 15.3 14.0 18.0 22.1 11.7 10.4 21.7 14.8 15.6 12.2 10.2 23.1 8.0 20.8 18.0 20.7 13.4 10.9 21.2 17.1 16.5 37.5 29.9 30.6 35.5 9.0 21.4 37.6 21.0 23.6 8.2 6.4 11.9 7.0 37.3 16.9 21.3 25.6 9.2 18.1 25.9 15.1 12.6 17.4 8.3 30.6 2.6 11.7 26.9 14.2 19.3 12.4 26.8 31.3 9.1 32.7 11.4 20.7 25.9 2.5 15.6 6.3 14.1 11.4 23.5 13.8 0.5 12.3 19.9 19.9 20.3 23.0 16.9 15.8 12.3 15.7 9.3 14.2 25.1 12.2 17.5 8.9 6.4 7.4 7.9 13.5 11.1 16.6 8.9 4.6 19.3 8.1 6.3 6.4 8.3 10.2 7.5 15.5 6.2 7.7 8.3 10.6 16.6 8.3 5.6 19.2 6.5 24.1 23.0 25.9 25.1 22.9 21.4 18.0 18.1 18.7 14.8 23.1 21.2 4.6 0.0 3.7 41.1 8.2 1.7 2.8 8.4 4.0 11.7 4.3 5.2 4.8 10.0 5.3 9.2 4.2 17.9 5.2 2.9 3.9 8.4 0.8 3.2 7.1 4.8 3.0 1.3 42.9 2.6 6.6 9.2 5.1 3.9 5.1 14.2 4.2 6.3 7.9 13.5 51.1 5.2 12.2 5.7 4.9 1.8 12.2 4.8 1.8 16.9 4.2 13.9 7.2 41.2 26.8 5.6 3.5 19.9 5.4 3.9 3.0 10.9 4.3 6.7 6.6 4.7 5.3 17.3 15.4 2.8 1.4 13.4 7.8 17.7 3.8 1.8 KLHL4 "DKELCHL, KHL4, KIAA1687" ENSG00000102271 "Kelch like family member 4" Q9C0H6 X 87517409-87670050 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.5;brain: 21.3" "Group enriched" "Detected in some" 4 "Oligodendrocytes: 286.2;Theca cells: 109.4" "Cancer enriched" "Detected in some" 8 "glioma: 9.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 14.7;GAMG: 18.2;HUVEC TERT2: 32.0;NTERA-2: 24.3;SuSa: 17.8;TIME: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029192 Approved Supported "Microtubules,Centriolar satellite" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Microtubules "Centriolar satellite" "HPA029192: AB_10602341" "unprognostic (6.70e-2)" "unprognostic (2.20e-1)" "unprognostic (8.74e-2)" "unprognostic (2.84e-3)" "unprognostic (1.48e-2)" "unprognostic (5.90e-2)" "unprognostic (1.71e-2)" "unprognostic (1.89e-2)" "unprognostic (5.21e-2)" "unprognostic (2.63e-1)" "unprognostic (5.98e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (8.08e-5)" "unprognostic (2.40e-4)" "unprognostic (1.05e-1)" "unprognostic (5.87e-2)" "unprognostic (7.25e-4)" 1.3 26.5 5.3 0.4 10.2 0.0 0.9 7.3 7.1 1.2 0.6 0.3 0.1 3.0 0.3 0.5 2.5 1.5 0.8 5.2 5.7 1.1 0.6 0.8 0.4 9.6 7.5 7.9 0.3 0.0 0.0 0.1 9.5 0.3 0.3 2.3 0.0 1.4 0.3 0.1 0.3 5.1 7.5 1.3 0.3 7.0 6.7 0.1 0.6 0.3 0.1 0.9 0.2 21.3 0.0 3.6 14.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.2 0.0 0.1 0.9 0.0 1.4 0.4 0.0 2.6 0.0 11.0 0.2 0.0 1.6 4.7 6.0 1.3 11.6 32.0 0.0 0.2 2.5 8.1 0.0 0.0 0.0 24.3 0.1 5.7 0.0 8.9 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 17.8 0.0 0.1 34.4 0.0 5.6 0.0 0.5 0.2 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 10.2 7.3 7.1 5.2 5.7 9.6 7.5 9.5 7.5 6.7 21.3 1.7 0.0 0.0 2.0 0.0 0.1 0.0 0.1 0.0 3.6 0.0 0.0 1.5 0.0 0.0 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.1 15.0 0.0 0.0 44.4 0.0 0.0 4.4 0.0 0.1 0.0 4.5 14.3 0.2 0.1 0.0 6.6 0.0 0.0 0.3 0.3 1.5 0.9 0.1 0.0 4.7 0.0 1.5 0.0 36.2 286.2 0.1 0.0 1.5 0.1 0.0 0.0 3.4 2.2 4.1 0.0 1.2 0.5 0.4 0.4 0.0 0.3 0.0 0.7 109.4 0.0 0.0 KLHL6 FLJ00029 ENSG00000172578 "Kelch like family member 6" Q8WZ60 3 183487551-183555706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 31.0" "Cell type enhanced" "Detected in many" "B-cells: 35.7;Endometrial ciliated cells: 28.3;granulocytes: 51.1;Hofbauer cells: 24.1;Macrophages: 33.3;Plasma cells: 63.6;Respiratory ciliated cells: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 41.3;HEL: 26.6;HMC-1: 26.7;U-266/70: 82.1;U-266/84: 45.5;U-698: 121.3" "Low region specificity" "Detected in all" HPA024512 Uncertain Approved "Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite" Yes NA "Cluster 2: Granulocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Centriolar satellite" "Plasma membrane, Microtubules, Mitotic spindle" "HPA024512: AB_2131015" "unprognostic (8.46e-2)" "unprognostic (3.67e-4)" "unprognostic (1.48e-2)" "unprognostic (6.03e-4)" "unprognostic (5.15e-2)" "unprognostic (1.30e-3)" "unprognostic (1.39e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (9.62e-2)" "unprognostic (8.24e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (3.53e-4)" "unprognostic (1.81e-1)" "unprognostic (3.68e-2)" "unprognostic (2.42e-1)" "unprognostic (5.73e-2)" 1.5 0.7 0.7 11.8 0.8 3.5 0.9 1.0 1.0 0.8 0.7 2.5 2.5 0.6 0.2 0.6 4.8 2.1 0.7 0.6 1.4 0.4 1.0 4.2 29.3 2.6 1.4 0.3 0.6 0.2 0.2 1.9 2.0 0.5 2.3 0.1 1.3 0.1 0.2 0.1 4.8 0.7 1.5 6.3 4.1 0.2 3.1 10.0 0.6 0.3 31.0 1.8 0.3 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 21.9 0.0 26.6 0.0 0.0 0.0 7.3 26.7 0.0 0.0 0.0 0.0 0.0 4.6 0.5 0.4 18.4 0.0 0.0 8.8 4.1 0.0 0.0 0.0 14.8 0.1 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 2.5 0.0 0.1 0.0 0.1 82.1 45.5 121.3 0.0 8.0 0.0 7.8 2.8 11.8 0.6 2.2 0.7 3.6 2.4 1.0 2.0 2.4 2.9 1.8 2.4 2.2 2.7 4.6 4.2 2.6 0.7 0.8 1.0 1.0 0.6 1.4 2.6 1.4 2.0 1.5 3.1 3.7 4.0 6.4 6.5 0.7 35.7 1.1 1.7 0.6 0.6 0.6 0.3 0.4 4.8 0.0 5.4 0.0 2.1 0.2 16.6 0.2 0.0 0.1 2.0 28.3 0.5 4.6 0.0 7.6 0.3 0.0 0.3 1.7 2.0 0.8 51.1 8.1 1.1 0.2 24.1 0.0 0.3 0.0 0.0 20.7 22.4 0.8 0.3 33.3 8.8 14.0 10.1 0.3 5.2 1.0 0.3 0.0 0.1 0.0 63.6 1.2 0.0 0.4 24.4 0.7 0.0 1.8 1.5 0.3 0.4 0.1 0.6 0.5 16.8 0.0 0.2 1.2 LANCL1 "GPR69A, p40" ENSG00000115365 "LanC like 1" O43813 2 210431249-210477652 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 140.7" "Cell type enhanced" "Detected in all" "Early spermatids: 140.5;Inhibitory neurons: 157.1;Oligodendrocytes: 599.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034994 Enhanced Uncertain Microtubules NA NA 22000 "Cluster 44: Non-specific - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Microtubules "HPA034994: AB_10601936" "unprognostic (2.34e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (2.67e-2)" "unprognostic (2.02e-2)" "unprognostic (1.20e-1)" "unprognostic (6.10e-2)" "unprognostic (9.76e-2)" "unprognostic (2.82e-2)" "unprognostic (2.08e-1)" "unprognostic (2.13e-3)" "unprognostic (1.23e-1)" "unprognostic (9.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.06e-1)" 28.1 26.8 57.3 15.5 91.9 19.1 33.6 85.2 81.5 23.1 21.5 22.1 21.5 28.8 19.6 29.5 23.4 23.0 40.9 59.0 67.7 37.6 23.6 21.2 26.7 95.1 79.4 32.1 24.6 64.9 19.2 22.1 89.0 33.0 22.7 48.5 20.3 31.7 28.5 42.2 20.7 33.0 92.8 23.3 19.0 53.9 77.5 40.0 24.3 51.2 27.7 21.4 16.6 140.7 26.3 29.2 45.9 46.8 51.3 71.9 32.0 39.3 50.3 35.5 46.4 32.8 29.4 22.5 50.3 44.9 57.8 26.6 30.2 63.6 59.4 26.1 32.4 39.6 96.1 58.3 42.5 50.5 13.6 52.1 51.2 46.7 37.8 80.3 52.2 68.3 50.1 35.6 46.4 23.1 68.5 27.9 30.7 31.9 20.2 30.5 64.1 33.4 65.2 25.4 43.6 60.4 46.0 97.5 51.2 67.3 33.2 26.7 53.5 62.2 41.4 32.9 41.8 21.8 43.8 31.3 58.4 38.5 73.4 8.6 2.5 6.8 11.8 5.3 11.5 7.9 10.4 11.8 8.3 8.8 11.0 12.7 0.8 8.1 8.5 7.3 11.7 6.8 57.3 91.9 85.2 81.5 59.0 67.7 95.1 79.4 89.0 92.8 77.5 140.7 13.5 12.8 14.2 36.2 11.6 26.3 10.0 13.2 31.3 27.2 19.0 13.5 35.7 10.0 12.3 20.2 18.8 10.8 12.3 5.9 15.6 8.7 140.5 11.6 12.6 13.4 6.7 17.9 68.4 12.0 5.6 16.1 9.2 10.7 6.3 24.0 11.4 20.1 8.8 50.5 157.1 7.6 12.2 10.3 6.4 114.7 13.1 5.0 16.0 20.6 4.5 20.7 15.5 70.4 599.1 5.3 6.0 19.2 11.0 6.5 9.2 18.8 14.2 24.1 19.7 14.8 22.0 41.7 19.0 25.3 33.1 5.1 13.8 14.8 12.7 8.1 LARP6 "acheron, FLJ11196" ENSG00000166173 "La ribonucleoprotein 6, translational regulator" Q9BRS8 15 70829130-70854157 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 429.0;Late spermatids: 259.8;Spermatocytes: 166.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 232.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020338, HPA049029" Approved Approved "Microtubules,Cytokinetic bridge" Yes No "Cluster 57: Non-specific - Angiogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Microtubules "Cytokinetic bridge" "HPA020338: AB_1844500, HPA049029: AB_2680604" "unprognostic (1.35e-3)" "unprognostic (1.95e-1)" "unprognostic (7.43e-2)" "unprognostic (2.63e-3)" "unprognostic (2.96e-2)" "unprognostic (4.70e-2)" "unprognostic (2.44e-2)" "unprognostic (2.80e-3)" "unprognostic (4.27e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "prognostic unfavorable (9.90e-5)" "unprognostic (4.51e-3)" "unprognostic (8.90e-2)" "unprognostic (2.13e-1)" "unprognostic (3.43e-1)" 51.4 9.8 42.8 6.5 69.8 0.1 44.0 56.9 65.5 27.5 22.8 18.5 2.1 22.8 28.4 7.9 29.0 10.9 43.4 44.5 52.0 27.9 10.6 17.9 2.3 57.8 56.6 30.4 10.9 19.6 23.6 7.7 56.4 26.1 4.0 11.8 19.5 14.1 17.6 14.0 10.3 12.1 46.8 2.6 26.9 9.6 55.9 5.1 40.8 26.1 1.5 21.1 31.0 90.4 42.3 44.2 14.1 28.3 70.2 77.9 0.1 127.7 99.0 67.4 71.2 12.9 12.0 0.0 50.9 69.9 65.4 22.7 32.0 11.2 66.4 0.4 78.3 0.2 37.6 12.0 127.1 0.2 0.2 49.0 45.6 67.9 107.5 70.6 22.2 15.4 0.1 0.6 30.4 7.3 0.3 0.3 14.9 0.0 113.9 0.2 50.6 0.3 22.0 35.9 8.4 18.5 42.5 0.5 93.1 21.7 2.3 2.4 29.6 27.4 109.6 232.0 107.5 0.2 0.3 0.4 116.9 0.0 14.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 42.8 69.8 56.9 65.5 44.5 52.0 57.8 56.6 56.4 46.8 55.9 90.4 32.3 0.0 1.1 2.9 0.1 18.1 47.7 20.4 9.6 41.4 15.4 18.3 22.2 24.3 11.8 12.9 2.1 0.5 1.0 0.3 54.8 59.4 429.0 24.6 31.8 24.5 12.0 0.0 10.8 25.1 0.8 87.5 4.1 8.4 0.0 7.5 11.4 15.3 1.2 25.2 11.8 1.5 10.2 0.6 13.3 259.8 73.3 3.2 19.6 7.5 0.1 28.5 0.0 5.5 105.9 62.9 0.0 45.9 0.5 61.9 0.0 100.9 16.8 4.8 19.7 28.3 34.8 166.8 11.0 1.4 8.9 0.4 1.9 5.3 0.6 37.7 LDLRAP1 "ARH, ARH2, DKFZp586D0624, FHCB1, FHCB2, MGC34705" ENSG00000157978 "Low density lipoprotein receptor adaptor protein 1" Q5SW96 1 25543606-25568886 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Atherosclerosis, Disease variant, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 7 "NK-cells: 39.5;T-cells: 107.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB003705, HPA050358" Uncertain Approved Microtubules NA NA "Cluster 32: T-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 2: Karpas-707 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" Microtubules "CAB003705: AB_425923, HPA050358: AB_2681103" "unprognostic (2.52e-2)" "unprognostic (5.39e-3)" "unprognostic (7.49e-3)" "unprognostic (4.12e-2)" "unprognostic (1.40e-1)" "unprognostic (1.18e-2)" "unprognostic (1.70e-2)" "unprognostic (7.27e-3)" "unprognostic (4.79e-1)" "unprognostic (1.18e-1)" "unprognostic (1.20e-3)" "unprognostic (9.96e-2)" "unprognostic (6.49e-2)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (2.74e-2)" "unprognostic (4.24e-1)" 11.0 19.7 14.2 18.8 25.0 8.6 11.7 28.4 17.7 11.3 25.5 18.2 11.3 8.8 8.0 19.4 9.8 8.0 12.6 14.4 17.5 14.4 27.2 15.7 37.2 30.6 25.0 9.3 39.6 14.7 19.4 21.1 27.6 21.5 16.4 5.5 30.9 9.8 13.1 21.2 16.8 10.4 21.4 58.1 15.8 5.6 22.7 14.2 17.2 9.3 22.0 9.7 15.4 37.9 32.2 12.5 17.5 18.5 10.7 12.3 14.1 20.0 19.5 30.0 20.8 5.1 26.0 7.1 14.2 27.4 20.9 33.3 11.9 20.3 15.1 8.5 18.5 11.4 14.5 9.8 17.0 13.1 16.4 13.4 28.6 24.2 9.0 7.3 26.1 7.1 16.0 68.1 10.0 18.6 0.2 22.4 22.2 25.7 13.2 1.9 19.7 57.6 11.2 6.6 8.7 4.9 27.8 43.9 32.3 14.1 20.0 22.2 15.7 13.1 19.1 25.0 14.1 64.8 81.6 20.2 44.2 10.9 16.3 0.0 7.0 0.3 23.6 5.7 27.1 10.5 55.2 43.4 9.4 5.4 107.3 89.8 3.1 39.5 5.9 1.3 49.7 50.6 14.2 25.0 28.4 17.7 14.4 17.5 30.6 25.0 27.6 21.4 22.7 37.9 9.8 0.0 11.0 2.6 11.5 8.3 20.6 21.5 15.4 4.0 10.3 13.3 3.6 5.7 21.1 7.3 18.8 35.2 13.3 33.6 3.9 9.7 0.2 2.9 4.1 10.8 6.7 3.8 2.3 17.8 8.6 8.9 4.6 5.4 2.5 8.6 12.1 25.6 11.0 70.7 1.2 23.9 10.2 6.0 3.5 0.0 10.2 23.7 17.8 11.2 6.9 4.0 22.6 2.0 50.1 12.9 23.4 8.6 19.3 19.1 11.9 5.9 6.1 19.5 26.3 16.9 9.1 3.2 10.1 12.4 5.7 23.7 28.7 9.7 22.0 20.0 LRRC25 "FLJ38116, MAPA" ENSG00000175489 "Leucine rich repeat containing 25" Q8N386 19 18391137-18397622 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 32.4;lymphoid tissue: 61.2" "Group enriched" "Detected in some" 6 "Hofbauer cells: 47.0;Kupffer cells: 123.6;Macrophages: 90.0;monocytes: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 320.6;eosinophil: 356.2;intermediate monocyte: 512.1;myeloid DC: 229.3;neutrophil: 573.0;non-classical monocyte: 706.7" "Group enriched" "Detected in all" 60 "dendritic cells: 229.3;granulocytes: 573.0;monocytes: 706.7" "Cell line enhanced" "Detected in some" "Hep G2: 1.0;HMC-1: 1.8;THP-1: 1.7;U-937: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029459 Approved Approved "Endoplasmic reticulum,Microtubules,Cytosol" NA NA 630000 "Cluster 51: Monocytes - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Endoplasmic reticulum, Microtubules, Cytosol" "HPA029459: AB_10610005" "unprognostic (2.72e-2)" "unprognostic (6.08e-2)" "unprognostic (1.76e-2)" "unprognostic (2.07e-1)" "unprognostic (3.77e-2)" "unprognostic (9.15e-2)" "unprognostic (5.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.20e-2)" "unprognostic (4.63e-2)" "unprognostic (2.02e-1)" "unprognostic (1.73e-1)" "unprognostic (1.19e-3)" "unprognostic (5.77e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (1.74e-1)" "unprognostic (1.14e-1)" 9.4 9.4 2.4 21.8 2.5 32.4 3.1 3.3 2.9 1.8 3.2 3.3 3.7 1.6 0.7 2.3 3.9 5.3 2.5 2.3 3.1 2.4 5.9 11.5 9.9 4.6 4.0 1.5 2.0 0.7 1.2 5.4 4.2 2.0 2.8 0.3 2.6 1.2 3.7 1.0 4.8 6.7 2.8 61.2 2.3 1.2 5.4 3.0 1.2 8.7 4.0 7.0 1.3 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.3 1.0 0.8 0.4 1.8 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.7 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.2 1.5 0.1 55.4 320.6 356.2 0.9 512.1 1.9 7.3 0.6 0.7 229.3 8.4 0.5 0.6 573.0 4.6 706.7 32.1 1.3 229.2 2.4 2.5 3.3 2.9 2.3 3.1 4.6 4.0 4.2 2.8 5.4 4.7 0.7 0.0 1.3 0.0 5.0 0.0 0.1 0.1 0.0 0.1 0.3 1.0 0.3 0.0 0.7 0.0 0.0 0.1 2.9 0.1 5.9 0.1 1.9 0.2 0.1 0.9 0.0 2.1 0.1 0.0 0.4 0.5 0.0 0.4 10.2 0.0 1.8 0.5 47.0 0.0 0.1 0.0 0.0 123.6 12.5 0.5 0.0 90.0 1.8 1.0 74.9 0.0 6.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 2.4 0.2 0.0 0.2 0.0 0.1 0.4 1.1 0.2 0.1 0.1 LRRC34 MGC27085 ENSG00000171757 "Leucine rich repeat containing 34" Q8IZ02 3 169793003-169812986 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 12.8" "Cell type enhanced" "Detected in many" "Early spermatids: 137.9;Respiratory ciliated cells: 129.6;Spermatocytes: 104.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 8.1;HL-60: 8.9;JURKAT: 7.1;NTERA-2: 7.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA035747 Approved Approved "Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 36: HEL - Hemostasis" "Cluster 49: Ciliated cells - Cilium organization" "Cell Junctions, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA035747: AB_10670120" "unprognostic (1.04e-2)" "unprognostic (5.71e-2)" "unprognostic (5.67e-2)" "unprognostic (5.64e-2)" "unprognostic (9.74e-3)" "unprognostic (5.46e-2)" "unprognostic (9.74e-2)" "unprognostic (8.24e-2)" "unprognostic (6.39e-3)" "unprognostic (2.57e-1)" "unprognostic (6.05e-2)" "unprognostic (1.23e-1)" "unprognostic (8.39e-2)" "unprognostic (1.16e-2)" "unprognostic (3.48e-1)" "unprognostic (3.37e-1)" "unprognostic (2.79e-1)" 1.5 0.4 1.6 0.6 2.1 1.4 1.1 1.6 2.7 0.9 2.8 0.5 0.2 0.7 0.3 0.2 5.5 0.3 1.1 1.2 2.1 0.7 0.2 1.0 0.8 2.1 2.5 0.8 0.2 0.3 2.8 0.2 2.2 0.6 0.1 5.6 0.3 0.7 0.4 0.5 0.4 0.2 2.1 0.7 0.4 12.8 1.9 0.6 0.9 0.4 0.3 0.4 0.4 1.8 2.3 0.4 0.5 0.0 0.9 3.0 0.0 0.9 1.9 2.4 2.1 0.1 0.0 1.5 0.1 0.6 3.1 0.0 1.8 0.0 0.8 0.4 5.6 8.1 0.2 0.0 0.6 8.9 1.8 0.9 0.4 0.8 0.0 0.1 1.6 7.1 0.2 0.0 0.9 0.0 0.8 1.1 7.7 0.0 2.6 4.0 0.0 0.4 2.1 0.2 4.0 3.1 0.5 0.3 0.0 0.2 0.0 4.2 0.5 0.4 0.0 0.3 0.1 0.1 0.1 1.9 3.5 0.1 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 1.6 2.1 1.6 2.7 1.2 2.1 2.1 2.5 2.2 2.1 1.9 1.8 3.9 3.2 2.6 8.5 1.5 0.4 0.9 5.3 0.0 6.9 0.4 0.9 3.2 0.0 12.9 5.5 37.5 0.2 1.6 0.1 1.9 0.5 137.9 33.8 5.8 3.0 4.2 4.2 15.1 0.2 0.3 5.0 0.5 1.0 1.3 1.0 10.4 0.3 2.4 11.8 12.5 0.4 6.1 0.8 1.2 36.3 10.5 1.2 0.0 3.7 3.8 7.4 0.0 9.5 3.6 0.3 0.0 10.5 0.7 0.4 0.0 3.6 129.6 18.8 0.0 3.6 3.7 104.4 9.2 0.1 0.3 0.5 0.9 1.9 0.2 0.4 LRTOMT "CFAP111, COMT2, DFNB63, LRRC51, LRTOMT1, LRTOMT2" ENSG00000184154 "Leucine rich transmembrane and O-methyltransferase domain containing" Q96E66 11 72080337-72096895 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 67.1;testis: 49.3" "Group enriched" "Detected in many" 12 "Early spermatids: 574.9;Late spermatids: 2222.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039949 Approved Uncertain Microtubules NA NA "Cluster 15: NK-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 25: Spermatids - Spermatogenesis" Microtubules "HPA039949: AB_10960708" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (1.85e-2)" "prognostic favorable (7.70e-4)" "unprognostic (8.09e-2)" "unprognostic (9.07e-2)" "unprognostic (1.42e-1)" "unprognostic (1.90e-1)" "unprognostic (4.22e-2)" "prognostic favorable (5.36e-4)" "unprognostic (6.12e-2)" "unprognostic (8.43e-2)" "unprognostic (2.64e-2)" "unprognostic (1.58e-1)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" 5.0 4.5 21.1 2.5 21.8 2.1 8.7 19.5 24.2 8.7 25.1 5.4 3.7 7.2 17.1 3.8 67.1 3.4 3.7 19.1 19.2 11.7 7.9 7.7 3.2 23.0 25.7 8.1 8.9 10.3 8.9 5.4 21.4 9.3 7.7 19.7 4.4 5.4 7.5 5.8 3.4 5.7 23.4 4.0 5.5 49.3 21.0 4.5 11.0 4.6 3.6 4.1 3.8 22.0 3.9 13.7 8.9 6.9 7.3 6.7 2.1 4.4 3.6 4.0 3.5 6.6 20.4 5.1 6.6 7.8 9.6 7.3 6.3 10.8 4.5 9.4 6.2 3.5 6.3 4.8 1.3 3.0 3.9 2.9 5.4 6.0 4.6 6.4 1.5 10.2 4.0 7.8 6.0 13.6 9.0 6.0 4.4 22.8 3.6 10.8 8.6 7.7 15.9 4.7 8.2 6.2 8.7 19.4 10.4 6.1 39.6 3.3 6.5 4.0 5.7 11.3 3.1 8.0 9.4 5.8 4.0 2.5 4.5 1.8 1.7 3.5 2.0 1.9 1.9 3.2 2.1 1.6 1.0 3.5 1.8 1.8 6.1 6.6 1.3 2.8 4.6 1.4 21.1 21.8 19.5 24.2 19.1 19.2 23.0 25.7 21.4 23.4 21.0 22.0 4.6 0.0 1.5 3.3 2.5 2.3 7.5 10.0 1.8 3.5 8.4 7.5 2.2 5.7 10.7 3.7 12.5 12.7 1.4 4.4 11.7 7.5 574.9 84.3 3.0 6.5 1.2 3.6 2.0 2.5 7.7 5.3 4.1 7.2 0.0 2.2 3.6 6.0 3.1 6.7 1.9 10.8 10.2 1.6 2.8 2222.2 14.9 3.3 1.8 1.9 1.4 21.3 4.1 2.0 3.6 2.0 2.5 10.1 5.1 6.8 4.0 19.9 113.1 16.6 6.6 6.1 7.9 90.3 28.1 2.2 2.4 13.1 1.7 2.9 3.4 6.5 MAP2K5 "HsT17454, MAPKK5, MEK5, PRKMK5" ENSG00000137764 "Mitogen-activated protein kinase kinase 5" Q13163 15 67542703-67807117 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Astrocytes: 119.5;Early spermatids: 138.1;Excitatory neurons: 201.4;Inhibitory neurons: 169.3;Late spermatids: 212.4;Microglial cells: 87.1;Oligodendrocyte precursor cells: 146.3;Oligodendrocytes: 146.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022094, HPA027347, HPA027755" Supported Approved Nucleoli,Microtubules NA NA "Cluster 15: NK-cells - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli, Microtubules" "CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883" "unprognostic (4.54e-2)" "unprognostic (1.87e-2)" "unprognostic (4.16e-2)" "unprognostic (9.06e-2)" "unprognostic (1.77e-3)" "unprognostic (1.06e-1)" "unprognostic (1.96e-1)" "unprognostic (3.73e-1)" "unprognostic (2.41e-2)" "unprognostic (2.83e-1)" "unprognostic (1.47e-2)" "unprognostic (5.41e-2)" "prognostic favorable (8.03e-5)" "unprognostic (1.68e-1)" "unprognostic (2.74e-1)" "unprognostic (3.99e-2)" "unprognostic (2.73e-2)" 14.3 14.8 9.2 6.3 9.8 10.3 12.4 11.2 14.1 13.2 4.6 15.7 9.2 11.5 6.1 8.7 12.1 8.8 15.0 11.6 9.9 9.9 10.0 9.7 8.5 9.6 6.5 17.2 13.2 18.8 10.2 11.1 9.4 9.4 8.8 11.2 10.5 10.6 23.2 14.5 10.1 8.9 5.6 9.0 11.6 13.8 7.3 17.2 10.6 17.8 7.6 11.8 11.1 12.3 9.0 23.4 13.8 16.3 20.0 34.9 10.9 8.8 17.8 16.3 17.7 9.4 15.8 14.8 18.2 14.8 17.7 13.3 23.8 14.3 13.4 21.6 23.7 20.2 17.0 10.3 25.1 12.3 12.1 23.9 18.3 11.8 26.6 35.7 21.7 33.6 18.0 24.1 13.6 11.6 20.1 14.7 19.4 10.4 11.3 19.7 16.0 24.9 9.8 16.3 8.6 13.4 9.9 14.5 36.5 23.6 18.2 23.7 18.2 16.7 10.9 11.7 12.1 33.7 43.4 17.5 22.4 27.6 12.3 10.9 5.8 5.6 5.6 4.4 8.3 4.8 5.3 6.7 8.1 4.3 7.3 7.0 1.4 9.4 5.4 3.0 6.2 4.4 9.2 9.8 11.2 14.1 11.6 9.9 9.6 6.5 9.4 5.6 7.3 12.3 7.9 6.4 5.8 119.5 10.0 6.9 8.1 3.7 8.6 12.6 8.6 6.1 8.1 5.7 3.2 5.5 10.4 13.4 10.2 13.2 7.9 9.3 138.1 4.4 5.0 7.6 9.5 9.4 201.4 8.5 10.7 9.7 7.7 3.9 2.5 12.3 12.5 8.7 10.0 5.0 169.3 9.2 4.1 10.1 6.1 212.4 12.5 7.9 10.6 87.1 7.2 17.9 11.3 146.3 146.5 7.5 12.5 11.7 5.6 5.3 12.2 9.7 4.0 8.2 0.0 7.9 6.3 11.9 13.0 9.9 8.2 9.9 10.4 11.6 10.4 4.6 MAP4 ENSG00000047849 "Microtubule associated protein 4" P27816 3 47850690-48089272 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 743.9" "Cell type enhanced" "Detected in all" "Bipolar cells: 392.2;Cardiomyocytes: 921.5;Cone photoreceptor cells: 625.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038149, HPA038150" Enhanced Approved "Plasma membrane,Microtubules,Cytosol" NA NA 880000 "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Microtubules, Cytosol" "Plasma membrane" "HPA038149: AB_10672471, HPA038150: AB_10672505" "unprognostic (2.51e-1)" "unprognostic (4.48e-1)" "unprognostic (2.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.36e-1)" "unprognostic (4.57e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (6.82e-2)" "unprognostic (1.46e-2)" "unprognostic (5.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.30e-2)" "unprognostic (2.25e-2)" "unprognostic (8.89e-2)" "unprognostic (6.45e-2)" "unprognostic (1.88e-1)" "unprognostic (1.21e-3)" 127.4 55.7 475.5 50.4 483.4 16.1 98.0 433.2 406.8 118.0 215.5 193.2 35.1 111.7 69.7 90.7 94.7 52.9 380.9 351.2 408.7 88.3 66.0 105.0 35.0 567.9 490.6 90.0 71.4 31.4 56.1 64.8 509.2 92.7 47.6 149.0 71.4 88.1 743.9 120.6 80.6 94.5 526.1 64.0 93.9 80.0 552.3 42.1 61.1 491.0 37.8 135.5 115.2 533.2 121.9 95.7 117.1 89.3 168.6 298.5 49.5 222.6 241.2 184.1 204.9 81.3 74.4 102.3 50.7 337.9 172.8 79.2 151.4 201.6 204.7 148.7 63.8 69.3 102.8 106.0 228.6 48.6 53.9 251.4 246.4 224.0 271.6 167.1 245.1 70.6 91.2 115.3 146.9 69.1 69.5 58.9 70.9 59.9 195.0 36.6 110.1 128.1 118.2 100.1 46.4 72.3 171.0 68.3 118.6 163.0 50.1 44.8 334.5 172.7 132.3 182.9 144.4 80.4 66.9 47.8 222.2 58.6 167.3 10.5 6.6 3.7 15.6 10.6 7.5 12.3 10.2 12.7 7.1 11.5 4.9 7.6 2.6 13.4 27.3 10.8 13.0 9.7 475.5 483.4 433.2 406.8 351.2 408.7 567.9 490.6 509.2 526.1 552.3 533.2 147.9 70.5 48.2 124.4 45.1 74.8 55.4 53.1 42.7 392.2 34.7 36.2 921.5 48.6 53.4 80.9 625.5 33.8 54.6 43.7 27.4 97.8 116.2 78.2 143.2 110.4 28.8 21.6 63.7 65.3 81.0 105.5 39.8 93.4 27.8 81.6 50.0 57.3 38.0 47.1 71.2 31.7 34.6 28.3 50.5 38.8 77.0 40.0 78.2 95.5 72.0 82.8 47.4 77.9 167.2 92.0 28.0 103.0 47.2 89.0 37.1 39.2 43.6 97.5 72.3 149.0 119.0 65.6 64.3 58.7 69.6 22.4 60.5 137.4 39.5 44.7 MAP7 E-MAP-115 ENSG00000135525 "Microtubule associated protein 7" Q14244 6 136342281-136550819 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 130.4" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1501.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 12.2" "Group enriched" "Detected in many" 4 "dendritic cells: 5.7;granulocytes: 12.2;monocytes: 3.1" "Cell line enhanced" "Detected in many" "CACO-2: 59.8;HeLa: 69.2;MCF7: 88.5;OE19: 55.3;RT4: 68.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029712, HPA029713" Enhanced Supported Microtubules,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 45: Intestine - Brush border" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol Microtubules "HPA029712: AB_10600303, HPA029713: AB_10601339" "unprognostic (8.68e-3)" "prognostic unfavorable (9.70e-5)" "unprognostic (2.33e-3)" "unprognostic (4.35e-3)" "unprognostic (6.95e-2)" "unprognostic (3.35e-1)" "prognostic favorable (9.22e-4)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.72e-1)" "unprognostic (4.61e-2)" "unprognostic (3.33e-1)" "prognostic favorable (5.07e-7)" "unprognostic (1.62e-3)" "unprognostic (7.84e-2)" "unprognostic (3.62e-1)" "unprognostic (6.51e-2)" 2.7 8.4 36.6 4.9 81.2 4.8 13.1 53.0 49.8 6.1 0.6 24.6 29.0 2.4 19.5 15.8 10.0 8.2 1.4 40.2 59.8 32.6 17.2 7.0 1.5 78.0 67.2 1.5 25.1 24.9 12.0 6.8 75.8 20.0 23.2 57.3 20.3 6.4 0.8 17.1 26.6 2.4 43.3 1.8 18.7 27.4 63.0 5.1 16.1 0.2 5.1 12.0 9.6 130.4 25.6 39.2 0.3 0.1 0.2 0.2 40.4 0.7 1.2 0.4 0.7 59.8 26.3 0.1 5.3 0.8 6.7 38.2 11.1 34.6 0.7 0.2 24.6 26.6 69.2 0.5 0.3 26.1 3.0 0.1 31.5 0.2 2.4 1.0 0.2 2.0 18.4 0.6 0.1 88.5 0.2 2.6 5.2 55.3 5.7 0.1 1.0 4.8 23.6 68.4 24.4 5.2 27.4 51.7 0.6 9.1 20.5 2.6 0.5 0.1 1.9 0.4 1.7 4.6 6.4 0.2 0.5 10.1 0.7 2.8 2.3 0.0 0.0 1.6 0.3 1.4 0.5 0.0 5.7 1.6 0.1 0.0 12.2 0.7 3.1 0.0 0.2 0.7 36.6 81.2 53.0 49.8 40.2 59.8 78.0 67.2 75.8 43.3 63.0 130.4 4.0 57.7 51.4 117.2 1.9 28.2 48.7 21.7 33.6 367.0 29.5 18.4 3.0 28.6 42.9 18.4 146.0 33.1 0.7 67.9 31.3 35.8 293.9 30.4 5.9 4.9 117.7 35.1 217.1 49.0 23.1 4.4 42.8 60.8 0.0 1.2 0.7 37.0 16.3 304.5 258.6 81.5 22.4 3.2 8.5 53.1 6.8 6.2 17.8 15.0 3.2 50.9 0.0 26.2 1501.2 37.2 51.9 3.4 4.4 56.6 60.7 81.8 56.0 104.7 19.7 2.0 5.2 37.5 23.4 49.0 30.4 76.2 3.4 2.8 64.2 62.8 MATK "CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101" ENSG00000007264 "Megakaryocyte-associated tyrosine kinase" P42679 19 3777970-3802129 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.5;brain: 41.9" "Cell type enhanced" "Detected in many" "dendritic cells: 177.0;Hofbauer cells: 57.4;NK-cells: 422.2;T-cells: 99.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 76.8" "Group enriched" "Detected in many" 57 "NK-cells: 76.8;T-cells: 46.2" "Cell line enhanced" "Detected in some" "HL-60: 108.3;HMC-1: 30.9;K-562: 48.9;MCF7: 34.4;NB-4: 74.8;SCLC-21H: 30.9;THP-1: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004847, HPA066547" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol" Yes NA "Cluster 48: NK-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 1: K-562 - Erythropoiesis" "Cluster 63: NK-cells & T-cells - Immune response" Microtubules "Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol" "HPA004847: AB_1079316, HPA066547: " "prognostic favorable (5.27e-4)" "unprognostic (1.28e-2)" "unprognostic (1.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.36e-1)" "unprognostic (3.39e-2)" "unprognostic (9.50e-2)" "unprognostic (1.23e-1)" "unprognostic (7.91e-2)" "unprognostic (3.19e-3)" "unprognostic (2.07e-2)" "unprognostic (4.51e-2)" "unprognostic (1.16e-2)" "unprognostic (7.59e-2)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (2.33e-2)" 4.7 1.3 18.3 6.6 21.3 20.5 2.5 2.9 41.9 1.1 1.6 2.1 6.6 0.9 0.1 2.1 4.0 4.4 1.4 25.9 8.7 2.4 3.2 9.9 9.4 10.4 11.0 0.7 1.2 0.7 2.7 1.0 8.8 1.3 1.1 2.2 3.2 0.7 0.8 1.9 6.2 0.8 4.7 16.5 4.0 3.1 14.1 3.8 1.6 0.2 4.0 1.6 1.1 23.6 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.2 1.7 0.0 1.0 10.6 13.8 0.4 0.0 0.0 18.1 12.0 1.5 2.9 0.0 108.3 30.9 0.1 0.0 0.2 0.1 0.0 0.0 1.2 48.9 0.1 0.0 34.4 0.3 74.8 8.4 9.0 0.3 0.0 0.1 0.0 0.0 0.0 30.9 0.1 0.1 0.1 0.1 0.9 0.0 27.4 3.3 0.0 0.6 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 46.2 0.0 31.3 0.0 5.7 29.3 0.8 0.9 2.7 16.4 1.0 76.8 0.2 0.3 0.4 7.6 18.3 21.3 2.9 41.9 25.9 8.7 10.4 11.0 8.8 4.7 14.1 23.6 1.4 0.0 1.1 0.3 11.1 0.4 0.1 0.0 0.0 1.4 4.9 7.2 1.3 0.0 0.0 0.0 12.5 0.3 177.0 0.3 0.0 0.0 2.0 0.2 0.5 1.9 7.1 28.6 17.7 0.0 0.5 0.8 11.7 0.5 44.5 0.1 8.6 1.1 57.4 0.0 8.3 0.3 0.0 6.0 14.6 5.1 0.0 11.5 1.8 4.7 3.0 1.3 422.2 2.0 1.6 0.0 1.1 0.0 17.1 0.1 0.3 0.2 0.7 2.0 0.0 0.5 1.2 0.4 4.5 1.3 1.1 0.3 99.7 0.0 1.1 0.0 MEGF6 EGFL3 ENSG00000162591 "Multiple EGF like domains 6" O75095 1 3487951-3611508 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Alveolar cells type 2: 20.6;Basal keratinocytes: 18.4;Basal squamous epithelial cells: 23.3;Melanocytes: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 51.1;HeLa: 56.3;hTERT-RPE1: 69.7;U-2197: 55.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052129 Uncertain Approved "Microtubules,Cytokinetic bridge" "Secreted to blood" Yes No 1700000 "Cluster 52: Eosinophils - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 20: HeLa - Mitochondria" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Microtubules "Cytokinetic bridge" "HPA052129: AB_2681739" "unprognostic (1.95e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "prognostic favorable (6.57e-4)" "unprognostic (1.19e-1)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "unprognostic (2.03e-1)" "unprognostic (3.09e-3)" "unprognostic (1.60e-1)" "unprognostic (1.64e-1)" "unprognostic (9.51e-2)" "unprognostic (3.43e-2)" 25.9 4.3 2.9 3.9 2.7 10.8 20.0 2.6 2.8 14.5 1.4 14.1 2.1 9.6 1.4 13.2 28.9 11.2 14.2 1.9 3.2 5.9 5.0 22.1 5.5 3.5 5.8 18.0 6.5 0.4 4.1 2.8 3.6 26.5 1.1 1.8 19.3 4.7 4.8 44.6 10.0 1.4 2.1 10.7 10.1 3.3 3.7 3.4 11.6 1.9 3.4 11.0 22.8 1.9 11.6 14.1 4.3 6.6 0.4 0.3 1.0 51.1 14.1 5.2 1.6 3.3 10.4 0.0 13.8 24.6 4.4 6.7 0.0 0.5 1.7 0.0 0.4 0.0 56.3 3.3 0.0 0.2 0.9 0.1 0.6 0.4 0.8 69.7 5.6 0.1 0.0 0.0 0.1 6.0 0.0 10.9 2.7 3.3 0.9 2.2 3.0 6.2 1.1 3.8 3.8 3.1 18.8 1.1 6.4 11.4 4.9 1.5 2.2 19.6 1.7 55.6 3.9 0.2 0.0 0.0 0.1 0.0 0.0 1.0 0.0 1.9 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.3 0.0 0.8 0.0 0.0 0.0 0.8 0.1 2.9 2.7 2.6 2.8 1.9 3.2 3.5 5.8 3.6 2.1 3.7 1.9 5.0 22.4 20.6 8.8 2.7 18.4 7.1 3.9 23.3 0.8 3.6 3.0 3.3 5.7 4.4 1.8 0.0 0.2 0.4 0.6 0.0 3.6 0.2 1.4 0.6 7.0 0.0 4.8 6.5 1.4 1.3 9.4 6.6 5.0 1.3 9.8 16.8 0.9 1.0 0.0 7.2 1.4 0.0 0.3 7.5 0.5 11.5 2.8 19.6 5.6 0.7 14.7 1.0 4.5 5.2 4.5 0.1 3.4 0.4 4.0 0.5 1.2 0.3 1.2 0.0 0.5 2.7 0.3 1.1 7.6 11.4 0.4 3.6 0.1 1.1 2.7 METTL7B "ALDI, MGC17301" ENSG00000170439 "Methyltransferase like 7B" Q6UX53 12 55681678-55684611 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.1;heart muscle: 124.2;liver: 284.3" "Cell type enhanced" "Detected in some" "Hepatocytes: 83.9;Hofbauer cells: 72.7;Proximal enterocytes: 192.4;Proximal tubular cells: 55.6" "Cancer enhanced" "Detected in many" "glioma: 97.9;liver cancer: 97.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.5;myeloid DC: 7.0;naive B-cell: 1.7;non-classical monocyte: 3.3" "Group enriched" "Detected in many" 45 "B-cells: 1.7;dendritic cells: 7.0;monocytes: 4.5" "Cell line enhanced" "Detected in many" "CACO-2: 28.4;CAPAN-2: 56.6;EFO-21: 41.3;Hep G2: 28.7;LHCN-M2: 47.0;OE19: 32.5;THP-1: 42.2;U-87 MG: 41.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA038644 Enhanced Approved Vesicles,Microtubules NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 45: Enterocytes - Digestion" Microtubules Vesicles "HPA038644: AB_2676130" "unprognostic (7.54e-2)" "unprognostic (7.15e-2)" "unprognostic (5.55e-2)" "unprognostic (3.07e-3)" "unprognostic (6.30e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (2.00e-1)" "unprognostic (2.22e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-2)" "unprognostic (5.33e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-2)" "unprognostic (7.10e-2)" "prognostic favorable (2.37e-4)" "unprognostic (2.43e-1)" 2.1 1.7 5.5 1.8 5.9 1.2 0.9 4.9 10.8 0.4 5.9 28.5 59.6 0.4 133.1 0.1 3.1 11.7 124.2 13.1 5.9 52.1 284.3 1.6 2.3 8.4 5.5 0.1 2.9 0.2 3.1 10.9 5.0 0.3 23.6 1.3 0.5 0.8 7.4 0.9 55.3 2.1 5.7 4.3 4.2 0.7 11.6 0.2 3.3 10.0 0.5 1.3 0.1 7.7 0.4 21.8 0.1 0.5 4.3 15.3 0.3 0.8 3.2 0.2 1.4 28.4 56.6 11.6 41.3 1.2 1.1 0.1 4.1 0.3 0.8 0.0 5.4 1.2 3.2 28.7 0.0 0.6 0.0 4.0 0.0 1.0 0.0 4.2 0.0 0.0 0.2 0.0 47.0 20.2 0.0 0.4 5.7 32.5 2.7 0.0 1.5 2.7 0.5 0.1 0.1 0.3 2.2 0.0 3.9 0.2 3.8 42.2 0.0 3.1 3.5 0.4 2.9 0.0 0.6 3.5 41.9 9.9 0.2 0.0 0.8 0.0 0.0 4.5 0.0 0.5 0.0 0.0 7.0 1.7 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.4 5.5 5.9 4.9 10.8 13.1 5.9 8.4 5.5 5.0 5.7 11.6 7.7 0.0 0.0 1.5 0.7 0.5 0.0 0.3 0.0 0.0 0.0 0.1 0.1 26.5 22.8 0.6 0.0 0.0 0.5 0.0 29.0 3.9 3.9 0.0 0.1 0.0 0.5 1.2 4.0 0.7 5.1 0.5 2.0 2.6 0.2 0.0 0.8 1.1 83.9 72.7 0.0 0.1 14.0 0.0 17.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.5 0.0 0.0 0.0 4.6 20.7 1.2 0.0 0.1 192.4 55.6 0.0 0.0 0.0 7.8 0.6 0.0 0.1 0.0 0.0 0.7 0.3 0.1 22.2 0.1 MRRF RRF ENSG00000148187 "Mitochondrial ribosome recycling factor" Q96E11 9 122264603-122331337 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 210.0;Late spermatids: 191.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047177, HPA049987" Supported Approved "Microtubules,Cytokinetic bridge" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Microtubules, Cytokinetic bridge" "HPA047177: AB_2679970, HPA049987: AB_2680984" "unprognostic (8.38e-2)" "unprognostic (2.17e-1)" "unprognostic (6.40e-2)" "unprognostic (6.06e-3)" "unprognostic (3.64e-2)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (3.71e-2)" "unprognostic (1.89e-2)" "unprognostic (4.44e-2)" "unprognostic (2.98e-1)" "unprognostic (9.01e-2)" "prognostic favorable (2.14e-8)" "unprognostic (3.89e-2)" "unprognostic (4.05e-1)" "unprognostic (8.02e-2)" "unprognostic (8.88e-3)" 18.9 19.3 10.4 12.1 10.7 14.2 19.3 11.7 13.3 13.9 15.3 25.1 23.7 10.1 13.1 25.5 11.4 8.8 28.2 10.6 11.3 23.4 24.3 13.3 14.0 11.4 10.9 11.3 18.3 23.2 12.5 9.0 11.3 14.7 28.6 14.5 15.3 10.6 40.6 22.1 18.5 10.1 10.6 15.6 14.4 18.1 11.3 13.8 16.3 32.1 20.4 16.9 16.4 11.5 34.7 45.8 25.6 43.0 35.7 32.5 48.7 33.7 43.0 44.5 26.0 55.0 40.6 75.0 16.7 27.0 35.5 99.3 74.1 78.8 36.3 25.2 30.3 25.6 53.4 30.5 23.6 72.3 32.7 30.5 52.7 40.0 70.8 22.4 50.4 29.6 44.2 27.8 45.1 55.1 36.2 23.6 30.0 86.0 45.7 26.8 48.8 79.7 76.6 34.8 30.3 19.9 36.2 58.3 27.9 24.3 62.8 18.2 27.1 19.5 29.6 51.0 42.0 19.1 50.1 33.0 36.8 42.4 22.8 4.7 17.5 6.0 13.3 29.0 14.2 15.6 13.3 12.5 29.8 12.7 13.8 16.5 2.0 22.9 31.3 12.9 16.3 11.1 10.4 10.7 11.7 13.3 10.6 11.3 11.4 10.9 11.3 10.6 11.3 11.5 22.7 3.2 9.1 21.9 18.8 15.4 22.1 30.3 26.2 13.2 20.1 17.3 21.8 18.6 17.8 14.7 12.5 29.0 10.8 21.4 35.2 36.0 210.0 16.2 15.7 22.5 7.8 29.3 28.6 29.5 49.2 11.1 23.9 12.1 24.7 14.5 14.3 19.2 30.4 5.0 39.1 22.0 18.3 17.0 16.5 191.7 9.6 16.0 14.2 20.6 18.3 6.3 11.3 22.1 31.0 24.0 20.6 7.5 19.4 18.1 41.2 37.3 16.2 23.5 19.7 15.1 11.7 30.2 16.6 32.5 22.4 37.1 12.3 31.1 33.9 22.7 MTUS1 "ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1" ENSG00000129422 "Microtubule associated scaffold protein 1" Q9ULD2 8 17643795-17800917 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 408.9;Alveolar cells type 2: 281.0;Oligodendrocytes: 469.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.4" "Lineage enriched" "Detected in single" 19 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "A549: 115.7;AN3-CA: 100.1;HUVEC TERT2: 296.8;SK-MEL-30: 84.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067903, HPA069795" Enhanced Nucleoli,Microtubules No No "Cluster 32: T-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoli, Microtubules" "HPA067903: AB_2685921, HPA069795: AB_2686198" "unprognostic (3.20e-1)" "unprognostic (3.29e-1)" "prognostic favorable (1.05e-4)" "unprognostic (2.50e-2)" "unprognostic (2.27e-1)" "unprognostic (7.72e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-3)" "unprognostic (2.44e-1)" "unprognostic (9.73e-2)" "unprognostic (7.93e-3)" "unprognostic (3.33e-1)" "prognostic favorable (2.76e-4)" "unprognostic (2.04e-1)" "unprognostic (2.38e-2)" "unprognostic (2.53e-3)" "unprognostic (2.43e-1)" 52.9 39.0 65.6 13.4 100.4 0.3 45.0 97.4 81.7 34.5 59.3 36.6 32.6 31.4 22.6 38.0 28.7 37.9 85.6 66.0 76.9 26.2 56.8 40.4 9.0 106.4 90.8 51.4 98.2 65.2 22.9 70.0 104.2 31.9 39.1 56.9 49.9 24.7 106.2 26.0 33.4 38.2 75.7 16.1 42.2 12.2 87.6 22.8 27.3 167.4 14.5 35.8 31.0 151.1 21.9 115.7 18.5 100.1 0.1 0.6 33.2 1.1 7.8 0.6 2.3 8.7 7.8 2.8 8.5 0.0 4.8 22.2 30.8 10.9 1.1 15.8 13.2 0.0 19.2 55.8 6.6 0.0 0.4 9.1 16.4 2.4 33.3 0.0 296.8 7.7 0.0 43.3 0.1 5.7 4.4 5.7 26.5 44.1 2.9 0.1 17.0 11.5 5.9 44.4 9.2 2.2 14.8 26.6 84.7 11.0 19.2 0.3 61.4 0.1 24.0 0.1 0.2 5.9 3.5 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.4 65.6 100.4 97.4 81.7 66.0 76.9 106.4 90.8 104.2 75.7 87.6 151.1 408.9 70.5 281.0 139.1 2.9 21.0 56.4 38.9 58.1 0.0 42.7 31.6 141.6 55.8 88.4 20.2 0.0 23.8 1.6 58.5 11.7 50.1 18.5 71.4 53.8 154.5 15.0 0.0 6.1 174.2 40.0 83.8 94.8 144.2 9.5 7.6 29.3 71.2 58.2 0.0 81.8 47.3 22.4 4.1 16.1 24.5 76.4 9.0 28.4 174.3 2.7 0.0 2.1 39.2 469.2 56.5 19.1 57.2 15.3 77.9 52.4 10.4 49.4 0.0 19.7 69.7 60.1 2.4 8.3 45.3 20.3 54.0 7.1 79.8 49.3 81.3 MTUS2 "CAZIP, ICIS, KIAA0774, TIP150" ENSG00000132938 "Microtubule associated scaffold protein 2" Q5JR59 13 28820339-29505947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 50.2" "Group enriched" "Detected in some" 4 "Excitatory neurons: 548.4;Inhibitory neurons: 671.8" "Cancer enhanced" "Detected in some" "urothelial cancer: 0.9" "Region enhanced" "Detected in many" "cerebral cortex: 9.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 13.2;HeLa: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031473, HPA031474, HPA031475" Enhanced Supported "Microtubules,Cytokinetic bridge" Yes NA "Cluster 49: Eosinophils - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Microtubules, Cytokinetic bridge" "HPA031473: AB_2673901, HPA031474: AB_10600109, HPA031475: AB_10600442" "unprognostic (1.67e-1)" "unprognostic (3.07e-1)" "unprognostic (1.96e-1)" "unprognostic (3.33e-3)" "unprognostic (1.00e-1)" "unprognostic (1.22e-2)" "unprognostic (2.79e-1)" "unprognostic (1.35e-1)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (1.30e-3)" "unprognostic (3.45e-2)" "unprognostic (3.91e-5)" "unprognostic (2.51e-2)" "unprognostic (5.46e-2)" "unprognostic (5.93e-2)" "unprognostic (9.62e-2)" 0.2 0.2 0.4 0.1 1.7 0.1 0.1 1.2 9.7 0.6 1.8 0.9 0.1 1.5 0.0 0.3 0.8 0.1 50.2 1.0 0.0 0.1 0.9 0.1 0.6 0.0 0.1 7.5 4.8 0.0 6.1 0.0 0.0 0.3 0.2 4.6 1.0 0.1 0.1 0.2 0.4 1.2 2.2 0.5 1.3 1.2 1.0 0.2 0.5 0.1 0.1 1.3 0.2 2.4 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 13.2 0.4 0.0 0.0 0.0 0.5 0.0 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.0 0.0 2.3 1.6 0.1 0.4 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 1.7 1.2 9.7 1.0 0.0 0.0 0.1 0.0 2.2 1.0 2.4 0.1 0.0 0.5 10.4 0.1 0.5 0.7 0.1 0.0 0.0 0.3 0.4 145.8 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.4 0.3 1.0 0.7 0.0 0.8 548.4 0.6 0.0 5.9 0.0 1.1 0.0 1.2 0.4 0.5 0.1 0.0 671.8 0.7 0.0 0.0 0.8 3.3 0.9 0.2 1.8 15.0 0.1 0.0 0.0 18.1 16.2 0.4 0.0 0.0 0.1 0.2 0.0 0.0 3.6 0.0 0.0 1.6 1.0 0.1 4.1 1.8 0.1 0.3 0.3 19.6 0.0 1.1 MYL10 "MGC3479, MYLC2PL, PLRLC" ENSG00000106436 "Myosin light chain 10" Q9BUA6 7 101613330-101629296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.4;Peritubular cells: 2.6;Skeletal myocytes: 3.7" "Cancer enhanced" "Detected in single" "melanoma: 0.5" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 1.9" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "HSkMC: 1.2;PC-3: 2.4;RH-30: 4.2;SuSa: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019763, HPA039262" Uncertain Uncertain Microtubules NA NA "Cluster 11: Basophils - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" Microtubules "HPA019763: AB_1854243, HPA039262: AB_2676418" "unprognostic (2.32e-2)" "unprognostic (3.09e-1)" "unprognostic (1.11e-1)" "unprognostic (1.74e-2)" "unprognostic (2.78e-3)" "unprognostic (5.04e-3)" "unprognostic (8.93e-2)" "unprognostic (1.10e-2)" 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.8 0.5 0.7 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.6 0.1 0.6 0.1 0.1 0.1 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.5 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.0 2.4 0.0 4.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 1.0 1.9 0.1 0.0 0.1 0.3 1.0 0.0 0.1 0.2 0.1 0.8 0.0 0.2 0.0 1.9 0.3 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.3 0.2 0.2 1.1 0.4 0.1 0.3 0.4 0.1 0.1 0.1 0.8 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYL2 CMH10 ENSG00000111245 "Myosin light chain 2" P10916 12 110910819-110921443 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 72 "heart muscle: 27910.5;skeletal muscle: 28967.7;tongue: 19823.2" "Cell type enriched" "Detected in some" 80 "Cardiomyocytes: 27611.5" "Group enriched" "Detected in some" 46 "head and neck cancer: 31.5;prostate cancer: 25.5" "Region enriched" "Detected in some" 6 "hypothalamus: 6.0" "Group enriched" "Detected in some" 12 "memory B-cell: 1.1;naive B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "EFO-21: 4.2;HSkMC: 8.8;U-2 OS: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA019763, HPA039262" Supported Uncertain Microtubules NA NA 180000 "Cluster 19: B-cells - Humoral immune response" "Cluster 38: Heart - Muscle contraction" "Cluster 9: U-2 OS - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" Microtubules "HPA019763: AB_1854243, HPA039262: AB_2676418" "unprognostic (2.07e-2)" "unprognostic (1.37e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.32e-1)" "unprognostic (4.05e-2)" "unprognostic (4.82e-2)" "unprognostic (2.05e-2)" "unprognostic (2.20e-1)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "unprognostic (3.55e-1)" 7.3 4.5 0.0 0.1 0.0 0.7 29.4 0.0 0.0 1.5 0.0 4.7 0.6 2.2 0.0 357.0 0.5 9.5 27910.5 0.0 6.0 3.0 5.4 5.0 15.2 0.6 1.0 2.4 5.8 0.0 2.5 0.1 0.3 249.8 0.1 0.0 108.7 0.2 28967.7 19.3 3.2 0.3 0.0 2.1 3.5 2.1 0.0 1.0 13.3 19823.2 1.1 2.2 4.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 4.2 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 17.7 0.0 0.1 0.0 0.0 1.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.6 1.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 27611.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 235.7 0.0 0.0 0.0 0.0 0.0 53.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 342.2 138.8 0.1 0.1 0.0 0.0 0.0 3.3 0.0 0.1 0.0 NAE1 "APP-BP1, APPBP1, ula-1" ENSG00000159593 "NEDD8 activating enzyme E1 subunit 1" Q13564 16 66802875-66873256 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatogonia: 219.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041178, HPA042041" Enhanced Approved Nucleoplasm,Microtubules,Centrosome NA NA 100000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "Microtubules, Centrosome" "HPA041178: AB_10964773, HPA042041: AB_10964772" "unprognostic (3.22e-2)" "unprognostic (1.73e-1)" "unprognostic (1.79e-2)" "unprognostic (1.13e-1)" "unprognostic (2.00e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (3.92e-8)" "unprognostic (2.31e-1)" "unprognostic (5.58e-2)" "unprognostic (3.12e-3)" "unprognostic (5.34e-2)" "unprognostic (3.85e-2)" "unprognostic (7.09e-3)" "unprognostic (2.50e-1)" "unprognostic (1.84e-1)" "prognostic favorable (9.44e-5)" "unprognostic (1.97e-1)" 23.9 28.3 26.0 26.0 26.0 38.8 32.5 28.8 29.6 23.0 27.1 31.9 32.4 32.9 35.2 30.3 26.8 24.2 29.7 25.5 27.1 26.5 28.6 22.5 36.1 25.8 26.1 35.6 27.3 41.5 22.6 28.4 27.1 28.8 35.3 33.9 25.9 26.7 35.0 33.1 33.2 30.3 27.0 22.2 21.6 47.1 27.1 35.0 32.3 33.0 31.6 28.6 22.1 30.3 107.6 81.1 140.4 139.4 55.1 78.9 116.9 79.9 80.3 115.6 139.8 99.5 80.9 118.1 89.1 60.4 74.8 105.6 107.7 96.5 162.0 43.8 122.1 83.9 53.6 153.9 63.2 157.3 100.7 64.0 69.6 92.8 80.7 61.0 82.5 141.2 201.9 40.3 89.9 37.5 165.7 177.7 196.2 83.4 144.6 175.7 167.8 157.7 89.1 92.6 151.3 110.6 239.5 50.7 94.7 86.0 54.2 105.2 64.7 80.2 80.1 84.7 93.9 75.3 125.3 423.8 72.3 103.0 99.7 2.8 6.0 13.4 27.3 5.8 34.9 18.2 29.0 30.1 8.2 14.4 31.0 31.4 2.7 17.1 6.5 12.2 27.4 18.3 26.0 26.0 28.8 29.6 25.5 27.1 25.8 26.1 27.1 27.0 27.1 30.3 29.2 32.1 32.2 23.5 30.1 33.0 66.6 87.2 17.1 52.0 28.4 31.4 30.7 18.6 53.4 31.3 12.5 101.3 33.9 28.0 39.2 70.0 4.6 27.7 23.2 30.7 22.9 38.9 41.3 60.2 70.9 38.4 20.9 22.9 35.4 55.9 19.2 21.3 28.6 50.5 40.7 33.3 67.1 10.4 13.5 14.3 48.7 16.2 49.8 17.8 25.7 68.4 51.5 33.2 39.8 65.0 114.3 54.2 32.0 68.8 34.7 48.2 44.8 35.9 19.7 41.0 63.7 145.4 219.3 33.6 32.1 52.4 36.9 49.4 42.5 49.5 NAP1L1 "MGC23410, MGC8688, NAP1, NAP1L, NRP" ENSG00000187109 "Nucleosome assembly protein 1 like 1" P55209 12 76036585-76084735 "Plasma proteins, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028861 Approved Uncertain Microtubules NA NA 10000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 32: Non-specific - Translation" Microtubules "HPA028861: AB_10603880" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (9.57e-2)" "unprognostic (1.77e-1)" "unprognostic (3.69e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.29e-9)" "unprognostic (1.67e-1)" "unprognostic (1.76e-1)" "unprognostic (1.66e-1)" "unprognostic (5.24e-3)" "unprognostic (1.32e-1)" "prognostic unfavorable (6.14e-13)" "unprognostic (5.59e-2)" "unprognostic (3.07e-2)" "unprognostic (4.81e-2)" "unprognostic (1.15e-1)" 270.7 293.7 240.6 215.5 261.7 337.4 248.4 224.3 295.7 341.7 182.2 255.2 76.7 274.1 172.3 156.9 260.9 217.2 250.2 207.8 239.1 155.4 113.2 320.7 456.3 249.6 239.0 602.9 137.4 125.5 175.6 201.9 257.8 228.5 123.5 199.8 193.1 211.0 378.2 142.5 175.1 190.2 285.6 278.3 158.5 127.7 254.0 341.4 178.1 144.9 386.7 253.7 244.1 275.2 765.7 575.6 1061.5 673.3 667.4 1066.2 596.5 479.3 655.2 724.9 532.1 633.5 278.5 1791.9 521.0 601.8 305.7 496.1 636.3 763.4 892.0 570.1 627.7 667.6 407.6 646.4 950.1 1075.1 624.2 748.0 810.0 502.4 842.5 1778.1 891.6 640.5 995.1 379.3 1162.6 366.2 1380.9 868.2 1214.7 278.7 529.9 1071.8 1053.2 748.8 640.6 421.8 455.7 654.4 400.9 580.4 1180.9 818.0 860.4 765.8 704.5 561.5 635.1 403.2 687.9 472.7 601.0 1115.1 343.2 552.1 371.0 6.9 114.4 183.5 95.1 350.0 192.7 248.1 218.5 154.4 226.1 205.7 250.8 207.1 28.1 153.6 732.5 165.3 242.4 225.4 240.6 261.7 224.3 295.7 207.8 239.1 249.6 239.0 257.8 285.6 254.0 275.2 184.6 166.7 227.5 77.4 506.6 459.2 637.5 478.4 352.3 158.1 308.0 327.8 453.8 197.3 271.3 136.1 79.2 523.7 313.5 39.7 238.7 360.5 225.9 333.6 833.9 340.2 247.1 254.9 181.9 281.7 460.0 386.6 66.8 198.3 435.9 345.2 260.9 125.6 428.1 252.4 149.0 160.6 195.3 546.8 738.3 249.5 709.3 644.0 403.8 93.7 839.2 372.8 241.0 92.5 109.3 397.4 61.3 832.8 183.4 601.2 9.7 266.6 341.6 127.0 374.7 457.2 448.4 350.7 159.2 268.7 337.6 417.0 408.4 353.4 182.9 430.0 NAV1 "DKFZp781D0314, FLJ12560, FLJ14203, KIAA1151, MGC14961, POMFIL3, steerin-1" ENSG00000134369 "Neuron navigator 1" Q8NEY1 1 201622885-201826969 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 169.1;Inhibitory neurons: 161.7;Oligodendrocyte precursor cells: 713.8;Oligodendrocytes: 224.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.4;myeloid DC: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 2.1;granulocytes: 3.4" "Cell line enhanced" "Detected in many" "TIME: 187.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012302, HPA018127, HPA027887" Enhanced Approved Microtubules NA NA "Cluster 46: Basophils - DNA binding" "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 68: Oligodendrocytes - Mixed function" Microtubules "CAB012302: AB_776716, HPA018127: AB_1854317, HPA027887: AB_10601040" "unprognostic (2.14e-1)" "unprognostic (1.82e-1)" "unprognostic (4.12e-2)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (3.87e-1)" "unprognostic (1.79e-1)" "unprognostic (3.45e-1)" "unprognostic (9.10e-2)" "unprognostic (5.63e-2)" "unprognostic (4.68e-1)" "unprognostic (8.24e-2)" "prognostic unfavorable (3.10e-6)" "unprognostic (3.45e-2)" "unprognostic (2.16e-1)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" 19.6 2.7 17.4 8.2 18.3 1.6 15.2 8.0 17.7 11.7 0.0 12.3 3.7 10.1 4.3 8.6 7.2 7.5 26.6 17.5 20.3 4.6 1.9 11.1 4.1 24.6 17.9 3.7 4.4 5.2 5.2 11.8 15.1 7.5 5.4 5.4 7.8 6.7 4.8 7.7 6.2 10.3 9.9 3.6 5.3 4.4 21.8 2.8 9.4 6.7 3.7 14.9 12.6 32.5 1.6 2.9 29.0 3.8 84.3 69.5 51.7 44.6 43.0 35.5 30.9 0.0 15.7 0.6 0.7 61.4 19.4 21.5 22.0 14.9 28.4 2.5 3.2 1.4 5.6 0.0 22.5 0.2 19.1 30.6 5.4 62.4 36.0 94.9 80.7 1.8 0.8 2.6 29.8 0.4 0.0 0.1 42.4 0.7 1.7 3.9 65.0 9.3 4.8 4.3 21.9 4.5 11.1 47.6 14.5 19.2 0.4 1.2 187.8 54.5 11.1 54.7 39.4 8.1 2.3 0.2 59.2 5.9 47.5 3.4 0.5 0.1 0.2 0.3 0.1 0.3 0.2 0.0 2.1 0.3 0.2 0.1 0.0 0.1 0.3 0.5 0.0 0.3 17.4 18.3 8.0 17.7 17.5 20.3 24.6 17.9 15.1 9.9 21.8 32.5 77.4 3.2 1.5 169.1 3.1 11.0 2.2 5.9 8.0 34.6 4.8 4.3 29.2 1.5 4.8 12.9 0.0 14.9 0.9 4.7 0.0 13.0 3.6 1.6 6.4 39.3 52.8 1.7 98.2 8.3 54.1 45.8 8.2 4.4 17.7 54.5 21.0 0.7 14.5 25.2 161.7 3.4 6.1 18.3 15.8 3.8 10.8 15.1 23.2 69.3 60.6 11.8 1.0 713.8 224.6 21.7 4.2 0.7 4.9 2.3 0.9 0.6 3.5 4.0 6.6 119.3 18.8 0.6 2.6 16.9 7.0 15.7 2.0 6.6 5.0 3.2 NBPF1 "FLJ20719, KIAA1693" ENSG00000219481 "NBPF member 1" Q3BBV0 1 16562319-16613562 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 73.8;Distal enterocytes: 66.4;Oligodendrocyte precursor cells: 68.3;Oligodendrocytes: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved Microtubules,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 71: Testis - DNA repair" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Microtubules "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (8.16e-3)" "unprognostic (6.96e-2)" "unprognostic (1.33e-2)" "unprognostic (6.09e-2)" "unprognostic (3.49e-1)" "unprognostic (4.76e-2)" "unprognostic (1.15e-5)" "unprognostic (2.16e-2)" "unprognostic (5.40e-2)" "unprognostic (2.99e-1)" "unprognostic (4.90e-2)" "unprognostic (2.14e-2)" "prognostic favorable (1.06e-4)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (1.68e-1)" 8.8 32.6 4.0 2.5 5.1 2.0 9.5 5.0 4.3 16.4 2.7 14.9 3.5 10.6 2.5 6.4 10.7 3.3 6.1 3.2 4.5 9.0 8.2 6.2 1.3 5.3 4.8 18.1 7.4 6.0 9.0 4.6 5.1 9.9 5.3 2.9 9.3 4.2 5.5 7.2 13.6 5.7 4.6 8.2 8.8 23.0 5.0 1.7 7.2 2.6 1.8 13.6 11.0 6.0 6.1 8.6 8.4 5.1 2.3 2.7 1.5 4.1 5.4 7.7 6.8 3.1 2.4 4.8 1.2 11.7 3.0 5.5 3.9 2.5 8.9 3.0 4.5 1.5 3.0 3.0 3.7 2.4 3.6 2.9 3.1 11.1 3.2 4.0 3.5 10.9 5.2 2.6 3.0 4.7 10.5 1.8 1.6 1.1 16.3 8.9 4.6 0.5 2.2 1.2 10.4 10.3 10.6 4.3 5.8 2.4 6.6 1.7 4.1 6.7 3.6 9.2 3.6 1.3 6.7 2.7 1.5 3.5 2.8 0.1 0.1 1.3 0.3 0.2 0.4 0.3 0.3 0.4 0.1 0.5 0.3 0.4 0.0 0.1 0.3 0.2 0.0 0.1 4.0 5.1 5.0 4.3 3.2 4.5 5.3 4.8 5.1 4.6 5.0 6.0 5.2 16.0 14.8 73.8 5.7 8.2 3.0 10.9 29.0 7.5 8.4 8.6 14.5 8.6 11.6 11.0 8.4 6.3 3.5 66.4 3.9 5.5 10.4 4.4 8.2 10.2 3.0 5.9 33.6 3.5 7.9 19.7 12.2 3.1 6.3 17.1 3.6 6.1 12.8 10.1 52.1 25.4 12.2 6.6 15.9 6.9 6.8 7.1 8.8 47.8 4.4 5.0 9.2 68.3 87.9 6.1 19.3 7.2 5.3 3.8 24.0 10.8 15.5 6.5 6.6 7.9 10.0 52.5 24.3 14.7 7.7 3.1 4.0 43.2 15.2 3.1 NBPF10 AG1 ENSG00000271425 "NBPF member 10" 1 146064711-146229000 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Alveolar cells type 2: 46.1;Basal keratinocytes: 57.0;Langerhans cells: 100.9;Suprabasal keratinocytes: 105.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved Microtubules,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol Microtubules "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.05e-1)" "unprognostic (8.84e-2)" "unprognostic (5.84e-2)" "unprognostic (5.61e-3)" "unprognostic (1.06e-1)" "unprognostic (5.16e-3)" "unprognostic (3.26e-1)" "unprognostic (2.17e-1)" "unprognostic (9.49e-2)" "unprognostic (6.64e-5)" "unprognostic (1.60e-1)" "unprognostic (6.01e-2)" "unprognostic (1.11e-3)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (9.61e-2)" "unprognostic (6.68e-2)" 3.7 1.1 3.4 2.8 2.8 7.6 4.3 2.2 6.4 4.9 7.4 2.8 1.1 3.5 3.8 2.8 3.0 2.2 1.3 3.6 2.2 1.9 3.2 3.3 2.5 3.8 3.1 5.4 3.3 3.2 0.3 2.5 2.9 2.7 2.8 4.6 2.0 3.0 1.0 7.4 1.2 3.4 1.7 4.4 1.8 3.3 4.5 2.7 2.3 2.2 2.4 2.2 1.4 4.1 6.4 1.7 3.6 2.4 11.3 13.6 3.0 3.3 4.5 3.3 3.3 1.5 3.0 2.7 0.7 6.4 3.2 3.0 4.0 4.5 6.7 3.4 3.0 6.3 5.0 0.8 4.5 2.7 1.9 12.4 4.1 9.2 8.8 10.6 3.9 1.7 2.0 8.7 7.1 7.3 1.1 2.4 1.5 1.6 4.7 1.4 2.6 3.6 2.3 4.5 0.4 0.4 5.1 4.9 1.8 5.8 4.2 3.6 12.3 3.2 2.9 2.9 4.4 5.8 2.3 3.4 2.9 2.9 2.7 2.2 2.0 2.7 0.3 1.0 0.4 1.5 0.3 0.3 0.8 1.5 0.3 0.2 5.6 0.3 2.3 2.2 0.3 0.1 3.4 2.8 2.2 6.4 3.6 2.2 3.8 3.1 2.9 1.7 4.5 4.1 0.5 76.9 46.1 13.7 12.8 57.0 4.9 15.4 5.2 0.5 3.7 2.0 8.4 2.8 22.0 0.0 0.0 0.7 9.2 1.5 0.0 5.3 15.1 2.8 2.8 3.4 0.0 10.5 0.8 2.7 5.0 18.2 3.1 6.1 20.2 6.4 0.7 1.8 1.4 0.0 1.1 2.7 14.2 5.0 100.9 3.3 6.5 17.7 30.2 4.7 14.2 2.0 9.2 5.0 0.1 5.5 25.3 8.2 5.7 2.1 2.2 0.2 19.6 2.0 0.0 7.6 9.9 9.9 5.4 23.8 105.8 0.5 6.6 1.4 3.4 4.5 NBPF11 NBPF24 ENSG00000263956 "NBPF member 11" Q86T75 1 148102046-148152322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 29: Non-specific - Vesicular transport" "Cluster 20: HeLa - Mitochondria" "Cluster 59: Non-specific - Transcription" Cytosol Microtubules "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.27e-1)" "unprognostic (6.10e-2)" "unprognostic (8.01e-2)" "unprognostic (8.20e-2)" "unprognostic (3.70e-1)" "unprognostic (1.37e-2)" "unprognostic (1.60e-1)" "prognostic favorable (6.87e-4)" "unprognostic (8.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.72e-3)" "unprognostic (4.78e-2)" "unprognostic (6.67e-6)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.68e-1)" "prognostic favorable (3.20e-5)" 9.5 7.6 4.0 5.7 5.0 7.6 9.5 4.1 5.4 11.7 4.6 8.5 4.2 9.5 17.0 6.5 10.3 3.8 5.6 3.9 4.0 7.3 18.1 7.0 7.5 6.1 4.6 11.6 12.1 7.7 7.8 4.6 6.0 9.8 5.7 7.2 8.8 7.0 3.3 12.3 10.6 6.5 4.8 12.6 12.0 6.6 5.1 6.1 9.8 1.5 7.7 9.0 8.5 7.1 5.4 4.4 8.6 8.3 5.8 4.7 5.8 4.7 4.5 3.9 4.2 3.4 5.4 9.3 3.7 5.8 3.7 7.1 5.4 1.8 4.8 5.1 5.8 4.2 15.6 3.8 4.1 5.9 14.4 4.1 5.0 5.1 9.8 6.0 3.0 7.9 6.8 0.4 4.0 11.0 6.9 11.0 7.5 12.6 5.6 9.1 4.8 3.6 4.0 10.8 3.4 8.9 7.8 5.3 8.0 11.2 7.7 10.1 7.3 5.0 4.3 7.8 6.1 5.3 4.7 6.3 4.9 3.7 2.9 3.7 0.9 3.0 1.8 0.6 1.3 1.6 1.6 1.1 0.9 2.2 1.6 1.3 0.1 0.5 1.9 1.9 0.6 0.6 4.0 5.0 4.1 5.4 3.9 4.0 6.1 4.6 6.0 4.8 5.1 7.1 6.0 12.8 12.0 19.9 11.9 1.1 2.3 0.3 9.6 4.5 7.8 6.2 6.9 5.7 5.2 3.7 10.4 4.9 9.1 5.5 0.0 3.4 9.7 4.3 4.5 6.9 3.5 8.8 28.1 3.3 4.2 7.0 11.2 7.5 13.9 6.6 7.5 19.1 3.3 5.0 16.8 8.0 0.0 9.6 3.4 1.4 5.3 6.6 7.2 24.4 15.9 3.8 6.2 30.7 29.9 4.1 16.0 2.6 6.9 1.5 4.9 2.7 3.8 6.8 6.6 4.4 5.5 6.9 3.9 8.6 1.4 2.9 8.1 3.3 8.4 1.1 NBPF12 "COAS1, KIAA1245" ENSG00000268043 "NBPF member 12" Q5TAG4 1 146938744-146996202 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "pancreas: 80.1;stomach 1: 57.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved Microtubules,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 25: Pancreas - Digestion" "Cluster 20: HeLa - Mitochondria" "Cluster 59: Non-specific - Transcription" Cytosol Microtubules "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (5.48e-2)" "unprognostic (3.97e-1)" "unprognostic (1.74e-1)" "unprognostic (8.96e-3)" "unprognostic (4.57e-2)" "unprognostic (5.00e-3)" "unprognostic (2.03e-2)" "unprognostic (5.76e-3)" "unprognostic (4.57e-2)" "unprognostic (2.90e-1)" "prognostic favorable (9.01e-7)" "unprognostic (2.23e-1)" "unprognostic (1.69e-3)" "unprognostic (2.96e-2)" "unprognostic (2.86e-1)" "unprognostic (2.08e-1)" "prognostic favorable (2.47e-5)" 10.7 7.8 8.4 9.4 11.1 17.5 10.2 7.5 10.6 11.0 5.9 9.7 8.3 10.8 10.7 7.4 9.9 5.9 5.9 6.8 7.5 7.5 22.3 10.1 11.6 13.2 8.8 12.3 80.1 9.8 10.9 4.8 13.0 9.5 6.5 13.9 9.7 6.7 5.0 10.6 12.3 9.0 7.6 11.7 57.3 9.6 11.7 10.5 11.2 5.4 9.9 9.5 8.6 17.5 8.1 6.2 13.0 11.1 5.7 5.4 8.5 8.3 6.0 5.7 5.6 5.7 7.4 17.9 5.0 6.9 6.2 5.9 9.4 4.5 5.3 6.7 6.5 7.8 16.1 5.0 4.9 5.9 11.0 5.8 8.1 5.4 12.7 7.2 5.1 12.7 12.6 2.8 4.4 11.9 12.8 7.5 7.5 9.7 8.1 12.3 4.8 4.2 4.1 17.3 6.5 13.5 10.7 9.4 5.5 19.2 7.9 17.5 6.2 4.7 8.1 11.6 11.4 10.5 8.2 7.2 5.1 4.0 5.8 2.9 1.0 0.8 1.2 0.4 0.7 1.5 0.8 0.7 0.4 1.3 0.9 0.7 0.2 0.3 0.6 1.0 0.9 0.3 8.4 11.1 7.5 10.6 6.8 7.5 13.2 8.8 13.0 7.6 11.7 17.5 6.3 32.1 24.0 18.6 15.2 3.8 3.0 3.3 11.4 17.0 7.0 4.4 10.9 2.8 7.8 5.5 45.9 4.4 12.9 6.2 0.0 11.8 14.0 2.7 4.0 6.1 10.7 12.8 21.4 8.7 4.7 9.2 6.1 5.2 24.6 4.7 7.9 12.9 3.8 10.1 15.1 9.6 0.0 14.0 6.4 3.8 5.6 11.0 1.8 6.5 16.4 9.4 8.2 24.6 29.3 12.7 15.7 10.5 6.4 1.9 15.9 2.0 6.5 16.7 6.6 6.0 8.6 12.2 6.8 11.4 4.3 1.9 12.1 2.6 10.5 1.5 NBPF14 DJ328E19.C1.1 ENSG00000270629 "NBPF member 14" 1 148531385-148679742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 89.8;Astrocytes: 95.0;Paneth cells: 174.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 128.6" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol Microtubules "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (5.28e-2)" "unprognostic (3.88e-2)" "unprognostic (7.92e-3)" "unprognostic (7.13e-2)" "unprognostic (2.46e-1)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (2.02e-2)" "unprognostic (7.69e-4)" "unprognostic (7.23e-3)" "unprognostic (5.20e-2)" "unprognostic (5.15e-4)" "unprognostic (2.28e-2)" "unprognostic (2.61e-1)" "unprognostic (3.73e-1)" "unprognostic (2.52e-2)" 31.3 10.3 18.1 26.1 16.8 44.2 26.1 11.0 31.9 21.4 40.8 19.6 9.1 29.4 22.4 24.2 22.5 19.9 9.3 23.5 12.1 13.9 21.2 22.1 22.2 21.2 17.3 45.2 26.9 18.4 3.9 15.7 14.4 19.3 20.1 26.1 16.3 14.7 13.6 51.8 11.3 27.5 10.4 31.9 11.4 23.6 25.1 16.3 16.5 12.2 18.6 16.6 15.7 20.7 80.9 12.9 30.7 21.1 64.1 90.4 14.4 26.5 25.4 16.9 20.2 11.5 21.3 16.0 6.6 32.0 25.1 23.7 20.0 26.4 29.4 29.4 21.3 36.5 47.1 2.3 22.8 30.9 14.9 83.2 23.9 55.7 58.5 97.3 29.2 11.5 13.9 50.8 43.8 44.2 7.8 20.8 13.1 14.8 31.4 11.7 25.4 39.8 17.9 34.0 0.4 0.5 54.4 28.6 15.6 30.2 36.7 26.7 128.6 23.4 23.2 22.9 50.1 41.7 16.2 35.5 39.1 27.0 31.1 11.9 16.2 15.2 2.0 8.3 1.0 11.8 1.5 1.3 4.5 11.3 2.0 1.8 34.9 2.4 15.6 17.7 1.8 1.7 18.1 16.8 11.0 31.9 23.5 12.1 21.2 17.3 14.4 10.4 25.1 20.7 2.9 89.8 83.7 95.0 34.8 2.2 47.3 0.6 10.8 2.0 16.9 9.3 20.2 11.5 15.2 12.9 4.2 1.3 28.1 10.7 0.0 37.4 47.3 11.4 8.5 3.7 3.6 15.5 3.7 16.2 14.0 31.8 6.1 20.0 53.7 21.2 3.3 9.9 13.7 0.0 4.4 7.4 0.0 45.3 3.4 43.8 28.3 49.6 1.8 17.8 61.8 13.3 6.2 28.1 0.7 26.4 174.5 17.0 13.3 22.2 6.9 8.6 9.1 9.8 13.1 14.0 18.1 47.5 13.0 38.2 6.3 1.5 12.4 8.4 21.0 41.3 NBPF15 "MGC8902, NBPF16" ENSG00000266338 "NBPF member 15" Q8N660 1 144421386-144461674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 8 "B-cells: 1.3;NK-cells: 1.3;T-cells: 2.5" "Low cell line specificity" "Detected in many" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved Microtubules,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 18: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" Cytosol Microtubules "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (2.03e-1)" "unprognostic (7.10e-2)" "unprognostic (1.96e-1)" "unprognostic (4.82e-3)" "unprognostic (1.84e-3)" "unprognostic (3.50e-3)" "unprognostic (8.16e-3)" "unprognostic (1.19e-1)" "unprognostic (4.73e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (4.11e-5)" "unprognostic (1.36e-1)" "unprognostic (1.91e-1)" "unprognostic (6.67e-2)" "unprognostic (6.26e-2)" 17.2 13.9 7.8 10.1 8.0 2.3 18.7 11.3 8.5 21.9 7.2 20.4 3.9 17.4 20.2 13.7 20.0 7.6 13.4 7.6 8.3 17.2 36.5 24.1 16.8 7.4 7.3 21.2 21.3 8.9 17.0 9.8 7.2 18.0 7.8 18.6 14.4 7.4 5.6 15.2 19.3 12.0 6.4 28.9 14.2 6.9 8.4 2.4 25.8 2.9 12.3 15.3 17.2 6.2 13.7 9.3 15.8 29.8 18.2 28.6 19.5 24.6 24.2 15.0 15.2 7.9 14.8 7.0 6.6 18.5 16.9 10.5 17.5 8.0 23.0 23.4 9.6 0.4 23.6 9.6 14.0 0.4 6.5 23.8 13.5 17.7 36.4 20.7 21.1 2.7 3.1 20.5 36.0 29.7 0.3 6.0 6.5 5.0 19.8 6.4 9.2 11.1 16.2 12.4 1.4 35.7 10.5 15.7 17.5 20.1 16.2 5.9 22.6 23.7 15.3 21.0 23.5 18.2 21.0 11.8 0.3 0.7 11.4 0.0 0.2 0.0 0.5 0.0 0.8 1.3 1.5 1.1 0.1 0.9 1.8 0.7 0.1 1.3 0.2 0.0 2.5 0.8 7.8 8.0 11.3 8.5 7.6 8.3 7.4 7.3 7.2 6.4 8.4 6.2 5.9 44.8 20.8 5.9 14.8 2.0 1.5 0.7 22.8 2.7 5.1 3.2 10.3 4.3 12.8 1.8 6.2 1.7 4.9 1.6 0.0 6.4 5.3 2.6 9.6 9.7 6.1 1.7 16.9 4.4 3.2 12.2 11.2 3.8 15.2 5.3 6.1 8.9 1.6 3.3 10.4 3.0 0.0 7.5 1.4 1.4 8.7 8.1 1.8 14.0 6.2 3.1 1.0 7.1 3.4 6.6 23.6 10.5 10.3 1.5 1.4 1.0 5.0 7.1 0.0 3.5 8.7 3.7 1.9 17.6 1.3 0.3 8.4 3.8 5.2 0.4 NBPF19 ENSG00000271383 "NBPF member 19" A0A087WUL8 1 149475338-149556361 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 73.1;Paneth cells: 123.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol Microtubules "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (7.92e-3)" "unprognostic (9.12e-2)" "unprognostic (2.95e-2)" "unprognostic (8.53e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-3)" "unprognostic (5.59e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-4)" "unprognostic (3.54e-3)" "unprognostic (2.12e-1)" "unprognostic (1.76e-2)" "unprognostic (1.92e-5)" "unprognostic (1.10e-1)" "unprognostic (3.32e-1)" "unprognostic (8.93e-2)" "unprognostic (4.61e-2)" 38.1 9.0 11.7 31.4 5.4 55.7 28.7 3.7 35.0 25.8 37.6 19.1 10.6 28.8 24.4 24.6 29.5 16.7 10.2 9.7 3.4 14.3 18.9 27.3 30.2 5.9 10.2 48.8 33.7 17.4 3.8 14.9 8.2 24.8 21.7 57.6 20.6 15.5 15.0 63.4 13.4 30.4 0.4 36.8 13.2 28.6 19.9 33.5 20.7 18.2 26.6 19.1 9.2 7.8 62.9 16.4 33.8 18.0 65.9 55.4 16.0 29.8 22.4 20.2 19.4 14.7 21.9 18.1 7.0 45.4 26.7 27.8 47.8 27.6 30.9 32.6 26.8 51.6 49.1 5.2 13.1 51.9 18.0 38.5 12.1 58.7 73.5 27.6 13.3 25.1 12.7 27.6 43.3 45.9 28.3 31.1 30.7 17.6 25.4 25.5 35.7 29.1 12.5 30.0 2.8 7.1 71.5 23.9 13.0 47.7 44.7 70.4 80.2 40.7 30.5 23.9 46.9 23.1 14.5 54.9 45.6 35.4 12.4 15.1 22.2 7.8 8.9 8.6 6.1 3.3 5.0 3.3 4.4 7.1 6.5 8.6 24.0 9.3 7.1 16.1 2.1 2.4 11.7 5.4 3.7 35.0 9.7 3.4 5.9 10.2 8.2 0.4 19.9 7.8 2.3 51.3 59.2 61.0 12.9 0.0 18.5 0.0 19.4 8.1 13.9 7.6 22.4 2.8 9.9 3.7 27.1 1.5 24.4 2.6 1.9 21.2 57.8 13.9 13.0 2.6 1.2 12.8 7.6 6.2 7.1 14.0 4.6 23.2 20.2 9.2 2.2 7.3 6.6 3.3 6.7 3.1 0.0 40.9 0.0 8.0 32.3 43.8 0.0 12.2 73.1 16.6 36.0 22.1 0.6 10.0 123.8 30.1 17.1 6.8 6.3 0.5 11.7 48.7 19.7 15.9 12.4 30.4 6.2 33.9 0.0 1.4 26.3 2.8 6.0 11.5 NBPF20 ENSG00000162825 "NBPF member 20" P0DPF2 1 145289900-145405778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "brain: 48.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Alveolar cells type 2: 30.6;Early spermatids: 25.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 9: U-2 OS - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" Cytosol Microtubules "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (6.25e-3)" "unprognostic (4.74e-2)" "unprognostic (1.23e-1)" "unprognostic (8.05e-2)" "unprognostic (1.20e-2)" "unprognostic (1.40e-1)" "unprognostic (2.25e-2)" "unprognostic (5.37e-2)" "unprognostic (3.22e-3)" "unprognostic (3.54e-1)" "unprognostic (4.26e-4)" "unprognostic (1.69e-1)" "unprognostic (1.45e-4)" "unprognostic (9.74e-2)" "unprognostic (5.21e-2)" "unprognostic (1.00e-1)" "unprognostic (1.70e-1)" 3.7 3.6 10.3 4.3 6.0 4.0 4.2 48.5 8.6 3.7 2.2 3.2 1.8 4.0 4.6 2.3 2.7 3.0 2.1 5.2 4.7 2.7 6.0 3.3 4.3 12.7 41.5 5.1 3.5 6.9 1.9 2.0 15.6 4.1 3.6 9.0 4.6 4.8 3.1 5.8 3.2 4.5 5.2 4.0 2.8 7.9 15.4 5.4 2.7 3.5 4.4 3.2 1.2 9.9 25.7 12.0 3.4 9.8 20.4 35.6 8.5 12.3 2.9 4.1 4.4 13.4 3.0 5.8 4.7 12.0 7.0 7.5 11.9 14.0 11.7 11.9 14.4 3.9 17.6 9.7 4.2 7.1 6.4 10.6 10.4 22.8 18.9 7.7 10.9 3.2 15.5 9.0 17.0 16.0 1.0 3.2 3.2 5.4 19.3 5.8 9.7 3.7 5.9 4.5 6.0 10.6 23.8 12.6 6.6 8.6 9.3 9.2 20.5 20.0 25.5 11.3 27.3 5.2 4.5 13.0 11.3 2.9 3.0 0.5 1.5 0.5 0.9 0.7 0.7 1.3 0.6 0.8 0.4 3.3 0.9 0.7 0.8 2.4 2.0 11.5 0.9 0.4 10.3 6.0 48.5 8.6 5.2 4.7 12.7 41.5 15.6 5.2 15.4 9.9 2.1 22.4 30.6 3.6 3.1 2.9 1.9 2.1 1.2 4.7 3.4 1.8 3.9 1.5 3.0 0.0 18.8 1.3 10.9 1.2 0.0 8.0 25.9 2.4 3.4 4.7 6.1 2.1 6.6 11.2 5.1 7.1 0.5 3.5 7.6 1.6 2.9 16.5 1.8 1.7 3.3 2.4 0.0 4.6 5.8 2.9 5.6 3.3 3.6 1.9 7.5 1.8 2.1 2.0 2.5 11.3 9.8 3.8 3.3 1.5 2.1 0.4 5.4 8.6 0.0 2.6 3.4 11.8 8.1 2.2 3.1 0.7 3.7 1.8 3.3 0.8 NBPF26 ENSG00000273136 "NBPF member 26" 1 120723949-120842110 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 54.5;B-cells: 36.4;Basal squamous epithelial cells: 37.0;Erythroid cells: 55.5;Macrophages: 54.4;Squamous epithelial cells: 106.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 13.3" "Group enriched" "Detected in all" 5 "granulocytes: 13.3;monocytes: 7.3" "Low cell line specificity" "Detected in many" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 18: U-2197 - ECM organization" "Cluster 59: Non-specific - Transcription" Cytosol Microtubules "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.42e-1)" "unprognostic (2.11e-1)" "unprognostic (2.24e-1)" "unprognostic (7.64e-3)" "unprognostic (4.21e-1)" "unprognostic (1.34e-3)" "unprognostic (1.69e-1)" "unprognostic (1.26e-2)" "unprognostic (6.31e-5)" "unprognostic (9.78e-3)" "unprognostic (3.01e-1)" "unprognostic (1.27e-1)" "unprognostic (2.82e-5)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (8.11e-2)" "unprognostic (1.65e-1)" 14.7 7.2 5.4 21.9 5.1 13.2 11.0 7.6 6.3 14.9 13.7 10.2 2.5 15.1 20.1 20.7 11.2 13.3 6.5 3.8 5.8 4.9 10.4 13.3 12.5 5.4 4.4 17.0 8.9 4.3 4.7 8.5 3.6 12.6 9.3 23.1 10.2 8.9 6.4 39.0 8.6 17.3 2.0 13.9 7.5 10.3 8.0 11.9 12.2 5.4 8.5 7.9 11.5 5.8 56.7 0.3 16.4 17.8 18.3 16.9 1.3 19.9 10.1 12.5 12.9 12.2 2.3 4.4 17.2 17.5 21.6 14.4 27.8 28.7 17.4 25.1 1.3 40.1 7.5 4.8 9.1 16.0 11.4 10.2 11.8 31.1 32.6 40.5 0.8 10.5 3.0 30.1 29.5 28.7 4.2 24.6 6.3 2.0 21.5 5.5 15.3 8.2 7.3 19.9 1.5 1.3 22.1 30.5 16.6 19.5 1.0 6.7 17.3 14.0 36.3 43.7 15.7 13.5 4.1 16.2 11.6 23.5 2.2 2.4 5.1 4.6 1.4 2.3 0.7 0.8 1.0 1.2 1.4 2.0 1.0 1.5 13.3 1.3 7.3 1.3 0.5 0.7 5.4 5.1 7.6 6.3 3.8 5.8 5.4 4.4 3.6 2.0 8.0 5.8 0.8 54.5 28.7 3.9 36.4 0.0 2.2 0.0 37.0 0.6 3.9 2.4 2.7 0.0 3.7 0.0 0.0 0.5 4.7 0.6 3.9 4.8 7.6 7.2 4.8 1.4 0.0 55.5 0.4 3.1 2.4 14.9 16.3 7.8 16.4 2.5 1.1 1.4 0.2 0.0 0.3 1.0 0.0 4.4 0.0 0.9 6.5 54.4 0.0 1.0 6.5 0.6 2.1 0.5 0.1 4.0 27.3 4.5 28.0 1.0 1.7 0.7 3.6 2.1 0.0 3.1 6.7 4.9 2.5 106.5 0.0 0.4 21.1 0.9 2.2 0.8 NBPF9 AE01 ENSG00000269713 "NBPF member 9" P0DPF3 1 149054027-149103561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Hepatocytes: 28.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 49.5" "Group enriched" "Detected in all" 4 "granulocytes: 49.5;monocytes: 14.2" "Low cell line specificity" "Detected in all" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved Microtubules,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 41: Macrophages - Immune response" Cytosol Microtubules "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (1.25e-2)" "unprognostic (1.02e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (1.94e-1)" "unprognostic (2.15e-2)" "unprognostic (2.93e-1)" "unprognostic (2.10e-1)" "unprognostic (6.90e-2)" "unprognostic (9.42e-6)" "unprognostic (6.23e-2)" "unprognostic (2.76e-1)" "unprognostic (6.63e-3)" "unprognostic (8.80e-2)" 15.8 10.5 8.8 11.5 8.6 8.9 13.7 17.3 9.1 16.6 11.4 14.4 6.4 14.2 17.0 9.6 14.6 9.5 10.0 9.0 8.9 11.5 33.8 17.2 13.6 9.6 10.2 14.9 18.6 9.6 13.8 7.5 8.7 12.8 9.0 21.4 10.2 7.2 6.8 12.8 15.2 11.5 7.5 15.5 13.2 10.7 10.6 4.0 25.9 2.6 10.7 12.4 12.5 8.1 50.1 21.4 26.2 35.5 23.0 28.1 20.7 44.7 32.5 23.1 25.0 16.2 21.0 11.9 12.1 23.1 27.8 14.7 18.2 20.9 39.4 30.2 19.1 3.8 41.2 9.7 26.7 5.0 13.8 27.8 15.4 25.4 44.1 42.7 20.5 9.0 14.1 30.1 28.4 38.8 1.4 7.4 9.8 8.8 28.8 13.5 16.3 18.0 18.8 22.9 16.9 34.9 14.8 35.7 19.5 16.0 26.5 9.3 48.6 52.0 15.2 38.2 69.8 36.7 20.8 23.0 18.9 3.2 18.6 49.5 14.2 0.6 0.6 5.1 1.0 2.7 1.8 0.6 1.9 5.5 2.5 1.4 8.2 7.8 2.0 7.7 2.5 1.4 8.8 8.6 17.3 9.1 9.0 8.9 9.6 10.2 8.7 7.5 10.6 8.1 2.5 38.5 16.0 8.5 9.0 5.5 8.7 2.6 2.8 4.8 4.7 2.8 4.2 4.3 12.5 5.5 6.2 2.9 7.2 0.8 0.0 3.4 11.1 8.6 8.7 5.3 1.8 2.1 8.5 2.0 4.0 12.4 4.1 8.8 18.9 7.3 2.2 28.2 3.6 0.0 6.2 1.0 4.1 12.1 17.0 3.8 7.2 12.7 3.6 6.5 14.3 3.7 3.1 7.5 3.2 2.9 7.7 4.1 9.8 3.6 1.6 1.0 6.8 12.0 6.6 7.0 5.2 9.9 4.2 5.9 14.2 1.4 6.3 3.8 1.1 5.9 NDRG1 "CAP43, DRG1, NDR1, RTP, TDD5" ENSG00000104419 "N-myc downstream regulated 1" Q92597 8 133237175-133302022 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 613.9" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 571.9;Distal enterocytes: 405.4;Horizontal cells: 588.9;Suprabasal keratinocytes: 667.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 606.9;hTERT-HME1: 1226.9;U-87 MG: 772.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006881 Approved Supported Microtubules,Cytosol NA NA 200000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 28: Keratinocytes - Keratinization" Cytosol Microtubules "HPA006881: AB_1078392" "unprognostic (6.96e-3)" "unprognostic (3.31e-3)" "unprognostic (8.53e-2)" "unprognostic (1.41e-3)" "unprognostic (1.54e-3)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.47e-4)" "unprognostic (3.04e-3)" "unprognostic (5.33e-2)" "unprognostic (4.29e-2)" "unprognostic (9.09e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (4.13e-4)" "unprognostic (7.27e-2)" "unprognostic (1.91e-1)" "unprognostic (2.47e-3)" "unprognostic (4.28e-2)" 161.2 72.9 299.1 55.9 523.6 130.0 107.6 413.5 300.2 169.4 132.8 130.0 242.2 92.9 34.3 343.1 106.4 87.8 99.8 254.5 316.6 192.4 49.6 116.6 38.7 523.2 500.0 126.1 52.8 69.1 82.2 110.8 476.8 354.3 77.8 86.0 130.8 60.0 28.2 262.6 258.1 61.9 333.7 39.4 154.0 28.1 423.1 55.1 80.5 44.6 88.1 105.5 273.8 613.9 191.6 24.0 1.7 0.8 116.3 86.8 26.0 13.7 103.0 9.8 52.5 12.5 27.6 1.5 133.0 58.0 21.9 62.4 1.7 316.8 18.0 13.3 226.8 1.9 55.6 14.7 46.3 7.0 4.6 79.2 606.9 51.2 1226.9 124.2 45.2 27.9 2.0 138.3 17.2 11.0 19.1 20.8 3.0 69.8 155.8 1.7 19.4 86.2 29.7 28.0 13.8 13.0 31.0 312.1 73.3 48.6 1.3 20.0 58.5 84.4 43.6 40.7 10.4 96.3 280.3 0.8 772.5 69.5 161.5 10.9 4.3 0.0 5.8 3.4 9.1 1.6 5.3 6.9 6.0 1.4 3.9 3.1 4.0 1.5 4.2 13.0 8.1 3.7 299.1 523.6 413.5 300.2 254.5 316.6 523.2 500.0 476.8 333.7 423.1 613.9 123.0 144.2 47.4 14.4 23.6 571.9 141.3 207.3 42.1 68.8 28.6 31.2 20.6 80.1 102.9 187.6 2.1 12.8 68.1 405.4 33.2 33.2 5.3 57.4 59.0 217.7 22.1 17.4 7.7 13.7 138.2 90.5 151.4 167.7 22.2 41.0 112.8 64.0 16.5 588.9 5.7 140.9 83.4 31.1 109.5 5.9 49.0 42.7 101.4 28.1 25.7 81.2 14.4 20.6 136.2 62.9 155.9 44.0 23.5 264.3 402.5 87.5 38.7 40.3 46.0 65.2 44.3 1.2 7.1 113.0 667.4 43.4 45.7 32.6 124.7 280.8 NEK3 "HSPK36, MGC29949" ENSG00000136098 "NIMA related kinase 3" P51956 13 52132639-52159861 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 87.0;Spermatocytes: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019062, HPA043230" Enhanced Approved Microtubules NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 66: Spermatocytes - Spermatogenesis" Microtubules "HPA019062: AB_2670037, HPA043230: AB_2678374" "unprognostic (8.97e-2)" "unprognostic (2.54e-2)" "unprognostic (8.12e-2)" "unprognostic (1.84e-1)" "unprognostic (2.01e-2)" "unprognostic (2.05e-1)" "unprognostic (2.71e-1)" "unprognostic (2.31e-1)" "unprognostic (1.31e-1)" "unprognostic (4.30e-3)" "unprognostic (1.16e-3)" "unprognostic (1.70e-2)" "unprognostic (1.17e-3)" "unprognostic (1.22e-2)" "unprognostic (4.66e-2)" "unprognostic (4.15e-2)" "unprognostic (5.34e-2)" 12.4 3.8 13.7 6.2 18.5 8.6 10.6 12.5 21.8 10.8 11.2 16.2 9.3 9.9 6.9 4.2 8.7 7.4 7.8 12.9 14.2 10.1 7.3 9.0 5.0 18.2 17.8 8.2 8.3 3.8 5.2 17.4 17.3 8.2 16.8 4.7 7.0 5.0 6.0 7.2 12.7 8.6 12.9 8.0 6.7 18.1 19.9 3.2 6.3 3.3 5.4 8.3 7.4 26.3 0.3 2.7 20.2 11.4 6.2 10.8 0.3 6.5 6.2 7.6 8.3 8.6 11.1 0.0 0.4 8.4 6.3 1.5 0.4 4.8 4.8 15.1 11.8 1.9 2.7 23.0 7.6 19.4 10.9 7.2 9.5 4.2 17.6 5.6 13.5 1.0 3.1 7.1 9.0 5.1 1.1 23.4 19.7 4.4 0.5 0.5 1.7 7.6 11.4 1.9 2.2 14.0 2.9 6.4 12.8 19.6 2.5 26.3 12.2 1.0 5.9 6.0 6.7 7.5 2.5 13.1 1.8 6.8 10.8 7.1 6.3 5.1 1.6 5.8 1.0 3.6 1.9 1.0 6.7 1.9 1.4 0.4 0.4 1.6 1.2 5.8 2.9 1.4 13.7 18.5 12.5 21.8 12.9 14.2 18.2 17.8 17.3 12.9 19.9 26.3 28.8 6.4 6.5 9.1 5.9 2.8 4.4 2.8 5.7 3.9 5.5 6.7 7.7 5.7 5.8 7.3 0.0 13.0 8.3 20.1 13.7 7.9 11.5 9.8 14.0 22.7 6.0 3.4 0.6 17.3 14.4 8.7 10.2 11.0 10.1 11.6 18.2 7.4 19.1 3.3 3.4 13.7 6.1 12.4 8.1 4.6 7.2 10.4 12.4 18.7 25.4 3.0 7.2 9.0 87.0 15.6 17.9 6.8 6.0 3.3 22.4 6.8 7.1 5.8 0.0 7.1 9.0 49.7 25.5 3.5 3.4 4.8 4.0 3.9 20.1 5.2 NEK8 NPHP9 ENSG00000160602 "NIMA related kinase 8" Q86SG6 17 28725897-28743455 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Ciliopathy, Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 14.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040661, HPA040679" Approved Approved "Nuclear speckles,Microtubules,Mitotic spindle" Yes NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 7: Kidney - Transmembrane transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Microtubules "Nuclear speckles, Mitotic spindle" "HPA040661: AB_10794065, HPA040679: AB_10796226" "unprognostic (2.63e-1)" "unprognostic (4.57e-2)" "prognostic unfavorable (6.98e-4)" "unprognostic (6.25e-2)" "unprognostic (2.23e-2)" "unprognostic (5.93e-3)" "unprognostic (6.48e-2)" "prognostic favorable (4.52e-4)" "unprognostic (7.85e-2)" "unprognostic (1.37e-1)" "unprognostic (1.51e-3)" "unprognostic (1.55e-1)" "unprognostic (4.87e-3)" "unprognostic (4.61e-2)" "unprognostic (3.58e-1)" "unprognostic (1.75e-1)" "unprognostic (4.67e-3)" 1.5 3.1 1.7 3.3 1.9 1.7 2.4 1.4 1.9 2.5 3.8 2.4 3.0 1.5 3.2 2.5 3.9 2.0 1.0 1.4 1.6 9.1 5.2 3.3 5.8 2.0 1.7 1.9 4.5 2.9 4.4 2.6 1.7 4.0 2.2 0.6 3.7 2.6 0.5 3.1 4.2 1.2 1.6 5.8 3.4 3.8 1.9 2.7 7.2 0.4 5.0 2.6 2.2 2.3 2.1 3.4 3.5 2.8 1.9 2.1 10.9 0.9 2.1 1.3 1.7 5.4 5.0 13.1 3.5 2.8 2.5 3.8 5.2 4.8 1.3 3.5 6.4 2.9 5.8 10.1 3.3 1.8 3.7 4.8 1.8 2.5 5.8 1.8 0.9 1.9 4.3 1.3 1.5 4.7 1.9 3.4 3.3 3.7 1.0 4.9 2.3 5.9 7.0 5.7 6.4 1.5 3.0 6.3 1.6 4.7 9.3 2.4 0.8 1.3 2.2 1.6 1.0 1.5 1.8 8.9 2.0 1.6 3.1 3.3 0.9 1.2 0.7 0.5 0.8 2.8 0.6 0.7 0.1 4.2 0.7 1.0 0.4 1.3 1.1 14.8 0.5 0.8 1.7 1.9 1.4 1.9 1.4 1.6 2.0 1.7 1.7 1.6 1.9 2.3 2.7 9.6 19.3 3.9 22.9 2.8 9.2 8.3 7.4 2.8 10.1 14.1 1.7 12.8 11.6 25.8 8.4 17.6 19.1 14.9 7.9 5.8 9.5 12.8 6.0 2.9 10.3 7.0 0.7 6.0 9.2 3.9 6.1 15.2 26.6 3.2 3.3 9.4 3.9 1.7 0.5 14.4 10.2 5.0 2.7 2.0 3.4 4.4 3.6 2.8 4.0 2.6 3.1 1.5 1.6 3.9 17.2 2.6 7.2 8.6 13.4 4.3 14.3 1.8 0.0 11.7 3.0 19.9 11.4 8.8 1.6 11.1 4.9 7.8 15.9 4.2 NINL "KIAA0980, NLP" ENSG00000101004 "Ninein like" Q9Y2I6 20 25452697-25585531 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 42.4;Granulosa cells: 29.6;Inhibitory neurons: 32.6;Oligodendrocyte precursor cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 37.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000686 Uncertain Uncertain "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" "Microtubules, Cytokinetic bridge, Cytosol" "HPA000686: AB_1079193" "unprognostic (7.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (2.63e-2)" "unprognostic (4.84e-2)" "unprognostic (4.64e-2)" "unprognostic (1.16e-1)" "unprognostic (8.56e-2)" "unprognostic (2.50e-1)" "unprognostic (7.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (3.39e-1)" "prognostic favorable (1.03e-5)" "unprognostic (3.95e-2)" "unprognostic (2.72e-1)" "unprognostic (1.51e-1)" "unprognostic (6.26e-2)" 4.0 8.6 4.9 2.0 5.9 0.6 4.0 10.4 6.1 10.1 8.8 9.8 3.2 7.2 7.2 5.8 5.2 3.3 4.0 4.4 6.9 15.1 8.1 4.1 2.2 7.9 7.1 18.9 5.4 8.2 9.9 1.5 7.0 8.8 2.1 4.7 4.4 3.7 4.5 2.4 3.9 3.5 5.5 4.9 6.3 7.7 6.5 15.7 10.2 1.2 2.2 3.6 8.5 6.8 1.0 10.8 23.0 15.1 2.6 7.5 7.1 3.6 3.1 3.1 4.4 2.8 7.5 0.6 5.0 5.6 7.6 0.8 3.4 0.7 2.6 0.5 4.7 1.6 5.0 37.5 5.4 0.6 0.1 9.2 0.7 3.6 0.0 8.8 6.8 17.8 1.9 0.3 3.8 9.6 21.7 0.7 6.5 0.1 1.1 0.5 17.9 0.8 1.5 1.3 22.7 16.0 8.2 3.0 9.1 18.3 4.9 6.4 0.3 0.1 8.6 0.1 0.2 2.3 4.4 0.1 0.2 0.6 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.9 5.9 10.4 6.1 4.4 6.9 7.9 7.1 7.0 5.5 6.5 6.8 1.2 0.0 14.6 42.4 0.8 2.0 4.9 2.5 5.7 3.0 2.8 3.3 6.5 12.8 4.8 7.3 25.0 2.8 0.6 0.4 0.0 5.6 0.6 4.2 7.3 2.3 6.1 0.0 7.4 1.2 1.3 8.7 4.6 3.4 0.0 29.6 8.9 8.4 2.3 8.4 32.6 2.3 8.2 0.3 2.0 2.7 13.1 0.8 0.0 12.2 0.0 3.2 2.1 47.3 19.4 2.8 1.5 12.4 0.9 4.5 0.7 8.8 13.7 1.9 6.6 10.8 4.7 2.5 5.0 4.3 0.9 1.5 1.1 21.0 2.5 1.9 NISCH "I-1, IRAS, KIAA0975" ENSG00000010322 Nischarin Q9Y2I1 3 52455118-52493068 "FDA approved drug targets, Predicted intracellular proteins" Apoptosis Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Enteroendocrine cells: 169.3;Peritubular cells: 246.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023189 Approved Approved "Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Nucleoplasm, Cytosol" "Vesicles, Microtubules, Cytokinetic bridge" "HPA023189: AB_1854495" "unprognostic (6.66e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (4.11e-3)" "unprognostic (1.64e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-2)" "unprognostic (6.56e-3)" "unprognostic (4.96e-2)" "unprognostic (8.33e-3)" "prognostic favorable (1.91e-4)" "unprognostic (1.40e-2)" "unprognostic (5.10e-2)" "unprognostic (1.19e-1)" "unprognostic (2.94e-2)" "unprognostic (1.47e-1)" "unprognostic (7.05e-3)" 55.2 69.8 46.5 28.7 55.5 38.7 60.5 78.2 56.6 105.8 22.2 68.5 24.3 76.2 34.0 51.3 72.0 29.9 48.5 56.3 38.7 54.6 45.6 56.2 32.5 20.9 32.6 93.0 54.1 32.5 181.8 39.1 32.9 107.5 20.6 19.0 53.6 51.6 36.3 80.7 55.3 33.0 9.1 54.1 52.7 84.5 35.2 30.1 60.8 16.3 23.3 78.1 71.6 35.2 15.6 16.0 48.8 40.1 35.7 39.2 40.0 32.8 21.5 25.7 26.0 24.2 22.8 21.7 9.0 45.6 21.0 20.4 26.1 35.7 15.1 22.3 28.2 39.2 65.2 23.9 32.4 23.2 33.6 61.9 28.2 27.7 23.5 54.0 42.0 42.4 21.1 23.4 24.3 22.2 41.8 51.2 30.1 19.8 27.1 24.5 13.4 25.4 29.2 30.6 20.6 35.9 35.6 9.3 23.1 42.3 28.9 38.5 46.3 36.0 34.1 36.9 24.1 38.7 23.8 27.3 24.7 37.3 22.4 5.2 4.5 3.5 3.0 4.0 3.1 2.5 2.6 4.0 2.3 2.8 3.1 3.3 1.5 3.2 0.6 3.4 3.0 3.6 46.5 55.5 78.2 56.6 56.3 38.7 20.9 32.6 32.9 9.1 35.2 35.2 26.1 25.6 32.3 34.0 14.9 27.5 14.6 23.3 40.5 40.9 29.2 37.1 20.4 8.6 19.1 14.7 8.4 32.4 24.2 20.5 9.8 12.1 10.3 14.5 26.7 22.1 169.3 4.6 64.9 9.4 14.0 23.4 23.4 18.9 25.3 40.2 46.1 15.3 30.5 28.6 44.0 19.1 22.4 50.5 14.5 25.9 88.3 24.3 19.6 15.0 13.0 12.1 17.5 21.1 26.1 10.0 14.2 246.0 12.4 12.6 16.5 15.6 15.2 22.4 26.3 17.2 24.8 31.2 18.0 16.7 22.3 24.2 18.4 47.6 15.7 11.7 NUAK1 "ARK5, KIAA0537" ENSG00000074590 "NUAK family kinase 1" O60285 12 106063345-106138954 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endothelial cells: 111.7;Excitatory neurons: 150.5;Hepatic stellate cells: 136.3;Microglial cells: 93.7;Oligodendrocytes: 73.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 58.0;EFO-21: 55.1;RH-30: 77.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057143 Approved "Nucleoplasm,Nucleoli fibrillar center,Microtubules" Yes No "Cluster 47: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli fibrillar center" "Nucleoplasm, Microtubules" "HPA057143: AB_2683349" "unprognostic (4.20e-2)" "unprognostic (8.42e-2)" "unprognostic (3.71e-2)" "prognostic unfavorable (9.83e-4)" "unprognostic (4.13e-2)" "unprognostic (2.34e-1)" "unprognostic (1.43e-1)" "unprognostic (4.80e-2)" "unprognostic (9.91e-2)" "unprognostic (4.06e-3)" "unprognostic (3.29e-1)" "unprognostic (1.31e-1)" "unprognostic (1.93e-3)" "prognostic unfavorable (4.27e-4)" "unprognostic (2.31e-1)" "unprognostic (8.70e-2)" "unprognostic (4.47e-2)" 17.5 3.6 12.6 2.3 17.5 0.6 12.1 9.4 25.4 9.8 0.0 4.1 2.2 9.5 3.1 3.5 9.0 4.9 18.8 17.4 5.6 4.2 4.0 9.3 3.2 6.1 5.9 6.1 3.2 17.5 2.7 4.5 8.3 6.0 3.9 5.4 3.4 6.0 20.6 20.8 4.3 10.2 5.5 0.8 3.8 2.6 5.5 3.3 4.3 17.2 2.3 4.8 8.1 31.8 13.0 8.3 58.0 0.6 23.7 2.5 27.0 14.2 9.5 9.9 8.0 4.3 2.1 0.0 55.1 27.4 5.0 11.9 12.6 11.2 4.8 0.2 3.4 0.0 9.7 4.7 5.0 0.1 0.1 11.0 8.1 6.0 1.7 19.2 21.2 0.1 0.0 40.3 7.8 1.3 0.2 0.6 11.1 0.2 3.3 0.1 77.7 10.5 6.6 13.3 6.8 0.4 6.9 1.9 0.5 37.2 2.9 0.4 16.6 9.4 29.7 3.3 17.0 0.0 0.0 0.7 2.8 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.6 17.5 9.4 25.4 17.4 5.6 6.1 5.9 8.3 5.5 5.5 31.8 56.4 0.0 2.4 15.7 0.6 13.5 32.9 29.8 10.2 32.3 2.1 4.2 48.9 10.0 7.2 7.3 0.0 0.8 13.5 0.9 3.9 6.2 0.4 5.1 6.6 111.7 0.0 5.3 150.5 9.6 5.2 17.9 2.0 3.8 0.0 2.9 136.3 12.1 8.0 40.4 55.4 2.3 12.2 8.4 8.8 2.6 4.1 1.3 10.6 93.7 0.6 1.9 1.0 15.6 73.5 18.4 0.5 3.0 3.2 10.6 0.2 1.8 2.2 2.9 0.0 7.1 26.4 1.0 5.5 2.5 15.9 0.3 2.7 0.4 0.8 5.2 NUCB1 "Calnuc, NUC" ENSG00000104805 "Nucleobindin 1" Q02818 19 48900312-48923372 "Plasma proteins, Predicted secreted proteins" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 453.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008176 Supported Supported "Golgi apparatus,Microtubules" "Secreted to blood" NA NA 27000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 16: U-266 - Nucleosome" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" Microtubules "HPA008176: AB_1845923" "unprognostic (2.13e-1)" "unprognostic (2.83e-1)" "unprognostic (4.36e-3)" "unprognostic (6.28e-2)" "unprognostic (1.06e-2)" "unprognostic (2.95e-1)" "unprognostic (6.86e-2)" "unprognostic (1.98e-1)" "unprognostic (9.51e-2)" "unprognostic (8.14e-3)" "unprognostic (2.34e-3)" "unprognostic (9.89e-2)" "unprognostic (5.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (8.90e-3)" "unprognostic (3.41e-1)" 181.3 103.5 55.8 106.8 60.4 82.3 141.6 65.5 68.1 115.0 79.4 122.1 179.9 127.6 61.3 111.2 116.9 108.3 204.0 58.2 63.0 154.6 264.5 157.1 82.1 65.9 62.9 125.6 130.1 173.5 69.5 114.8 67.5 109.2 54.8 30.2 117.8 103.0 180.1 96.6 163.6 106.0 57.7 111.1 118.8 34.7 73.1 49.5 122.2 110.7 53.1 130.1 108.9 61.6 54.8 182.1 84.2 188.5 304.6 249.2 97.6 208.1 189.9 103.3 144.2 92.9 203.1 54.7 151.8 250.6 98.9 132.0 48.6 107.0 43.3 194.6 90.3 141.6 119.0 131.6 156.6 85.1 183.6 288.0 52.1 96.8 62.9 275.2 167.2 60.7 173.1 278.8 107.0 71.6 42.3 68.6 42.2 132.1 93.5 78.7 125.3 114.9 90.2 134.6 61.2 123.2 247.1 152.2 88.1 79.7 78.8 112.1 234.6 172.3 114.3 107.0 99.3 210.8 501.1 37.1 132.5 54.3 207.3 102.9 108.5 105.7 100.6 128.5 75.3 46.8 67.5 77.2 79.0 37.3 55.3 56.7 104.7 69.2 114.2 113.9 74.6 129.5 55.8 60.4 65.5 68.1 58.2 63.0 65.9 62.9 67.5 57.7 73.1 61.6 154.5 41.7 72.1 17.6 51.0 48.3 67.2 81.3 66.0 21.7 57.6 57.5 58.0 78.6 51.5 69.9 14.6 101.5 69.6 153.0 41.1 148.0 10.8 27.4 65.5 116.0 74.4 54.5 14.5 118.3 150.9 126.7 76.0 50.2 95.2 64.1 122.0 149.2 213.7 20.2 18.9 109.9 69.2 138.3 74.6 9.3 110.3 101.9 101.4 17.8 120.3 52.6 74.2 8.5 11.8 100.0 149.2 124.1 126.3 63.8 453.3 135.4 24.4 20.5 92.1 51.0 79.0 21.9 37.6 65.6 49.9 102.1 73.0 103.9 123.3 68.1 NUDCD2 "DKFZp686E10109, NudCL2" ENSG00000170584 "NudC domain containing 2" Q8WVJ2 5 163446526-163460102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037384, HPA037385" Uncertain Supported "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA 18000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Microtubules "Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA037384: AB_2675447, HPA037385: AB_10673630" "unprognostic (3.96e-1)" "unprognostic (3.69e-2)" "prognostic favorable (2.80e-4)" "unprognostic (1.46e-1)" "unprognostic (9.12e-2)" "unprognostic (3.75e-3)" "unprognostic (1.84e-1)" "unprognostic (4.74e-1)" "unprognostic (3.47e-2)" "unprognostic (7.63e-3)" "unprognostic (1.81e-1)" "unprognostic (2.45e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" "unprognostic (6.86e-2)" "unprognostic (3.40e-2)" "unprognostic (7.85e-2)" 13.9 11.8 11.1 13.2 13.2 11.7 11.2 13.2 14.0 8.1 10.2 11.2 14.5 10.2 6.4 12.8 9.7 5.7 8.3 11.0 11.4 11.7 15.3 8.7 15.1 12.8 12.6 8.9 15.4 6.8 9.3 10.3 13.7 8.9 6.1 7.3 14.0 3.6 20.9 10.7 13.3 6.3 12.8 12.8 11.8 10.4 12.5 8.1 9.4 5.0 9.8 9.2 10.3 17.7 62.3 32.3 23.5 37.1 14.1 10.4 31.3 24.6 7.0 8.7 13.9 28.6 46.3 35.5 57.5 4.0 39.8 30.6 12.6 13.9 10.7 70.6 36.6 32.4 42.0 26.4 15.3 37.3 35.3 3.8 7.7 8.4 12.1 12.3 9.8 39.1 35.1 42.6 8.9 25.2 55.1 80.9 25.8 18.4 35.2 45.7 39.2 63.0 8.0 14.3 59.6 33.6 38.7 24.7 66.3 13.8 47.2 37.8 21.9 29.4 43.8 32.6 56.7 35.0 63.8 61.5 34.2 63.2 31.4 49.9 48.3 32.5 60.2 59.8 76.5 91.7 84.0 71.8 68.0 68.0 88.7 79.0 6.2 83.8 51.5 81.1 83.5 69.1 11.1 13.2 13.2 14.0 11.0 11.4 12.8 12.6 13.7 12.8 12.5 17.7 58.0 28.9 23.8 9.1 47.5 59.4 54.9 92.6 42.7 30.7 70.4 88.6 43.1 35.8 53.1 38.6 22.9 118.7 43.8 25.4 148.7 63.6 95.1 57.6 44.1 47.4 43.8 78.4 18.8 64.0 55.8 48.6 32.1 38.3 31.6 35.7 36.0 55.1 69.8 10.1 14.0 45.3 87.5 41.8 42.7 24.5 51.6 35.7 49.8 11.2 46.4 51.4 52.5 11.1 36.0 59.9 33.6 51.1 55.5 95.2 31.5 112.5 65.1 38.2 39.5 51.3 46.5 87.6 44.2 56.0 67.6 56.8 48.3 64.8 68.6 59.3 NUDT14 UGPP ENSG00000183828 "Nudix hydrolase 14" O95848 14 105172938-105181323 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 176.1;Proximal enterocytes: 206.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046755, HPA058759" Approved Approved Nucleoli,Microtubules NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 39: Non-specific - Basic cellular processes" Microtubules Nucleoli "HPA046755: AB_10963433, HPA058759: AB_2683809" "unprognostic (1.05e-2)" "unprognostic (6.01e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.55e-1)" "unprognostic (1.05e-3)" "unprognostic (9.17e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.16e-3)" "unprognostic (3.13e-1)" "prognostic favorable (1.18e-5)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (7.21e-3)" "unprognostic (2.38e-1)" 16.5 23.9 17.4 3.5 20.1 2.1 19.3 19.9 28.4 9.0 27.5 14.5 12.5 6.4 3.5 17.5 8.9 6.4 27.5 19.9 21.5 28.8 19.5 20.1 5.9 19.0 17.4 6.4 40.4 16.0 61.1 3.2 19.1 18.6 2.9 4.7 17.2 2.9 31.6 14.1 16.3 1.8 17.9 12.5 17.6 13.9 17.2 3.6 22.1 12.7 2.1 8.4 11.3 21.1 18.1 24.2 2.1 9.4 2.8 3.3 38.1 5.0 6.5 8.0 11.5 17.5 18.7 1.3 24.4 2.6 17.8 22.7 1.1 13.6 0.7 9.5 17.7 4.0 10.4 12.2 19.9 4.8 46.7 4.7 16.7 1.9 1.4 3.4 15.9 8.8 6.4 2.9 2.8 52.5 0.6 0.0 12.6 42.7 33.5 9.4 21.9 10.8 8.8 51.2 32.8 4.8 9.0 0.2 21.7 3.9 18.8 23.1 38.3 13.2 5.8 9.5 5.1 1.4 1.0 2.2 19.4 5.5 4.9 6.2 40.5 1.2 12.6 40.8 7.5 12.8 9.6 8.0 33.5 10.2 9.4 10.8 1.3 15.2 68.6 17.0 6.0 19.2 17.4 20.1 19.9 28.4 19.9 21.5 19.0 17.4 19.1 17.9 17.2 21.1 66.1 12.8 28.5 5.2 12.4 38.9 101.7 123.4 52.9 12.1 46.8 78.5 54.5 40.0 41.2 35.0 18.8 44.7 16.1 88.2 176.1 94.1 3.1 59.3 8.0 61.6 37.3 10.1 5.9 30.8 18.2 14.7 30.5 31.0 38.8 11.9 27.1 28.0 137.0 35.3 3.0 62.6 73.2 27.4 27.1 9.8 11.5 33.9 46.2 12.2 35.6 38.3 22.6 0.5 5.8 51.2 132.4 3.8 7.7 51.9 206.9 169.1 65.7 19.1 0.0 39.0 11.4 12.4 48.5 30.4 19.0 38.2 26.8 5.2 75.4 82.2 OCRL "Dent-2, OCRL1" ENSG00000122126 "OCRL inositol polyphosphate-5-phosphatase" Q01968 X 129539849-129592561 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" Hydrolase "Cataract, Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.6" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;monocytes: 3.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012495 Approved Approved "Microtubules,Centriolar satellite,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" Cytosol "Microtubules, Centriolar satellite" "HPA012495: AB_1851804" "prognostic unfavorable (2.93e-5)" "unprognostic (3.17e-2)" "unprognostic (2.30e-1)" "unprognostic (6.34e-3)" "unprognostic (9.88e-2)" "unprognostic (1.35e-1)" "unprognostic (2.82e-2)" "unprognostic (2.68e-1)" "unprognostic (3.08e-3)" "unprognostic (2.56e-2)" "unprognostic (6.30e-3)" "unprognostic (1.74e-1)" "unprognostic (4.61e-3)" "unprognostic (4.10e-1)" "unprognostic (5.83e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" 13.9 23.8 12.4 4.7 13.2 5.0 12.7 5.3 13.6 14.9 27.2 16.4 8.0 19.4 16.1 11.6 16.7 8.3 10.7 13.1 20.3 9.5 15.7 10.0 2.8 9.6 14.0 28.4 13.0 34.6 25.6 11.2 17.4 18.5 12.4 9.9 11.0 21.3 14.8 12.4 12.2 15.0 7.6 7.9 14.5 24.6 18.6 4.4 16.8 6.7 3.0 22.8 12.3 8.6 19.3 20.5 17.0 18.7 29.3 24.1 17.1 28.5 22.3 28.2 26.3 14.2 13.3 1.5 46.7 24.1 33.0 11.6 30.5 20.9 29.2 0.1 21.5 5.8 18.5 14.1 21.1 5.7 0.6 20.7 27.3 28.3 27.3 27.7 21.2 8.4 7.9 13.6 28.7 24.2 4.3 8.2 6.2 24.4 30.9 4.2 17.6 11.5 16.1 19.1 20.5 26.1 13.5 18.0 14.6 21.5 13.2 10.0 19.3 23.0 10.6 24.6 29.1 3.8 3.3 3.7 16.2 21.4 18.8 0.0 1.0 0.0 0.1 1.1 0.3 0.1 0.0 0.0 1.2 0.1 0.2 0.1 0.1 0.0 3.6 0.4 0.0 0.4 12.4 13.2 5.3 13.6 13.1 20.3 9.6 14.0 17.4 7.6 18.6 8.6 6.7 3.2 7.8 14.4 2.6 4.7 3.4 5.4 3.4 9.9 9.3 5.6 10.3 4.3 8.8 18.4 6.2 6.4 0.3 14.4 3.9 5.3 31.2 4.9 6.9 6.4 17.5 3.8 20.0 3.6 5.4 7.8 11.7 6.1 0.0 17.0 8.2 11.5 5.0 13.5 23.1 11.8 6.1 11.8 4.0 8.9 23.0 5.8 8.8 21.5 4.3 9.6 0.0 17.6 21.0 8.5 8.3 34.3 1.4 5.9 15.7 5.2 5.4 7.2 0.0 4.5 6.0 6.8 14.6 8.3 7.4 5.7 1.0 7.6 12.2 8.4 OFD1 "71-7A, CXorf5, JBTS10, RP23" ENSG00000046651 "OFD1 centriole and centriolar satellite protein" O75665 X 13734745-13769357 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "plasmacytoid DC: 64.2" "Lineage enriched" "Detected in all" 4 "dendritic cells: 64.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031102, HPA031103, HPA031104" Approved Supported Microtubules NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 25: RPMI-8226 - Immune response" "Cluster 44: Endometrium - Transcription" Microtubules "HPA031102: AB_10670836, HPA031103: AB_10602188, HPA031104: AB_10669655" "unprognostic (3.10e-3)" "prognostic favorable (9.62e-4)" "unprognostic (2.83e-1)" "unprognostic (2.68e-2)" "unprognostic (1.10e-1)" "unprognostic (7.42e-3)" "unprognostic (2.20e-3)" "unprognostic (3.03e-3)" "unprognostic (1.82e-2)" "unprognostic (1.43e-3)" "unprognostic (2.82e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (3.32e-2)" "unprognostic (3.90e-2)" "unprognostic (1.04e-2)" "prognostic favorable (2.76e-7)" 5.8 5.9 8.3 11.7 8.7 15.6 14.6 10.8 9.8 11.2 10.1 9.4 10.2 10.5 11.5 9.9 9.6 7.3 5.9 8.2 9.4 9.6 7.2 9.2 19.1 9.7 8.3 11.2 11.2 15.3 10.9 5.3 8.9 11.7 8.2 11.2 15.6 6.5 5.2 11.8 12.8 7.6 8.2 13.9 12.2 9.9 8.4 10.1 12.9 4.1 16.8 8.5 10.4 10.0 16.0 7.1 10.3 18.4 8.4 13.0 7.7 4.9 11.3 5.7 7.3 12.8 17.7 23.2 12.5 5.9 10.6 15.3 7.5 13.7 9.2 11.6 18.9 10.8 22.3 10.8 6.4 14.4 19.1 10.4 9.1 12.9 12.7 10.6 6.4 4.2 16.5 20.4 6.4 12.6 9.9 17.3 10.8 5.8 10.2 24.9 11.9 46.6 8.9 13.5 10.5 16.6 23.2 18.5 11.6 22.7 17.5 13.0 5.8 10.0 5.2 12.1 6.3 15.1 15.1 26.9 8.3 6.4 8.3 4.3 1.7 6.2 11.6 2.2 13.4 13.7 10.1 14.2 3.8 15.4 8.3 12.5 4.7 14.1 3.1 64.2 8.6 4.4 8.3 8.7 10.8 9.8 8.2 9.4 9.7 8.3 8.9 8.2 8.4 10.0 40.2 70.5 64.1 60.4 90.8 22.4 89.3 51.8 38.1 47.9 65.9 64.1 17.8 35.8 66.7 31.3 89.6 34.5 219.8 82.3 7.9 60.2 178.6 232.2 33.0 39.5 48.6 30.1 43.3 59.3 23.4 31.2 58.1 180.8 27.3 41.1 24.7 13.3 25.2 37.0 50.2 60.3 42.7 19.8 43.0 187.4 52.2 35.1 17.8 32.8 38.2 41.3 145.2 76.9 64.5 60.7 72.9 33.8 50.5 84.4 83.8 15.3 81.3 107.2 39.5 42.4 25.2 72.7 59.9 32.6 27.3 87.0 102.2 30.7 52.2 82.8 OTUD7B "CEZANNE, ZA20D1" ENSG00000264522 "OTU deubiquitinase 7B" Q6GQQ9 1 149937812-150010726 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 106.3;Oligodendrocytes: 176.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027045, HPA076357" Supported Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 41: Basophils - Cellular respiration" "Cluster 70: Brain - Nervous system development" "Cluster 2: Karpas-707 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA027045: AB_1854847, HPA076357: " "unprognostic (2.17e-2)" "unprognostic (2.93e-2)" "unprognostic (1.90e-1)" "prognostic favorable (7.47e-4)" "unprognostic (1.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.23e-3)" "unprognostic (1.46e-2)" "prognostic favorable (5.09e-5)" "unprognostic (4.90e-2)" "unprognostic (7.72e-2)" "unprognostic (8.94e-2)" "unprognostic (3.37e-2)" "unprognostic (1.67e-2)" "unprognostic (1.18e-1)" "unprognostic (4.52e-2)" "unprognostic (1.58e-2)" 11.7 7.7 21.0 3.8 39.2 1.1 7.8 28.7 18.5 9.9 6.8 7.6 6.2 10.5 3.8 7.7 9.3 4.8 7.1 15.3 22.1 5.6 10.7 7.3 1.9 41.4 37.2 10.9 6.1 10.9 3.4 7.1 35.5 6.6 7.1 10.1 7.8 7.5 18.6 5.8 6.2 10.8 27.9 3.6 6.7 12.7 31.7 2.1 6.7 16.2 3.2 6.3 5.2 43.0 17.2 13.5 9.3 15.6 12.0 11.1 8.8 11.8 17.3 14.0 9.6 10.0 13.6 0.2 7.5 21.7 6.3 13.4 13.2 13.1 14.6 16.5 6.7 6.6 18.9 6.8 12.8 7.6 6.9 12.4 9.9 23.7 20.6 10.9 11.5 2.0 18.4 18.1 10.1 17.5 1.3 2.1 11.9 12.8 13.1 1.8 12.9 4.4 5.4 23.2 6.0 11.4 20.8 15.2 18.5 12.1 12.6 4.0 13.9 14.4 13.2 9.8 14.0 19.1 20.0 2.0 12.8 2.2 24.1 2.0 0.0 0.4 0.7 0.0 0.5 0.1 0.3 0.4 0.0 0.1 0.2 0.3 0.3 0.4 0.0 0.1 0.1 0.0 21.0 39.2 28.7 18.5 15.3 22.1 41.4 37.2 35.5 27.9 31.7 43.0 10.2 35.3 11.7 56.8 3.0 15.9 22.7 8.7 13.1 28.0 18.3 9.3 22.2 12.8 15.3 11.0 106.3 23.5 5.1 41.1 7.9 14.5 63.4 21.8 17.8 16.7 17.4 14.9 20.6 11.1 11.6 14.8 21.4 40.2 0.0 22.0 20.3 33.0 3.1 23.5 24.6 15.8 8.2 0.8 5.9 79.4 14.6 2.4 37.4 22.5 4.3 23.6 15.5 33.2 176.8 20.6 21.3 23.0 4.7 20.2 17.1 11.5 17.4 66.9 0.0 19.8 17.9 11.1 7.2 11.8 16.6 21.2 7.5 11.1 11.1 34.0 OVGP1 "CHIT5, MUC9" ENSG00000085465 "Oviductal glycoprotein 1" Q12889 1 111414319-111427735 "Plasma proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 134 "fallopian tube: 2071.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 9.7;Excitatory neurons: 10.4;Glandular and luminal cells: 12.0;Inhibitory neurons: 8.5;Syncytiotrophoblasts: 17.4" "Group enriched" "Detected in many" 13 "endometrial cancer: 58.7;ovarian cancer: 27.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 4.9;OE19: 6.4;SK-BR-3: 5.0" "Region enhanced" "Detected in many" "cerebellum: 5.9" "Not detected" "Not detected" "HPA031666, HPA062205" Enhanced Supported Vesicles,Microtubules "Secreted in female reproductive system" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 21: OE19 - Mitochondria" "Cluster 44: Endometrium - Transcription" Vesicles Microtubules "HPA031666: , HPA062205: AB_2684710" "unprognostic (1.52e-1)" "unprognostic (2.06e-2)" "unprognostic (3.35e-2)" "prognostic favorable (1.36e-4)" "unprognostic (8.39e-2)" "unprognostic (3.58e-2)" "unprognostic (2.33e-2)" "unprognostic (3.34e-2)" "unprognostic (5.44e-2)" "unprognostic (3.82e-2)" "unprognostic (7.68e-3)" "unprognostic (2.58e-1)" "unprognostic (5.35e-3)" "unprognostic (2.39e-1)" "unprognostic (1.38e-1)" "unprognostic (3.86e-3)" "prognostic favorable (3.93e-5)" 4.1 1.6 7.6 1.1 7.8 1.9 3.5 8.0 10.6 3.8 5.8 3.4 1.1 15.4 5.1 3.0 2071.7 1.1 2.3 7.7 7.0 5.0 8.0 3.9 2.2 7.3 6.9 6.7 1.5 6.8 2.4 2.0 7.2 5.5 2.2 4.3 4.2 1.5 2.6 7.6 5.2 1.4 6.5 4.6 2.8 9.2 6.9 1.2 2.4 1.0 2.0 4.6 3.8 8.2 0.4 0.4 0.9 0.5 1.8 2.0 1.7 0.2 1.4 0.3 0.7 0.6 0.0 0.8 1.7 0.6 0.0 0.5 0.3 0.3 0.5 2.0 4.9 0.3 0.8 2.4 0.6 0.9 2.2 1.8 2.9 0.0 1.0 1.4 0.4 3.2 0.3 1.5 0.1 0.5 0.6 1.2 0.2 6.4 1.7 0.6 0.2 0.7 1.4 3.7 0.6 0.6 0.1 5.0 0.7 2.4 0.3 0.8 0.8 0.1 0.2 2.5 0.7 1.8 0.5 0.4 0.2 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 7.8 8.0 10.6 7.7 7.0 7.3 6.9 7.2 6.5 6.9 8.2 1.2 0.0 1.1 3.3 0.6 3.1 1.1 0.3 0.0 2.1 1.7 1.9 0.6 0.0 0.5 0.0 0.0 5.6 0.2 1.1 1.9 0.2 4.0 9.7 0.7 1.6 0.0 0.0 10.4 0.0 2.6 0.6 0.0 12.0 0.0 1.0 1.4 2.9 0.6 0.0 8.5 1.5 2.0 0.6 1.4 6.1 1.5 0.5 0.0 3.7 0.0 0.4 0.0 1.5 2.4 0.2 0.5 1.9 0.1 1.6 0.6 2.8 1.3 0.6 0.0 0.7 1.1 3.8 0.7 1.0 3.1 17.4 0.8 0.2 1.6 1.6 PACS1 "FLJ10209, KIAA1175" ENSG00000175115 "Phosphofurin acidic cluster sorting protein 1" Q6VY07 11 66070272-66244744 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038914 Approved Approved Microtubules,Cytosol NA NA 17000 "Cluster 46: Basophils - DNA binding" "Cluster 14: B-cells - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Microtubules, Cytosol" "HPA038914: AB_10672831" "unprognostic (7.03e-2)" "unprognostic (3.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.40e-1)" "unprognostic (3.49e-2)" "unprognostic (1.46e-1)" "unprognostic (3.80e-3)" "unprognostic (1.40e-2)" "unprognostic (3.55e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (5.31e-2)" "unprognostic (5.23e-2)" "unprognostic (3.46e-1)" 30.6 24.0 26.4 33.7 28.4 26.0 26.4 28.4 29.0 30.4 11.0 29.7 13.3 26.7 17.7 32.1 22.2 23.6 45.4 27.2 18.5 28.0 11.4 30.2 49.8 18.2 20.4 32.4 26.8 18.7 21.6 18.9 17.1 34.6 10.2 35.1 92.8 22.2 22.4 27.6 25.6 30.3 13.0 34.9 24.9 42.2 20.7 35.1 34.0 17.2 46.2 33.9 29.6 18.8 44.1 45.6 21.1 13.3 38.5 46.1 23.7 59.3 41.9 40.6 25.2 28.4 34.3 27.6 38.2 102.5 37.7 27.9 15.6 42.7 54.4 43.7 18.3 45.0 41.7 41.2 45.8 6.5 34.6 46.8 19.8 37.0 47.2 78.1 39.8 18.2 16.7 52.2 44.7 83.3 48.1 16.8 9.8 12.0 21.2 31.6 21.5 47.9 28.9 43.4 29.8 33.6 61.5 34.5 29.1 33.9 39.7 8.3 54.4 52.2 23.1 71.9 25.6 26.2 19.1 7.4 45.0 10.4 26.0 3.7 1.3 2.8 3.4 1.0 2.2 2.9 3.1 2.9 1.3 4.8 3.5 3.1 7.4 2.0 2.9 0.8 4.0 3.0 26.4 28.4 28.4 29.0 27.2 18.5 18.2 20.4 17.1 13.0 20.7 18.8 19.9 3.2 3.0 93.7 41.3 10.1 17.6 8.8 16.5 31.4 16.5 16.3 16.9 8.6 12.1 12.9 50.1 8.1 31.9 2.8 5.9 20.5 17.0 11.1 17.3 18.2 6.1 14.1 113.5 62.7 10.9 15.8 13.7 16.3 23.5 80.3 26.0 4.6 13.1 92.5 90.0 2.2 6.1 14.5 14.7 27.6 18.6 22.7 10.6 96.5 33.4 13.9 38.1 87.4 49.2 54.7 1.2 18.0 13.5 23.3 1.0 13.1 11.8 41.2 13.1 12.3 16.5 20.6 21.8 16.5 9.9 5.7 36.3 16.5 3.6 17.0 PAM16 "Magmas, Tim16, TIMM16" ENSG00000217930 "Presequence translocase associated motor 16" Q9Y3D7 16 4331549-4355607 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 109.3" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 67.2;Gastric mucus-secreting cells: 36.2;Plasma cells: 39.5;Squamous epithelial cells: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 184.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062721 Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 18: U-2197 - ECM organization" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Mitochondria" Microtubules "HPA062721: AB_2684849" "unprognostic (2.69e-2)" "unprognostic (1.64e-1)" "unprognostic (4.06e-1)" "unprognostic (6.81e-2)" "unprognostic (6.98e-2)" "unprognostic (9.68e-2)" "unprognostic (1.83e-1)" "unprognostic (6.32e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-1)" "unprognostic (4.79e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (5.73e-5)" "unprognostic (7.25e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "prognostic favorable (1.33e-4)" 26.2 44.3 16.2 6.4 16.9 14.4 24.5 14.8 29.0 21.8 15.6 23.8 14.9 20.5 7.0 25.9 22.3 3.9 70.7 16.4 16.2 28.7 66.4 22.4 7.6 15.5 15.9 20.0 39.2 7.4 27.7 6.2 15.6 20.6 4.8 4.7 19.1 8.2 109.3 21.5 19.6 5.1 14.9 22.4 26.8 34.5 15.9 5.8 17.9 17.6 6.1 26.2 20.7 16.2 20.7 41.2 13.8 41.1 5.2 15.2 44.1 34.3 9.8 23.3 15.5 39.0 28.5 49.4 43.7 10.6 22.6 28.5 12.0 16.3 5.5 56.1 87.8 44.8 26.0 20.4 23.4 33.0 34.6 17.7 27.6 17.2 13.0 12.5 13.2 44.1 68.9 24.8 13.2 57.1 40.1 92.8 41.6 16.2 71.5 54.5 18.6 61.5 10.0 12.8 61.8 49.6 32.7 31.7 52.4 8.3 25.7 54.0 13.2 26.0 41.9 184.8 49.7 34.0 46.7 71.1 15.3 30.3 34.8 0.3 25.0 3.2 17.9 16.2 17.0 26.0 16.3 16.4 17.5 23.2 20.0 20.7 14.3 18.3 18.1 33.2 21.7 18.9 16.2 16.9 14.8 29.0 16.4 16.2 15.5 15.9 15.6 14.9 15.9 16.2 2.6 3.2 4.8 0.0 12.8 4.0 1.4 6.9 67.2 0.8 9.8 7.7 0.5 10.0 5.0 0.0 0.0 2.3 3.7 1.8 7.9 4.0 3.3 14.3 11.9 4.4 0.0 18.5 0.0 3.1 2.8 7.0 36.2 10.0 1.3 12.0 3.3 14.6 1.6 1.7 0.0 2.6 2.0 4.3 1.5 2.2 5.0 6.9 1.8 0.0 4.5 0.4 0.0 0.0 0.0 4.8 2.5 3.8 39.5 1.2 5.5 7.3 5.1 0.6 6.6 2.0 5.1 9.7 13.7 81.3 5.8 1.2 8.8 1.7 3.5 1.3 PCIF1 "bA465L10.1, C20orf67, CAPAM, PPP1R121" ENSG00000100982 "Phosphorylated CTD interacting factor 1" Q9H4Z3 20 45934683-45948023 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049517 Enhanced Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 39: CACO-2 - Unknown function" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Microtubules, Cytokinetic bridge" "HPA049517: AB_2680801" "unprognostic (5.42e-3)" "unprognostic (7.76e-2)" "unprognostic (7.69e-2)" "prognostic unfavorable (8.86e-4)" "unprognostic (1.39e-2)" "unprognostic (4.20e-2)" "unprognostic (1.89e-2)" "unprognostic (2.11e-1)" "unprognostic (1.90e-1)" "unprognostic (1.72e-1)" "unprognostic (7.57e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.50e-6)" "unprognostic (1.01e-1)" "unprognostic (4.44e-2)" "unprognostic (9.14e-3)" "unprognostic (1.24e-1)" 28.7 28.0 20.7 18.6 23.0 33.9 28.7 30.2 24.2 36.1 17.6 30.7 16.5 39.7 10.8 24.4 35.3 16.3 31.9 20.4 20.2 23.4 19.5 28.2 27.3 22.7 21.6 41.7 29.5 22.8 26.0 17.0 22.1 26.2 11.7 15.9 23.6 21.3 41.7 36.7 27.2 21.3 20.9 34.7 25.4 18.1 21.7 34.4 32.0 27.6 19.6 28.6 29.3 24.9 21.2 29.0 22.0 27.2 15.3 18.2 24.2 8.3 25.1 24.9 24.2 49.3 27.7 22.7 27.4 22.6 28.7 23.4 15.8 29.0 10.8 14.1 11.4 29.1 23.1 33.4 28.2 26.4 28.1 25.5 29.9 15.3 24.5 22.3 21.0 37.1 20.8 30.9 17.9 44.6 52.3 48.3 7.8 25.5 24.9 32.2 20.4 28.0 20.1 21.8 30.2 30.0 31.5 29.5 16.1 11.6 31.0 30.7 18.1 30.7 24.1 27.3 16.8 35.4 22.1 21.0 37.7 23.8 18.2 75.5 47.5 80.2 54.5 47.2 43.0 51.6 47.3 50.2 50.3 56.2 48.6 43.0 74.6 74.3 48.0 40.4 54.4 64.0 20.7 23.0 30.2 24.2 20.4 20.2 22.7 21.6 22.1 20.9 21.7 24.9 19.7 3.2 14.2 4.6 33.7 8.7 26.4 7.9 26.2 9.9 17.0 19.7 21.9 20.0 7.1 11.0 2.1 19.5 32.4 14.6 15.6 21.4 9.6 13.3 10.7 16.1 26.5 25.4 2.5 38.6 22.6 15.4 17.3 13.5 14.5 14.9 9.7 12.4 16.9 13.5 3.6 14.0 4.1 16.0 8.7 8.1 11.5 21.5 17.8 1.0 24.9 12.0 33.0 3.0 3.9 28.3 13.1 12.8 35.5 25.4 14.8 23.2 11.0 13.4 0.0 20.2 19.3 14.4 11.9 23.8 10.7 27.8 30.8 15.1 12.0 38.8 PDCL2 GCPHLP ENSG00000163440 "Phosducin like 2" Q8N4E4 4 55556519-55592245 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 197 "testis: 65.1" "Group enriched" "Detected in some" 19 "Early spermatids: 1285.9;Late spermatids: 634.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.0;testis cancer: 3.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.1;HaCaT: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048260, HPA072384" Enhanced Approved Microtubules,Centrosome NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 29: Early spermatids - Spermatogenesis" Microtubules Centrosome "HPA048260: AB_2680333, HPA072384: " "unprognostic (5.93e-3)" "unprognostic (1.19e-7)" "unprognostic (1.04e-1)" "unprognostic (3.01e-3)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (4.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 65.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1285.9 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 634.7 7.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 13.1 0.0 0.1 40.4 50.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 PGAP2 "CWH43-N, FRAG1, MRT17, MRT21" ENSG00000148985 "Post-GPI attachment to proteins 2" Q9UHJ9 11 3797724-3826371 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "GPI-anchor biosynthesis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "epididymis: 216.2" "Group enriched" "Detected in all" 4 "Cytotrophoblasts: 74.9;Early spermatids: 147.6;Late spermatids: 296.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063099 Approved Approved Microtubules NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Microtubules "HPA063099: AB_2684940" "unprognostic (1.94e-1)" "unprognostic (1.14e-1)" "unprognostic (2.19e-1)" "unprognostic (3.18e-2)" "unprognostic (5.13e-2)" "unprognostic (6.06e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (3.07e-1)" "unprognostic (1.11e-1)" "unprognostic (6.44e-2)" "unprognostic (3.85e-2)" "unprognostic (4.66e-3)" "unprognostic (4.13e-2)" "unprognostic (2.17e-2)" "unprognostic (2.67e-2)" 8.9 14.9 16.4 6.4 17.5 9.5 11.5 15.9 18.2 13.7 17.0 13.9 18.4 8.3 216.2 34.9 19.2 7.6 21.7 16.6 16.3 13.9 30.9 16.2 10.4 17.8 16.6 11.2 28.9 17.6 15.1 14.2 17.2 16.7 13.3 9.2 18.4 33.4 11.4 48.0 16.0 7.6 16.3 11.3 14.1 28.5 17.3 13.1 19.4 9.5 13.5 10.9 18.8 20.9 27.1 36.3 17.2 15.8 15.2 28.9 27.3 10.9 9.4 15.6 14.2 31.1 46.6 29.0 12.3 8.0 9.4 44.1 27.6 30.2 15.5 35.5 30.9 17.7 14.7 38.4 10.7 23.0 22.0 22.8 41.9 11.6 39.3 10.2 18.0 38.4 38.4 41.8 16.6 39.9 28.0 19.3 32.4 56.7 21.5 44.0 2.0 27.8 30.0 31.6 22.7 22.5 19.7 52.0 12.3 20.1 43.2 9.6 16.5 9.9 9.2 23.8 6.8 26.2 31.3 21.6 12.9 15.3 19.1 3.0 6.4 5.9 9.1 9.2 11.0 11.4 13.2 11.3 9.7 12.7 17.3 11.8 18.2 10.7 9.2 6.6 13.3 8.8 16.4 17.5 15.9 18.2 16.6 16.3 17.8 16.6 17.2 16.3 17.3 20.9 8.4 12.8 10.6 7.5 10.6 31.7 15.1 23.3 33.6 14.1 19.2 18.0 13.7 11.5 13.0 12.9 22.9 74.9 5.2 11.4 1.9 15.6 147.6 11.7 6.6 9.0 3.0 13.2 15.4 21.3 18.4 7.6 10.2 14.7 8.8 13.4 3.6 14.6 16.0 3.3 19.1 10.5 10.2 5.0 8.0 296.8 8.7 5.5 5.4 4.7 8.9 9.3 8.2 10.6 23.0 14.2 9.3 6.8 12.2 9.1 39.8 10.2 15.2 9.5 6.6 11.0 7.2 17.7 21.6 31.1 28.6 29.3 9.4 11.8 20.1 13.0 PIAS1 "DDXBP1, GBP, GU/RH-II, ZMIZ3" ENSG00000033800 "Protein inhibitor of activated STAT 1" O75925 15 68054309-68198603 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 248.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005743, CAB012304" Supported Approved Microtubules NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Microtubules "CAB012304: AB_777265, HPA005743: " "unprognostic (1.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.40e-1)" "unprognostic (6.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.75e-1)" "unprognostic (4.21e-2)" "unprognostic (1.68e-1)" "unprognostic (4.35e-2)" "unprognostic (1.10e-1)" "unprognostic (3.47e-1)" "unprognostic (1.90e-2)" "unprognostic (1.10e-3)" "unprognostic (6.93e-2)" "unprognostic (6.35e-2)" "unprognostic (1.31e-1)" "unprognostic (9.28e-2)" 10.2 10.2 5.6 14.1 7.0 23.2 11.7 11.9 9.4 15.3 5.7 12.0 12.0 14.7 13.9 15.1 14.0 12.7 11.5 7.6 8.3 10.8 9.7 14.9 18.2 4.8 4.9 22.7 11.3 12.5 6.5 12.9 4.9 15.5 11.1 21.3 10.4 17.7 12.4 12.6 12.3 13.6 4.7 15.3 12.7 20.6 6.9 24.9 18.8 16.3 17.6 14.1 10.8 7.0 13.1 17.6 27.9 13.6 16.4 16.8 8.4 19.6 19.8 21.1 23.6 14.7 19.2 24.6 13.1 16.5 13.5 35.5 41.5 10.7 22.7 14.2 15.5 29.6 17.3 16.3 10.7 29.0 23.0 15.2 30.5 13.7 12.4 16.2 15.1 14.1 20.7 18.3 16.3 10.7 24.1 15.0 15.8 14.4 9.9 21.2 26.8 24.1 13.8 16.4 23.3 9.8 13.1 12.1 13.4 25.4 10.7 26.9 13.5 18.3 19.3 10.6 14.6 13.6 19.2 26.2 11.4 30.2 13.7 33.8 31.4 41.9 18.7 23.9 19.3 20.8 18.7 19.8 30.7 19.5 22.3 19.6 70.8 19.2 25.7 16.7 21.5 27.3 5.6 7.0 11.9 9.4 7.6 8.3 4.8 4.9 4.9 4.7 6.9 7.0 38.7 109.0 58.4 106.7 91.5 38.0 58.2 29.4 132.1 72.2 30.3 25.1 28.3 45.8 35.9 12.9 106.3 35.5 61.3 35.2 21.5 32.5 67.1 23.5 48.2 42.0 27.6 41.0 165.7 22.6 20.4 37.5 43.8 27.2 56.3 30.6 40.0 34.9 45.8 48.8 136.6 30.2 14.2 102.4 38.8 33.4 123.6 62.6 21.4 248.3 104.9 57.8 56.7 120.1 126.2 25.5 25.0 113.6 59.3 48.3 38.1 20.0 25.0 64.8 32.9 47.7 31.6 66.7 45.4 51.1 33.0 36.0 67.6 22.6 22.4 64.5 PIK3R4 "p150, VPS15" ENSG00000196455 "Phosphoinositide-3-kinase regulatory subunit 4" Q99570 3 130678934-130746829 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036032, HPA036033" Approved Approved Vesicles,Microtubules NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Vesicles Microtubules "HPA036032: AB_10610281, HPA036033: AB_2674911" "unprognostic (7.50e-2)" "unprognostic (3.90e-3)" "unprognostic (1.68e-1)" "unprognostic (4.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.28e-1)" "unprognostic (1.34e-1)" "unprognostic (1.21e-1)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (1.02e-3)" "unprognostic (7.26e-2)" "prognostic favorable (4.40e-6)" "unprognostic (8.25e-2)" "unprognostic (3.72e-1)" "unprognostic (2.27e-1)" "unprognostic (1.05e-1)" 8.8 8.5 3.7 7.8 4.2 8.9 10.0 5.2 4.9 9.4 5.6 8.2 7.5 10.1 7.9 8.0 9.1 7.2 7.6 4.1 4.5 10.5 21.2 9.6 9.4 3.2 3.6 12.4 6.9 17.6 6.1 9.7 3.8 9.8 8.1 16.5 7.6 9.6 7.3 7.8 8.0 10.4 3.8 10.0 7.5 11.4 3.2 11.4 13.1 8.6 10.4 9.0 6.5 7.1 20.7 12.9 18.5 13.4 26.6 21.1 12.8 15.0 17.9 20.2 23.3 16.7 17.1 24.2 18.4 15.2 16.1 28.7 30.7 23.3 31.6 14.7 11.3 19.7 13.8 11.7 12.2 30.3 9.5 14.7 16.4 21.7 13.6 12.6 19.0 13.8 23.3 11.9 18.1 18.1 24.9 9.2 23.3 18.6 12.4 17.2 21.4 21.9 13.2 16.7 17.0 12.4 21.6 13.4 15.3 21.5 18.6 13.1 15.2 15.5 13.3 17.6 12.2 13.8 13.5 31.2 17.0 11.3 14.7 9.7 5.3 7.0 6.3 6.0 9.3 5.6 5.7 4.7 6.9 3.5 6.6 6.0 4.4 8.5 6.6 2.4 6.8 5.3 3.7 4.2 5.2 4.9 4.1 4.5 3.2 3.6 3.8 3.8 3.2 7.1 8.3 6.4 8.7 18.6 8.8 3.8 3.9 5.7 10.8 8.1 5.7 4.7 7.7 8.6 9.6 11.0 14.6 5.6 7.2 5.5 1.9 5.0 4.4 8.9 7.5 8.9 3.0 9.2 28.5 5.8 3.4 6.9 13.3 9.9 9.5 9.5 7.5 18.2 5.9 5.0 30.3 6.8 8.2 6.4 2.6 3.1 9.6 7.3 5.4 20.6 7.1 9.0 6.2 22.1 32.9 6.6 4.3 11.7 6.9 4.8 6.2 4.2 12.6 12.6 6.6 8.9 6.2 17.0 13.9 9.5 4.4 4.2 7.5 9.6 6.1 3.4 PLCB4 ENSG00000101333 "Phospholipase C beta 4" Q15147 20 9068763-9481242 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.6;salivary gland: 57.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 105.9;Horizontal cells: 164.9;Inhibitory neurons: 113.8;Microglial cells: 183.6;Oligodendrocyte precursor cells: 168.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.5" "Region enhanced" "Detected in all" "cerebellum: 55.6" "Immune cell enriched" "Detected in single" 18 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 18 "dendritic cells: 3.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 91.4;hTERT-HME1: 45.9;LHCN-M2: 77.6;OE19: 48.2;RPTEC TERT1: 96.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007951 Approved Approved Nucleoplasm,Microtubules NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 21: Non-specific - Transcription" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Microtubules Nucleoplasm "HPA007951: AB_2667944" "unprognostic (3.88e-2)" "unprognostic (3.62e-1)" "unprognostic (1.19e-2)" "prognostic favorable (2.11e-4)" "unprognostic (1.44e-2)" "unprognostic (9.72e-3)" "unprognostic (3.32e-3)" "unprognostic (2.57e-2)" "unprognostic (7.75e-2)" "unprognostic (4.23e-2)" "unprognostic (5.21e-3)" "unprognostic (1.35e-1)" "unprognostic (4.64e-3)" "unprognostic (7.12e-2)" "unprognostic (1.37e-1)" "unprognostic (2.22e-1)" "unprognostic (4.45e-2)" 6.3 7.2 8.6 3.4 3.7 0.5 7.0 55.6 6.3 4.6 31.0 20.5 2.6 8.2 24.4 9.0 15.0 5.9 17.9 2.5 10.8 3.0 0.3 5.4 1.7 13.4 17.8 2.1 2.1 0.7 8.2 6.5 12.0 9.7 17.9 15.1 57.4 6.1 2.7 4.6 4.2 9.1 5.3 1.3 14.4 2.4 23.3 4.5 32.7 6.8 2.3 8.2 5.3 6.5 0.0 15.1 7.9 0.0 0.0 0.4 0.1 35.8 9.5 10.9 6.1 3.4 2.6 0.0 0.6 91.4 39.0 0.1 2.3 7.6 14.7 0.0 5.3 3.8 5.7 0.0 1.6 0.0 0.0 2.3 3.0 12.7 45.9 18.7 0.1 0.0 4.3 0.4 77.6 5.0 0.0 0.0 8.8 48.2 10.4 0.0 0.0 0.7 96.9 5.8 25.5 18.4 0.0 23.8 15.1 10.5 19.2 0.2 0.5 11.2 0.9 1.2 14.2 0.0 0.0 0.0 1.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.0 8.6 3.7 55.6 6.3 2.5 10.8 13.4 17.8 12.0 5.3 23.3 6.5 37.8 6.4 0.5 60.1 0.3 2.4 3.8 1.5 2.2 82.9 5.7 5.3 72.6 0.0 8.9 5.5 0.0 0.0 4.5 17.9 0.0 0.7 1.4 46.2 4.6 40.4 42.0 0.0 105.9 0.2 0.0 9.0 18.8 53.5 0.0 36.6 1.8 0.0 0.1 164.9 113.8 36.4 14.2 0.0 2.1 1.2 1.5 0.8 7.2 183.6 0.6 2.9 0.0 168.9 2.9 7.1 9.7 20.7 0.2 8.5 2.1 1.2 39.5 6.6 13.1 10.5 36.0 1.5 2.0 0.5 1.0 0.1 1.4 4.8 40.4 2.5 PLCD1 ENSG00000187091 "Phospholipase C delta 1" P51178 3 38007496-38029642 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 89.5;Theca cells: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 25.3;fHDF/TERT166: 26.3;hTCEpi: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009913, HPA020107, HPA021677" Approved Approved Microtubules NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" Microtubules "CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319" "unprognostic (1.75e-3)" "unprognostic (1.01e-2)" "unprognostic (4.29e-2)" "unprognostic (1.45e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-3)" "unprognostic (1.55e-1)" "unprognostic (7.25e-3)" "unprognostic (3.95e-1)" "unprognostic (1.45e-1)" "unprognostic (2.80e-1)" "unprognostic (2.24e-1)" "prognostic favorable (9.25e-11)" "unprognostic (1.50e-1)" "unprognostic (7.71e-2)" "unprognostic (2.93e-1)" "unprognostic (7.88e-2)" 14.8 12.9 14.3 4.6 16.1 4.3 10.6 15.4 15.6 15.9 9.7 15.7 4.9 11.5 4.2 26.2 9.8 5.6 7.2 12.8 19.0 10.1 5.4 11.3 6.6 20.3 18.5 12.7 6.0 3.9 9.3 3.8 19.6 9.1 10.1 2.8 13.0 8.8 2.9 18.5 8.3 5.6 19.4 7.2 8.3 32.6 16.9 9.1 8.3 4.1 6.6 15.7 19.0 21.9 1.0 2.7 9.4 2.6 25.3 22.2 2.8 2.8 11.1 4.2 6.4 1.0 2.3 0.6 1.4 26.3 2.9 15.0 4.8 3.0 1.3 3.9 1.2 0.5 1.7 4.7 14.7 0.0 1.6 18.0 31.6 12.9 1.7 9.4 8.2 2.2 16.3 1.3 9.6 1.2 2.2 1.1 2.4 5.5 2.7 0.9 1.3 3.6 5.1 5.0 0.1 2.6 0.8 12.4 3.2 3.1 2.7 1.2 4.4 2.5 6.3 6.7 0.1 5.2 2.2 0.6 6.4 0.1 1.3 14.6 2.7 0.2 13.0 3.7 15.2 1.3 16.9 12.8 3.8 0.6 10.1 7.9 9.9 5.9 2.2 2.0 16.6 7.4 14.3 16.1 15.4 15.6 12.8 19.0 20.3 18.5 19.6 19.4 16.9 21.9 5.2 3.2 7.5 22.9 3.6 2.8 12.4 9.6 8.0 0.9 5.4 6.1 4.7 8.6 7.3 9.2 2.1 1.8 4.2 89.5 3.9 11.4 1.7 3.3 11.3 8.1 4.9 3.6 1.9 3.0 5.1 10.2 6.6 3.8 4.5 3.6 20.0 4.1 4.0 3.3 2.3 28.3 10.2 3.8 14.5 3.6 12.8 4.3 1.8 3.7 3.4 13.3 1.0 7.1 2.2 4.1 34.7 14.3 5.9 13.2 10.0 5.8 6.2 1.7 6.6 5.4 7.2 3.1 3.7 12.6 5.8 0.8 7.4 53.4 11.3 14.7 PPDPF "C20orf149, dJ697K14.9, exdpf" ENSG00000125534 "Pancreatic progenitor cell differentiation and proliferation factor" Q9H3Y8 20 63520765-63522206 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 2997.4;Paneth cells: 2752.7;Proximal enterocytes: 2849.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "eosinophil: 26.0" "Lineage enriched" "Detected in all" 4 "granulocytes: 26.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040929 Approved Nucleoplasm,Nucleoli,Microtubules Yes No "Cluster 52: Eosinophils - Transcription" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Microtubules" Nucleoli "HPA040929: AB_10794155" "unprognostic (3.75e-2)" "unprognostic (5.39e-2)" "unprognostic (4.37e-2)" "unprognostic (9.03e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-2)" "unprognostic (1.91e-1)" "unprognostic (2.00e-1)" "unprognostic (4.20e-1)" "prognostic favorable (3.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-1)" "unprognostic (4.20e-1)" "unprognostic (2.09e-2)" 215.1 72.2 192.7 71.1 203.3 79.6 237.4 194.7 262.1 312.4 108.7 298.3 81.3 217.8 43.8 622.2 185.6 40.8 412.9 164.7 189.8 421.8 134.9 243.4 42.2 220.9 217.1 197.5 197.9 47.1 196.8 30.3 221.9 365.0 60.6 25.6 432.4 93.4 438.3 461.5 167.1 53.4 201.1 117.0 298.8 129.3 202.5 32.1 249.8 64.2 47.3 264.0 410.7 253.9 287.2 87.8 57.9 118.5 65.4 107.9 185.4 169.1 54.1 217.5 85.2 162.8 166.3 60.7 222.8 115.2 83.2 294.3 29.5 196.0 35.5 110.5 58.5 24.8 83.0 31.9 175.3 0.2 124.3 106.5 384.9 55.3 76.4 72.7 86.5 74.9 104.5 138.9 81.1 394.9 288.7 2.7 63.3 228.1 494.5 132.0 132.2 125.7 159.8 117.4 197.1 150.9 170.3 272.6 124.4 39.1 390.7 168.8 147.3 184.1 206.9 245.8 143.5 108.9 93.3 41.1 130.7 70.9 122.6 2.3 3.0 26.0 5.7 3.6 4.7 5.0 5.1 5.4 3.4 5.8 4.3 5.2 1.2 3.0 5.7 4.0 5.7 5.7 192.7 203.3 194.7 262.1 164.7 189.8 220.9 217.1 221.9 201.1 202.5 253.9 328.1 314.1 220.3 15.7 462.8 574.5 714.7 1076.0 375.6 51.8 1282.8 1173.8 70.1 906.5 763.6 960.0 12.5 428.4 422.5 2528.3 2997.4 916.1 222.0 440.1 449.6 294.2 796.4 399.0 15.4 755.9 761.0 430.8 1120.8 520.2 337.8 293.3 376.3 224.2 600.6 50.5 12.5 1549.5 850.4 390.4 755.8 1154.3 371.9 366.4 1191.7 6.5 831.8 236.9 435.6 6.6 67.2 971.0 2752.7 288.5 280.4 1021.9 2849.8 1715.5 542.0 60.0 197.2 216.3 541.5 129.0 261.6 1559.8 932.1 414.1 541.7 158.5 1132.9 1492.7 PPP1R3E FLJ00089 ENSG00000235194 "Protein phosphatase 1 regulatory subunit 3E" Q9H7J1 14 23295652-23302859 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 47.0" "Cell type enhanced" "Detected in all" "Early spermatids: 111.9;Late spermatids: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 41.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061600 Approved Approved "Microtubules,Mitotic spindle,Mitochondria" Yes No "Cluster 51: Monocytes - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Microtubules, Mitochondria" "Mitotic spindle" "HPA061600: AB_2684566" "unprognostic (3.45e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.89e-5)" "unprognostic (4.05e-1)" "unprognostic (2.85e-2)" "unprognostic (1.29e-2)" "unprognostic (7.12e-2)" "prognostic favorable (3.10e-4)" "unprognostic (1.73e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-3)" "unprognostic (2.41e-1)" "unprognostic (8.67e-3)" "unprognostic (8.46e-2)" "unprognostic (2.88e-1)" "unprognostic (8.12e-2)" "unprognostic (5.46e-2)" 5.8 8.0 15.2 5.7 17.9 3.9 6.4 17.9 23.8 10.2 9.7 7.4 6.3 6.4 10.1 6.0 9.5 3.3 6.2 15.0 15.3 11.6 11.2 5.7 9.5 18.5 16.5 12.5 10.6 5.7 19.3 2.7 19.4 12.1 5.9 47.0 8.5 6.2 14.9 10.9 13.3 3.4 13.8 15.1 9.0 14.7 17.7 8.2 14.9 5.4 8.2 7.9 8.5 23.3 1.1 3.0 3.6 2.5 6.9 2.9 1.7 1.2 2.2 2.0 1.7 1.7 5.8 11.2 0.8 1.6 2.2 7.6 2.1 1.2 2.5 4.0 2.1 2.0 6.9 4.0 1.8 2.3 4.4 2.5 4.5 1.2 6.1 3.3 0.9 6.0 1.9 9.8 1.7 2.6 2.1 3.6 0.9 3.6 2.8 3.4 2.5 7.2 1.1 2.5 4.5 1.2 1.8 1.6 1.2 1.8 1.9 0.8 1.7 2.4 1.3 4.1 0.9 41.1 4.6 5.1 1.9 4.0 1.5 0.2 0.4 0.2 0.5 1.4 0.6 1.0 0.1 0.2 0.3 0.6 0.5 0.3 0.4 0.2 1.8 0.3 0.4 0.3 15.2 17.9 17.9 23.8 15.0 15.3 18.5 16.5 19.4 13.8 17.7 23.3 5.8 3.2 4.8 30.0 25.4 5.6 9.0 5.3 11.4 59.4 7.8 11.6 8.8 7.2 5.0 20.2 37.5 8.2 12.8 8.0 5.9 2.1 111.9 3.7 6.6 7.2 8.4 7.2 25.0 3.3 2.0 6.1 20.4 4.3 3.8 9.4 7.5 7.2 7.4 32.0 33.0 7.7 4.1 9.5 9.6 62.9 27.4 9.2 10.6 15.9 8.1 20.4 26.8 16.1 56.1 2.4 11.6 25.9 11.9 6.7 19.5 9.5 4.8 38.1 13.1 3.5 5.4 36.5 13.9 8.4 9.1 5.2 15.7 7.2 9.6 8.6 PRC1 ASE1 ENSG00000198901 "Protein regulator of cytokinesis 1" O43663 15 90966040-90995629 "Predicted intracellular proteins" "Cell cycle, Cell division" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 89.9;testis: 55.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 142.9;Extravillous trophoblasts: 68.3;Spermatocytes: 136.4;Spermatogonia: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 34.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 34.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034521, HPA048816" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody" Yes Yes "Cluster 38: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Microtubules, Cytokinetic bridge, Midbody" Nucleoplasm "HPA034521: AB_10670169, HPA048816: " "unprognostic (1.14e-1)" "unprognostic (3.98e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-3)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.24e-3)" "unprognostic (3.86e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (2.49e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.79e-1)" "unprognostic (7.90e-2)" "unprognostic (3.92e-2)" 7.4 6.2 6.4 10.0 6.1 89.9 6.4 10.3 8.4 8.1 5.0 16.3 10.6 5.7 2.3 37.6 6.0 3.0 6.9 5.6 4.9 5.6 4.8 9.0 16.9 4.8 5.2 8.1 8.9 2.6 3.6 15.3 5.2 4.9 16.5 4.9 9.5 1.5 4.1 20.1 13.0 9.4 4.9 12.5 11.7 55.0 4.2 43.0 4.3 2.3 24.9 4.8 13.7 5.6 167.9 199.9 164.8 113.6 16.8 28.7 87.5 237.8 139.3 257.2 195.3 134.6 158.5 65.5 91.4 151.9 156.9 220.9 188.8 101.2 240.6 118.7 206.4 135.6 263.5 123.5 4.1 71.4 109.0 7.7 12.8 145.8 146.9 56.6 146.4 100.5 114.0 132.4 241.1 144.4 66.9 98.5 66.6 216.4 84.9 69.7 205.1 86.3 115.3 123.6 151.2 118.9 225.4 121.9 82.7 112.3 149.1 127.1 91.2 168.2 146.0 140.5 345.1 43.5 127.7 80.0 74.5 162.0 265.3 34.4 0.6 2.9 0.6 0.1 0.4 1.1 1.3 1.3 2.4 0.5 1.2 0.4 0.4 3.0 0.3 2.6 8.0 1.0 6.4 6.1 10.3 8.4 5.6 4.9 4.8 5.2 5.2 4.9 4.2 5.6 2.5 0.0 3.1 1.3 6.8 16.6 6.6 8.0 2.2 6.4 3.4 4.3 3.2 0.0 7.6 3.7 0.0 45.5 2.8 16.5 0.0 3.2 41.5 4.5 4.0 4.7 5.4 142.9 5.0 2.9 68.3 7.2 16.3 6.8 8.9 13.2 9.3 2.1 21.5 3.3 5.2 17.0 10.2 8.7 15.0 15.4 3.7 5.2 3.6 1.9 5.5 3.8 4.1 2.0 1.7 2.3 3.2 1.9 17.5 5.9 2.0 0.1 3.2 4.6 6.6 7.4 10.9 136.4 74.2 38.0 14.2 14.6 6.8 0.4 24.1 6.7 PRKCI "DXS1179E, PKCI" ENSG00000163558 "Protein kinase C iota" P41743 3 170222424-170305977 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026574, HPA038635" Approved Supported "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 46: Fibroblasts - ECM organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Cytosol "Microtubules, Cytokinetic bridge" "HPA026574: AB_1855428, HPA038635: AB_2676124" "unprognostic (2.26e-1)" "unprognostic (6.75e-2)" "unprognostic (4.57e-2)" "prognostic unfavorable (3.93e-6)" "unprognostic (1.59e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (2.52e-1)" "unprognostic (7.10e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (5.32e-3)" "prognostic favorable (3.10e-4)" "unprognostic (1.16e-1)" "unprognostic (2.65e-1)" "unprognostic (1.06e-1)" "unprognostic (9.73e-2)" 6.7 5.0 2.0 6.9 2.4 2.6 10.4 2.0 3.2 12.7 0.3 12.4 11.6 11.0 8.2 15.1 15.9 11.4 6.9 3.4 1.1 13.5 7.3 16.6 4.6 0.4 0.2 13.6 7.0 13.0 3.1 10.9 0.5 17.3 13.1 6.2 17.5 12.7 6.2 6.9 10.8 11.0 0.2 5.2 34.5 12.5 0.9 10.9 24.5 9.8 10.4 16.1 6.2 1.1 81.6 20.2 20.0 21.6 17.3 23.9 32.2 20.4 29.9 26.4 28.3 29.7 38.6 24.7 65.3 28.8 36.4 37.3 37.9 40.0 44.8 18.2 23.5 22.9 24.3 16.6 27.9 20.9 10.0 21.8 27.5 22.6 35.1 42.8 20.9 13.3 25.8 19.8 27.4 28.0 30.5 8.5 42.3 86.4 22.1 21.8 30.7 41.2 42.3 24.4 31.5 25.8 44.1 57.7 20.0 29.5 63.0 14.5 22.4 27.5 21.1 26.0 34.3 33.9 34.9 35.2 19.8 16.4 11.0 0.0 0.6 0.4 1.1 0.6 1.7 0.9 1.5 2.0 0.8 1.2 1.6 0.9 0.3 2.6 0.5 0.8 1.1 0.7 2.0 2.4 2.0 3.2 3.4 1.1 0.4 0.2 0.5 0.2 0.9 1.1 17.6 73.7 82.1 23.2 5.8 57.1 49.5 39.8 30.7 16.4 29.0 19.7 16.2 24.3 45.3 49.7 14.6 30.2 15.0 29.0 25.4 16.5 8.4 42.0 29.7 20.5 29.3 10.5 77.2 22.0 26.6 32.2 59.7 72.3 8.8 20.4 17.5 17.7 10.0 15.2 55.2 28.3 50.8 18.6 26.8 6.8 23.3 11.6 17.8 22.5 12.7 8.8 6.2 33.2 33.5 55.2 18.6 28.6 29.4 99.4 18.7 20.4 31.9 9.4 19.7 23.7 18.7 15.8 20.6 38.5 63.6 20.7 14.8 14.3 28.5 80.1 PRMT9 "FLJ46629, PRMT10" ENSG00000164169 "Protein arginine methyltransferase 9" Q6P2P2 4 147637785-147684163 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 112.6;Rod photoreceptor cells: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036844, HPA042537" Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Microtubules "Nucleoplasm, Cytosol" "HPA036844: AB_10672341, HPA042537: AB_2678043" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" "unprognostic (4.65e-3)" "unprognostic (2.35e-1)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (4.14e-2)" "unprognostic (7.29e-2)" "unprognostic (2.11e-2)" "unprognostic (2.33e-1)" "prognostic favorable (3.58e-7)" "unprognostic (1.72e-1)" "unprognostic (4.52e-2)" "unprognostic (1.54e-2)" "unprognostic (1.30e-2)" 3.2 9.9 1.4 2.8 1.8 8.5 4.1 3.1 2.4 2.8 1.8 2.3 1.4 4.6 3.1 2.9 3.3 3.0 2.8 2.0 1.8 4.3 3.4 3.2 3.5 1.4 1.6 11.3 3.3 6.1 3.6 3.0 1.5 3.4 2.6 5.2 2.7 3.3 3.3 2.8 1.8 2.7 1.6 2.8 3.1 7.1 1.7 4.5 5.7 2.5 3.0 2.5 2.3 1.6 2.8 1.8 4.3 3.3 3.3 5.6 3.8 3.1 4.9 4.6 4.8 1.4 3.1 9.8 1.3 2.7 2.3 1.9 5.1 2.6 6.3 3.5 3.0 5.4 3.6 2.3 2.5 8.0 2.8 3.9 2.7 2.8 2.5 3.7 3.9 4.8 5.4 5.5 3.9 1.6 6.8 3.1 2.2 2.7 3.2 4.5 3.7 3.6 3.7 2.2 2.7 4.1 4.9 3.8 2.5 2.8 1.6 1.7 3.3 2.9 2.4 3.3 3.4 6.2 5.3 6.1 3.3 4.8 2.2 6.1 4.2 8.6 4.7 4.7 4.6 7.4 5.7 5.8 3.0 7.2 7.1 6.2 2.8 4.3 3.5 4.4 5.5 2.1 1.4 1.8 3.1 2.4 2.0 1.8 1.4 1.6 1.5 1.6 1.7 1.6 8.7 0.0 5.3 9.8 40.4 0.0 4.2 0.0 26.7 56.5 11.7 21.8 5.9 7.2 0.6 35.0 112.6 14.5 51.6 6.2 5.9 7.0 73.1 9.2 9.5 8.4 17.4 10.3 29.8 6.5 14.8 12.9 11.2 13.0 33.7 15.6 12.8 6.9 17.2 50.5 29.8 7.2 0.0 36.5 0.0 13.4 18.0 63.7 0.0 17.8 10.9 48.1 16.5 20.6 16.3 7.4 6.2 17.0 18.4 4.1 7.4 5.5 1.5 81.1 13.1 6.2 18.5 36.5 19.6 4.3 0.0 15.2 61.2 18.5 6.3 2.0 PRR23A ENSG00000206260 "Proline rich 23A" A6NEV1 3 139003962-139006268 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 17 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 78: Testis - Spermatogenesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.48e-1)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.2 0.1 0.0 0.2 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR23B FLJ46116 ENSG00000184814 "Proline rich 23B" Q6ZRT6 3 139019031-139020926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 1.3" "Group enriched" "Detected in some" 8 "Spermatocytes: 6.4;Spermatogonia: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 83: Testis - Spermatogenesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (7.57e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 PRR23C FLJ46210 ENSG00000233701 "Proline rich 23C" Q6ZRP0 3 139042102-139044892 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Early spermatids: 3.5;Late spermatids: 2.0;Spermatocytes: 1.6;Spermatogonia: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Not detected" "Not detected" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 17: Basophils - Unknown function" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.00e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PSMD12 "p55, Rpn5" ENSG00000197170 "Proteasome 26S subunit, non-ATPase 12" O00232 17 67337916-67366605 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023119 Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA 73000 "Cluster 51: Monocytes - Innate immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Microtubules "Nucleoplasm, Cytosol" "HPA023119: AB_1855845" "unprognostic (6.06e-2)" "unprognostic (3.16e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.35e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.28e-2)" "unprognostic (3.72e-2)" "prognostic favorable (6.32e-4)" "unprognostic (2.63e-1)" "unprognostic (7.32e-3)" "prognostic unfavorable (4.73e-6)" "unprognostic (1.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" 14.8 13.9 11.2 11.4 12.2 12.5 11.9 15.0 19.4 9.4 9.7 10.4 8.2 10.5 10.9 12.5 7.6 9.7 13.7 12.6 17.2 14.9 28.0 9.4 10.8 17.8 17.8 9.1 15.6 14.8 7.6 11.0 18.9 10.7 11.6 8.9 10.0 7.7 35.8 10.3 8.7 11.3 12.9 9.4 11.2 14.4 16.0 12.1 10.3 29.1 15.1 14.7 8.0 12.5 63.8 38.5 29.2 32.2 21.9 26.3 40.6 44.2 27.9 47.8 42.0 40.4 27.4 36.6 28.0 35.9 37.4 37.0 51.1 45.1 70.7 17.8 38.5 43.2 29.9 41.1 28.6 44.7 25.0 29.6 29.4 45.3 35.2 21.2 47.6 27.8 57.4 21.0 45.0 43.5 41.0 42.6 35.7 30.0 50.1 20.9 75.6 32.5 36.1 52.0 28.0 40.6 32.9 62.6 45.2 34.1 45.0 36.9 49.5 50.5 34.4 38.6 81.4 21.4 35.2 30.5 59.8 46.5 29.9 14.0 9.9 8.9 8.7 16.7 12.3 8.0 11.5 9.9 10.3 8.9 10.1 10.7 7.3 10.9 19.6 7.0 12.1 8.7 11.2 12.2 15.0 19.4 12.6 17.2 17.8 17.8 18.9 12.9 16.0 12.5 59.6 48.1 58.8 9.8 37.9 112.3 119.5 109.0 43.3 40.8 37.9 33.0 108.1 25.8 97.7 46.0 25.0 88.3 47.9 29.7 70.5 80.7 158.1 99.1 62.3 73.8 32.9 67.3 21.0 78.7 88.8 64.0 33.1 125.3 50.6 39.9 41.0 84.1 56.0 92.5 22.0 28.6 65.1 44.7 90.6 197.0 46.3 50.6 48.0 10.3 59.8 58.6 37.0 14.6 15.0 84.9 22.7 44.0 58.2 93.4 26.0 77.2 68.1 44.6 26.3 78.6 146.8 126.2 108.0 52.9 94.8 123.0 53.8 53.8 34.1 123.2 PTPN7 "HEPTP, LC-PTP" ENSG00000143851 "Protein tyrosine phosphatase non-receptor type 7" P35236 1 202147013-202161588 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 39.7;lymphoid tissue: 31.1" "Cell type enhanced" "Detected in many" "B-cells: 46.8;dendritic cells: 112.7;granulocytes: 140.7;NK-cells: 99.9;Plasma cells: 63.9;T-cells: 127.2;Theca cells: 54.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "basal ganglia: 9.8" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 5 "granulocytes: 24.9;NK-cells: 14.9;T-cells: 14.0" "Cell line enhanced" "Detected in some" "HEL: 54.1;HL-60: 118.6;HMC-1: 150.8;NB-4: 51.4;THP-1: 53.7;U-937: 84.0" "Region enriched" "Detected in single" 9 "basal ganglia: 6.1" "Region enriched" "Detected in many" 8 "basal ganglia: 13.3" "CAB009530, HPA019118" Approved Supported "Microtubules,Mitotic spindle,Cytosol" Yes NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "Microtubules, Mitotic spindle" "CAB009530: AB_2173845, HPA019118: AB_1855755" "unprognostic (4.19e-3)" "unprognostic (1.08e-3)" "unprognostic (3.09e-2)" "prognostic favorable (1.52e-4)" "unprognostic (2.91e-2)" "prognostic favorable (1.84e-4)" "unprognostic (3.01e-2)" "unprognostic (3.16e-2)" "unprognostic (1.43e-2)" "unprognostic (4.84e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.42e-8)" "unprognostic (1.46e-1)" "unprognostic (4.51e-2)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" 1.3 4.2 0.6 10.2 9.8 39.7 0.7 1.0 1.8 0.8 0.5 2.2 4.5 1.1 0.0 1.5 0.6 3.2 0.5 0.6 1.2 1.3 1.1 2.5 20.8 2.3 1.5 0.3 0.4 0.1 0.3 0.5 1.8 0.8 2.7 0.0 1.3 0.6 0.1 1.2 5.6 1.5 1.4 9.9 2.4 8.3 2.9 31.1 0.8 0.5 20.8 3.2 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.6 0.0 54.1 0.0 0.0 0.0 118.6 150.8 0.0 0.0 0.0 0.0 0.0 0.1 40.0 2.3 5.0 0.0 0.0 16.3 51.4 0.0 0.0 0.0 2.4 0.0 39.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 53.7 0.3 0.0 0.5 0.0 0.1 22.8 6.3 33.7 0.1 84.0 0.1 17.9 1.5 24.9 13.7 1.5 12.5 2.6 9.2 14.0 2.9 3.2 6.7 8.2 9.9 14.9 0.6 3.8 12.8 4.5 0.6 9.8 1.0 1.8 0.6 1.2 2.3 1.5 1.8 1.4 2.9 2.5 3.2 3.2 5.1 3.3 46.8 2.3 1.3 0.1 0.0 2.7 1.5 1.8 0.7 1.5 0.7 0.0 0.0 0.5 112.7 0.5 0.0 0.5 0.6 0.9 0.8 5.6 0.0 35.5 0.7 0.0 0.2 2.2 1.5 0.7 140.7 6.7 3.6 0.4 15.4 0.0 0.7 0.1 0.0 11.2 31.2 2.4 5.3 21.3 8.8 1.0 10.4 3.8 99.9 1.0 4.6 0.1 0.1 2.2 63.9 0.6 0.2 0.7 0.1 3.7 0.0 0.9 1.1 0.8 0.7 0.5 2.4 0.8 127.2 54.6 0.5 0.6 RAPGEFL1 Link-GEFII ENSG00000108352 "Rap guanine nucleotide exchange factor like 1" Q9UHV5 17 40177010-40195656 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 199.1;skin 1: 237.7;vagina: 113.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 87.7;Excitatory neurons: 47.8;Proximal enterocytes: 55.3;Squamous epithelial cells: 95.4;Suprabasal keratinocytes: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HaCaT: 92.4;hTCEpi: 45.8;T-47d: 80.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022895 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Microtubules" "Cytokinetic bridge" "HPA022895: AB_1856071" "prognostic favorable (8.43e-4)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.13e-2)" "unprognostic (4.64e-3)" "unprognostic (3.48e-2)" "unprognostic (5.92e-2)" "unprognostic (1.80e-1)" "unprognostic (3.64e-2)" "unprognostic (2.67e-1)" "unprognostic (7.46e-3)" "unprognostic (8.84e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.23e-2)" "unprognostic (1.50e-1)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" 6.3 4.4 38.4 6.8 36.1 4.4 9.1 12.1 58.3 48.7 1.8 53.8 48.3 4.6 9.9 199.1 6.6 8.8 6.8 55.1 12.9 3.8 10.5 8.0 2.2 12.0 11.4 3.7 7.9 1.1 14.2 2.3 10.9 17.7 44.5 6.1 27.4 6.9 12.6 237.7 40.6 4.0 8.3 7.3 31.8 10.2 15.2 3.3 4.5 2.8 20.7 21.9 113.2 30.6 5.3 2.6 13.7 10.2 1.5 3.3 6.6 1.9 1.4 2.7 3.2 6.0 7.6 4.2 1.9 2.7 2.4 92.4 2.7 3.3 3.8 7.7 6.9 2.5 3.6 6.0 1.7 5.2 8.5 3.9 45.8 2.8 1.3 4.0 4.1 13.9 1.9 2.8 2.1 14.6 4.9 6.3 4.3 26.1 2.6 8.8 1.6 2.6 1.7 27.6 26.2 5.3 3.3 31.2 1.3 11.5 80.7 3.9 7.9 3.3 6.8 3.5 3.2 4.6 4.7 3.4 7.8 3.2 4.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 38.4 36.1 12.1 58.3 55.1 12.9 12.0 11.4 10.9 8.3 15.2 30.6 1.9 0.0 1.1 7.5 1.0 45.5 9.7 14.0 13.1 5.7 2.6 3.7 2.4 11.5 10.9 1.8 6.2 0.2 0.7 87.7 0.0 0.9 2.7 5.9 2.1 2.2 4.9 2.7 47.8 0.8 0.3 1.4 32.6 9.4 5.7 1.7 3.9 4.4 0.5 1.7 32.1 31.9 6.1 1.2 5.2 2.2 3.4 1.9 5.4 1.0 2.4 2.9 1.0 8.0 5.0 1.6 44.6 3.8 0.1 10.9 55.3 0.1 6.5 4.4 0.0 2.1 1.9 12.0 15.0 95.4 97.0 0.7 1.1 1.8 44.1 39.2 RASEF "FLJ31614, RAB45" ENSG00000165105 "RAS and EF-hand domain containing" Q8IZ41 9 82979590-83063177 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 41.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 101.7;Gastric mucus-secreting cells: 356.8;Prostatic glandular cells: 106.4;Respiratory ciliated cells: 100.6;Urothelial cells: 107.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 53.2;RT4: 38.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021431, HPA078596" Approved Uncertain Microtubules NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 22: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 35: Glandular cells - Unknown function" Microtubules "HPA021431: AB_1856087, HPA078596: " "unprognostic (1.22e-1)" "unprognostic (1.20e-1)" "unprognostic (1.73e-2)" "unprognostic (1.26e-1)" "unprognostic (2.59e-1)" "unprognostic (2.40e-2)" "unprognostic (9.91e-3)" "unprognostic (1.61e-1)" "unprognostic (1.20e-1)" "unprognostic (8.60e-2)" "unprognostic (1.66e-3)" "unprognostic (3.67e-1)" "unprognostic (1.41e-3)" "unprognostic (5.07e-2)" "unprognostic (6.05e-3)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" 1.1 1.6 16.2 2.8 15.4 3.6 17.6 21.2 21.9 2.9 18.0 15.2 6.3 2.7 10.2 7.1 6.3 12.6 1.1 13.9 9.2 5.3 2.4 8.2 1.5 10.0 6.3 1.5 23.1 5.3 3.9 3.4 9.8 15.2 15.2 5.1 15.3 3.8 1.9 3.8 8.6 1.1 1.0 1.5 41.0 4.0 9.8 3.4 25.9 0.0 3.5 13.8 2.3 24.7 14.0 15.5 1.8 1.5 0.3 0.5 5.6 1.0 0.2 1.6 3.9 8.7 16.9 2.3 13.7 0.4 11.0 16.3 0.3 0.4 1.9 1.4 17.3 1.9 11.9 2.2 0.2 1.7 1.6 0.3 6.7 7.6 0.2 2.1 0.1 2.4 2.5 16.8 0.2 27.2 2.3 1.8 10.5 53.2 6.1 2.5 4.8 6.0 18.0 38.5 5.6 8.3 2.8 26.8 1.1 6.7 22.9 2.0 2.6 2.6 14.6 2.1 1.7 11.3 10.1 1.4 5.8 1.0 3.0 6.5 2.0 1.9 3.7 1.4 3.5 3.9 3.5 2.9 1.1 5.3 3.8 3.3 9.8 3.6 1.6 3.8 2.9 0.7 16.2 15.4 21.2 21.9 13.9 9.2 10.0 6.3 9.8 1.0 9.8 24.7 0.7 76.9 101.7 0.3 1.1 0.8 5.4 7.9 4.0 1.1 61.3 21.1 0.6 42.9 59.7 9.2 4.2 5.5 0.5 61.8 7.9 35.4 0.6 39.7 7.9 4.5 3.6 0.8 1.0 37.4 10.3 5.7 356.8 88.2 22.1 0.4 0.7 1.7 0.8 0.0 0.6 85.7 48.8 0.0 0.4 2.1 0.3 4.2 1.8 4.7 1.6 0.1 0.0 0.0 0.2 46.2 40.0 0.0 1.5 106.4 10.4 8.3 100.6 1.3 0.0 0.7 2.8 0.5 4.8 28.2 0.9 7.5 3.1 1.2 35.7 107.7 RBM39 "CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2" ENSG00000131051 "RNA binding motif protein 39" Q14498 20 35701347-35742312 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001591 Supported Supported "Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite" NA NA 19000 "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear speckles" "Microtubules, Centriolar satellite" "HPA001591: AB_1079749" "unprognostic (1.37e-2)" "unprognostic (4.97e-1)" "unprognostic (2.72e-2)" "unprognostic (9.09e-2)" "unprognostic (3.47e-1)" "unprognostic (4.99e-2)" "unprognostic (3.55e-3)" "unprognostic (4.56e-2)" "unprognostic (7.83e-2)" "unprognostic (2.65e-1)" "unprognostic (2.04e-2)" "unprognostic (7.65e-3)" "prognostic unfavorable (2.78e-5)" "unprognostic (1.88e-1)" "unprognostic (2.86e-1)" "unprognostic (2.64e-1)" "unprognostic (2.28e-3)" 70.1 55.8 18.4 37.7 17.6 172.0 44.6 33.5 28.0 57.8 22.2 56.0 35.1 54.5 9.2 62.3 61.4 40.8 57.3 16.5 25.0 52.2 47.7 62.2 42.3 24.2 24.0 71.1 41.2 27.3 50.0 40.9 19.4 50.2 16.9 49.5 53.4 22.3 70.3 51.2 46.9 19.2 16.0 56.4 49.7 34.3 16.9 51.1 54.2 33.1 24.1 50.7 62.1 26.5 98.8 87.6 77.0 78.5 48.8 53.8 78.8 131.0 50.6 59.6 60.2 109.3 78.5 137.5 90.6 38.9 67.9 91.2 122.3 67.9 66.5 94.6 96.7 174.6 80.7 101.2 23.4 158.6 99.9 14.4 97.6 68.9 38.4 63.7 57.8 46.4 195.5 117.6 46.3 72.2 194.5 87.9 103.2 87.5 96.8 104.9 136.2 91.7 41.5 56.2 77.9 63.4 91.1 94.7 78.4 109.3 70.6 94.6 91.4 100.8 92.5 90.5 115.8 71.6 164.3 204.0 64.7 123.2 79.2 250.9 120.4 197.5 104.7 111.1 103.6 131.1 91.5 97.6 111.8 140.5 85.7 82.1 427.7 127.2 102.2 160.9 114.7 95.7 18.4 17.6 33.5 28.0 16.5 25.0 24.2 24.0 19.4 16.0 16.9 26.5 302.0 233.9 280.9 144.3 441.7 616.4 521.0 283.0 284.0 258.5 339.1 295.4 189.2 191.6 267.6 200.5 316.9 375.2 624.9 278.1 189.8 203.8 48.1 359.2 496.0 299.7 295.3 214.2 130.1 186.0 389.6 337.9 254.9 540.8 525.8 304.4 215.3 202.1 199.8 220.4 120.9 331.3 215.7 207.7 469.5 41.9 262.5 335.5 270.3 129.3 274.3 208.7 400.6 136.2 160.5 221.3 254.8 214.4 391.0 453.6 271.8 150.6 248.0 386.5 164.3 504.0 410.2 263.5 228.1 215.8 586.9 561.6 490.8 218.2 282.8 532.1 RELL1 ENSG00000181826 "RELT like 1" Q8IUW5 4 37590800-37686376 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 39.7" "Cell type enhanced" "Detected in many" "Adipocytes: 30.5;Microglial cells: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 59.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013377 Approved Supported "Plasma membrane,Microtubules" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane, Microtubules" "HPA013377: AB_1844403" "unprognostic (1.70e-1)" "unprognostic (1.70e-1)" "unprognostic (4.78e-2)" "unprognostic (5.30e-2)" "unprognostic (6.80e-2)" "unprognostic (7.28e-2)" "unprognostic (7.35e-2)" "unprognostic (2.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.46e-1)" "unprognostic (3.41e-1)" "unprognostic (7.88e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (6.15e-2)" "unprognostic (1.71e-2)" 13.5 2.4 10.6 4.9 15.5 25.6 7.8 20.1 14.9 5.1 9.3 8.3 6.2 5.5 2.7 6.4 5.1 6.1 6.0 8.0 13.3 3.9 4.8 6.6 4.7 29.7 19.3 3.5 2.3 1.5 1.4 6.1 27.7 3.0 6.6 3.1 3.5 3.8 15.8 12.4 5.5 6.0 24.4 7.3 12.3 1.6 20.1 3.7 12.5 4.3 4.8 7.8 4.1 39.7 4.8 5.1 12.9 11.1 10.8 6.2 10.8 8.0 6.9 5.5 7.2 16.8 5.7 1.3 5.7 6.9 9.8 4.3 4.1 7.2 9.6 0.2 2.1 1.8 4.7 18.2 8.1 6.0 4.5 10.6 10.2 7.5 8.2 3.4 24.9 3.3 3.1 5.0 6.4 4.4 7.5 8.3 3.2 6.9 1.5 2.5 45.0 2.2 13.2 5.9 2.9 8.5 6.1 6.6 10.6 3.2 18.0 3.2 29.6 13.8 8.7 10.1 9.5 2.5 2.6 7.3 11.7 12.8 11.4 0.8 15.2 27.4 5.1 5.7 6.3 0.7 6.2 4.9 8.5 0.2 5.3 7.0 59.3 7.7 5.5 9.8 5.5 5.1 10.6 15.5 20.1 14.9 8.0 13.3 29.7 19.3 27.7 24.4 20.1 39.7 30.5 9.6 3.1 16.3 2.9 3.3 2.5 1.7 10.8 0.4 8.1 9.5 2.1 5.7 3.9 0.0 0.0 1.4 9.8 8.4 0.0 3.1 6.5 5.5 9.9 14.4 1.2 3.4 3.3 8.6 3.6 10.7 22.4 2.4 2.5 0.5 6.4 0.9 2.6 3.3 2.4 1.6 0.0 3.2 2.7 8.1 3.7 9.2 1.8 36.5 4.1 4.0 0.0 22.6 12.5 10.3 2.9 6.0 15.5 2.7 6.7 0.2 3.3 1.4 13.1 18.8 16.4 0.8 0.3 5.5 4.7 5.2 10.6 5.1 1.1 3.8 RHBDD3 "C22orf3, PTAG" ENSG00000100263 "Rhomboid domain containing 3" Q9Y3P4 22 29259872-29268209 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043979 Approved Approved Microtubules NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 43: Testis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" Microtubules "HPA043979: AB_10960539" "unprognostic (9.38e-2)" "unprognostic (1.19e-2)" "unprognostic (1.22e-1)" "prognostic favorable (2.67e-6)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.13e-3)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (8.46e-2)" "unprognostic (4.42e-3)" "unprognostic (1.80e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (2.11e-3)" "unprognostic (1.84e-1)" "unprognostic (1.03e-1)" "unprognostic (3.42e-3)" 7.6 20.7 6.8 2.4 7.7 2.9 6.9 6.7 10.8 7.2 6.4 7.3 4.9 9.0 1.3 8.6 8.6 1.7 10.2 6.4 7.2 10.0 16.8 6.7 1.9 8.7 7.9 8.0 11.8 2.6 14.8 2.1 7.7 13.4 0.6 0.9 7.7 4.4 10.1 6.2 7.1 1.6 7.1 10.7 7.1 22.2 7.3 2.3 10.7 0.5 0.9 7.0 6.0 7.6 4.6 7.7 4.2 12.3 1.3 2.2 23.5 2.9 3.8 3.5 4.4 6.9 10.1 12.6 12.4 2.8 2.1 14.2 2.5 2.3 0.4 16.7 19.9 4.6 6.5 8.6 15.0 10.4 11.5 6.6 6.2 1.5 4.2 2.5 4.8 5.1 5.6 8.3 2.6 9.0 6.8 15.8 19.8 2.9 8.6 11.9 7.8 14.6 1.5 4.6 9.2 4.8 9.9 10.6 12.3 1.0 7.0 9.0 7.0 9.5 4.2 4.0 4.4 20.3 6.6 15.1 4.0 4.6 8.1 0.0 4.6 1.9 2.5 4.1 3.1 1.8 2.4 3.7 4.7 0.9 1.8 2.5 1.4 3.6 3.8 11.2 3.9 2.5 6.8 7.7 6.7 10.8 6.4 7.2 8.7 7.9 7.7 7.1 7.3 7.6 8.4 6.4 7.0 22.2 5.1 6.1 11.7 19.9 5.2 17.2 12.1 9.8 8.4 8.6 16.0 14.7 6.2 44.4 12.8 19.0 0.0 18.6 9.0 19.0 12.8 10.0 8.4 11.2 14.4 19.8 18.7 14.1 21.9 24.6 0.0 21.7 12.8 15.7 25.6 16.8 16.5 15.1 12.2 9.7 5.5 7.4 14.0 7.5 7.2 12.2 7.8 14.5 7.2 11.1 9.9 13.2 16.1 12.0 9.5 16.0 15.9 7.1 12.1 22.9 6.6 9.0 10.2 29.8 26.6 8.6 6.0 38.3 7.4 26.3 17.7 9.6 RNF141 "ZFP26, ZNF230" ENSG00000110315 "Ring finger protein 141" Q8WVD5 11 10511673-10541230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 1045.8;Late spermatids: 666.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 176.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018133 Approved Approved Nucleoplasm,Microtubules NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 34: Spermatids - Unknown function" Microtubules Nucleoplasm "HPA018133: AB_1859142" "unprognostic (7.41e-2)" "unprognostic (1.16e-1)" "unprognostic (7.88e-3)" "unprognostic (8.42e-2)" "unprognostic (2.12e-1)" "unprognostic (3.09e-2)" "unprognostic (1.08e-3)" "unprognostic (1.48e-1)" "unprognostic (1.44e-1)" "unprognostic (5.50e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (4.57e-2)" "prognostic favorable (2.60e-4)" "unprognostic (6.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.71e-2)" "unprognostic (1.61e-2)" 24.0 28.3 41.2 26.8 61.9 19.8 26.9 56.4 61.6 17.6 22.9 17.3 21.7 13.7 19.7 56.3 16.3 14.5 22.7 34.0 51.6 23.5 21.8 21.7 17.9 61.3 52.7 10.9 14.5 30.6 10.0 14.9 63.4 22.6 16.8 18.6 38.3 14.2 43.4 42.9 30.0 13.3 52.1 27.7 21.6 82.7 48.4 18.8 22.9 35.7 25.6 21.0 22.9 79.7 48.3 24.6 34.5 21.1 51.7 50.2 24.6 32.2 26.1 12.6 15.1 38.3 176.3 19.9 28.3 25.0 22.3 34.8 15.3 38.4 19.0 21.7 20.1 13.3 15.8 19.9 20.0 22.2 15.2 33.0 44.0 6.7 41.1 45.8 33.9 25.2 38.4 18.7 31.6 20.6 21.2 8.3 17.5 32.3 14.0 27.3 14.8 22.9 20.4 52.9 11.0 21.5 31.1 36.8 20.6 29.5 23.4 11.3 36.3 30.1 18.5 24.6 10.4 8.2 16.5 22.7 37.7 31.3 37.3 34.2 52.3 92.7 8.3 106.8 13.9 67.6 9.6 8.1 28.9 69.9 10.5 7.3 152.4 9.2 103.9 26.6 12.8 33.9 41.2 61.9 56.4 61.6 34.0 51.6 61.3 52.7 63.4 52.1 48.4 79.7 15.1 19.2 49.2 14.4 39.4 40.8 39.7 47.7 37.0 20.3 31.7 22.0 46.7 18.6 36.9 20.2 12.5 14.4 18.8 16.6 41.1 21.2 1045.8 18.5 14.0 18.4 21.0 15.4 10.7 24.7 15.1 15.9 16.8 23.0 13.3 18.8 21.0 28.0 41.6 37.0 11.8 28.2 16.2 107.4 10.5 666.5 19.6 52.6 19.6 4.7 41.7 27.8 4.1 12.1 67.9 41.6 11.2 19.5 15.2 53.3 58.8 33.5 48.0 11.0 6.6 19.1 18.6 83.4 39.4 49.1 40.1 17.9 11.7 23.3 21.1 74.8 RNF215 ENSG00000099999 "Ring finger protein 215" Q9Y6U7 22 30368811-30421771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 12.9;Cone photoreceptor cells: 12.5;Rod photoreceptor cells: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029427, HPA056498" Approved Approved Nucleoli,Microtubules NA NA "Cluster 15: NK-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 5: Muller glia cells - Visual perception" Microtubules Nucleoli "HPA029427: AB_2732447, HPA056498: AB_2683154" "unprognostic (1.24e-2)" "unprognostic (3.20e-1)" "unprognostic (3.67e-4)" "unprognostic (8.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (2.47e-2)" "unprognostic (1.97e-1)" "unprognostic (5.32e-2)" "unprognostic (1.03e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (6.37e-10)" "unprognostic (2.48e-1)" "unprognostic (1.99e-1)" "unprognostic (3.17e-1)" "unprognostic (1.78e-2)" 8.4 8.7 19.2 5.6 19.0 7.0 9.3 18.7 22.5 17.6 17.9 11.8 7.8 15.2 9.2 6.7 13.3 6.8 9.5 19.2 20.4 12.1 11.1 8.7 4.7 20.2 18.7 13.7 13.2 10.7 10.0 6.9 18.3 13.1 3.9 8.5 6.5 8.3 8.0 6.1 7.7 7.9 16.9 11.6 8.9 10.5 20.0 2.8 12.2 2.9 3.9 12.3 10.8 17.4 6.8 14.0 14.4 23.4 13.8 14.3 14.2 11.4 10.1 11.3 6.8 3.8 7.4 2.7 20.1 9.3 21.1 8.4 8.9 13.1 9.0 15.8 10.8 4.5 17.8 5.1 18.9 3.6 18.5 19.4 15.8 19.3 10.3 36.7 13.3 7.0 4.0 12.6 13.6 11.0 2.6 8.5 4.5 9.7 15.4 12.2 8.4 10.8 14.9 10.3 6.3 16.2 11.6 8.3 8.9 13.1 7.6 3.9 18.6 30.2 13.3 8.8 6.7 13.3 3.4 3.7 17.7 2.6 11.9 0.4 0.9 1.5 0.9 0.7 1.0 1.0 1.0 0.8 0.5 1.9 1.8 1.7 0.5 2.5 0.8 1.4 0.5 0.4 19.2 19.0 18.7 22.5 19.2 20.4 20.2 18.7 18.3 16.9 20.0 17.4 7.1 3.2 3.9 8.8 1.4 0.3 1.2 1.6 2.8 12.9 3.2 3.9 2.2 1.5 2.7 0.0 12.5 1.9 3.7 1.0 0.0 1.5 0.8 3.7 6.4 3.5 0.0 0.4 5.0 1.4 1.5 5.4 6.1 6.6 0.0 8.2 4.6 2.3 1.8 8.4 4.6 0.5 2.0 1.2 0.5 0.4 0.9 1.9 1.8 1.0 2.3 11.7 1.0 2.5 1.1 1.9 0.2 1.2 1.8 1.3 0.7 1.0 0.6 13.7 6.6 4.8 4.8 2.1 0.9 0.6 0.1 1.6 2.0 5.3 0.7 1.2 RPL6 "L6, TAXREB107, TXREB1" ENSG00000089009 "Ribosomal protein L6" Q02878 12 112405189-112418838 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060903, HPA068418" Approved Approved "Microtubules,Cytokinetic bridge" Yes No 620000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Microtubules, Cytokinetic bridge" "HPA060903: AB_2732653, HPA068418: AB_2685987" "unprognostic (5.95e-2)" "unprognostic (1.31e-1)" "unprognostic (1.40e-1)" "unprognostic (5.49e-2)" "unprognostic (1.10e-2)" "unprognostic (2.50e-1)" "unprognostic (1.02e-2)" "unprognostic (3.74e-1)" "unprognostic (5.63e-2)" "unprognostic (1.07e-2)" "unprognostic (4.19e-3)" "unprognostic (2.52e-2)" "prognostic unfavorable (6.95e-4)" "unprognostic (2.45e-1)" "unprognostic (2.40e-2)" "unprognostic (3.38e-2)" "unprognostic (5.90e-2)" 1199.2 1080.7 788.0 937.3 801.7 2387.8 1856.5 776.8 1063.3 1357.1 828.3 1249.1 789.1 1236.7 1570.4 1485.5 1241.3 734.2 856.8 756.3 814.1 985.6 1026.1 803.0 1847.2 805.2 807.2 2777.7 1984.2 1103.8 1049.8 763.3 801.3 1017.4 1222.4 531.8 1632.2 850.0 1451.0 1598.1 946.0 1018.7 822.2 1015.0 1214.8 279.2 808.0 1815.8 1223.2 1298.0 2204.7 1349.1 1216.0 818.0 1973.8 1887.6 2227.1 2264.4 2725.6 4486.8 2932.4 1843.2 2670.8 2471.8 1408.6 2975.9 1213.3 4225.2 1547.6 2008.9 962.8 1881.4 2395.5 3288.1 2456.2 1682.6 3199.4 2274.7 1590.4 2693.3 2854.8 4103.6 1708.4 4171.2 4542.3 1876.9 4294.7 4571.2 2818.5 2754.1 3060.8 1134.5 2888.4 2727.7 3013.0 6699.3 3096.5 4209.0 2233.7 2731.0 2375.5 4144.9 3118.1 3283.8 2050.1 2651.9 1297.5 3446.9 3342.3 2007.3 3621.2 4189.6 1657.8 1215.8 1484.2 1572.8 2110.7 1542.6 2549.7 3377.6 1573.3 2948.5 1861.4 730.3 2260.1 463.1 2285.0 1851.6 3814.8 3463.8 3465.4 2972.5 2896.3 3116.2 3751.8 3251.5 262.6 2839.0 1688.0 3372.7 3027.9 7777.8 788.0 801.7 776.8 1063.3 756.3 814.1 805.2 807.2 801.3 822.2 808.0 818.0 1483.8 798.0 1587.2 31.0 3121.1 3145.3 3907.2 3373.8 2996.4 271.4 3790.3 6493.7 262.3 1818.7 1733.0 636.4 137.6 3077.0 2809.4 731.3 3502.2 2270.2 414.6 1133.8 2774.3 1661.9 1388.1 1929.0 42.6 3043.9 4721.2 1695.5 1135.6 1287.6 1290.2 1743.7 1854.3 1727.8 1880.0 121.1 48.2 2036.2 1112.9 2566.7 2790.5 714.3 2849.7 1964.8 1899.7 30.9 3399.6 854.8 2699.3 34.7 48.9 2582.7 1646.1 1589.9 2173.6 3165.2 1095.4 3376.3 776.7 412.3 927.0 2550.9 1835.3 376.5 461.6 3977.5 3650.1 3068.7 2710.6 2783.0 2512.8 3577.6 RPUSD2 "C15orf19, C18B11, FLJ31409, PUS9" ENSG00000166133 "RNA pseudouridine synthase domain containing 2" Q8IZ73 15 40569299-40574949 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042079, HPA042194" Approved Approved Nucleoplasm,Microtubules NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Microtubules" "HPA042079: AB_10794643, HPA042194: AB_10794416" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (1.32e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (1.31e-1)" "unprognostic (6.60e-2)" "unprognostic (8.32e-2)" "unprognostic (4.41e-2)" "unprognostic (1.26e-2)" "unprognostic (1.16e-1)" "prognostic favorable (7.63e-7)" "unprognostic (7.27e-2)" "unprognostic (8.28e-2)" "unprognostic (3.12e-2)" "unprognostic (2.75e-2)" 5.1 8.9 5.7 4.8 6.2 9.7 5.8 5.8 6.4 6.6 6.2 7.5 4.8 9.2 5.3 7.1 7.2 2.4 9.5 5.6 5.6 8.0 8.9 4.5 6.7 5.4 5.6 7.7 5.3 5.3 7.9 3.7 5.8 6.5 4.0 2.5 7.7 4.7 14.5 9.5 7.0 3.6 4.9 8.0 6.3 6.1 5.5 6.1 6.1 7.6 6.2 6.2 5.2 6.0 10.4 11.5 9.6 16.0 8.1 6.1 18.2 9.0 10.8 15.4 12.2 14.3 6.4 9.9 12.8 10.5 14.1 27.7 22.3 15.9 8.7 11.5 15.3 17.1 15.9 17.1 12.1 14.7 12.1 8.6 14.7 10.1 13.8 7.1 9.7 16.1 21.9 11.4 7.7 12.3 17.7 18.6 12.4 15.0 12.4 22.3 10.7 15.3 10.0 8.9 10.9 12.6 12.3 13.8 7.6 7.9 13.2 19.9 6.0 10.5 12.3 13.7 10.5 11.8 25.2 27.3 9.2 22.9 8.4 0.1 6.4 5.6 23.4 8.0 21.3 28.2 22.6 24.9 12.5 35.5 26.8 22.5 0.7 33.6 18.4 16.5 26.3 14.4 5.7 6.2 5.8 6.4 5.6 5.6 5.4 5.6 5.8 4.9 5.5 6.0 5.7 6.4 2.6 2.3 10.4 10.6 16.4 11.5 10.8 11.7 6.4 8.6 8.2 8.6 7.0 7.3 16.7 15.7 9.3 5.4 25.4 9.6 2.1 5.4 5.7 5.7 13.2 8.2 2.8 10.9 9.3 7.6 6.6 4.6 4.5 9.0 3.6 9.1 7.1 18.5 2.9 6.2 12.2 2.2 3.1 1.7 7.2 2.6 3.6 1.0 3.4 15.6 7.2 4.0 3.1 6.5 5.0 10.1 8.9 9.0 4.9 13.2 9.9 16.0 13.1 11.6 8.1 7.1 15.1 9.6 10.7 5.6 7.3 12.4 8.5 8.0 SCLT1 "FLJ30655, hCAP-1A" ENSG00000151466 "Sodium channel and clathrin linker 1" Q96NL6 4 128864921-129093600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Astrocytes: 110.0;Excitatory neurons: 111.1;Inhibitory neurons: 116.0;Oligodendrocyte precursor cells: 109.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 66.0" "Group enriched" "Detected in all" 5 "granulocytes: 66.0;monocytes: 31.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036560, HPA036561" Approved Uncertain Microtubules,Cytosol NA Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Microtubules, Cytosol" "HPA036560: AB_2675190, HPA036561: AB_10673658" "unprognostic (2.15e-1)" "unprognostic (2.01e-1)" "unprognostic (1.62e-2)" "unprognostic (3.77e-2)" "unprognostic (5.05e-2)" "unprognostic (9.18e-2)" "unprognostic (1.33e-3)" "unprognostic (1.64e-2)" "unprognostic (1.94e-2)" "unprognostic (4.99e-2)" "unprognostic (3.86e-1)" "unprognostic (3.09e-2)" "unprognostic (5.34e-4)" "unprognostic (6.54e-2)" "unprognostic (2.70e-1)" "unprognostic (6.05e-2)" "unprognostic (8.92e-2)" 3.6 3.0 3.7 6.4 4.5 14.4 3.5 7.4 4.8 3.7 0.9 3.7 4.3 3.5 2.2 3.9 3.1 4.6 3.6 2.4 2.8 2.7 3.5 3.5 7.3 4.5 4.3 4.5 3.3 2.9 2.9 4.6 3.5 2.4 4.4 2.9 2.6 2.7 1.5 3.2 3.4 3.6 4.7 7.5 3.5 4.9 5.3 8.8 3.0 1.8 6.7 4.4 3.4 3.9 19.9 5.3 18.8 12.4 6.5 10.5 10.3 16.5 14.8 17.8 16.3 5.7 17.1 17.0 10.4 9.3 12.4 7.4 12.5 12.2 18.5 38.9 10.0 22.7 10.2 6.5 8.9 27.1 17.0 6.7 4.3 14.2 14.2 8.5 14.0 8.6 25.7 39.8 15.6 8.8 20.8 13.0 8.4 14.2 10.5 12.2 19.2 10.6 11.4 5.5 28.1 8.2 12.7 11.5 11.1 8.2 6.8 10.8 13.2 14.5 17.6 19.7 22.3 19.3 15.5 29.0 8.1 29.7 22.2 18.3 16.9 36.8 3.8 24.6 2.2 3.9 2.6 2.7 9.5 3.7 2.5 3.4 66.0 10.2 31.1 4.4 3.7 6.5 3.7 4.5 7.4 4.8 2.4 2.8 4.5 4.3 3.5 4.7 5.3 3.9 16.1 12.8 9.8 110.0 18.0 11.1 8.9 5.8 8.0 15.2 6.1 7.4 21.2 15.7 9.0 1.8 29.2 13.8 34.8 9.1 3.9 6.5 63.2 20.3 18.4 11.9 5.4 9.0 111.1 6.3 21.5 16.3 28.1 14.3 12.0 16.5 9.3 1.6 13.3 16.8 116.0 8.1 8.2 21.6 18.0 51.8 10.8 28.4 8.8 87.1 33.8 8.9 82.4 109.1 90.5 9.0 9.8 9.1 24.0 2.7 8.2 3.1 16.7 21.6 13.1 14.4 16.5 19.6 12.1 13.1 13.9 9.3 21.2 30.5 10.6 5.6 SCYL3 "PACE-1, PACE1" ENSG00000000457 "SCY1 like pseudokinase 3" Q8IZE3 1 169849631-169894267 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005624 Approved Uncertain "Nuclear bodies,Microtubules" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" Microtubules "Nuclear bodies" "HPA005624: AB_1854916" "unprognostic (2.35e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (8.36e-2)" "unprognostic (7.13e-2)" "unprognostic (2.72e-3)" "unprognostic (1.31e-1)" "unprognostic (2.12e-2)" "unprognostic (2.85e-2)" "unprognostic (7.17e-2)" "unprognostic (8.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.20e-3)" "unprognostic (3.54e-1)" "unprognostic (1.75e-1)" "unprognostic (4.60e-2)" "prognostic favorable (8.85e-4)" 5.6 5.8 2.7 7.4 3.0 4.0 10.9 4.0 3.5 6.7 5.0 7.8 7.7 7.0 8.3 7.3 6.3 7.6 5.2 3.0 3.0 7.5 11.3 6.2 10.5 2.9 2.8 7.6 6.1 12.0 4.1 8.1 3.1 7.6 9.6 11.4 8.2 6.7 7.9 7.7 6.8 6.2 2.9 7.5 7.7 6.6 3.0 9.7 7.6 9.1 9.8 7.3 6.5 3.9 4.1 5.2 7.9 5.5 9.9 7.2 9.1 6.3 8.1 7.2 6.7 4.8 7.7 8.4 4.5 6.5 4.0 9.4 4.7 5.5 6.4 15.5 4.4 5.8 6.1 3.1 7.0 8.5 7.3 7.0 5.4 5.0 6.8 6.7 6.9 9.2 9.4 10.8 6.9 3.2 6.9 6.5 6.4 27.5 2.5 6.3 4.3 10.1 7.6 7.3 5.9 8.6 5.0 16.3 10.1 11.2 9.1 7.8 5.2 5.1 3.4 6.2 5.1 14.4 13.7 9.9 3.9 6.3 5.7 13.5 3.2 8.6 6.3 3.4 8.5 6.7 8.3 7.0 5.1 6.2 7.0 5.8 6.7 10.7 3.8 11.5 8.1 4.8 2.7 3.0 4.0 3.5 3.0 3.0 2.9 2.8 3.1 2.9 3.0 3.9 5.9 6.4 14.4 11.8 9.6 2.4 2.5 3.6 6.2 10.2 9.6 8.3 4.2 22.8 7.8 1.8 10.4 17.6 19.0 14.0 9.8 7.4 5.1 11.1 8.2 6.6 9.1 4.2 15.8 9.1 5.1 5.1 7.1 5.8 5.7 7.2 11.0 13.2 6.5 10.1 12.5 10.4 8.2 11.4 3.5 2.6 4.4 5.3 1.8 9.4 8.4 10.0 16.5 17.6 14.1 6.2 10.2 5.7 10.5 4.7 13.3 6.4 9.0 19.9 6.6 5.5 5.4 10.9 6.8 8.3 1.8 11.6 11.0 6.3 10.3 3.3 SEPTIN12 "FLJ25410, SEPT12" ENSG00000140623 "Septin 12" Q8IYM1 16 4777606-4788398 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 87 "testis: 98.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA041128 Uncertain Microtubules NA NA "Cluster 74: Testis - Spermatogenesis" Microtubules "HPA041128: AB_10796568" "unprognostic (2.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.56e-2)" "unprognostic (2.29e-2)" "unprognostic (2.71e-1)" "unprognostic (5.45e-2)" "unprognostic (7.40e-2)" "unprognostic (1.39e-1)" "unprognostic (3.80e-2)" "unprognostic (1.61e-1)" "unprognostic (1.49e-8)" "unprognostic (7.41e-2)" "unprognostic (9.87e-2)" "unprognostic (8.36e-3)" 0.0 0.0 0.1 0.0 0.3 0.1 0.1 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 98.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.1 0.5 0.3 0.1 0.4 0.1 0.4 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SH2D3A NSP1 ENSG00000125731 "SH2 domain containing 3A" Q9BRG2 19 6752160-6767463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 32.5" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 117.9;Pancreatic endocrine cells: 81.3;Urothelial cells: 87.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 43.2;HaCaT: 34.2;HBEC3-KT: 67.4" "Not detected" "Not detected" "HPA035722, HPA064382" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes NA "Cluster 30: Non-specific - Translation" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA035722: AB_10670024, HPA064382: AB_2685251" "unprognostic (3.32e-2)" "unprognostic (5.48e-2)" "unprognostic (1.82e-2)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (3.96e-1)" "unprognostic (2.60e-3)" "unprognostic (3.63e-1)" "unprognostic (8.41e-2)" "unprognostic (6.48e-3)" "prognostic unfavorable (6.21e-4)" "prognostic favorable (1.42e-4)" "unprognostic (7.31e-2)" "unprognostic (1.74e-1)" "unprognostic (1.32e-3)" "unprognostic (1.81e-3)" 0.9 0.4 0.2 4.6 0.2 3.4 7.5 0.1 0.6 8.0 0.5 12.8 14.3 1.2 1.0 32.5 4.3 3.5 0.6 0.1 0.1 19.6 2.6 10.8 5.2 0.4 0.2 0.8 19.7 5.9 2.8 5.9 0.2 18.1 5.4 0.9 18.7 4.1 1.5 27.6 14.4 0.3 0.2 5.7 14.2 4.4 0.3 3.3 13.0 0.0 4.1 9.1 17.0 0.5 43.2 6.2 0.1 0.2 0.0 0.0 22.6 0.3 0.0 0.0 0.0 20.3 30.8 6.6 19.6 0.0 0.0 34.2 2.3 67.4 0.0 3.6 6.6 0.3 6.9 2.6 0.1 0.6 8.6 0.0 30.3 0.0 5.9 0.8 0.0 14.8 7.3 14.3 0.0 15.3 3.2 0.2 1.6 21.5 12.0 1.2 0.1 24.8 11.5 31.4 0.0 0.2 2.3 31.7 0.1 1.0 22.0 0.4 0.7 0.7 2.2 0.5 0.4 14.1 15.8 9.2 0.2 4.8 0.3 0.1 0.0 0.0 2.6 0.1 4.2 3.6 5.9 5.2 0.1 5.6 7.7 4.2 0.1 1.8 0.1 0.4 3.2 0.9 0.2 0.2 0.1 0.6 0.1 0.1 0.4 0.2 0.2 0.2 0.3 0.5 0.7 19.2 14.2 0.3 25.8 30.7 117.9 51.4 25.0 4.1 13.6 11.4 1.9 40.0 43.9 40.5 10.4 23.8 7.7 46.6 1.9 54.1 1.6 15.4 2.9 2.8 12.1 7.8 0.1 37.1 52.8 2.6 50.0 24.9 5.7 0.3 1.8 2.9 3.6 0.0 0.2 37.9 28.5 0.6 10.3 0.8 0.6 2.2 3.6 0.0 4.2 0.8 14.4 0.0 0.1 81.3 69.7 0.0 8.0 58.6 53.9 13.1 27.0 4.6 0.0 2.2 3.5 8.7 11.4 17.6 39.9 10.8 18.0 1.1 32.0 87.9 SH3GL2 "CNSA2, EEN-B1, SH3D2A, SH3P4" ENSG00000107295 "SH3 domain containing GRB2 like 2, endophilin A1" Q99962 9 17579066-17797124 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 123.8;retina: 75.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 89.4;Excitatory neurons: 390.8;Inhibitory neurons: 140.9" "Cancer enhanced" "Detected in many" "glioma: 8.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 9.3;HeLa: 21.1;JURKAT: 18.7;RT4: 41.8;SCLC-21H: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010056, HPA026685, HPA063573" Enhanced Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes No "Cluster 6: Brain - Smell perception" "Cluster 15: RT4 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045" "unprognostic (4.78e-2)" "unprognostic (3.24e-2)" "unprognostic (1.68e-2)" "unprognostic (5.05e-5)" "unprognostic (4.23e-2)" "unprognostic (3.40e-1)" "unprognostic (1.21e-1)" "unprognostic (5.90e-2)" "unprognostic (3.90e-1)" "unprognostic (5.07e-3)" "unprognostic (8.76e-3)" "unprognostic (1.26e-1)" "prognostic favorable (6.68e-12)" "unprognostic (2.65e-2)" "unprognostic (8.29e-2)" "unprognostic (2.25e-2)" "unprognostic (8.44e-2)" 0.3 0.2 63.0 0.1 69.0 0.0 0.1 92.3 123.8 2.3 1.9 0.5 0.2 2.2 1.2 0.5 2.0 0.0 4.3 77.7 26.6 16.8 0.2 1.1 0.0 27.9 28.5 1.8 3.0 0.3 26.2 0.0 25.9 1.8 0.6 75.0 0.1 0.1 0.1 0.1 0.5 1.7 29.3 0.1 8.7 6.5 41.1 0.7 1.5 0.0 0.0 4.3 0.4 55.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.0 7.5 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 9.3 0.0 21.1 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 18.7 0.0 0.1 0.0 0.0 0.1 0.2 2.5 0.0 2.4 0.0 0.0 0.0 0.0 41.8 26.5 0.0 0.3 0.0 0.8 0.8 0.0 0.0 0.0 0.0 2.2 0.0 1.5 0.0 0.4 0.0 1.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.0 69.0 92.3 123.8 77.7 26.6 27.9 28.5 25.9 29.3 41.1 55.5 0.0 0.0 0.0 16.3 0.0 0.1 0.4 0.0 0.0 89.4 0.1 0.0 1.8 0.0 0.0 7.3 22.9 0.0 0.0 0.1 11.7 0.0 16.7 0.2 0.1 0.3 5.3 0.0 390.8 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 13.5 140.9 0.7 0.0 0.0 0.3 47.4 1.2 0.1 0.0 13.1 0.1 9.0 0.0 41.7 10.2 0.2 0.1 0.4 0.0 2.2 0.0 22.2 0.0 28.0 0.0 0.0 0.1 2.4 6.1 0.0 0.0 0.1 0.0 1.2 0.7 0.4 SHCBP1 "FLJ22009, PAL" ENSG00000171241 "SHC binding and spindle associated 1" Q8NEM2 16 46578591-46621379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.4;lymphoid tissue: 10.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 36.2;Extravillous trophoblasts: 28.7;Plasma cells: 38.3;Spermatocytes: 33.7;Spermatogonia: 23.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA048876 Uncertain Approved "Nuclear bodies,Microtubules,Midbody,Mitotic spindle" Yes Yes "Cluster 19: B-cells - Humoral immune response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies" "Microtubules, Midbody, Mitotic spindle" "HPA048876: AB_2680542" "unprognostic (2.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.98e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-2)" "unprognostic (2.35e-2)" "unprognostic (2.96e-4)" "unprognostic (2.26e-3)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.47e-5)" "unprognostic (4.81e-2)" "unprognostic (2.22e-16)" "unprognostic (3.59e-2)" "unprognostic (3.86e-2)" "unprognostic (2.66e-1)" "unprognostic (2.66e-1)" 0.7 0.5 0.5 5.1 0.5 17.4 0.9 1.2 0.6 0.6 0.4 1.9 1.2 0.6 0.6 3.5 0.2 0.6 1.0 0.4 0.2 5.4 0.2 1.0 9.8 0.4 0.3 0.3 0.2 0.2 0.2 2.4 0.4 0.3 2.2 0.2 0.8 0.2 1.5 3.3 1.5 1.7 0.1 4.4 0.9 5.2 0.5 8.8 0.3 0.2 10.6 1.2 1.2 0.7 33.8 30.8 11.9 15.3 3.1 6.2 16.2 60.7 24.6 59.2 26.8 14.6 20.8 28.0 30.2 28.8 26.8 21.0 29.3 21.7 73.8 17.7 17.2 28.2 25.8 30.3 0.1 28.5 35.4 1.2 1.6 45.9 18.1 5.9 33.0 14.9 12.7 28.3 69.7 21.5 24.0 23.7 10.0 17.2 31.6 45.4 89.9 44.8 13.7 9.4 5.0 7.2 46.0 23.7 11.1 11.4 13.0 23.4 16.1 43.9 28.7 43.5 54.0 24.9 36.7 46.7 21.4 31.3 45.8 0.2 0.3 0.6 0.2 0.5 0.0 1.7 0.3 0.1 0.3 1.2 0.0 0.1 0.4 0.1 2.4 0.7 1.2 1.1 0.5 0.5 1.2 0.6 0.4 0.2 0.4 0.3 0.4 0.1 0.5 0.7 0.2 0.0 1.1 1.3 7.1 1.7 0.7 1.2 0.0 0.3 0.6 1.1 1.9 1.5 1.4 0.0 0.0 11.3 0.8 1.9 0.0 0.2 8.4 0.7 1.7 1.7 0.0 36.2 2.1 0.0 28.7 3.7 4.1 1.5 0.0 7.6 1.8 0.3 12.6 0.0 0.7 2.2 2.0 4.5 3.3 2.3 0.6 4.0 1.8 2.8 2.8 0.8 0.0 1.0 0.5 0.1 0.1 0.4 38.3 0.5 0.4 0.1 0.1 0.3 0.0 0.5 6.3 33.7 23.7 3.6 0.6 3.7 2.2 0.8 3.4 1.1 SHMT2 SHMT ENSG00000182199 "Serine hydroxymethyltransferase 2" P34897 12 57229573-57234935 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 182.3" "Cell type enhanced" "Detected in many" "Hepatocytes: 182.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 2292.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020543, HPA020549" Enhanced Supported Microtubules,Mitochondria NA NA 390000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 85: Liver - Metabolism" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria Microtubules "HPA020543: AB_1856833, HPA020549: AB_1856834" "prognostic unfavorable (8.37e-5)" "unprognostic (1.24e-1)" "unprognostic (1.90e-1)" "unprognostic (2.65e-2)" "unprognostic (1.65e-1)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (9.83e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.00e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (4.84e-8)" "unprognostic (3.05e-1)" "unprognostic (2.30e-1)" "unprognostic (2.72e-1)" "unprognostic (4.74e-2)" 25.4 25.4 18.5 43.3 18.6 41.4 23.8 20.7 22.2 22.5 18.4 32.4 35.5 19.4 18.9 46.5 23.3 20.2 24.2 21.1 20.3 32.4 182.3 23.6 52.2 20.6 20.6 25.8 62.2 15.6 15.8 33.6 21.2 13.8 27.2 13.9 30.7 11.7 36.6 36.4 27.0 27.3 20.1 34.9 32.2 5.1 21.8 36.0 34.7 30.5 58.6 26.4 23.6 23.0 246.9 137.6 123.5 368.0 101.8 152.4 238.1 140.8 237.9 197.0 176.5 200.1 120.4 499.8 217.3 186.5 80.6 167.3 229.4 250.6 108.9 265.0 201.9 199.7 79.6 180.1 680.9 333.1 181.0 191.2 351.9 163.4 538.4 176.0 175.3 283.8 223.0 472.3 141.0 210.6 271.0 217.9 123.1 111.8 223.4 181.2 2292.7 433.6 95.9 151.1 265.4 119.9 73.0 170.1 518.3 48.5 222.9 424.2 108.8 84.6 150.5 96.1 185.0 574.1 338.4 421.4 169.6 320.2 154.0 34.9 41.2 23.3 26.6 50.6 31.5 127.5 46.3 29.4 59.6 137.9 21.1 22.0 2.0 40.1 34.1 20.4 202.8 53.8 18.5 18.6 20.7 22.2 21.1 20.3 20.6 20.6 21.2 20.1 21.8 23.0 9.1 9.6 14.1 4.2 58.2 34.7 23.0 43.5 39.9 7.0 26.5 24.0 12.1 21.5 23.5 3.7 0.0 55.4 11.6 9.6 13.7 45.7 0.4 6.3 22.6 17.1 9.6 53.8 3.7 47.7 52.7 25.5 23.4 10.9 29.2 18.7 22.1 182.8 50.2 8.4 3.2 24.2 34.6 36.0 25.1 0.9 18.0 23.5 39.2 3.7 32.0 45.3 21.6 4.0 2.4 40.1 18.7 16.1 74.4 18.2 15.9 63.6 13.3 6.2 6.6 23.9 40.2 1.9 6.6 52.9 32.5 37.4 21.1 39.5 37.4 23.8 SKA1 "C18orf24, MGC10200" ENSG00000154839 "Spindle and kinetochore associated complex subunit 1" Q96BD8 18 50375040-50394168 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 12.0;lymphoid tissue: 4.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 22.3;Extravillous trophoblasts: 9.2;Plasma cells: 10.0;Spermatocytes: 16.7;Spermatogonia: 13.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "Karpas-707: 82.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA045495 Approved Approved Microtubules NA Yes "Cluster 17: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Microtubules "HPA045495: AB_10960405" "unprognostic (2.18e-2)" "unprognostic (7.85e-3)" "unprognostic (7.66e-3)" "unprognostic (5.93e-3)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (9.60e-8)" "unprognostic (1.03e-3)" "unprognostic (1.16e-2)" "unprognostic (1.20e-2)" "unprognostic (1.18e-4)" "unprognostic (3.91e-3)" "unprognostic (0.00e+0)" "unprognostic (4.50e-3)" "unprognostic (4.66e-2)" "unprognostic (2.22e-2)" "unprognostic (1.79e-1)" 0.4 0.5 0.9 2.2 0.8 12.0 0.3 2.5 1.1 0.4 0.8 1.6 1.7 0.6 0.2 2.5 0.2 0.3 0.2 1.0 0.5 0.1 0.3 0.4 4.9 1.0 0.9 0.2 0.4 0.1 0.0 1.6 1.2 0.3 2.1 0.4 0.3 0.1 0.6 1.5 1.4 1.1 0.3 1.3 0.8 4.3 1.3 3.6 0.3 0.2 4.8 0.5 0.7 2.4 27.1 10.8 18.6 19.0 1.2 2.1 9.9 30.7 10.6 29.9 28.5 4.7 10.6 21.1 7.6 11.0 25.8 23.6 25.6 13.0 31.4 34.6 2.6 27.0 5.5 18.3 2.3 42.2 26.8 1.5 1.3 20.7 8.2 3.2 20.0 20.0 30.8 82.6 26.4 5.7 34.6 12.1 14.2 6.5 6.4 17.3 18.3 23.5 8.5 1.6 13.7 10.9 17.2 9.9 13.6 15.3 11.4 20.2 10.1 32.8 19.0 12.8 31.8 27.5 41.6 32.4 18.2 34.9 33.3 0.9 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.2 0.3 0.2 0.1 0.6 0.6 0.2 0.2 0.4 0.2 0.9 0.8 2.5 1.1 1.0 0.5 1.0 0.9 1.2 0.3 1.3 2.4 0.2 0.0 2.2 0.0 2.8 1.0 0.2 0.4 0.0 0.4 0.7 0.6 0.4 0.0 0.8 0.0 2.1 4.4 0.7 1.6 0.0 0.1 4.5 0.5 0.7 0.4 1.2 22.3 0.2 0.0 9.2 1.4 0.5 1.1 0.0 4.9 2.2 0.1 5.3 0.0 0.1 2.7 0.0 0.8 0.9 2.2 0.3 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 1.1 0.0 10.0 0.4 0.1 0.1 0.2 0.8 0.0 0.2 1.4 16.7 13.5 3.7 0.3 1.5 1.4 0.5 3.4 1.0 SLC16A4 "MCT4, MCT5" ENSG00000168679 "Solute carrier family 16 member 4" O15374 1 110362851-110391082 "Metabolic proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 124.1" "Cell type enhanced" "Detected in many" "Collecting duct cells: 71.7;Proximal tubular cells: 192.3" "Cancer enhanced" "Detected in all" "renal cancer: 35.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 4 "B-cells: 1.5" "Cell line enhanced" "Detected in many" "BEWO: 20.4;BJ hTERT+: 20.7;CAPAN-2: 30.8;HHSteC: 19.2;hTERT-RPE1: 42.6;SK-MEL-30: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046986, HPA060163" Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Cluster 43: B-cells - Humoral immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Microtubules, Cytosol" "Cytokinetic bridge" "HPA046986: AB_2679892, HPA060163: " "unprognostic (2.04e-1)" "unprognostic (1.69e-1)" "unprognostic (2.56e-1)" "unprognostic (2.77e-3)" "unprognostic (1.53e-1)" "unprognostic (2.22e-1)" "unprognostic (2.00e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.70e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.69e-4)" "unprognostic (3.68e-2)" "unprognostic (9.16e-2)" "unprognostic (1.71e-2)" "unprognostic (9.46e-2)" 4.9 2.9 2.7 4.6 3.1 1.0 6.9 5.8 4.4 4.2 15.4 3.6 9.5 3.0 22.4 2.7 4.0 13.7 4.6 3.5 4.1 124.1 16.3 9.2 3.4 4.1 3.1 21.4 0.9 0.4 3.8 28.6 3.9 3.8 1.6 2.3 3.6 5.8 1.3 1.3 11.4 3.4 4.1 2.7 2.7 5.2 3.0 0.6 8.5 3.9 1.1 7.9 3.5 4.2 0.4 9.8 2.3 2.7 6.3 12.9 20.4 5.3 20.7 1.8 5.3 3.1 30.8 0.6 5.7 17.1 0.1 0.5 0.1 1.9 1.9 0.5 2.5 0.5 2.7 3.3 19.2 0.9 0.5 10.0 0.3 3.0 0.2 42.6 4.1 0.8 0.5 1.2 3.3 1.0 0.4 0.6 0.9 0.0 0.3 0.2 1.3 0.1 3.7 0.4 1.2 0.9 0.6 9.8 30.6 9.0 0.7 0.1 0.4 1.4 0.7 0.3 1.5 0.5 0.1 1.6 1.1 0.4 6.1 0.0 0.2 0.1 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.3 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.1 2.7 3.1 5.8 4.4 3.5 4.1 4.1 3.1 3.9 4.1 3.0 4.2 1.9 12.8 20.8 2.3 5.8 3.1 6.1 11.2 1.2 11.5 14.7 6.5 1.1 11.5 6.8 71.7 6.2 39.5 5.8 0.9 3.9 2.7 0.5 3.3 6.8 4.6 3.5 2.7 8.2 0.9 34.6 18.2 1.5 3.3 5.1 5.2 4.2 5.0 4.2 3.3 7.1 0.9 4.1 1.6 3.0 2.2 18.0 1.8 10.6 15.0 1.8 2.4 9.2 2.5 4.7 1.9 1.2 11.7 1.2 3.1 38.4 192.3 3.5 20.1 0.0 4.5 5.4 3.4 1.9 0.5 3.7 35.2 3.9 7.0 1.4 7.2 SLC24A1 "CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX" ENSG00000074621 "Solute carrier family 24 member 1" O60721 15 65611366-65660995 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision" "Congenital stationary night blindness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 34 "retina: 193.5" "Cell type enriched" "Detected in many" 11 "Rod photoreceptor cells: 338.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA039370 Enhanced Approved Microtubules NA NA "Cluster 6: Non-specific - Transcription" "Cluster 79: Retina - Phototransduction" "Cluster 21: OE19 - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" Microtubules "HPA039370: AB_10960279" "unprognostic (9.47e-2)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.66e-3)" "unprognostic (6.39e-3)" "unprognostic (4.64e-1)" "unprognostic (8.82e-2)" "unprognostic (1.86e-1)" "unprognostic (4.69e-2)" "unprognostic (3.94e-1)" "unprognostic (2.01e-1)" "unprognostic (9.91e-2)" "prognostic favorable (2.33e-6)" "unprognostic (8.45e-2)" "unprognostic (9.22e-2)" "unprognostic (3.04e-2)" "unprognostic (1.96e-2)" 4.0 3.0 2.4 1.9 2.2 1.8 4.9 5.7 2.7 4.8 2.5 2.6 2.2 3.8 4.7 2.4 5.1 3.8 1.6 2.1 2.1 5.1 2.9 3.1 3.3 2.3 2.3 5.4 2.9 3.8 2.7 3.6 2.3 3.2 2.4 193.5 2.6 3.1 1.0 5.1 3.0 2.9 2.3 3.9 2.5 4.1 2.1 2.4 5.1 1.3 1.8 3.0 3.2 2.5 1.5 3.0 3.2 2.9 4.7 7.9 4.0 3.7 4.2 3.7 2.4 1.4 6.5 2.1 12.4 3.7 1.3 4.1 3.9 4.2 2.1 2.2 2.8 4.6 2.5 6.8 6.8 3.1 6.0 6.7 5.9 2.1 12.3 5.1 6.4 4.8 5.0 7.0 6.0 6.4 2.0 2.8 4.1 13.5 1.2 2.0 1.0 1.4 5.6 6.0 1.5 2.1 1.0 2.8 8.0 4.4 6.0 4.2 9.3 3.7 3.7 1.4 2.6 2.8 5.5 2.4 3.9 6.4 3.1 2.6 0.4 0.7 0.4 0.4 0.5 0.4 0.4 0.4 0.3 1.0 0.3 0.4 0.6 0.8 0.2 0.8 0.1 0.1 2.4 2.2 5.7 2.7 2.1 2.1 2.3 2.3 2.3 2.3 2.1 2.5 4.0 6.4 5.1 5.2 3.4 1.5 1.4 1.2 1.8 29.8 3.5 2.8 2.3 0.0 3.8 0.0 27.1 4.2 1.6 2.9 0.0 1.5 1.6 6.3 5.4 15.6 1.8 1.7 2.2 1.3 2.7 2.6 4.1 7.9 2.5 4.7 3.6 1.4 1.9 20.2 2.0 2.5 2.0 3.1 1.6 2.5 3.1 2.7 1.8 4.7 1.2 26.1 2.1 3.0 1.4 2.6 0.5 2.2 3.3 1.4 2.6 0.7 4.1 338.3 0.0 3.4 2.5 20.3 10.1 2.9 1.0 2.5 2.5 8.3 2.6 0.9 SLC26A1 "EDM4, SAT-1" ENSG00000145217 "Solute carrier family 26 member 1" Q9H2B4 4 979073-993440 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Ion channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 16.8" "Cell type enhanced" "Detected in some" "Astrocytes: 6.2;Excitatory neurons: 4.4;Hepatocytes: 10.4;Inhibitory neurons: 4.4;Oligodendrocyte precursor cells: 5.5;Proximal enterocytes: 6.4;Proximal tubular cells: 9.7" "Cancer enhanced" "Detected in many" "liver cancer: 5.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "basophil: 5.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.4" "Cell line enhanced" "Detected in many" "Hep G2: 13.8;HMC-1: 8.7;T-47d: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA041654 Uncertain Approved Microtubules NA NA "Cluster 34: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Microtubules "HPA041654: AB_10796350" "unprognostic (1.96e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-1)" "unprognostic (4.91e-2)" "unprognostic (1.74e-1)" "unprognostic (2.67e-4)" "unprognostic (5.13e-2)" "unprognostic (5.82e-2)" "unprognostic (2.16e-1)" "unprognostic (3.88e-2)" "unprognostic (1.53e-3)" "unprognostic (2.92e-2)" "prognostic favorable (1.19e-4)" "unprognostic (1.18e-2)" "unprognostic (2.22e-1)" "unprognostic (1.27e-1)" "unprognostic (1.65e-3)" 1.8 7.0 2.5 1.5 2.5 1.4 2.7 5.4 3.3 2.9 0.1 2.2 5.2 2.1 0.2 1.6 2.1 1.2 1.2 2.9 2.0 5.8 16.8 2.0 1.5 3.9 2.5 2.5 3.3 0.1 3.3 0.3 3.2 3.0 0.1 0.6 3.2 0.1 1.4 2.5 4.5 0.0 1.0 2.4 3.1 1.2 2.0 0.1 3.2 0.3 0.1 1.8 1.9 2.6 1.3 2.1 0.0 1.6 0.1 0.4 4.1 1.7 0.1 0.0 0.0 4.6 2.7 0.7 2.4 0.0 1.6 1.3 0.1 0.0 0.0 2.7 0.8 3.0 3.3 13.8 0.1 2.1 8.7 0.5 0.2 0.1 0.0 1.0 0.3 2.6 3.3 0.0 0.3 2.8 1.4 3.5 0.8 1.6 7.2 6.9 0.0 0.3 0.7 4.5 0.2 1.2 0.4 0.2 1.2 0.3 9.1 1.3 2.0 4.4 0.9 4.8 1.3 6.5 3.2 1.0 1.4 4.1 2.1 5.4 0.3 0.2 0.2 0.1 0.3 0.2 0.5 0.4 0.1 0.0 0.3 0.7 0.0 0.6 0.1 0.1 0.8 0.3 2.5 2.5 5.4 3.3 2.9 2.0 3.9 2.5 3.2 1.0 2.0 2.6 0.3 0.0 1.1 6.2 0.2 0.0 0.2 0.3 0.0 0.0 0.8 0.8 1.1 0.0 0.0 0.0 0.0 0.1 0.1 0.5 1.9 0.1 0.0 0.7 0.3 0.3 0.0 0.0 4.4 0.4 3.6 0.3 0.5 0.8 1.3 0.8 1.4 10.4 0.7 0.0 4.4 0.8 0.0 0.3 0.0 0.0 0.9 0.4 1.8 1.0 0.3 0.3 0.0 5.5 1.7 0.4 1.3 0.4 0.1 0.2 6.4 9.7 0.0 0.3 0.0 0.4 0.3 0.1 0.1 0.2 0.1 0.8 0.5 0.6 0.7 0.1 SLC29A4 "ENT4, FLJ34923" ENSG00000164638 "Solute carrier family 29 member 4" Q7RTT9 7 5274369-5306912 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 43.3;choroid plexus: 55.5" "Group enriched" "Detected in many" 5 "Enteroendocrine cells: 103.2;Horizontal cells: 168.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 49.2;SH-SY5Y: 70.7;U-2 OS: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052829 Approved "Microtubules,Cytokinetic bridge" Yes No "Cluster 40: NK-cells - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "Microtubules, Cytokinetic bridge" "HPA052829: AB_2681967" "unprognostic (6.04e-2)" "unprognostic (1.22e-2)" "unprognostic (8.49e-5)" "unprognostic (2.53e-1)" "unprognostic (1.47e-3)" "unprognostic (4.24e-2)" "unprognostic (9.59e-3)" "unprognostic (2.05e-1)" "unprognostic (2.55e-2)" "unprognostic (5.73e-2)" "prognostic favorable (4.52e-4)" "unprognostic (2.06e-1)" "unprognostic (3.02e-2)" "unprognostic (3.24e-2)" "unprognostic (2.63e-2)" "unprognostic (1.29e-3)" "unprognostic (6.60e-2)" 43.3 8.2 13.2 0.7 16.2 0.6 13.3 16.0 20.0 4.9 55.5 3.1 4.6 5.4 5.0 1.1 4.0 1.6 3.7 26.3 28.5 7.9 9.2 0.9 0.2 23.2 26.1 2.2 15.4 1.7 3.6 0.6 23.6 5.8 1.8 4.1 1.3 0.7 2.6 3.0 5.5 1.8 17.2 1.6 6.5 2.6 30.0 0.3 9.7 0.4 0.1 2.4 2.0 7.4 0.0 21.7 12.6 49.2 0.6 0.2 2.4 1.8 0.1 1.6 0.9 12.3 0.4 0.0 2.4 1.9 8.1 0.3 4.8 0.4 0.5 0.1 2.8 0.2 0.7 18.3 3.8 0.2 3.0 1.5 16.2 0.3 0.9 2.9 1.5 4.5 3.6 0.1 1.2 10.8 2.0 0.9 16.0 1.5 1.3 8.3 2.1 1.9 3.2 0.5 8.4 70.7 1.3 4.4 0.9 10.7 5.5 5.9 0.7 17.3 23.4 1.6 0.5 1.1 0.0 0.1 2.2 0.7 8.0 0.8 0.3 0.2 0.2 0.1 0.4 0.2 0.1 0.2 0.1 0.4 0.2 0.2 1.3 1.6 0.1 0.3 0.1 0.1 13.2 16.2 16.0 20.0 26.3 28.5 23.2 26.1 23.6 17.2 30.0 7.4 0.5 3.2 0.5 8.8 0.0 0.1 0.2 0.1 0.0 6.9 0.7 0.6 2.5 0.0 0.2 0.0 16.7 0.3 0.2 6.3 0.0 5.3 0.1 3.3 3.0 0.6 103.2 0.0 2.4 0.2 0.4 2.2 2.0 0.7 0.0 25.7 0.0 1.0 0.4 168.2 14.3 4.4 0.0 0.3 0.7 0.7 0.3 0.3 0.0 0.0 0.1 4.8 0.0 4.0 0.6 1.4 0.5 0.4 0.1 2.3 0.8 0.2 1.4 1.6 0.0 0.5 2.2 0.4 4.2 0.1 0.3 0.3 0.3 1.7 1.0 0.2 SLC38A3 "G17, SN1" ENSG00000188338 "Solute carrier family 38 member 3" Q99624 3 50205246-50221486 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "liver: 331.6;retina: 172.9" "Group enriched" "Detected in many" 6 "Bipolar cells: 88.3;Cone photoreceptor cells: 187.7;Hepatocytes: 114.6;Muller glia cells: 80.1;Rod photoreceptor cells: 124.0" "Cancer enriched" "Detected in many" 9 "liver cancer: 140.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.9" "Group enriched" "Detected in some" 5 "Hep G2: 49.8;SCLC-21H: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031871 Approved Microtubules,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol Microtubules "HPA031871: AB_2674080" "unprognostic (2.14e-1)" "unprognostic (2.10e-1)" "unprognostic (8.60e-2)" "unprognostic (6.19e-4)" "unprognostic (7.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.34e-2)" "unprognostic (2.30e-2)" "unprognostic (4.68e-3)" "unprognostic (1.46e-1)" "unprognostic (2.06e-1)" "unprognostic (5.71e-2)" "unprognostic (1.23e-3)" "unprognostic (1.90e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.96e-1)" 1.4 0.1 30.8 0.1 33.8 1.0 1.4 38.7 42.1 0.5 27.4 0.2 1.3 0.3 0.4 1.1 0.6 0.4 5.6 29.8 30.8 5.1 331.6 0.2 0.5 35.8 40.5 6.3 37.2 7.9 4.6 1.2 34.9 0.5 0.1 172.9 1.8 0.1 35.8 0.8 0.6 0.2 32.4 0.2 1.9 1.9 36.4 0.0 1.3 35.8 0.3 0.1 0.4 35.0 0.0 0.0 1.2 7.0 0.1 0.0 1.7 0.0 0.0 1.3 0.6 4.1 0.0 0.1 1.1 0.0 0.3 0.0 1.9 0.0 0.9 0.1 0.6 0.0 1.0 49.8 0.1 0.5 0.0 0.1 0.0 0.1 0.0 5.6 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.5 0.5 0.0 0.2 0.2 15.4 1.3 0.7 0.2 0.0 2.1 2.0 0.3 0.0 0.2 1.2 0.0 1.0 0.3 0.0 0.1 0.2 0.3 0.1 2.9 0.2 0.3 0.2 0.0 0.1 0.3 0.1 0.1 0.0 0.2 0.2 0.2 0.8 0.4 0.0 0.2 0.1 0.1 30.8 33.8 38.7 42.1 29.8 30.8 35.8 40.5 34.9 32.4 36.4 35.0 0.3 0.0 0.0 17.6 0.4 0.0 0.1 0.0 0.6 88.3 3.2 1.7 3.3 17.2 0.0 0.0 187.7 0.2 0.0 0.0 0.0 1.8 0.3 0.4 0.0 3.9 3.5 2.7 0.2 2.2 0.1 0.2 0.0 0.5 0.0 0.1 2.2 114.6 0.1 8.4 0.6 0.2 0.0 2.6 0.0 0.0 2.1 0.1 0.0 7.5 0.6 80.1 0.0 4.5 3.7 0.6 0.0 0.4 0.0 0.0 0.0 4.2 0.0 124.0 0.0 0.6 0.3 2.9 3.3 0.9 0.0 1.4 0.2 0.0 0.2 0.0 SLC38A6 NAT-1 ENSG00000139974 "Solute carrier family 38 member 6" Q8IZM9 14 60981114-61083733 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 178.2;Excitatory neurons: 98.8;Hofbauer cells: 100.3;Inhibitory neurons: 77.4;Late spermatids: 124.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018508 Approved Approved "Plasma membrane,Cell Junctions,Microtubules" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Cell Junctions" "Plasma membrane, Microtubules" "HPA018508: AB_2190518" "unprognostic (7.08e-2)" "unprognostic (4.14e-2)" "unprognostic (1.75e-1)" "unprognostic (3.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (9.47e-6)" "unprognostic (9.89e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-2)" "unprognostic (2.20e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (1.37e-5)" "unprognostic (1.73e-1)" "unprognostic (4.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-1)" 7.6 9.1 6.0 4.7 6.6 2.9 7.4 6.1 9.5 7.3 8.9 4.8 3.1 5.1 13.2 3.3 5.6 9.9 3.7 6.9 6.5 12.0 6.3 8.6 7.8 5.4 6.0 5.8 3.4 21.3 7.2 9.6 6.0 5.1 6.6 7.5 5.9 3.9 2.1 2.9 3.5 5.3 5.0 6.6 3.8 5.0 7.4 5.0 6.3 3.0 4.8 7.0 5.0 6.7 16.2 21.5 6.8 12.3 68.7 25.3 4.9 11.6 34.5 10.7 10.2 5.4 41.0 4.0 19.2 10.6 22.5 13.5 6.8 11.9 9.8 6.0 3.2 6.7 8.6 14.2 22.7 3.7 12.1 19.9 4.9 10.5 12.2 43.2 14.3 6.8 9.3 8.4 37.5 9.2 6.6 8.4 4.0 9.5 14.3 1.6 20.1 11.9 30.7 8.5 3.3 3.0 9.9 7.0 19.1 9.3 10.4 5.8 15.6 16.4 7.1 20.0 6.5 1.6 4.9 1.6 34.0 3.0 13.1 0.0 6.6 0.1 1.7 7.1 2.2 2.2 3.1 2.4 3.6 2.0 2.7 3.4 0.2 0.8 4.5 4.4 4.5 2.8 6.0 6.6 6.1 9.5 6.9 6.5 5.4 6.0 6.0 5.0 7.4 6.7 6.8 22.4 6.7 31.6 6.0 5.2 11.4 14.6 8.0 19.7 7.2 7.5 4.3 7.2 10.0 5.5 22.9 5.6 4.9 2.6 1.9 5.3 178.2 13.0 11.0 7.2 4.2 3.4 98.8 2.8 9.4 11.2 5.1 6.2 6.3 7.3 4.2 4.6 100.3 5.0 77.4 3.1 6.1 24.8 10.0 124.4 10.8 26.2 5.4 20.6 6.4 11.7 2.1 54.3 30.8 7.4 1.9 6.0 5.8 6.6 3.3 23.1 40.4 24.9 0.0 12.3 9.1 16.6 11.5 6.4 2.8 6.7 7.8 5.0 2.8 6.9 SLN "MGC12301, MGC125854, MGC125855" ENSG00000170290 Sarcolipin O00631 11 107707378-107719693 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 8190.2;tongue: 3399.6" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 730.3;Muller glia cells: 462.5;Skeletal myocytes: 225.1" "Group enriched" "Detected in many" 5 "glioma: 21.6;head and neck cancer: 22.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HSkMC: 2.5;Karpas-707: 1.2;PC-3: 1.1;SuSa: 2.5;U-2 OS: 1.1" CAB011628 Approved Microtubules NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 37: Myocytes - Muscle contraction" Microtubules "CAB011628: AB_2195046" "unprognostic (6.85e-2)" "unprognostic (6.18e-8)" "unprognostic (2.60e-1)" "unprognostic (3.66e-2)" "unprognostic (2.40e-3)" "unprognostic (4.12e-3)" "unprognostic (5.28e-3)" "unprognostic (1.31e-2)" "unprognostic (2.76e-1)" "unprognostic (6.35e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.52e-9)" "unprognostic (3.27e-2)" "unprognostic (2.54e-1)" "unprognostic (5.09e-4)" "unprognostic (3.77e-2)" 5.1 8.3 2.8 0.0 3.4 0.0 2.1 3.9 7.8 0.2 1.3 4.7 0.3 0.2 0.8 149.2 0.7 0.3 975.1 2.4 1.4 2.6 0.7 6.4 0.2 1.5 2.3 0.6 1.8 0.2 0.7 1.3 2.3 37.0 0.1 60.7 59.4 0.3 8190.2 4.4 1.5 1.4 1.3 0.3 0.8 1.3 1.4 2.7 2.0 3399.6 0.9 0.4 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.4 3.9 7.8 2.4 1.4 1.5 2.3 2.3 1.3 1.4 2.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 2.4 0.0 0.0 730.3 0.0 0.0 0.0 2.1 1.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 10.5 0.0 0.0 0.3 0.4 1.9 42.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.3 0.0 0.0 0.0 0.0 1.1 8.8 0.0 1.0 0.0 0.0 0.0 462.5 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.2 0.0 0.4 0.0 19.9 0.0 225.1 40.5 0.1 0.0 0.0 1.4 5.7 1.0 0.0 0.0 0.1 SNX10 ENSG00000086300 "Sorting nexin 10" Q9Y5X0 7 26291862-26374383 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Disease variant, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.1" "Cell type enhanced" "Detected in many" "Distal tubular cells: 285.7;Hofbauer cells: 148.7;Kupffer cells: 215.5;Macrophages: 166.5;monocytes: 152.3;Muller glia cells: 310.5;Proximal tubular cells: 204.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 336.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 103.1;U-937: 87.3;WM-115: 297.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015605, HPA064782" Approved Supported Nucleoplasm,Nucleoli,Microtubules NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Microtubules" Nucleoli "HPA015605: AB_1857342, HPA064782: AB_2685349" "unprognostic (6.42e-2)" "unprognostic (2.72e-3)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.92e-2)" "unprognostic (2.48e-3)" "unprognostic (4.51e-2)" "unprognostic (4.87e-1)" "unprognostic (9.36e-2)" "unprognostic (1.59e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (8.06e-5)" "unprognostic (1.12e-2)" "unprognostic (3.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.50e-1)" 23.7 14.5 26.4 34.7 27.8 42.1 11.0 17.6 45.9 4.5 6.1 5.6 4.1 9.0 1.1 2.9 3.0 8.8 1.8 30.2 42.2 37.8 69.1 41.2 36.9 29.1 28.2 1.1 7.8 1.3 4.7 10.9 40.3 3.5 6.4 47.1 1.7 2.1 1.0 1.4 6.2 9.5 18.6 42.1 3.9 5.1 32.0 15.8 2.9 2.7 24.8 10.9 1.6 26.8 55.8 5.0 0.2 10.1 0.1 0.0 57.8 0.0 3.9 0.1 0.0 0.5 18.4 24.0 41.4 0.0 36.2 1.7 13.5 3.6 0.0 33.3 12.4 2.5 0.4 36.3 0.1 52.2 8.9 0.6 5.4 0.0 4.2 0.1 0.8 30.7 1.5 0.3 0.0 9.7 22.2 54.3 15.3 0.9 5.1 0.1 0.1 1.3 103.1 12.0 22.5 7.1 11.7 8.5 62.7 18.1 15.2 72.6 0.3 0.1 12.2 0.2 13.7 17.9 15.5 16.4 0.5 87.3 297.4 55.9 144.7 3.7 18.6 158.5 18.2 82.3 13.2 16.4 101.2 71.7 6.9 12.0 336.7 47.7 162.5 37.0 29.6 70.0 26.4 27.8 17.6 45.9 30.2 42.2 29.1 28.2 40.3 18.6 32.0 26.8 3.3 3.2 14.7 6.8 63.4 5.4 1.2 0.7 1.8 20.3 17.6 9.5 1.8 34.3 4.4 23.9 2.1 14.9 18.6 2.5 285.7 66.0 1.3 2.1 40.7 7.6 9.5 19.1 63.1 27.1 111.8 3.4 0.0 2.3 31.1 2.9 2.2 109.8 148.7 35.3 53.4 3.3 0.0 215.5 130.3 2.1 1.2 166.5 8.8 19.7 152.3 310.5 33.0 7.1 8.5 14.1 1.5 0.0 8.0 4.4 4.5 204.9 0.8 23.2 0.0 0.7 4.7 7.1 29.5 0.8 3.0 28.7 31.6 0.9 8.7 1.3 SPRY2 hSPRY2 ENSG00000136158 "Sprouty RTK signaling antagonist 2" O43597 13 80335976-80341126 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 267.9;SK-MEL-30: 156.9;WM-115: 136.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037205, HPA042198" Approved Supported "Actin filaments,Microtubules" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" "Actin filaments, Microtubules" "CAB037205: AB_261923, HPA042198: AB_2677896" "unprognostic (9.37e-3)" "unprognostic (3.71e-2)" "unprognostic (1.10e-1)" "unprognostic (9.12e-3)" "unprognostic (3.80e-2)" "unprognostic (8.99e-2)" "unprognostic (3.95e-3)" "unprognostic (2.43e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-1)" "unprognostic (1.53e-1)" "unprognostic (4.28e-2)" "unprognostic (1.56e-2)" "unprognostic (9.89e-2)" "unprognostic (3.22e-1)" "unprognostic (1.04e-1)" "unprognostic (1.86e-2)" 69.6 24.1 37.4 11.8 38.0 29.5 66.2 57.6 42.9 31.0 27.7 40.4 17.6 29.3 15.3 20.0 46.7 30.1 50.9 38.5 36.0 21.1 27.8 31.5 8.9 50.2 40.4 16.9 27.4 10.2 17.3 13.9 40.2 26.2 27.3 34.2 34.8 18.9 39.1 26.5 25.4 23.5 42.0 30.8 25.9 4.1 39.7 11.3 27.1 41.4 4.9 27.0 30.8 43.4 1.8 7.6 84.2 267.9 108.4 70.6 5.8 69.3 31.1 15.3 18.2 34.9 10.3 0.0 11.6 28.5 10.6 6.7 4.8 13.9 17.0 0.1 15.3 12.0 4.5 8.9 24.9 63.4 4.8 31.8 14.6 26.1 63.3 95.6 29.9 13.0 4.4 0.3 35.0 1.5 8.6 28.8 33.7 23.6 19.6 25.6 112.0 0.2 28.8 11.7 1.0 46.7 5.7 3.1 156.9 32.9 6.3 56.0 44.3 14.3 5.6 30.3 13.6 0.1 0.1 0.0 97.6 23.9 136.9 0.0 0.0 2.1 0.3 0.0 0.1 0.4 0.0 0.8 0.9 0.0 0.0 0.1 0.0 4.1 0.0 0.1 0.0 0.1 37.4 38.0 57.6 42.9 38.5 36.0 50.2 40.4 40.2 42.0 39.7 43.4 48.5 25.6 29.3 59.4 2.9 43.5 38.0 12.5 53.5 5.9 12.4 21.3 20.5 18.6 6.3 1.8 6.2 8.7 12.1 33.4 5.9 11.3 0.3 25.2 17.6 22.3 12.0 8.4 22.1 8.0 2.9 65.9 11.2 41.7 16.4 7.2 32.5 17.0 10.9 8.4 15.3 36.1 4.1 27.3 10.7 1.5 29.5 12.2 14.2 15.9 0.8 68.5 3.1 39.7 17.6 18.0 33.7 5.7 1.7 23.1 7.2 8.3 4.8 23.3 26.3 57.7 67.6 0.1 1.5 16.2 29.1 9.6 11.1 8.5 27.6 11.9 SPTAN1 ENSG00000197694 "Spectrin alpha, non-erythrocytic 1" Q13813 9 128552558-128633662 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding, Calmodulin-binding" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Bipolar cells: 296.6;Cone photoreceptor cells: 310.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004581, HPA007927" Enhanced Approved Vesicles,Microtubules NA NA 1600000 "Cluster 13: T-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" "Vesicles, Microtubules" "CAB004581: AB_671135, HPA007927: AB_1857435" "unprognostic (1.46e-2)" "unprognostic (2.73e-2)" "unprognostic (1.56e-1)" "unprognostic (9.06e-2)" "unprognostic (3.24e-1)" "unprognostic (4.02e-2)" "unprognostic (2.56e-3)" "unprognostic (2.20e-1)" "unprognostic (1.81e-1)" "unprognostic (1.30e-2)" "unprognostic (2.49e-1)" "unprognostic (1.36e-1)" "prognostic favorable (1.84e-12)" "unprognostic (2.94e-2)" "unprognostic (1.60e-1)" "unprognostic (4.18e-3)" "unprognostic (2.19e-3)" 48.8 31.4 81.7 38.6 85.0 28.1 36.6 54.4 99.7 39.4 0.4 47.3 24.7 57.1 32.9 36.8 54.0 32.5 65.7 90.9 43.5 34.6 22.8 55.1 38.5 142.7 49.6 51.6 24.0 47.1 32.5 57.1 155.0 32.7 36.3 103.1 31.9 46.5 23.9 69.4 34.9 58.8 65.6 44.3 31.1 44.9 61.5 45.4 38.4 22.3 38.0 40.0 36.4 55.3 108.1 116.9 75.2 83.4 107.6 121.0 61.5 90.2 75.2 99.4 74.1 167.3 74.6 94.3 78.3 137.0 69.8 193.3 80.7 90.4 61.1 53.2 47.9 15.9 324.4 94.4 61.3 70.9 51.0 58.3 71.6 166.3 55.8 83.9 134.4 87.2 9.1 107.6 98.6 74.6 136.3 29.5 96.1 125.9 72.1 91.0 90.2 59.7 80.2 91.1 58.1 91.1 296.1 40.3 42.9 91.8 70.0 19.8 232.5 68.5 102.2 100.0 71.2 65.3 82.6 51.8 83.5 31.5 65.9 3.3 1.6 3.9 9.7 1.3 13.5 6.3 12.4 9.2 2.4 5.8 7.6 7.9 1.5 7.1 1.2 3.0 15.3 5.8 81.7 85.0 54.4 99.7 90.9 43.5 142.7 49.6 155.0 65.6 61.5 55.3 144.9 70.5 27.5 123.7 56.3 37.3 27.8 34.3 25.6 296.6 69.8 83.2 68.5 68.6 33.9 101.2 310.6 27.5 112.6 145.4 7.9 67.6 18.0 108.2 71.4 103.8 56.9 13.7 159.5 59.2 16.0 77.8 76.5 87.5 12.0 47.9 96.8 36.2 29.2 124.5 183.8 54.1 30.5 22.2 29.4 40.5 85.1 32.8 35.6 74.9 24.4 97.7 48.4 87.4 17.4 102.2 93.0 94.8 70.5 45.9 62.4 22.8 71.3 156.5 26.3 53.0 60.0 33.0 44.5 43.7 45.5 18.2 95.4 22.0 73.6 65.7 SPTLC3 "C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L" ENSG00000172296 "Serine palmitoyltransferase long chain base subunit 3" Q9NUV7 20 13008972-13169103 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 28.4;Early spermatids: 27.9;Glandular and luminal cells: 47.4;Microglial cells: 35.6;Syncytiotrophoblasts: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 33.3;RPTEC TERT1: 43.7;U-2197: 30.4;U-87 MG: 57.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA044247, HPA048079" Enhanced Approved Microtubules NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 44: Endometrium - Transcription" Microtubules "HPA044247: AB_2678872, HPA048079: AB_2680252" "unprognostic (6.81e-2)" "unprognostic (7.76e-2)" "unprognostic (4.46e-2)" "unprognostic (1.25e-3)" "unprognostic (5.43e-2)" "unprognostic (2.12e-1)" "unprognostic (5.70e-2)" "unprognostic (7.99e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (5.08e-2)" "prognostic favorable (4.51e-7)" "unprognostic (2.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.18e-1)" 4.6 4.3 1.4 1.4 1.4 0.6 8.3 1.2 1.3 7.4 8.5 6.1 15.7 4.7 16.8 5.9 6.7 10.9 6.4 1.5 2.7 18.2 20.0 7.8 1.3 2.4 2.1 7.1 5.6 11.0 2.7 20.9 2.4 5.9 7.4 2.8 6.7 3.6 0.4 25.6 16.2 3.9 1.8 2.9 4.5 6.4 3.8 5.0 24.4 2.0 1.7 5.7 5.1 2.5 1.5 2.4 1.8 0.0 14.1 20.2 11.4 0.0 3.2 2.1 8.2 18.6 9.3 0.0 1.2 0.6 18.2 25.0 0.0 7.0 3.0 0.0 0.1 0.0 5.6 26.4 1.3 0.0 0.2 11.5 21.4 8.4 2.8 7.7 1.4 4.4 0.0 33.3 23.7 0.5 0.1 0.0 0.1 2.2 2.9 2.3 4.2 15.1 43.7 18.2 0.0 0.3 0.2 2.3 0.1 3.1 18.6 0.5 3.3 9.2 3.1 30.4 2.2 0.2 0.0 0.0 57.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.4 1.4 1.2 1.3 1.5 2.7 2.4 2.1 2.4 1.8 3.8 2.5 3.6 6.4 22.3 5.2 0.1 2.4 5.3 2.3 4.6 0.1 5.4 5.0 17.9 4.3 4.9 9.2 0.0 28.4 1.0 3.4 7.9 3.0 27.9 18.7 5.2 4.6 0.0 2.1 0.5 4.4 13.0 5.4 4.6 47.4 1.3 5.6 1.8 20.7 2.8 0.0 0.9 5.7 6.1 2.6 0.4 11.6 3.7 2.4 0.0 35.6 0.0 12.3 3.1 0.0 0.1 3.2 6.7 2.6 0.1 2.3 10.9 18.6 3.5 0.4 0.0 6.1 0.8 1.2 0.1 4.9 2.3 46.1 1.2 2.9 7.3 2.6 SRA1 "SRA, STRAA1" ENSG00000213523 "Steroid receptor RNA activator 1" Q9HD15 5 140537340-140558252 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Activator, Receptor, Ribonucleoprotein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044598, HPA050153" Approved Supported "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA044598: AB_2679013, HPA050153: AB_2681033" "unprognostic (1.51e-1)" "unprognostic (1.04e-2)" "unprognostic (8.69e-2)" "prognostic favorable (8.01e-6)" "unprognostic (9.32e-2)" "unprognostic (2.56e-1)" "unprognostic (2.90e-1)" "unprognostic (2.43e-1)" "unprognostic (9.38e-2)" "unprognostic (7.41e-2)" "unprognostic (5.58e-3)" "unprognostic (2.61e-1)" "unprognostic (5.34e-2)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (3.71e-1)" "unprognostic (1.04e-1)" 12.2 34.0 8.7 7.7 9.0 9.6 9.7 15.8 12.3 10.0 9.2 12.5 5.1 8.2 6.0 9.3 9.4 5.6 12.0 9.9 9.3 12.4 25.8 15.0 6.3 8.4 8.2 14.9 7.5 4.7 22.2 5.8 8.8 12.5 4.7 7.2 14.8 6.2 14.5 9.4 11.9 5.4 8.6 17.6 14.0 22.6 8.9 5.6 12.9 2.5 5.2 9.4 8.8 9.2 9.7 22.7 11.8 12.3 5.6 7.6 16.4 16.1 9.1 10.3 10.8 41.8 5.9 8.2 11.7 6.2 5.5 6.4 2.1 12.0 4.1 12.7 13.9 7.2 25.0 16.1 12.0 13.1 9.4 14.7 6.1 5.5 2.8 9.1 4.7 13.8 7.4 12.1 6.9 29.5 10.7 20.4 3.6 5.2 18.0 11.7 10.0 7.9 5.4 11.3 8.3 9.8 9.4 8.5 11.6 4.1 10.5 14.7 7.5 9.7 5.1 8.5 13.2 15.1 10.9 8.6 12.0 16.8 6.5 16.1 26.0 20.3 10.7 23.8 9.9 15.8 10.2 10.4 25.2 14.0 8.2 9.4 43.0 13.6 23.6 15.2 19.5 26.8 8.7 9.0 15.8 12.3 9.9 9.3 8.4 8.2 8.8 8.6 8.9 9.2 43.3 6.4 49.4 13.4 46.7 52.4 68.5 126.1 38.7 23.6 57.8 48.9 71.7 57.2 86.4 33.1 8.4 103.7 56.9 87.8 113.5 102.7 104.6 59.5 33.4 39.8 38.4 35.1 15.5 148.2 117.9 48.6 64.7 43.1 68.4 21.8 42.1 69.7 93.1 15.2 17.2 71.6 107.8 61.2 71.5 150.0 25.1 82.0 67.6 7.5 90.4 59.5 42.2 9.0 11.5 186.0 78.7 29.7 113.7 82.9 83.7 131.0 84.1 23.7 26.3 26.7 76.1 77.2 30.7 62.3 45.9 179.0 47.4 66.8 49.2 142.6 SRRM3 FLJ37078 ENSG00000177679 "Serine/arginine repetitive matrix 3" 7 76201896-76287288 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 56.0;retina: 27.2" "Group enriched" "Detected in many" 7 "Bipolar cells: 153.1;Cone photoreceptor cells: 479.6;Excitatory neurons: 139.1;Horizontal cells: 171.6;Inhibitory neurons: 144.4;Rod photoreceptor cells: 421.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SCLC-21H: 10.9;SH-SY5Y: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019337 Approved "Plasma membrane,Intermediate filaments,Microtubules" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane" "Intermediate filaments, Microtubules" "HPA019337: AB_1848909" "unprognostic (1.65e-1)" "unprognostic (1.96e-1)" "unprognostic (8.37e-3)" "unprognostic (4.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (6.51e-2)" "unprognostic (1.89e-3)" "unprognostic (1.62e-2)" "unprognostic (5.07e-3)" "unprognostic (6.37e-2)" "unprognostic (3.73e-3)" "unprognostic (5.05e-1)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.15e-2)" 0.0 2.1 6.0 0.1 13.2 0.0 0.0 56.0 30.7 0.1 0.0 0.3 0.1 0.2 0.2 0.1 0.0 0.0 0.1 4.8 0.2 0.0 0.0 0.0 0.0 41.5 3.2 0.2 0.3 0.3 8.9 0.0 40.1 0.1 0.1 27.2 0.1 0.0 0.1 0.0 0.1 0.0 1.6 0.0 0.4 2.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 4.7 0.3 0.2 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 8.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 13.2 56.0 30.7 4.8 0.2 41.5 3.2 40.1 1.6 0.9 4.7 0.3 0.0 0.0 8.1 0.0 2.0 6.4 1.9 7.4 153.1 1.8 0.5 6.9 1.5 1.2 0.0 479.6 0.4 0.0 0.2 0.0 2.0 22.2 0.5 4.2 1.2 12.1 0.0 139.1 2.4 8.1 4.8 0.5 1.0 0.0 12.0 1.8 0.0 0.5 171.6 144.4 0.1 2.0 0.0 0.8 32.2 2.1 0.2 3.6 5.6 0.0 15.9 0.0 18.6 4.9 0.9 0.1 2.2 0.0 2.2 0.0 0.4 0.2 421.8 0.0 1.2 2.0 8.6 3.1 4.9 1.1 2.2 0.1 0.2 0.0 4.9 SYNJ2 INPP5H ENSG00000078269 "Synaptojanin 2" O15056 6 157981863-158099176 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 116.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 102.1;Glandular and luminal cells: 114.2;Oligodendrocytes: 502.1;Pancreatic endocrine cells: 140.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 133.4;TIME: 109.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031575 Approved Approved Microtubules,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Microtubules Cytosol "HPA031575: AB_10604101" "prognostic unfavorable (2.63e-4)" "unprognostic (1.94e-2)" "unprognostic (7.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.48e-2)" "unprognostic (7.68e-2)" "unprognostic (1.24e-1)" "unprognostic (7.06e-2)" "unprognostic (2.91e-1)" "unprognostic (7.29e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.02e-6)" "unprognostic (1.66e-2)" "unprognostic (3.75e-2)" "unprognostic (1.75e-1)" "unprognostic (9.45e-2)" 4.2 5.8 26.1 6.2 69.9 20.0 8.0 58.6 42.0 4.5 1.9 10.6 7.1 7.6 10.5 7.7 5.5 9.4 10.7 22.5 32.4 8.4 4.9 4.5 5.9 98.1 74.7 3.6 8.1 1.5 4.1 3.5 78.9 6.9 10.4 2.3 16.5 5.8 7.2 4.3 6.8 7.7 57.8 4.2 8.5 9.4 58.2 6.5 5.2 9.5 6.5 11.0 4.6 116.2 16.4 56.6 4.5 7.3 3.4 11.2 24.2 29.8 60.4 35.0 41.1 28.7 13.5 0.5 19.8 57.9 133.4 15.4 10.1 18.5 40.1 22.9 9.3 31.8 29.8 30.9 6.5 10.9 32.6 5.9 9.9 53.3 12.4 47.1 61.7 16.4 24.7 6.5 16.1 7.6 14.0 12.2 5.1 51.4 31.2 6.0 19.1 13.4 11.8 18.8 34.8 2.0 22.7 14.2 5.9 17.2 10.9 7.1 109.7 25.8 26.8 61.4 36.5 2.5 7.8 0.4 49.2 17.5 18.4 3.0 0.6 0.5 0.9 0.3 1.9 1.0 1.3 0.8 0.6 2.0 1.1 0.8 4.3 1.0 0.4 0.5 1.2 0.5 26.1 69.9 58.6 42.0 22.5 32.4 98.1 74.7 78.9 57.8 58.2 116.2 17.2 3.2 3.3 5.2 15.4 21.7 19.9 7.5 14.2 2.4 25.4 18.4 13.9 21.5 8.6 18.4 0.0 7.7 12.8 20.0 3.9 59.0 35.5 48.5 13.7 26.4 17.4 5.5 102.1 35.2 5.0 16.6 34.1 114.2 5.1 37.7 7.9 5.2 2.0 0.0 10.1 14.8 10.2 2.2 17.6 56.5 1.2 12.5 10.6 7.5 6.9 1.6 16.5 8.5 502.1 140.2 7.1 6.4 13.5 50.6 13.1 1.7 14.4 0.6 0.0 7.3 18.9 0.9 1.1 11.5 17.2 15.9 17.1 2.2 15.7 36.2 SYTL5 ENSG00000147041 "Synaptotagmin like 5" Q8TDW5 X 38006553-38128819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;stomach 1: 12.1" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 37.2;Inhibitory neurons: 92.0;Intestinal goblet cells: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.2;MCF7: 5.8;OE19: 8.4;SK-MEL-30: 14.8;SuSa: 19.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026074 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Microtubules, Cytosol" "HPA026074: AB_1857697" "unprognostic (3.60e-2)" "unprognostic (1.71e-1)" "unprognostic (2.35e-1)" "unprognostic (6.68e-2)" "unprognostic (3.09e-3)" "unprognostic (3.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.10e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (5.21e-2)" "unprognostic (1.51e-1)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" 0.0 8.2 6.5 0.3 7.2 0.0 2.5 0.0 5.6 5.6 0.1 2.8 2.2 2.2 0.8 3.1 0.4 0.5 1.1 6.7 10.7 1.2 4.4 0.6 0.0 3.4 13.6 0.1 5.8 0.0 0.6 7.4 6.3 0.9 3.2 0.5 2.2 0.4 0.0 0.1 2.4 3.3 2.5 0.0 12.1 0.6 8.6 0.0 0.1 0.0 0.0 0.9 0.8 0.9 0.0 1.2 0.2 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 6.2 1.4 0.0 0.0 0.5 2.2 0.7 0.0 0.0 0.0 0.0 0.6 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 0.7 0.1 0.0 0.1 0.2 0.2 5.8 0.0 0.0 2.5 8.4 0.0 0.0 2.0 0.0 0.0 0.4 3.2 0.0 0.3 1.2 14.8 19.5 0.0 0.0 0.0 0.1 4.7 0.0 3.3 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.5 7.2 0.0 5.6 6.7 10.7 3.4 13.6 6.3 2.5 8.6 0.9 0.0 0.0 2.0 1.6 0.0 0.0 0.2 0.8 0.0 0.0 4.0 1.5 0.3 0.0 8.7 0.0 0.0 3.3 0.0 4.6 0.0 0.0 0.0 0.7 3.6 0.1 3.0 0.0 1.4 0.9 3.6 0.6 37.2 4.0 0.0 1.0 0.4 1.3 0.3 0.0 92.0 20.8 6.1 0.0 0.0 0.0 0.6 0.2 0.0 1.0 0.2 0.0 0.0 0.0 1.1 4.9 3.0 2.6 0.3 0.6 0.6 0.1 3.3 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 8.9 0.1 0.0 0.7 1.0 TAGLN "DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10" ENSG00000149591 Transgelin Q01995 11 117199370-117207464 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 9628.1;intestine: 11712.2" "Group enriched" "Detected in many" 4 "Breast myoepithelial cells: 2508.6;Peritubular cells: 2306.4;Sertoli cells: 2866.2;Smooth muscle cells: 4563.9" "Cancer enhanced" "Detected in all" "prostate cancer: 279.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "intermediate monocyte: 41.6;non-classical monocyte: 63.1" "Lineage enriched" "Detected in many" 12 "monocytes: 63.1" "Cell line enhanced" "Detected in all" "BJ: 1913.4;BJ hTERT+ SV40 Large T+: 1641.8;CACO-2: 1531.4;EFO-21: 2145.6;fHDF/TERT166: 2094.4;hTERT-RPE1: 1499.7;LHCN-M2: 1377.1;U-138 MG: 1598.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001447, HPA019467" Enhanced Approved Microtubules,Mitochondria,Cytosol No No 6300000 "Cluster 51: Monocytes - Innate immune response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Microtubules, Mitochondria" Cytosol "CAB001447: AB_564012, HPA019467: AB_1857245" "unprognostic (1.36e-2)" "unprognostic (1.06e-1)" "unprognostic (3.57e-3)" "unprognostic (1.91e-1)" "unprognostic (6.58e-2)" "unprognostic (1.02e-2)" "unprognostic (2.39e-2)" "unprognostic (7.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.24e-1)" "unprognostic (4.43e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.12e-7)" "unprognostic (9.58e-3)" "unprognostic (3.03e-1)" "unprognostic (1.10e-1)" "unprognostic (2.52e-3)" 2235.7 512.7 118.5 963.9 144.4 12.1 1680.5 126.1 215.9 3611.3 172.5 11712.2 451.2 9628.1 693.9 1954.6 4610.6 893.8 1583.5 119.6 120.4 774.5 302.8 1258.6 245.5 137.0 127.0 1643.4 218.6 65.3 254.6 348.0 129.2 4624.1 1154.6 22.9 461.8 6383.6 356.4 619.8 1948.4 7108.7 127.2 532.0 3148.4 202.5 138.2 52.2 723.2 152.4 59.9 5521.7 2331.2 130.0 17.5 5.5 293.3 8.2 140.0 123.8 226.7 1913.4 788.1 1641.8 609.0 1531.4 28.4 3.2 2145.6 2094.4 1.7 46.1 4.4 16.8 543.3 6.8 4.4 5.0 66.9 130.2 708.7 1.7 5.2 304.6 57.5 267.1 36.1 1499.7 3.3 4.5 3.3 6.7 1377.1 4.5 1.7 15.8 84.6 18.8 2.1 2.7 23.1 12.0 4.4 25.8 1.9 9.6 29.9 11.0 1.5 807.6 9.2 5.1 182.0 1598.8 276.9 14.4 86.6 8.9 8.8 21.7 9.1 7.7 6.2 1.8 2.7 0.1 0.3 41.6 0.5 3.6 0.1 0.0 3.2 5.1 0.2 0.1 0.3 0.0 63.1 1.6 0.5 2.1 118.5 144.4 126.1 215.9 119.6 120.4 137.0 127.0 129.2 127.2 138.2 130.0 264.8 38.5 6.1 4.6 10.3 63.9 453.4 248.6 10.8 9.9 74.0 2508.6 1.3 4.3 22.5 40.5 18.8 57.0 8.6 3.1 0.0 577.8 3.3 14.6 455.5 260.3 3.0 2.7 4.5 74.5 35.3 464.4 41.3 12.8 1.3 32.4 639.7 8.9 41.5 1.7 6.5 18.3 24.4 23.1 91.8 23.9 48.4 33.8 96.0 37.5 8.1 4.9 2.1 3.0 11.9 38.4 4.5 2306.4 3.2 414.0 12.1 2.2 23.0 9.9 2866.2 177.6 4563.9 6.0 13.7 8.6 60.9 32.2 15.1 8.3 3.1 62.0 TBCA ENSG00000171530 "Tubulin folding cofactor A" O75347 5 77691166-77868780 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 1298.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036487 Approved Supported Nucleoli,Microtubules NA NA 1800000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 2: Hepatocytes - Metabolism" Microtubules Nucleoli "HPA036487: AB_10669794" "unprognostic (2.03e-2)" "unprognostic (2.12e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-2)" "unprognostic (2.06e-1)" "unprognostic (1.78e-2)" "unprognostic (4.95e-2)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (5.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" "unprognostic (7.63e-2)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" 152.9 255.7 134.2 112.1 136.7 156.5 146.4 137.9 177.2 149.1 137.7 152.0 105.3 131.3 246.2 170.6 142.3 89.0 153.9 134.8 152.7 189.9 286.7 114.4 146.2 144.7 151.8 194.1 131.7 162.1 150.7 122.9 150.4 127.7 106.2 108.8 124.4 100.0 147.1 98.1 104.6 104.7 138.3 108.7 153.0 79.3 145.4 155.0 130.2 108.1 140.7 133.1 136.9 140.9 427.1 286.2 526.4 515.1 227.5 322.7 285.1 352.9 303.2 377.9 432.6 389.5 456.0 654.1 627.0 200.5 562.2 258.0 328.1 453.9 372.7 306.6 524.8 310.9 286.4 426.5 331.7 271.8 248.1 326.4 350.4 270.0 401.0 372.1 329.6 532.2 331.9 396.4 346.7 367.4 575.7 650.3 320.5 122.1 265.0 383.6 434.5 703.6 373.7 358.0 501.1 324.3 339.3 236.6 668.0 455.3 337.2 679.0 307.2 192.2 214.2 341.5 563.3 323.0 339.3 580.9 438.0 463.3 391.1 73.3 138.4 77.5 135.4 153.6 153.5 218.6 160.9 162.4 172.5 196.0 150.8 194.9 82.2 132.7 168.3 253.7 241.6 156.8 134.2 136.7 137.9 177.2 134.8 152.7 144.7 151.8 150.4 138.3 145.4 140.9 177.5 153.8 141.9 53.2 234.6 210.9 264.5 447.5 140.0 167.4 310.9 371.0 88.5 275.9 217.0 303.5 58.4 453.9 195.5 231.4 718.1 377.4 46.5 458.4 263.1 185.2 253.5 189.1 71.2 388.5 374.1 216.1 151.4 238.8 159.0 394.1 297.0 1298.8 411.2 148.0 73.9 300.7 252.3 495.5 401.4 42.7 306.6 226.3 225.9 40.3 394.9 231.3 254.3 66.9 126.8 476.2 283.1 258.8 182.6 406.3 256.6 1037.0 360.8 133.3 236.7 214.8 223.0 236.5 119.0 261.6 226.0 563.8 203.7 505.0 303.6 303.3 TCTN1 "FLJ21127, JBTS13, TECT1" ENSG00000204852 "Tectonic family member 1" Q2MV58 12 110614027-110663431 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 98.9;Respiratory ciliated cells: 203.7;Spermatocytes: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039687, HPA040036" Approved Approved "Nucleoplasm,Vesicles,Actin filaments,Microtubules" "Intracellular and membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Actin filaments" "Nucleoplasm, Vesicles, Microtubules" "HPA039687: AB_10795293, HPA040036: AB_10794759" "unprognostic (2.54e-1)" "unprognostic (7.22e-3)" "unprognostic (2.28e-1)" "prognostic favorable (1.13e-5)" "unprognostic (2.89e-2)" "unprognostic (6.53e-2)" "unprognostic (2.11e-1)" "unprognostic (3.05e-2)" "unprognostic (6.02e-2)" "unprognostic (4.54e-2)" "unprognostic (5.20e-3)" "unprognostic (9.60e-2)" "unprognostic (9.97e-2)" "unprognostic (2.15e-2)" "unprognostic (8.41e-2)" "unprognostic (1.24e-1)" "unprognostic (4.27e-2)" 8.8 14.0 5.6 2.0 5.3 1.0 8.4 9.3 7.5 10.1 18.2 7.1 1.5 9.0 10.7 4.5 15.3 5.6 17.0 5.7 4.5 19.0 9.1 8.3 2.5 4.5 5.0 12.8 10.8 15.2 26.2 4.0 4.4 10.0 0.9 3.0 9.5 6.1 10.3 5.3 4.0 3.6 3.6 4.6 6.9 21.1 5.2 1.3 17.6 1.9 0.8 7.7 7.0 7.0 11.6 11.7 6.7 17.6 24.9 18.0 4.3 6.3 16.2 5.9 4.4 1.2 2.7 2.0 6.9 18.6 7.2 6.1 4.7 4.6 5.0 4.7 8.7 0.3 4.1 3.6 8.6 1.2 1.3 14.8 7.8 7.7 7.9 34.7 3.3 3.0 7.4 2.5 9.7 9.4 0.9 2.2 4.1 3.5 16.7 2.4 2.9 14.6 16.8 1.8 5.5 11.7 13.1 1.6 5.3 5.5 22.7 16.0 4.0 8.2 2.4 3.5 6.0 4.2 2.6 2.6 11.1 1.3 9.3 0.0 2.0 0.0 0.8 3.6 2.2 4.9 1.5 2.5 3.4 9.1 2.2 1.6 6.4 1.0 1.9 4.3 0.5 2.0 5.6 5.3 9.3 7.5 5.7 4.5 4.5 5.0 4.4 3.6 5.2 7.0 6.5 3.2 18.8 25.5 24.0 13.8 28.4 38.4 18.2 10.7 22.8 19.3 13.0 24.3 26.0 16.5 31.3 30.9 5.8 1.0 9.8 24.3 82.7 98.9 29.0 11.5 18.0 1.3 15.0 4.7 8.5 30.5 8.2 9.8 3.8 27.1 9.3 6.9 11.8 3.3 12.1 4.8 32.6 3.8 12.4 18.7 17.1 7.0 23.2 7.5 1.7 30.5 0.0 12.5 9.3 4.2 2.4 28.6 9.6 20.0 0.4 42.5 203.7 34.1 6.6 16.2 18.3 96.9 30.1 8.5 11.2 18.3 4.2 38.1 4.7 16.6 TCTN3 "C10orf61, DKFZP564D116, JBTS18, TECT3" ENSG00000119977 "Tectonic family member 3" Q6NUS6 10 95659823-95694143 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026987 Approved Approved Microtubules "Intracellular and membrane" NA NA 4400000 "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 41: Macrophages - Immune response" Microtubules "HPA026987: AB_10600911" "unprognostic (1.58e-1)" "unprognostic (1.54e-1)" "unprognostic (9.78e-2)" "prognostic favorable (5.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.50e-2)" "unprognostic (8.88e-3)" "unprognostic (1.08e-1)" "unprognostic (3.03e-2)" "unprognostic (9.25e-3)" "unprognostic (3.78e-3)" "unprognostic (7.29e-2)" "unprognostic (4.60e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (9.30e-3)" "unprognostic (1.59e-1)" 21.3 25.3 8.6 15.7 9.0 5.1 25.2 9.1 11.3 26.3 24.0 22.1 17.6 24.8 65.0 17.0 35.4 22.7 18.4 8.8 9.8 32.5 26.8 19.4 14.3 9.7 9.5 30.6 27.1 69.9 22.8 26.9 9.5 25.6 25.6 22.2 25.4 27.7 9.5 20.5 15.4 26.8 9.2 17.3 19.1 19.4 9.6 14.0 70.6 11.5 18.0 23.9 18.6 9.2 34.0 54.1 44.1 89.3 93.6 74.6 25.7 45.3 94.8 46.9 55.3 35.4 57.3 31.3 40.1 60.4 49.8 46.7 43.9 54.5 56.5 33.6 36.4 10.9 21.6 49.2 46.9 37.4 22.8 65.2 49.2 46.6 72.4 88.0 80.7 27.7 21.0 40.3 63.4 32.5 23.4 27.9 12.1 49.7 38.1 25.3 33.9 38.3 67.8 23.3 11.5 24.5 37.7 18.5 52.6 40.8 71.0 35.1 37.9 35.6 24.9 23.9 49.5 18.9 37.9 20.7 57.5 47.1 19.0 6.8 14.2 4.9 25.8 21.9 32.0 28.3 23.1 25.2 45.2 19.4 24.2 20.0 1.6 26.8 24.3 23.6 22.2 21.3 8.6 9.0 9.1 11.3 8.8 9.8 9.7 9.5 9.5 9.2 9.6 9.2 14.8 19.2 16.2 16.6 29.3 14.4 23.7 33.8 31.3 24.0 18.2 15.0 8.5 27.1 20.3 31.3 37.5 50.3 18.8 20.2 7.9 27.2 18.6 25.5 25.7 20.4 13.8 11.6 17.3 20.3 44.2 27.3 11.7 18.3 8.2 29.8 21.4 16.8 28.5 25.2 17.7 12.5 26.4 14.1 59.1 14.1 20.8 18.7 16.0 16.9 14.8 36.7 15.5 20.6 13.7 14.1 12.7 25.2 35.9 19.8 16.2 16.1 27.5 44.4 13.1 23.9 19.8 39.8 34.1 15.3 11.5 31.5 23.0 34.2 23.7 14.6 TDRD6 "bA446F17.4, CT41.2, NY-CO-45, SPATA36" ENSG00000180113 "Tudor domain containing 6" O60522 6 46687875-46704319 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 30.3" "Group enriched" "Detected in many" 4 "Early spermatids: 224.8;Spermatocytes: 82.7" "Cancer enhanced" "Detected in some" "prostate cancer: 2.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA075923, HPA077353" Enhanced Approved "Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 21: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 29: Early spermatids - Spermatogenesis" "Microtubules, Cytokinetic bridge, Mitotic spindle" Vesicles "HPA075923: , HPA077353: " "unprognostic (2.01e-1)" "unprognostic (7.41e-3)" "unprognostic (7.25e-3)" "unprognostic (3.88e-2)" "unprognostic (3.54e-1)" "unprognostic (4.10e-2)" "unprognostic (1.03e-1)" "unprognostic (4.32e-2)" "unprognostic (7.97e-2)" "unprognostic (2.50e-1)" "unprognostic (2.20e-3)" "unprognostic (2.20e-1)" "unprognostic (2.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.00e-1)" "unprognostic (2.16e-2)" "unprognostic (4.38e-3)" 0.7 1.7 3.3 3.0 5.1 0.2 0.8 7.8 5.4 1.2 1.8 1.0 0.7 0.9 3.4 0.6 0.8 2.2 1.6 4.1 2.6 2.1 2.5 0.7 4.0 3.9 3.2 1.1 1.1 0.4 3.0 1.6 4.1 2.0 0.3 8.9 1.3 0.6 2.3 3.5 0.7 0.4 2.7 2.5 0.8 30.3 3.7 0.0 5.6 0.1 0.1 1.1 0.8 4.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 5.1 7.8 5.4 4.1 2.6 3.9 3.2 4.1 2.7 3.7 4.0 0.8 9.6 0.5 3.9 0.0 0.5 0.4 0.1 1.2 11.3 0.4 0.8 3.4 0.0 3.8 7.3 6.2 0.0 0.0 0.0 1.9 0.3 224.8 1.0 2.2 1.2 4.2 0.0 13.6 0.2 0.0 1.0 0.0 0.7 0.0 0.4 0.7 3.0 0.1 5.0 14.7 0.3 0.0 0.3 0.0 33.8 4.1 0.5 3.6 6.5 0.0 1.1 0.0 14.6 17.8 0.1 0.0 4.5 0.0 0.6 0.4 0.4 0.2 7.5 13.1 3.0 0.5 82.7 34.7 0.0 1.6 0.0 0.0 1.4 0.5 0.2 TEKT2 TEKTB1 ENSG00000092850 "Tektin 2" Q9UIF3 1 36084094-36088275 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 62.8;testis: 71.2" "Group enriched" "Detected in some" 4 "Early spermatids: 523.7;Late spermatids: 306.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 13 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enriched" "Detected in some" 8 "NB-4: 37.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA027248, HPA027461" Approved Approved Microtubules NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" Microtubules "HPA027248: AB_1857884, HPA027461: AB_10600912" "unprognostic (1.02e-3)" "unprognostic (1.21e-2)" "unprognostic (2.96e-2)" "unprognostic (2.12e-3)" "unprognostic (2.64e-1)" "unprognostic (1.78e-2)" "unprognostic (1.98e-2)" "unprognostic (3.42e-2)" "unprognostic (1.35e-1)" "unprognostic (1.13e-3)" "unprognostic (5.28e-4)" "unprognostic (6.11e-2)" "prognostic favorable (1.98e-4)" "unprognostic (9.78e-2)" "unprognostic (8.35e-2)" "unprognostic (5.29e-2)" "unprognostic (7.68e-2)" 0.2 0.5 2.2 0.1 2.4 1.5 0.9 1.9 2.6 3.5 12.2 0.6 0.1 1.5 0.1 0.2 62.8 0.1 0.1 2.3 3.0 3.1 0.1 6.3 0.1 4.6 6.3 0.5 2.4 0.7 4.3 0.0 3.7 0.7 0.0 0.1 0.4 0.5 0.0 0.2 0.2 0.3 4.4 0.0 0.4 71.2 3.1 1.1 2.7 0.0 0.0 0.1 0.3 3.3 0.0 0.0 4.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 37.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 1.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 2.2 2.4 1.9 2.6 2.3 3.0 4.6 6.3 3.7 4.4 3.1 3.3 0.2 0.0 0.0 0.0 0.2 0.1 0.6 9.4 0.0 0.0 0.8 0.6 0.6 0.0 8.0 1.8 0.0 0.2 0.0 0.0 0.0 0.9 523.7 81.2 0.8 0.4 1.8 0.0 0.1 0.0 0.1 0.2 0.0 1.5 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.1 12.2 0.0 0.0 306.1 5.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.1 0.0 3.8 0.0 0.4 0.0 2.5 84.7 0.1 0.0 0.0 2.6 27.6 4.0 0.0 0.0 0.0 0.2 0.4 0.1 0.5 TIMM17B "DXS9822, JM3" ENSG00000126768 "Translocase of inner mitochondrial membrane 17B" O60830 X 48893447-48898143 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029093 Approved Approved Microtubules,Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Microtubules Mitochondria "HPA029093: AB_10600913" "unprognostic (7.87e-2)" "prognostic favorable (6.63e-4)" "unprognostic (8.44e-2)" "unprognostic (3.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.89e-3)" "unprognostic (1.44e-1)" "unprognostic (2.01e-1)" "unprognostic (1.14e-2)" "unprognostic (2.04e-1)" "unprognostic (2.16e-1)" "unprognostic (2.67e-2)" "unprognostic (9.40e-2)" "unprognostic (5.24e-3)" "unprognostic (8.67e-2)" "prognostic favorable (7.88e-4)" 24.0 42.0 49.8 18.8 51.1 28.2 25.9 50.6 60.6 29.2 47.0 40.3 25.5 27.7 21.0 38.2 29.1 17.6 75.3 50.1 49.6 47.5 48.7 28.1 27.8 49.5 48.9 27.3 33.4 47.6 45.1 23.0 48.9 36.4 19.4 26.2 25.3 27.7 99.1 35.4 32.2 18.0 50.5 37.9 40.5 18.7 50.6 40.7 30.4 83.2 26.8 35.5 28.7 53.1 71.0 127.8 78.7 78.1 24.2 19.3 65.4 31.3 47.7 81.1 52.9 113.3 93.4 51.8 47.4 27.2 131.1 52.5 125.1 68.3 30.4 111.2 140.1 37.6 69.2 101.4 68.3 56.5 35.0 24.9 67.3 60.9 80.8 40.3 37.6 90.1 56.5 118.2 37.8 183.5 89.4 136.7 102.8 93.2 118.3 62.1 51.0 187.8 80.9 41.1 77.6 69.7 48.6 77.0 47.0 98.5 168.7 97.4 26.2 37.1 72.4 89.8 54.9 107.8 137.1 64.3 51.4 100.3 44.6 178.2 123.4 179.9 67.2 123.9 77.4 113.4 67.1 76.3 121.1 113.4 64.8 59.7 139.6 75.7 104.8 127.6 74.4 124.3 49.8 51.1 50.6 60.6 50.1 49.6 49.5 48.9 48.9 50.5 50.6 53.1 23.8 25.6 34.9 4.9 56.5 30.2 52.4 99.0 21.1 40.4 52.9 62.2 40.0 41.5 59.4 73.5 16.7 94.4 45.0 40.2 185.9 94.5 5.6 42.4 25.5 24.6 81.5 48.8 4.3 73.1 94.3 31.0 34.1 37.8 52.0 50.3 24.7 56.0 99.6 35.3 5.6 68.3 91.6 37.6 49.8 7.4 23.9 48.9 44.4 3.7 85.9 48.7 55.6 2.5 9.1 89.9 92.7 23.0 103.7 63.3 102.4 160.0 56.6 43.8 32.9 21.2 45.0 29.0 39.9 52.0 34.4 79.6 48.2 52.7 59.8 61.2 TIPARP "ARTD14, DDF1, DKFZP434J214, DKFZp686N0351, PARP-1, PARP-7, PARP7, pART14, RM1" ENSG00000163659 "TCDD inducible poly(ADP-ribose) polymerase" Q7Z3E1 3 156673235-156706770 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 302.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 53.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 53.5" "Cell line enhanced" "Detected in all" "HBEC3-KT: 168.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036796 Approved Microtubules NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" Microtubules "HPA036796: AB_10672268" "prognostic favorable (2.00e-5)" "unprognostic (3.50e-1)" "unprognostic (7.62e-2)" "unprognostic (5.21e-2)" "unprognostic (2.62e-1)" "unprognostic (4.56e-2)" "unprognostic (9.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.23e-1)" "unprognostic (1.43e-1)" "unprognostic (4.27e-3)" "unprognostic (2.01e-1)" "unprognostic (4.69e-2)" "unprognostic (7.26e-2)" "unprognostic (1.73e-1)" "unprognostic (6.16e-3)" "unprognostic (4.90e-3)" 67.5 56.6 16.5 16.0 19.3 74.1 39.7 17.7 22.3 29.8 15.2 15.1 13.5 30.6 14.7 55.1 39.5 27.9 34.6 16.4 21.2 28.2 44.3 27.4 13.7 33.4 27.9 40.2 29.6 99.2 15.1 12.5 22.9 25.9 14.4 18.3 10.3 27.8 17.6 39.5 23.1 43.7 19.9 10.9 21.9 50.3 25.7 21.7 17.0 9.6 18.1 65.0 24.0 21.9 42.8 29.6 9.8 8.4 35.7 25.9 8.0 70.0 56.4 34.9 48.2 17.2 86.9 12.7 22.2 79.9 46.5 42.1 25.1 168.0 51.4 27.3 18.5 21.0 29.0 11.7 15.2 7.4 38.1 21.3 103.0 35.6 84.9 93.8 32.3 9.4 16.9 49.9 122.5 8.2 6.4 9.8 11.2 53.5 24.5 10.5 22.5 43.6 36.7 20.1 29.5 7.5 55.2 16.9 11.9 22.5 26.2 12.5 70.2 15.1 4.9 28.5 25.1 53.9 10.6 11.3 25.7 11.3 51.4 53.5 5.0 7.5 6.1 3.3 8.6 2.9 5.9 8.2 3.6 5.4 3.6 4.9 15.9 11.6 9.2 5.0 7.4 3.3 16.5 19.3 17.7 22.3 16.4 21.2 33.4 27.9 22.9 19.9 25.7 21.9 112.8 86.6 98.3 27.7 43.9 196.0 117.3 51.7 185.5 5.0 62.0 57.7 29.9 31.5 66.5 7.3 39.6 5.1 97.0 38.3 21.5 35.2 302.3 114.6 118.7 45.6 54.5 7.0 3.6 23.5 10.3 109.0 57.6 169.4 115.0 12.2 20.3 18.9 19.2 21.9 8.7 32.4 18.3 18.5 97.5 28.0 19.6 101.7 37.4 12.2 17.3 10.1 16.5 22.1 20.4 36.9 40.1 19.2 60.5 83.9 40.4 16.2 43.5 10.4 13.1 138.0 87.7 58.0 33.4 100.1 121.5 7.5 105.4 7.3 18.2 187.8 TMEM116 FLJ90167 ENSG00000198270 "Transmembrane protein 116" Q8NCL8 12 111931282-112013185 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "parathyroid gland: 59.7" "Cell type enhanced" "Detected in many" "Early spermatids: 67.8;Spermatocytes: 123.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in all" 4 "T-cells: 19.3" "Cell line enhanced" "Detected in many" "RT4: 33.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040720 Approved Approved Nucleoplasm,Microtubules NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 15: RT4 - Unknown function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Microtubules Nucleoplasm "HPA040720: AB_10795623" "unprognostic (8.91e-2)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.71e-1)" "unprognostic (5.48e-2)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (6.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.34e-1)" "unprognostic (3.27e-3)" "unprognostic (9.12e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.41e-1)" "unprognostic (1.33e-1)" "unprognostic (2.85e-2)" "unprognostic (3.19e-3)" 3.8 8.8 7.0 2.2 7.8 1.2 11.4 9.2 8.4 6.0 27.5 4.2 11.1 2.7 7.1 4.2 4.9 6.8 26.3 6.4 6.5 30.8 12.3 8.5 4.5 7.2 7.5 5.2 4.2 59.7 6.5 2.9 7.2 3.9 3.7 7.0 13.3 5.9 6.6 11.1 6.3 2.1 6.9 3.4 10.2 27.1 7.5 5.4 6.3 5.8 6.8 7.4 3.2 8.5 6.2 6.4 8.9 9.7 8.3 6.6 6.0 5.1 7.5 6.1 6.6 4.6 5.1 6.9 2.9 3.5 7.6 5.9 4.8 5.1 5.4 17.1 4.1 4.4 5.4 5.1 13.2 1.6 0.7 7.8 8.5 7.7 13.5 6.7 2.2 13.2 8.7 5.0 6.5 9.4 2.3 14.2 10.6 14.5 3.9 7.0 3.8 12.2 18.9 33.1 8.1 5.6 5.3 4.4 8.3 11.7 16.0 22.9 1.6 5.8 1.8 5.1 2.2 6.5 12.1 6.6 7.9 5.5 8.0 1.1 2.6 4.5 8.1 4.5 6.8 2.9 18.5 15.6 2.9 3.6 9.6 10.8 0.4 2.4 3.5 4.2 19.3 4.0 7.0 7.8 9.2 8.4 6.4 6.5 7.2 7.5 7.2 6.9 7.5 8.5 4.0 3.2 18.5 17.3 6.2 5.5 6.2 8.8 7.4 11.2 14.0 12.8 21.7 7.2 10.1 29.5 16.7 18.6 10.2 5.7 23.5 4.2 67.8 7.0 4.3 3.5 0.0 3.4 28.3 4.0 5.9 5.9 7.7 3.7 5.7 7.0 2.2 5.4 5.1 10.1 25.6 4.6 24.4 4.1 4.5 33.5 9.3 3.9 7.2 7.5 3.6 13.4 11.3 13.0 33.3 2.7 3.2 4.9 5.5 4.2 20.9 10.3 18.6 17.3 6.6 6.5 6.6 123.5 37.4 6.2 5.4 40.1 17.4 7.0 6.0 7.6 TMEM138 "HSPC196, JBTS16" ENSG00000149483 "Transmembrane protein 138" Q9NPI0 11 61362344-61369509 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 194.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042373 Approved Approved Microtubules NA Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 77: Retina - Visual perception" "Cluster 30: Epithelial cell lines - Translation" "Cluster 46: Photoreceptor cells - Phototransduction" Microtubules "HPA042373: AB_10793880" "unprognostic (1.30e-1)" "unprognostic (4.69e-3)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (2.15e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (7.90e-4)" "unprognostic (1.06e-2)" "unprognostic (1.58e-1)" "unprognostic (1.86e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.12e-6)" "unprognostic (2.28e-1)" "unprognostic (4.42e-2)" "unprognostic (3.49e-1)" "unprognostic (4.46e-1)" 13.8 40.6 8.4 11.5 8.5 18.1 14.3 10.3 9.7 16.3 10.0 13.4 10.8 17.5 25.9 10.8 17.3 11.6 9.1 8.7 9.1 17.9 22.2 15.3 18.0 9.0 11.0 23.7 13.9 18.4 12.6 14.9 8.6 17.1 18.7 50.7 11.1 13.8 6.8 18.6 15.9 18.6 9.0 18.4 13.5 12.5 8.9 14.0 13.5 8.5 22.8 17.8 13.3 9.5 16.3 35.5 14.0 20.3 48.9 20.1 16.5 24.9 30.7 36.2 32.8 17.7 24.6 14.0 21.0 29.7 56.5 30.2 26.0 31.0 39.8 18.0 14.4 10.1 28.7 21.0 35.0 21.8 26.3 32.4 47.7 60.5 39.4 13.5 31.4 16.7 29.8 23.0 60.1 45.4 17.3 21.6 22.8 28.2 34.5 11.9 10.3 30.4 32.3 39.6 14.9 11.1 31.7 30.4 34.2 12.8 47.3 19.0 18.7 45.2 18.7 31.5 24.7 24.0 24.6 13.6 23.7 26.5 24.0 41.7 26.0 26.5 23.1 26.6 25.3 26.1 21.7 22.3 15.9 24.1 24.0 21.4 5.3 27.8 18.2 28.0 30.2 24.1 8.4 8.5 10.3 9.7 8.7 9.1 9.0 11.0 8.6 9.0 8.9 9.5 12.6 16.0 23.2 16.0 23.1 19.9 16.1 49.8 25.0 28.9 15.7 17.1 4.2 4.3 26.2 20.2 81.3 54.8 27.3 13.9 15.6 17.1 21.7 22.0 16.6 18.7 9.6 22.1 12.5 16.0 39.9 20.5 9.2 7.0 37.3 17.8 13.6 16.3 45.7 15.2 12.1 11.6 16.2 15.6 10.7 7.6 31.7 35.6 37.4 3.7 25.5 25.9 36.0 10.1 8.1 18.6 11.5 28.6 18.1 22.1 26.7 20.8 59.6 194.1 0.0 15.3 14.3 24.9 16.2 16.3 20.5 27.5 23.3 56.9 14.3 12.9 TMEM200C TTMA ENSG00000206432 "Transmembrane protein 200C" A6NKL6 18 5882072-5895955 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.7;salivary gland: 5.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 9.3;Cone photoreceptor cells: 6.2;Inhibitory neurons: 8.0;Oligodendrocyte precursor cells: 17.6" "Cancer enhanced" "Detected in single" "glioma: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.1;NTERA-2: 4.7;PC-3: 22.0;U-2 OS: 10.9;U-251 MG: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA047253, HPA050490" Uncertain Approved Microtubules NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Microtubules "HPA047253: AB_2680001, HPA050490: AB_2681144" "unprognostic (6.57e-4)" "unprognostic (3.09e-1)" "unprognostic (1.05e-2)" "unprognostic (3.74e-2)" "unprognostic (2.13e-1)" "unprognostic (5.07e-2)" "unprognostic (3.20e-1)" "unprognostic (2.07e-1)" "unprognostic (4.12e-2)" "unprognostic (2.29e-2)" "unprognostic (6.31e-2)" "unprognostic (3.82e-4)" "unprognostic (2.48e-10)" "unprognostic (2.94e-2)" "unprognostic (6.38e-2)" "unprognostic (7.22e-2)" "unprognostic (2.38e-2)" 0.2 3.9 2.2 0.3 2.2 0.0 0.6 0.3 2.2 0.7 0.0 0.5 0.1 0.5 1.1 0.2 0.5 0.4 2.1 1.0 2.5 1.6 1.0 0.1 0.4 2.2 7.7 0.7 0.0 0.1 2.3 0.0 2.6 0.7 0.0 0.8 5.5 0.2 0.0 0.2 0.6 0.1 2.5 0.6 0.4 0.9 2.6 0.1 0.1 0.0 0.3 0.4 0.1 0.9 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 22.0 1.3 0.0 0.0 0.0 0.0 1.1 3.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 10.9 0.0 3.9 0.0 0.0 0.0 1.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.2 0.3 2.2 1.0 2.5 2.2 7.7 2.6 2.5 2.6 0.9 0.1 0.0 1.1 0.3 0.0 0.1 0.0 0.0 0.0 9.3 0.5 2.0 2.4 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.1 2.0 3.4 0.1 0.7 0.0 0.0 1.6 0.0 0.1 2.2 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 8.0 0.0 0.0 0.0 0.4 1.1 1.2 0.2 0.0 1.0 0.0 0.8 0.0 17.6 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.1 0.2 1.3 0.0 0.0 1.4 0.3 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.1 TMEM9 TMEM9A ENSG00000116857 "Transmembrane protein 9" Q9P0T7 1 201134772-201171574 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008483 Approved "Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 33: Fibroblasts - ECM organization" Vesicles "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA008483: " "unprognostic (1.88e-1)" "prognostic unfavorable (6.57e-4)" "unprognostic (2.95e-1)" "unprognostic (3.67e-2)" "unprognostic (3.96e-1)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.05e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-2)" "unprognostic (1.69e-2)" "unprognostic (2.46e-2)" "unprognostic (2.99e-1)" "unprognostic (1.88e-2)" "unprognostic (2.38e-1)" "unprognostic (9.17e-2)" "unprognostic (3.32e-1)" "unprognostic (9.90e-2)" 34.1 102.3 103.1 20.8 104.4 27.8 45.0 93.5 126.6 76.8 122.7 45.0 25.4 70.9 65.4 31.1 75.4 39.5 51.3 107.8 113.2 73.8 73.8 44.5 23.5 99.4 111.5 81.4 73.9 92.2 63.4 28.5 102.8 60.3 25.4 43.9 60.7 45.9 44.9 35.5 30.4 37.5 100.2 31.2 49.8 67.0 112.5 26.3 68.5 24.9 17.7 45.7 51.8 100.2 63.1 117.0 72.6 168.9 38.5 54.5 128.5 48.6 51.5 76.0 68.2 115.7 99.8 33.2 69.2 73.4 70.1 123.3 76.5 80.1 37.3 21.3 131.9 58.1 182.4 76.6 73.8 28.2 51.9 65.0 87.0 71.2 43.0 91.3 47.7 46.2 105.6 35.5 66.2 81.0 34.1 46.1 111.0 57.3 285.3 60.7 108.4 44.0 87.9 48.0 67.6 137.7 86.7 146.9 91.8 107.4 180.3 48.5 35.7 84.8 70.0 68.5 59.8 143.9 135.2 26.1 64.4 30.1 42.0 49.8 59.8 33.7 45.7 41.8 52.2 54.5 44.0 37.8 51.5 49.2 64.6 42.7 41.0 32.9 38.5 56.1 43.0 75.5 103.1 104.4 93.5 126.6 107.8 113.2 99.4 111.5 102.8 100.2 112.5 100.2 20.9 51.3 49.5 17.0 13.4 12.9 31.4 65.6 27.3 61.0 56.2 65.7 39.3 40.0 48.0 36.8 31.3 44.4 9.3 7.9 17.6 88.8 58.0 37.3 58.6 26.3 31.8 43.6 15.7 74.7 52.1 59.9 20.9 46.4 13.3 46.3 30.0 40.4 28.1 8.4 22.1 26.9 36.7 13.4 11.9 60.9 70.8 15.6 23.2 8.4 11.8 102.3 25.7 15.6 10.1 40.3 18.8 53.0 18.8 28.5 8.3 56.9 54.5 32.8 13.1 33.3 42.1 54.8 76.7 14.5 13.9 13.0 13.0 130.7 28.4 27.8 TNKS2 "ARTD6, PARP-5b, PARP-5c, PARP5B, PARP5C, pART6, TANK2, TNKL" ENSG00000107854 "Tankyrase 2" Q9H2K2 10 91798426-91865475 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036606 Approved Microtubules NA NA "Cluster 24: B-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" Microtubules "HPA036606: AB_10673470" "unprognostic (1.12e-1)" "unprognostic (2.66e-1)" "unprognostic (4.16e-1)" "unprognostic (1.61e-2)" "unprognostic (3.07e-2)" "unprognostic (1.51e-2)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "unprognostic (2.93e-1)" "unprognostic (2.59e-2)" "unprognostic (1.50e-1)" "unprognostic (2.26e-2)" "unprognostic (1.00e-1)" "unprognostic (2.35e-1)" "unprognostic (1.69e-1)" "unprognostic (7.97e-2)" "unprognostic (2.53e-1)" 18.4 19.3 14.7 21.2 16.1 38.5 22.2 18.0 17.0 21.1 25.0 14.8 14.9 22.5 19.8 22.8 17.8 20.8 11.1 14.3 14.9 17.4 21.2 19.7 28.1 14.6 15.1 30.3 22.0 21.8 14.4 31.2 15.8 19.6 17.1 31.2 18.5 16.6 55.6 27.3 15.3 20.7 16.0 30.0 19.8 11.8 17.4 37.7 29.6 40.5 29.4 24.1 17.1 19.7 29.1 24.3 48.9 41.7 33.8 30.6 54.5 30.6 55.5 36.5 44.5 21.7 23.2 27.2 14.3 40.0 24.6 30.6 31.0 23.6 51.3 27.7 29.9 22.6 22.9 24.3 32.9 44.0 32.3 31.4 30.6 37.0 65.3 54.8 34.8 24.1 16.9 29.4 38.5 15.6 38.1 29.9 24.6 13.2 16.1 35.2 30.5 20.9 25.0 30.9 12.8 22.9 30.8 13.4 38.7 39.2 32.5 30.3 37.8 19.6 16.5 26.1 29.5 36.7 32.1 34.8 25.9 32.4 17.9 0.2 0.7 1.2 0.9 0.6 0.8 1.0 0.9 0.8 1.0 1.0 0.7 0.6 0.7 1.0 0.6 1.5 0.5 0.4 14.7 16.1 18.0 17.0 14.3 14.9 14.6 15.1 15.8 16.0 17.4 19.7 39.1 41.7 22.3 63.3 51.6 74.6 32.5 23.8 56.9 41.7 38.8 24.0 23.2 8.6 31.0 44.1 47.9 45.2 48.7 19.2 7.9 16.0 4.7 41.1 29.3 37.1 33.0 27.5 77.5 24.5 55.1 30.9 50.4 52.1 2.5 34.8 35.7 35.9 26.1 42.1 78.5 19.3 26.4 55.3 49.4 8.1 31.1 48.4 33.8 67.5 46.5 24.9 37.0 66.9 68.0 29.0 12.3 35.3 45.7 44.7 16.1 16.6 47.4 34.8 46.0 40.5 28.0 19.1 21.7 75.9 109.1 101.0 49.1 30.5 14.9 61.7 TNNT2 "CMD1D, CMH2, CMPD2" ENSG00000118194 "Troponin T2, cardiac type" P45379 1 201359008-201377764 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 205 "heart muscle: 10670.6" "Cell type enriched" "Detected in many" 32 "Cardiomyocytes: 12561.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "RH-30: 1077.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 3.8" "CAB015371, HPA015774, HPA017888" Enhanced Approved "Nucleoplasm,Nucleoli,Focal adhesion sites,Microtubules" No No 57000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Nucleoli" "Focal adhesion sites, Microtubules" "CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "unprognostic (2.33e-4)" "unprognostic (1.85e-1)" "unprognostic (7.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-2)" "unprognostic (5.50e-3)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (9.98e-2)" 2.2 4.9 12.4 0.6 13.9 0.1 11.9 11.7 20.4 2.3 11.7 1.3 0.3 3.2 0.8 7.8 1.9 3.8 10670.6 16.8 11.6 51.9 2.3 22.0 2.7 11.6 11.6 1.3 5.0 0.0 4.5 10.3 11.6 6.1 0.1 0.4 3.6 0.7 16.5 21.7 1.6 0.1 11.6 0.7 2.0 1.7 11.6 2.1 2.0 9.4 0.5 19.3 5.0 15.8 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.5 0.0 0.0 6.7 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.5 0.0 44.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 1.1 0.0 0.0 2.2 3.3 0.0 0.0 1077.7 0.0 0.7 0.4 1.1 0.8 0.1 2.0 0.0 61.2 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 13.9 11.7 20.4 16.8 11.6 11.6 11.6 11.6 11.6 11.6 15.8 0.6 3.2 3.0 0.3 0.0 3.4 1.4 1.7 1.8 3.9 0.9 1.7 12561.8 0.0 1.1 1.8 0.0 3.5 0.0 2.3 0.0 0.4 11.6 1.2 0.2 93.3 0.0 0.0 9.4 0.4 1.2 385.3 1.1 2.4 0.0 0.0 0.0 0.0 3.1 0.0 0.5 1.7 0.0 0.0 0.8 19.3 0.6 0.3 0.0 1.9 2.6 0.0 0.0 0.5 0.7 1.2 1.4 1.2 0.0 2.1 0.8 0.9 0.7 0.6 0.0 8.7 145.8 0.5 0.2 2.5 7.2 4.2 0.1 0.8 3.2 1.5 TRAPPC8 "GSG1, HsT2706, KIAA1012, TRS85" ENSG00000153339 "Trafficking protein particle complex 8" Q9Y2L5 18 31829197-31953136 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 8.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041107 Approved Approved Microtubules,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Cytosol Microtubules "HPA041107: AB_10793869" "unprognostic (4.04e-1)" "unprognostic (4.35e-2)" "unprognostic (2.62e-3)" "unprognostic (9.80e-2)" "unprognostic (8.18e-2)" "unprognostic (4.06e-2)" "unprognostic (9.68e-2)" "unprognostic (1.37e-1)" "unprognostic (7.67e-3)" "unprognostic (4.42e-2)" "unprognostic (3.00e-1)" "unprognostic (6.35e-3)" "prognostic favorable (1.85e-9)" "unprognostic (3.55e-2)" "unprognostic (7.03e-2)" "unprognostic (4.26e-1)" "unprognostic (2.92e-1)" 10.5 9.9 5.4 10.1 6.1 10.2 9.8 8.5 6.7 9.3 11.3 9.9 10.2 8.5 5.9 11.5 9.6 7.6 10.5 5.8 5.6 12.7 18.1 8.9 13.0 6.3 5.2 9.0 9.8 14.6 7.1 9.7 5.8 8.3 10.9 20.9 10.4 8.7 16.9 13.6 11.9 9.4 5.0 10.7 10.0 30.2 5.5 16.3 12.4 12.4 13.4 9.2 9.7 8.7 12.3 10.2 11.9 9.0 17.3 16.3 13.0 16.0 16.9 14.7 14.4 7.0 9.1 17.6 12.6 15.5 13.4 18.4 17.2 9.1 20.2 19.8 8.0 14.4 9.5 8.7 13.5 42.4 16.1 14.9 12.1 13.8 19.6 16.4 17.0 14.6 21.2 15.7 15.0 8.4 18.2 14.5 11.9 36.1 8.7 19.0 14.1 18.5 14.4 19.1 9.0 10.6 20.5 12.2 14.3 18.7 13.5 18.3 20.8 15.5 7.8 5.7 9.9 19.6 23.5 25.9 15.0 18.2 16.3 8.7 1.6 1.7 1.0 1.5 2.2 1.3 1.4 1.2 1.6 1.4 1.2 1.3 2.3 1.9 1.5 1.2 1.7 0.7 5.4 6.1 8.5 6.7 5.8 5.6 6.3 5.2 5.8 5.0 5.5 8.7 16.9 28.9 15.1 44.1 26.3 18.0 8.7 10.0 31.9 12.2 14.3 9.7 21.6 21.5 14.6 11.0 29.2 11.2 19.9 27.3 1.9 11.0 35.3 23.4 14.9 16.1 12.6 20.0 68.1 9.4 9.6 14.8 32.6 17.4 3.8 11.1 19.6 34.2 16.6 11.8 71.6 14.7 8.2 24.0 13.3 42.4 15.5 22.3 10.6 43.1 23.4 11.0 23.7 55.3 82.8 14.2 10.1 9.4 18.7 16.1 26.2 15.5 25.8 24.7 13.1 14.8 14.3 88.8 47.4 21.8 27.1 20.5 16.6 11.6 13.7 15.5 TRMT112 "HSPC152, HSPC170, hTrm112, TRM112, TRMT11-2" ENSG00000173113 "TRNA methyltransferase subunit 11-2" Q9UI30 11 64316460-64317559 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039901, HPA040006" Uncertain Approved Nucleoplasm,Microtubules NA NA 17000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Microtubules Nucleoplasm "HPA039901: AB_10796334, HPA040006: AB_10793859" "unprognostic (1.48e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" "unprognostic (2.44e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (6.08e-3)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (1.44e-3)" "unprognostic (6.28e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (2.53e-1)" "unprognostic (1.73e-1)" "unprognostic (3.15e-3)" "unprognostic (1.32e-2)" 159.1 273.6 158.4 109.5 159.8 149.7 152.5 161.3 182.3 182.2 172.7 143.8 68.5 173.0 140.7 167.7 167.5 90.9 138.0 157.3 175.5 176.0 164.7 129.6 170.8 165.9 169.2 238.2 145.5 109.9 182.0 112.2 170.3 137.7 65.4 64.3 116.5 96.4 159.4 146.6 110.0 105.6 163.0 146.8 129.4 130.7 169.0 152.3 142.0 81.8 153.4 145.8 150.3 177.6 411.4 590.3 203.2 298.9 238.0 195.8 199.9 195.3 245.2 231.2 188.3 308.0 401.7 320.5 575.6 204.5 353.1 338.8 367.8 430.1 157.7 373.0 340.1 359.7 503.6 708.9 264.3 282.2 225.2 227.1 401.0 205.5 409.7 241.4 239.7 218.3 298.2 394.5 220.0 1070.4 414.0 527.9 543.0 279.2 511.0 249.6 233.0 451.3 270.6 416.8 133.3 599.3 278.1 322.8 571.4 178.1 503.8 249.7 197.0 241.7 297.2 408.7 365.7 338.7 591.5 512.8 330.2 276.3 255.4 780.9 377.7 573.3 428.7 331.8 444.1 956.3 559.0 481.0 404.8 808.8 617.8 534.8 459.0 392.8 303.5 671.5 551.1 883.6 158.4 159.8 161.3 182.3 157.3 175.5 165.9 169.2 170.3 163.0 169.0 177.6 234.8 160.3 164.3 8.1 269.6 349.9 421.7 465.9 299.9 89.4 219.5 323.8 137.4 135.8 255.8 274.0 22.9 561.1 239.3 96.1 491.0 232.1 71.3 270.9 200.4 236.0 154.4 251.8 10.0 224.4 469.8 249.8 96.8 257.8 217.4 251.8 189.5 196.0 395.2 52.2 10.9 160.6 205.4 174.6 312.3 63.1 299.5 179.1 336.2 12.2 321.2 177.2 247.2 9.0 24.5 221.2 126.4 218.6 296.7 304.4 111.0 610.2 305.0 88.1 216.9 196.2 246.6 230.6 531.2 276.6 396.4 412.1 261.6 258.2 155.3 386.8 TSPAN12 "NET-2, TM4SF12" ENSG00000106025 "Tetraspanin 12" O95859 7 120787320-120858402 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Angiogenesis "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 91.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 118.6;Collecting duct cells: 103.0;Distal tubular cells: 189.8;Glandular and luminal cells: 87.5;Proximal tubular cells: 111.1" "Cancer enhanced" "Detected in all" "renal cancer: 44.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 53.0;HUVEC TERT2: 58.3;RH-30: 52.2;RPTEC TERT1: 90.5;RT4: 65.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051570, HPA058244" Uncertain Approved Vesicles,Microtubules NA NA "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" Microtubules Vesicles "HPA051570: , HPA058244: AB_2683652" "unprognostic (2.40e-2)" "unprognostic (7.60e-2)" "unprognostic (3.66e-3)" "unprognostic (1.82e-2)" "unprognostic (3.97e-1)" "unprognostic (7.34e-3)" "unprognostic (1.60e-1)" "unprognostic (8.12e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.63e-2)" "unprognostic (1.05e-1)" "unprognostic (9.53e-2)" "unprognostic (7.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.18e-2)" "unprognostic (1.43e-1)" 11.9 65.9 4.1 5.3 4.4 0.4 8.7 5.2 5.2 21.4 2.8 24.0 39.4 10.5 14.9 5.0 10.9 20.4 47.7 3.3 4.7 91.6 35.8 45.8 4.5 8.0 6.2 1.7 17.4 10.7 7.5 20.3 5.2 6.8 20.4 1.8 46.8 22.4 3.3 1.6 42.0 11.9 4.6 28.2 22.1 3.9 8.1 2.7 23.4 5.5 4.3 17.5 4.0 3.6 0.0 1.4 15.1 0.2 3.1 1.0 14.7 0.3 0.6 1.2 5.0 2.5 4.0 0.0 10.4 0.4 1.8 0.2 7.7 1.6 1.9 0.0 53.0 2.8 14.5 2.2 8.1 0.1 2.5 0.3 0.0 0.4 0.3 2.1 58.3 0.0 0.7 1.8 6.8 2.0 0.2 0.4 24.5 11.1 9.4 0.1 52.2 2.0 90.5 65.4 12.5 7.4 0.7 1.3 0.0 20.0 8.0 1.9 2.5 12.3 3.8 0.1 6.5 15.8 0.0 0.2 1.7 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 4.4 5.2 5.2 3.3 4.7 8.0 6.2 5.2 4.6 8.1 3.6 40.0 118.6 45.0 18.6 1.7 2.5 20.3 1.8 14.8 0.0 19.4 3.8 62.5 64.3 19.9 103.0 0.0 40.5 0.0 18.0 189.8 6.8 0.6 63.4 9.0 38.0 9.6 2.7 1.8 7.2 53.5 10.0 14.8 87.5 2.5 1.8 18.2 32.9 4.1 0.0 2.9 16.9 6.1 0.8 3.6 1.5 4.1 1.5 5.4 3.7 0.0 0.5 0.0 10.1 0.4 4.7 30.5 0.7 2.2 9.1 68.3 111.1 5.7 0.1 0.0 11.6 16.6 0.6 8.9 13.8 2.0 24.2 1.9 9.6 35.5 28.3 TSPAN33 "MGC50844, Penumbra" ENSG00000158457 "Tetraspanin 33" Q86UF1 7 129144707-129169699 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 64.8" "Cell type enhanced" "Detected in many" "B-cells: 27.8;Langerhans cells: 84.0;Macrophages: 32.0;monocytes: 44.8;Peritubular cells: 32.7;Proximal tubular cells: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.1;naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 23.2;HEL: 38.2;U-266/70: 48.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020357 Enhanced Approved Microtubules NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Microtubules "HPA020357: AB_1858410" "unprognostic (3.95e-2)" "unprognostic (1.27e-2)" "unprognostic (4.41e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (5.62e-2)" "unprognostic (2.29e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (2.66e-1)" "prognostic favorable (8.88e-4)" "unprognostic (1.67e-1)" "prognostic favorable (8.74e-5)" "unprognostic (2.50e-2)" "unprognostic (2.73e-1)" "unprognostic (1.55e-2)" "unprognostic (1.16e-2)" 3.2 4.4 8.2 9.1 8.0 3.9 3.0 6.9 7.2 2.0 5.4 6.4 3.6 1.5 10.9 3.9 2.1 3.1 8.6 6.8 11.9 64.8 28.2 5.0 16.3 10.8 13.4 2.4 21.2 11.1 19.9 3.8 12.2 7.4 3.4 1.3 18.8 7.0 13.0 7.6 12.3 2.2 11.0 16.9 6.2 11.4 14.1 6.7 8.4 4.4 14.4 7.9 3.8 10.0 1.5 4.3 1.0 23.2 0.0 0.0 0.9 0.0 0.2 0.5 0.1 0.7 2.1 18.4 1.8 0.4 12.9 1.7 12.3 4.0 0.5 18.7 14.0 38.2 0.8 8.2 0.9 5.5 0.8 0.9 3.8 0.2 1.2 0.0 0.5 9.4 0.4 2.6 0.0 4.6 11.5 0.1 8.5 0.8 4.5 3.9 0.5 0.4 1.4 5.0 5.8 6.9 2.3 0.7 13.6 5.3 4.7 2.4 0.1 0.1 1.8 1.9 0.6 48.8 5.8 8.1 0.4 18.4 2.7 0.0 0.3 0.0 0.0 0.7 0.0 1.1 0.0 0.0 0.6 1.3 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.4 8.2 8.0 6.9 7.2 6.8 11.9 10.8 13.4 12.2 11.0 14.1 10.0 0.9 0.0 0.6 3.3 27.8 2.5 0.7 0.8 0.6 3.5 10.5 9.8 6.2 0.0 0.2 5.5 4.2 0.1 7.6 0.7 13.7 2.2 2.5 2.7 0.5 1.4 3.5 5.2 3.6 8.7 0.2 6.7 0.0 1.6 0.0 1.4 0.4 15.8 8.4 0.0 1.7 0.6 0.0 23.6 84.0 4.2 2.8 32.0 1.8 3.7 44.8 8.4 0.0 3.5 0.1 2.4 1.1 32.7 1.3 1.9 1.0 59.2 2.2 1.7 0.0 11.3 1.0 0.8 4.1 0.4 3.0 0.1 2.2 8.4 0.4 1.3 TTC28 KIAA1043 ENSG00000100154 "Tetratricopeptide repeat domain 28" Q96AY4 22 27978014-28679865 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Astrocytes: 291.5;Excitatory neurons: 169.6;Inhibitory neurons: 289.8;Microglial cells: 332.6;Oligodendrocyte precursor cells: 318.7;Oligodendrocytes: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001080 Approved "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 89: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Microtubules, Cytokinetic bridge, Mitotic spindle" Cytosol "HPA001080: " "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-1)" "unprognostic (8.55e-3)" "unprognostic (4.83e-2)" "unprognostic (5.20e-2)" "unprognostic (2.25e-1)" "prognostic favorable (4.30e-4)" "unprognostic (3.91e-2)" "unprognostic (1.18e-2)" "unprognostic (5.40e-2)" "unprognostic (5.10e-2)" "prognostic favorable (5.65e-5)" "unprognostic (5.54e-3)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (4.36e-1)" 7.2 4.6 4.3 2.9 3.0 0.8 6.3 0.4 3.4 8.8 2.6 6.9 3.1 10.2 9.8 5.2 8.7 6.4 4.9 3.9 1.8 4.9 3.5 7.2 2.0 2.4 2.0 16.8 5.0 3.8 3.8 8.8 1.4 5.1 2.9 3.4 6.8 6.9 5.4 3.0 3.8 8.5 1.8 3.5 4.8 8.1 2.1 2.7 6.8 5.1 1.4 6.3 5.0 2.1 0.0 6.8 17.1 7.4 10.0 14.8 0.3 5.1 9.4 7.1 6.1 0.5 0.0 0.1 6.9 14.9 2.3 1.0 11.1 0.3 3.8 0.7 7.5 1.1 8.6 6.5 4.5 0.2 6.8 14.9 0.3 4.6 3.2 4.8 13.0 4.5 4.5 0.6 1.6 2.5 0.1 0.6 3.1 0.0 4.3 7.0 4.3 0.1 3.3 0.2 4.8 10.6 7.1 0.2 4.5 4.7 3.5 0.6 12.2 8.4 4.0 5.5 3.8 2.2 0.2 0.1 3.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 4.3 3.0 0.4 3.4 3.9 1.8 2.4 2.0 1.4 1.8 2.1 2.1 29.4 3.2 12.5 291.5 3.2 6.0 5.8 1.7 11.4 34.1 8.7 8.0 9.7 8.6 1.6 12.9 18.8 6.0 2.3 2.1 0.0 6.2 10.8 7.9 28.9 30.9 9.0 7.0 169.6 6.0 1.5 27.3 4.1 12.4 1.3 32.3 36.8 15.3 3.7 28.6 289.8 5.8 0.0 9.4 7.2 9.1 31.4 4.3 10.6 332.6 0.7 11.5 5.2 318.7 116.3 3.9 4.4 45.5 3.1 5.0 4.8 18.6 1.9 24.9 13.1 27.2 19.7 23.8 11.6 6.7 3.8 2.5 3.2 27.4 6.9 4.0 TTLL6 FLJ35808 ENSG00000170703 "Tubulin tyrosine ligase like 6" Q8N841 17 48762235-48817214 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 18.9" "Group enriched" "Detected in some" 4 "Early spermatids: 49.7;Late spermatids: 176.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HDLM-2: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA052397 Enhanced Approved Vesicles,Microtubules NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" Microtubules Vesicles "HPA052397: AB_2681812" "unprognostic (5.74e-2)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (2.18e-1)" "unprognostic (8.04e-2)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (1.02e-1)" "unprognostic (1.27e-2)" "unprognostic (2.35e-1)" "unprognostic (2.21e-5)" "unprognostic (1.10e-2)" "unprognostic (6.01e-5)" "unprognostic (1.17e-1)" "unprognostic (3.28e-1)" "unprognostic (6.68e-2)" "unprognostic (2.09e-3)" 0.1 0.0 0.6 0.1 0.6 0.0 0.1 0.5 1.0 0.2 1.6 2.8 1.3 0.1 0.0 0.0 3.6 0.5 0.0 0.7 0.6 2.5 0.0 0.6 0.0 0.8 0.9 0.0 0.6 0.0 0.4 0.0 0.6 0.1 3.9 0.4 0.0 0.0 0.0 0.0 1.7 0.1 0.6 0.0 0.2 18.9 0.8 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.5 1.0 0.7 0.6 0.8 0.9 0.6 0.6 0.8 0.6 0.1 3.2 2.6 5.2 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.6 0.0 3.8 1.8 0.0 0.0 0.0 7.4 1.9 0.3 49.7 2.6 0.1 0.5 4.2 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.1 0.1 0.0 1.0 2.6 0.0 0.0 0.0 176.1 1.2 0.1 0.0 0.0 0.0 0.4 0.0 13.0 0.7 0.0 2.2 0.0 0.0 0.4 4.1 3.2 23.8 0.7 0.0 0.0 0.0 11.2 0.4 0.0 0.0 0.0 0.0 0.4 3.5 0.1 TTLL9 "C20orf125, dJ310O13.1" ENSG00000131044 "Tubulin tyrosine ligase like 9" Q3SXZ7 20 31870702-31944963 "Cancer-related genes, Predicted intracellular proteins" Ligase "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.4;choroid plexus: 10.3;epididymis: 2.6;fallopian tube: 6.2;testis: 5.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 20.8;Early spermatids: 39.3;Endometrial ciliated cells: 25.8;Late spermatids: 69.8;Oligodendrocytes: 28.0;Respiratory ciliated cells: 50.2" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041772, HPA055676" Uncertain Uncertain Nucleoplasm,Microtubules NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Microtubules" "HPA041772: AB_10959904, HPA055676: AB_2682881" "unprognostic (8.77e-2)" "unprognostic (8.19e-3)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (4.63e-1)" "unprognostic (1.53e-3)" "unprognostic (1.80e-1)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.05e-3)" "unprognostic (6.17e-2)" "unprognostic (8.35e-3)" "unprognostic (1.84e-1)" "unprognostic (1.70e-1)" "unprognostic (1.25e-3)" "unprognostic (2.23e-2)" 0.1 0.1 2.0 0.0 2.1 0.0 0.2 2.2 2.2 0.9 10.3 0.0 0.0 0.1 2.6 0.0 6.2 0.1 0.0 2.5 2.3 0.7 0.0 1.1 0.1 3.8 4.4 0.1 0.2 0.6 0.9 0.0 3.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 3.0 0.2 0.0 5.0 2.4 0.0 0.6 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.1 2.2 2.2 2.5 2.3 3.8 4.4 3.0 3.0 2.4 2.6 0.2 12.8 20.8 13.1 0.1 0.1 1.1 1.1 0.0 1.8 0.4 0.6 0.9 0.0 8.1 0.0 4.2 0.1 0.1 0.0 0.0 0.2 39.3 25.8 0.7 1.1 0.0 0.0 5.6 0.0 0.0 1.6 0.0 0.8 7.6 0.8 0.4 0.1 0.0 5.0 7.8 0.2 2.0 0.6 0.5 69.8 1.5 3.5 0.0 1.0 0.8 0.4 0.0 15.1 28.0 0.1 0.0 1.2 0.0 0.5 0.0 0.2 50.2 0.8 0.0 0.8 0.7 13.8 1.2 0.0 0.1 0.0 2.7 0.4 0.0 0.4 TUBA1A "B-ALPHA-1, FLJ25113, TUBA3" ENSG00000167552 "Tubulin alpha 1a" Q71U36 12 49184686-49189080 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease variant, FDA approved drug targets, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 1313.3" "Cell type enhanced" "Detected in all" "Ductal cells: 1162.0;Respiratory ciliated cells: 1173.3;Smooth muscle cells: 1005.3" "Cancer enriched" "Detected in all" 9 "glioma: 942.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1660.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 3100.7;SCLC-21H: 1983.9" "Low region specificity" "Detected in all" "CAB008686, HPA039247, HPA043684, HPA063394" Enhanced Enhanced Microtubules NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 12: NES - Nervous system development" "Cluster 10: Non-specific - Unknown function" Microtubules "CAB008686: AB_1624202, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (3.11e-1)" "unprognostic (1.61e-1)" "unprognostic (3.77e-1)" "unprognostic (1.14e-1)" "unprognostic (4.73e-1)" "unprognostic (1.15e-2)" "unprognostic (2.56e-2)" "unprognostic (2.12e-1)" "unprognostic (3.49e-2)" "unprognostic (3.80e-1)" "unprognostic (1.11e-3)" "unprognostic (9.79e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.07e-2)" "unprognostic (4.27e-2)" "unprognostic (1.12e-2)" "unprognostic (1.27e-3)" 150.3 133.5 803.3 166.9 990.4 152.0 179.7 1083.4 882.6 185.8 692.7 466.4 54.4 406.3 166.6 140.0 342.0 193.1 156.5 784.4 1066.9 64.9 21.1 214.3 71.7 1209.8 1002.4 172.8 53.5 79.1 163.4 123.9 1136.6 173.4 126.5 259.7 104.7 267.3 37.4 107.9 125.9 865.4 1083.5 84.7 135.6 69.0 987.8 162.7 39.7 94.1 55.9 210.1 117.1 1313.3 3.2 154.4 3100.7 419.3 263.1 613.9 10.5 286.4 325.6 163.2 390.4 9.4 54.8 120.7 322.4 824.7 304.0 6.4 388.0 97.3 120.3 97.0 138.1 41.5 27.6 34.4 54.1 70.2 3.2 359.5 33.8 325.0 31.8 627.1 945.9 237.2 45.0 124.5 888.7 70.3 276.5 59.2 335.0 3.6 112.5 225.4 232.3 14.1 718.9 13.8 1983.9 1150.3 79.1 4.5 106.0 449.9 210.4 97.3 929.1 178.6 108.5 21.2 80.5 41.5 126.9 234.2 93.8 117.2 191.6 503.5 260.5 824.7 159.0 554.9 118.1 158.2 140.0 146.7 314.0 166.9 134.2 125.2 1660.9 89.9 812.8 101.1 172.8 495.5 803.3 990.4 1083.4 882.6 784.4 1066.9 1209.8 1002.4 1136.6 1083.5 987.8 1313.3 296.9 230.8 181.5 49.9 220.8 87.2 250.6 179.3 59.7 233.0 140.0 291.6 187.9 25.8 148.1 64.4 77.2 10.5 202.9 4.5 25.4 1162.0 10.0 414.9 413.6 334.2 785.8 48.0 78.2 16.2 12.8 391.5 63.2 102.4 547.9 695.0 165.6 2.8 452.0 249.0 60.6 15.5 329.6 80.7 277.6 20.7 193.6 204.2 183.2 37.5 616.6 788.9 77.2 73.4 432.6 333.3 12.8 142.6 32.5 60.4 1.5 73.3 1173.3 349.6 164.3 542.7 1005.3 15.4 31.2 20.9 99.3 15.9 266.5 40.6 12.4 95.7 TUBA1B K-ALPHA-1 ENSG00000123416 "Tubulin alpha 1b" P68363 12 49127782-49131397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 2143.3;Extravillous trophoblasts: 2555.5;Hofbauer cells: 2114.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011513, HPA039247, HPA043684, HPA063394" Enhanced Supported Microtubules NA Yes "Cluster 51: Monocytes - Innate immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Microtubules "CAB011513: AB_2210057, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "prognostic unfavorable (5.49e-4)" "unprognostic (4.19e-2)" "unprognostic (3.84e-3)" "unprognostic (5.84e-2)" "unprognostic (2.91e-1)" "unprognostic (7.10e-2)" "prognostic unfavorable (1.68e-7)" "unprognostic (2.98e-3)" "unprognostic (9.28e-2)" "unprognostic (1.78e-1)" "unprognostic (3.69e-2)" "unprognostic (9.46e-2)" "prognostic unfavorable (2.85e-12)" "unprognostic (1.60e-1)" "unprognostic (3.52e-1)" "unprognostic (4.67e-2)" "unprognostic (3.55e-3)" 531.9 319.3 1071.9 650.0 1115.9 1491.9 453.7 941.8 1318.4 306.5 841.2 598.4 279.4 460.5 403.7 550.9 369.1 305.6 509.3 1108.8 1139.4 310.3 233.9 511.3 750.8 1176.0 1108.8 325.9 179.9 262.6 322.2 582.9 1162.2 247.8 665.1 652.9 304.6 394.1 243.9 404.3 352.5 1004.6 993.4 435.8 355.7 322.7 1127.4 1557.3 267.3 242.0 882.3 639.5 339.4 1076.7 3063.5 3381.9 3587.5 2051.4 910.0 1321.7 1939.2 2635.0 2642.5 5018.6 4034.6 4300.0 3144.6 3430.1 1854.8 3732.5 2047.5 1864.3 3993.2 3609.1 4586.7 1938.3 2103.5 2445.9 1822.2 2219.9 251.5 3705.8 1863.3 793.6 540.2 3930.9 1298.9 1697.4 4353.5 3121.3 2788.0 2182.3 4142.7 3362.1 4985.5 2943.8 2504.9 7570.8 3944.4 3980.1 3023.6 2137.4 2377.1 2008.1 2250.7 1921.9 2211.7 1697.3 803.9 1804.3 2403.1 3624.8 2321.3 2393.9 2752.4 2404.5 3470.2 1196.5 1876.2 3685.5 1668.2 2924.3 2303.6 197.9 240.0 411.5 241.8 1022.1 266.7 268.9 230.1 225.3 632.4 239.6 241.0 192.4 271.6 230.9 1107.4 632.0 293.2 731.1 1071.9 1115.9 941.8 1318.4 1108.8 1139.4 1176.0 1108.8 1162.2 993.4 1127.4 1076.7 702.9 198.7 231.8 36.6 445.8 584.0 653.7 875.4 288.5 426.4 267.9 391.8 0.8 90.1 373.4 187.6 492.1 1143.1 514.2 482.6 361.9 814.5 272.5 189.3 218.3 643.9 303.7 2143.3 201.8 630.1 2555.5 603.4 237.0 203.9 542.8 1069.6 353.4 106.3 2114.8 498.0 99.1 508.1 512.7 361.8 1353.1 204.8 326.8 729.8 473.2 68.4 1248.5 455.7 228.6 34.7 82.7 703.3 298.4 236.6 595.9 373.5 240.0 245.1 287.7 970.8 263.0 321.5 957.4 161.6 488.9 560.6 449.8 304.4 480.3 172.4 551.2 539.1 TUBA1C "bcm948, MGC10851, MGC14580, TUBA6" ENSG00000167553 "Tubulin alpha 1c" Q9BQE3 12 49188736-49274600 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 479.4" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 1118.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 98.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 4114.3" "Low region specificity" "Detected in all" "HPA039247, HPA043684, HPA063394" Supported Supported Microtubules NA Yes 160000000 "Cluster 38: Basophils - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Microtubules "HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "prognostic unfavorable (2.90e-4)" "unprognostic (1.15e-2)" "prognostic favorable (7.37e-5)" "unprognostic (3.25e-2)" "unprognostic (4.60e-2)" "unprognostic (2.88e-2)" "prognostic unfavorable (8.48e-8)" "prognostic unfavorable (6.85e-4)" "unprognostic (2.11e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (5.64e-6)" "unprognostic (1.49e-1)" "prognostic unfavorable (6.26e-7)" "unprognostic (2.95e-1)" "unprognostic (1.26e-1)" "unprognostic (2.49e-1)" "unprognostic (5.45e-3)" 92.6 57.8 12.4 110.5 12.1 148.8 54.7 13.9 18.0 101.0 41.9 158.2 106.9 59.6 62.7 479.4 50.8 92.1 55.3 12.8 16.4 113.5 69.3 74.1 78.6 15.7 14.1 38.3 52.6 22.5 28.0 109.9 15.5 43.7 156.5 2.5 139.0 46.4 45.3 166.1 117.6 129.8 15.7 42.1 115.2 26.3 22.6 103.3 56.3 42.5 170.7 222.5 168.8 15.4 1295.3 987.5 211.7 363.9 220.5 368.4 816.3 1010.1 1126.1 1742.1 927.3 966.9 947.0 578.9 1053.2 1194.2 1047.3 580.5 1246.0 1412.1 1150.2 564.1 449.7 703.4 406.7 943.7 165.2 550.9 498.4 269.8 663.0 1485.6 619.9 550.6 1139.5 320.6 1026.8 308.3 1521.8 811.1 306.5 535.8 639.6 4114.3 1928.6 344.0 414.5 319.7 770.3 602.8 169.8 9.1 875.5 574.4 386.0 828.3 559.4 426.0 835.1 819.3 911.5 821.9 1717.4 101.6 306.5 565.2 431.6 536.1 725.9 98.8 14.6 29.9 12.3 17.3 19.7 10.5 13.1 11.7 27.0 7.4 7.0 7.9 12.2 13.6 13.1 21.6 17.6 20.8 12.4 12.1 13.9 18.0 12.8 16.4 15.7 14.1 15.5 15.7 22.6 15.4 94.3 118.6 136.1 2.6 54.9 194.5 354.2 317.7 306.7 1.3 61.3 75.8 0.9 45.8 150.9 58.8 0.0 291.9 50.1 432.7 70.5 285.8 7.9 107.7 65.8 83.0 77.5 155.5 2.1 559.2 1118.2 109.7 153.4 204.4 67.2 110.8 39.3 55.9 276.8 0.0 1.9 190.5 101.7 65.6 121.7 8.4 68.0 163.3 46.2 2.8 265.5 2.8 6.2 1.0 1.4 465.6 330.2 40.6 71.0 206.3 234.1 137.1 51.9 0.6 39.5 84.3 258.2 9.0 65.5 530.8 183.1 161.6 77.6 46.1 187.9 293.4 TUBA3C "bA408E5.3, TUBA2" ENSG00000198033 "Tubulin alpha 3c" P0DPH7 13 19173772-19181824 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 714 "testis: 404.9" "Group enriched" "Detected in some" 25 "Early spermatids: 703.3;Late spermatids: 250.4;Spermatocytes: 947.8;Spermatogonia: 255.9" "Cancer enhanced" "Detected in many" "liver cancer: 2.7;testis cancer: 2.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 49 "HDLM-2: 107.5;U-2 OS: 256.9;U-266/70: 84.2;U-266/84: 109.7" "HPA039247, HPA043684, HPA063394" Uncertain Supported Microtubules NA Yes "Cluster 36: Testis - Spermatogenesis" "Cluster 9: U-2 OS - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" Microtubules "HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (3.76e-3)" "unprognostic (1.33e-1)" "unprognostic (3.00e-1)" "unprognostic (1.04e-1)" "unprognostic (1.26e-1)" 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 404.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 107.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.4 256.9 0.2 0.3 84.2 109.7 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 703.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 250.4 21.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.6 947.8 255.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 TUBA3D H2-ALPHA ENSG00000075886 "Tubulin alpha 3d" P0DPH8 2 131476119-131482934 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "heart muscle: 86.2;testis: 220.2" "Cell type enhanced" "Detected in some" "Early spermatids: 358.9;Late spermatids: 119.6;Spermatocytes: 667.9;Spermatogonia: 326.1" "Cancer enhanced" "Detected in many" "testis cancer: 7.6" "Region enhanced" "Detected in single" "cerebellum: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.1" "Not detected" "Not detected" "CAB004972, HPA039247, HPA043684, HPA063394" Uncertain Supported Microtubules NA NA "Cluster 43: Testis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Microtubules "CAB004972: AB_425727, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "prognostic favorable (4.65e-4)" "unprognostic (6.66e-2)" "unprognostic (1.10e-1)" "unprognostic (2.96e-3)" "unprognostic (1.82e-1)" "unprognostic (1.50e-3)" "unprognostic (2.17e-1)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (2.89e-1)" "unprognostic (1.08e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (4.75e-9)" "unprognostic (4.60e-2)" "unprognostic (2.28e-1)" "unprognostic (9.96e-4)" "unprognostic (2.28e-1)" 0.1 0.1 0.4 0.2 0.3 0.4 0.6 1.6 0.4 2.8 0.0 0.1 0.1 4.8 6.8 0.2 4.0 0.2 86.2 0.6 0.2 0.1 0.4 0.1 0.4 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 10.1 0.0 0.3 0.3 0.4 0.1 0.6 0.2 0.3 0.0 0.2 0.2 220.2 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.5 0.2 0.2 0.9 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.8 0.3 0.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.7 0.1 0.6 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.3 0.0 0.5 0.5 1.1 0.7 0.0 0.3 0.4 0.0 0.2 0.0 0.2 0.5 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.2 0.3 0.4 0.5 0.3 0.1 0.2 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.6 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.4 36.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 358.9 0.4 1.1 1.2 0.0 0.0 0.4 0.0 0.1 0.6 0.0 1.1 0.0 0.4 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 119.6 12.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.1 0.0 4.8 0.0 0.0 0.0 0.0 52.6 0.0 0.1 667.9 326.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TUBA3E ENSG00000152086 "Tubulin alpha 3e" Q6PEY2 2 130191745-130198439 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 29 "heart muscle: 53.3;testis: 175.3" "Group enriched" "Detected in some" 6 "Early spermatids: 259.8;Late spermatids: 109.4;Spermatocytes: 415.4;Spermatogonia: 172.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BEWO: 4.2;U-2 OS: 2.7" "HPA039247, HPA043684, HPA063394" Uncertain Supported Microtubules NA NA "Cluster 43: Testis - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Microtubules "HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (1.02e-3)" "unprognostic (2.79e-1)" "unprognostic (3.73e-2)" "unprognostic (1.51e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" "unprognostic (6.81e-3)" "unprognostic (1.33e-1)" "unprognostic (3.21e-1)" "unprognostic (2.54e-1)" "unprognostic (1.21e-2)" "unprognostic (7.89e-2)" "unprognostic (2.65e-7)" "unprognostic (1.39e-1)" "unprognostic (2.10e-1)" "unprognostic (2.02e-3)" "unprognostic (8.94e-3)" 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.4 0.1 1.7 0.0 0.0 0.0 3.9 0.4 0.0 2.5 0.0 53.3 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 175.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 259.8 0.0 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 109.4 9.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 39.5 0.0 0.1 415.4 172.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TUBA4A "FLJ30169, H2-ALPHA, TUBA1" ENSG00000127824 "Tubulin alpha 4a" P68366 2 219249710-219278170 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 360.2;tongue: 210.3" "Cell type enhanced" "Detected in many" "Early spermatids: 423.0;Late spermatids: 823.0;Pancreatic endocrine cells: 613.5;Smooth muscle cells: 408.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 265.9;HBEC3-KT: 439.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004621, CAB005887, HPA039247, HPA043684, HPA063394" Approved Enhanced Microtubules NA NA 130000000 "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 10: Non-specific - Unknown function" Microtubules "CAB004621: AB_628411, CAB005887: AB_2288001, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (8.08e-2)" "unprognostic (2.31e-1)" "unprognostic (4.03e-2)" "unprognostic (2.56e-2)" "unprognostic (5.18e-3)" "unprognostic (3.99e-2)" "prognostic unfavorable (4.54e-6)" "unprognostic (1.52e-3)" "unprognostic (4.47e-1)" "unprognostic (8.85e-2)" "unprognostic (1.49e-2)" "unprognostic (5.27e-2)" "unprognostic (1.94e-1)" "unprognostic (2.70e-1)" "unprognostic (2.36e-1)" "unprognostic (7.38e-3)" "unprognostic (9.32e-2)" 14.3 41.4 33.6 34.1 47.5 107.1 16.4 22.3 133.1 27.7 8.1 32.9 18.6 9.8 10.1 84.8 12.6 13.5 97.7 42.6 32.3 31.9 29.5 26.7 56.7 46.3 27.3 12.9 18.2 34.6 23.1 5.0 31.4 19.7 27.8 39.2 46.9 22.4 360.2 161.4 35.5 12.8 3.9 56.8 30.6 32.4 14.9 16.9 12.3 210.3 63.4 22.6 57.3 54.0 106.0 90.0 0.0 0.3 9.1 6.9 0.3 16.2 49.7 2.8 1.9 20.4 106.7 144.2 172.2 11.7 172.7 265.9 49.3 439.9 3.9 81.7 0.7 184.2 154.5 15.4 7.3 60.9 60.8 6.7 158.0 23.7 49.2 27.4 17.3 2.4 20.5 91.3 100.6 4.3 0.3 107.9 32.3 83.2 107.4 6.5 139.0 84.5 129.7 7.5 85.8 1.5 213.2 18.7 0.7 1.8 8.0 50.9 12.3 49.8 27.4 58.4 56.7 38.0 48.8 171.4 183.3 116.4 2.5 141.7 63.3 170.2 107.1 45.7 110.1 124.9 150.3 142.8 20.9 95.5 140.2 138.4 331.2 82.0 71.9 3.8 143.8 270.9 33.6 47.5 22.3 133.1 42.6 32.3 46.3 27.3 31.4 3.9 14.9 54.0 55.3 44.8 47.1 16.3 160.6 181.8 201.2 235.3 68.9 123.3 42.3 51.6 60.9 28.6 62.0 49.7 77.2 0.7 311.6 87.3 140.8 199.3 423.0 9.8 3.3 36.5 107.9 56.2 34.8 205.6 0.5 11.5 40.8 26.1 15.8 0.1 36.0 33.0 6.0 67.3 22.5 141.9 48.8 15.3 54.9 823.0 16.8 159.5 78.2 9.4 27.8 38.6 50.4 10.6 10.6 613.5 51.2 7.5 202.3 46.7 87.5 137.5 11.1 72.9 0.0 21.1 408.5 5.7 5.0 130.6 244.5 2.5 290.1 1.4 58.9 113.0 TUBA8 TUBAL2 ENSG00000183785 "Tubulin alpha 8" Q9NY65 22 18110100-18146683 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 128.9;skeletal muscle: 332.2;tongue: 154.7" "Cell type enhanced" "Detected in some" "Early spermatids: 16.4;Excitatory neurons: 8.1;Inhibitory neurons: 5.6;Late spermatids: 22.9;Sertoli cells: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basophil: 2.8;eosinophil: 2.7;neutrophil: 5.0;NK-cell: 10.4" "Group enriched" "Detected in many" 7 "granulocytes: 5.0;NK-cells: 10.4" "Group enriched" "Detected in many" 5 "NB-4: 30.2;SCLC-21H: 10.9;TIME: 36.3" "Group enriched" "Detected in all" 4 "cerebellum: 54.7;olfactory bulb: 53.9" "Low region specificity" "Detected in all" "HPA043684, CAB046031, HPA063394" Approved Supported Microtubules NA NA 80000000 "Cluster 48: NK-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 24: NB-4 - Immune response" "Cluster 34: Spermatids - Unknown function" Microtubules "CAB046031: AB_11124541, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (1.07e-1)" "unprognostic (1.34e-2)" "unprognostic (2.79e-3)" "unprognostic (1.52e-2)" "unprognostic (2.74e-1)" "unprognostic (8.92e-2)" "unprognostic (6.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.64e-2)" "unprognostic (1.92e-2)" "unprognostic (3.36e-1)" "unprognostic (2.90e-5)" "unprognostic (9.12e-2)" "unprognostic (6.05e-2)" "unprognostic (4.08e-2)" "unprognostic (5.61e-4)" 7.3 1.9 9.0 1.0 11.8 4.7 7.2 24.3 16.3 2.5 0.8 2.0 0.8 2.7 6.3 4.3 4.8 1.0 128.9 15.0 2.8 2.3 4.3 2.4 3.5 0.6 9.0 2.3 4.4 2.7 14.5 0.6 0.8 2.5 0.5 2.8 4.4 0.6 332.2 4.4 2.6 0.7 1.5 4.2 4.7 52.3 11.5 0.8 6.5 154.7 1.0 2.0 2.2 12.5 0.6 1.1 1.2 1.4 1.8 0.5 0.4 0.6 0.3 1.4 0.8 0.9 1.1 0.9 2.2 0.7 0.4 0.6 2.2 0.4 0.3 0.8 1.6 2.2 1.7 0.9 1.0 1.0 1.0 0.7 0.8 0.8 0.6 0.5 2.0 0.9 0.6 0.9 0.6 3.4 1.0 30.2 1.0 0.5 0.5 0.9 0.5 0.2 0.7 1.1 10.9 1.1 0.6 1.9 1.0 0.5 0.6 4.8 36.3 0.9 1.0 1.0 0.4 2.2 1.3 0.7 0.9 1.4 0.6 2.8 0.7 2.7 0.5 0.6 0.7 0.4 0.4 0.3 0.4 0.6 0.7 0.4 5.0 10.4 0.4 1.0 0.8 17.1 9.0 11.8 24.3 16.3 15.0 2.8 0.6 9.0 0.8 1.5 11.5 12.5 0.2 0.0 1.7 1.6 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 4.7 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.3 16.4 0.2 0.1 0.4 0.0 0.0 8.1 1.1 0.0 0.3 0.0 0.2 2.5 0.1 0.7 0.0 0.1 3.3 5.6 0.0 0.0 0.3 0.0 22.9 0.3 0.1 0.0 0.0 0.2 0.1 1.0 3.5 1.7 0.6 0.1 0.4 0.0 0.0 0.4 0.1 0.0 0.2 6.6 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 TUBB "M40, MGC16435, OK/SW-cl.56, Tubb5" ENSG00000196230 "Tubulin beta class I" P07437 6 30717435-30725538 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 2296.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005417, CAB012406, HPA043640, HPA046280" Enhanced Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes Yes 170000000 "Cluster 39: Non-specific - mRNA processing" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (1.01e-1)" "unprognostic (2.33e-1)" "unprognostic (2.17e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (2.18e-3)" "unprognostic (1.27e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (2.62e-8)" "unprognostic (8.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (2.50e-1)" 229.5 164.8 74.6 243.5 81.8 541.0 186.9 46.2 367.7 228.7 87.0 250.3 87.6 333.0 174.5 246.3 227.0 158.5 245.3 73.5 119.7 137.8 236.6 205.3 369.2 80.5 74.8 467.5 138.1 74.4 97.0 194.4 99.2 145.2 194.4 82.4 160.2 194.6 185.7 211.9 159.4 371.0 57.5 195.0 172.8 77.8 94.0 620.4 142.4 98.6 487.6 222.3 213.8 63.5 2281.7 1027.3 2650.0 1458.4 733.2 1265.2 568.2 396.9 469.5 943.3 863.5 1329.2 703.9 1494.1 1105.1 1408.1 1877.8 805.3 2160.6 1968.0 160.3 892.5 1321.1 461.4 207.3 1306.7 345.8 2550.0 1223.9 943.6 455.9 416.0 443.6 967.1 1493.3 2058.1 1270.4 294.1 1844.8 1398.2 2719.0 249.3 377.3 604.1 948.6 102.6 708.5 911.6 1564.5 1071.4 940.8 1516.7 969.0 911.2 354.7 1625.5 1148.3 422.4 880.6 2712.0 1526.0 614.5 917.7 835.3 1735.4 2101.3 538.8 2494.6 3548.7 119.8 115.6 122.8 187.3 182.5 218.8 166.1 152.3 188.8 111.7 113.0 143.2 163.3 46.8 165.1 222.4 227.7 180.8 342.5 74.6 81.8 46.2 367.7 73.5 119.7 80.5 74.8 99.2 57.5 94.0 63.5 215.8 131.4 47.3 21.5 214.9 576.2 358.4 698.6 434.2 72.7 234.2 312.8 114.9 244.5 238.7 171.0 39.6 811.9 198.7 133.4 311.0 1091.0 9.1 69.1 261.6 370.8 163.6 1322.1 28.2 1061.1 2296.1 471.5 95.3 140.2 207.3 643.6 298.4 267.8 955.2 109.4 25.0 185.3 376.4 454.5 689.6 24.4 402.6 295.8 321.9 30.9 774.0 192.6 246.1 20.1 23.0 1087.0 90.7 237.3 304.6 199.5 117.9 245.9 66.6 65.4 118.3 124.0 838.6 58.0 126.5 447.0 430.6 220.4 244.0 224.9 253.2 229.0 TUBB1 dJ543J19.4 ENSG00000101162 "Tubulin beta 1 class VI" Q9H4B7 20 59019429-59026654 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.5;lymphoid tissue: 4.3" "Cell type enriched" "Detected in some" 10 "Macrophages: 191.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 17 "basophil: 63.5;neutrophil: 26.0" "Lineage enriched" "Detected in many" 24 "granulocytes: 63.5" "Cell line enriched" "Detected in some" 19 "HEL: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004286, HPA043640, HPA046280" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA 87000000 "Cluster 34: Basophils - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (3.76e-1)" "unprognostic (2.69e-1)" "unprognostic (6.10e-4)" "unprognostic (1.02e-1)" "unprognostic (5.00e-2)" "unprognostic (2.02e-1)" "unprognostic (5.86e-2)" "unprognostic (7.51e-4)" "unprognostic (1.90e-2)" "unprognostic (2.63e-1)" "unprognostic (6.80e-5)" "unprognostic (3.46e-1)" "unprognostic (1.16e-1)" "unprognostic (2.55e-1)" "unprognostic (1.40e-1)" "unprognostic (2.31e-1)" "unprognostic (1.00e-1)" 0.2 0.2 0.2 0.3 0.2 8.5 0.1 0.5 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.3 2.4 0.2 0.3 0.2 0.1 0.1 0.0 0.3 1.1 0.2 0.0 0.0 0.2 0.1 0.0 0.4 0.1 0.2 0.0 0.1 4.3 0.1 0.9 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.3 0.1 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.2 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 29.5 0.8 1.5 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.4 0.0 0.0 0.1 0.3 0.3 0.0 0.1 0.4 0.2 0.1 0.3 0.0 0.3 0.3 0.2 0.2 0.6 0.1 0.1 0.1 0.2 0.0 0.2 0.2 0.3 0.1 0.2 0.3 0.2 0.1 0.2 0.4 63.5 2.4 1.9 0.5 0.6 0.4 0.9 0.2 0.0 1.1 0.5 0.4 0.0 26.0 0.2 0.3 2.6 0.5 281.6 0.2 0.2 0.5 0.5 0.1 0.2 0.3 0.2 0.2 0.1 0.2 0.3 0.1 0.0 1.1 0.3 1.4 0.0 0.0 0.0 0.0 1.7 0.1 0.1 0.1 0.0 0.6 0.0 4.2 0.0 3.1 0.0 0.0 0.0 16.0 0.3 0.2 1.5 0.0 19.0 0.2 0.0 0.1 0.1 0.0 0.7 1.3 0.0 3.6 0.2 0.3 0.0 0.2 0.0 0.0 2.8 0.0 5.9 0.3 191.2 0.0 0.0 13.8 0.2 13.4 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 1.9 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 1.0 0.1 0.1 0.1 TUBB2A "dJ40E16.7, TUBB, TUBB2" ENSG00000137267 "Tubulin beta 2A class IIa" Q13885 6 3153497-3157544 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 364.3" "Cell type enhanced" "Detected in many" "Horizontal cells: 516.5;Suprabasal keratinocytes: 368.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.2;monocytes: 1.6;T-cells: 3.2" "Cell line enhanced" "Detected in all" "AF22: 241.1;CACO-2: 247.6;SuSa: 365.5;WM-115: 280.1" "Low region specificity" "Detected in all" "CAB015339, HPA043640, HPA046280" Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 27: Brain & Skin - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 61: Squamous epithelial cells - Keratinization" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB015339: AB_2210539, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.57e-1)" "unprognostic (9.86e-3)" "unprognostic (5.90e-3)" "unprognostic (7.98e-3)" "unprognostic (4.02e-3)" "unprognostic (1.67e-1)" "unprognostic (1.82e-3)" "unprognostic (7.53e-2)" "unprognostic (1.48e-3)" "unprognostic (9.99e-2)" "unprognostic (1.24e-2)" "unprognostic (1.42e-2)" "prognostic favorable (4.65e-4)" "unprognostic (2.39e-2)" "unprognostic (1.79e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (1.61e-4)" 58.8 17.8 266.1 19.3 251.1 67.5 47.8 130.1 287.5 32.7 10.0 78.0 24.2 50.8 28.0 90.6 23.5 21.5 29.4 248.3 364.3 31.1 67.0 16.4 11.0 292.6 212.2 15.5 39.4 2.2 56.3 23.9 334.3 17.5 8.2 49.9 52.2 15.6 22.3 151.4 34.9 41.7 131.6 7.7 41.0 9.5 204.4 6.4 10.0 11.8 9.6 23.6 51.2 169.4 55.9 45.3 241.1 53.6 30.6 34.0 14.5 119.8 44.7 80.6 115.7 247.6 18.4 27.4 72.9 115.5 80.2 26.0 86.6 26.8 28.0 134.1 57.7 9.4 11.4 77.0 31.6 1.5 8.4 35.1 31.1 85.1 5.3 28.9 37.3 10.6 33.7 8.8 74.2 25.1 14.9 2.8 207.2 16.0 58.3 12.4 22.6 18.9 28.0 27.4 57.6 52.9 30.5 8.5 179.7 365.5 19.1 2.0 76.0 53.9 56.7 117.3 65.8 3.2 4.6 18.8 19.7 7.0 280.1 0.0 1.1 0.0 2.2 1.6 2.4 3.2 2.1 3.1 0.5 0.6 1.0 2.0 0.3 0.4 1.3 0.2 3.2 1.2 266.1 251.1 130.1 287.5 248.3 364.3 292.6 212.2 334.3 131.6 204.4 169.4 125.3 16.0 13.1 43.1 31.6 311.4 63.3 87.0 132.6 105.6 32.0 134.6 20.4 42.9 62.7 12.9 16.7 6.0 53.4 87.0 217.2 54.0 60.9 46.7 29.6 40.6 73.1 322.3 59.9 182.4 50.4 96.2 185.0 57.9 34.9 10.1 12.5 55.6 50.8 516.5 73.0 103.9 73.2 6.3 164.4 32.9 20.8 36.7 129.9 24.4 72.7 261.0 0.0 18.1 23.0 103.4 181.8 15.4 15.8 34.9 126.3 40.4 50.3 86.2 6.6 95.6 87.9 32.4 14.9 140.6 368.5 6.2 58.9 6.4 60.0 54.7 TUBB2B "bA506K6.1, DKFZp566F223, MGC8685" ENSG00000137285 "Tubulin beta 2B class IIb" Q9BVA1 6 3223324-3231730 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurogenesis "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 387.9;choroid plexus: 154.0" "Group enriched" "Detected in many" 4 "Distal tubular cells: 414.8;Horizontal cells: 430.7;Muller glia cells: 847.3;Skeletal myocytes: 350.1" "Cancer enriched" "Detected in many" 9 "glioma: 216.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 541.9;CACO-2: 415.3;NTERA-2: 268.0;RPMI-8226: 277.7;SCLC-21H: 797.7;SH-SY5Y: 390.2;SuSa: 245.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Supported Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 43: B-cells - Humoral immune response" "Cluster 70: Brain - Nervous system development" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 5: Muller glia cells - Visual perception" Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.66e-2)" "unprognostic (3.41e-1)" "unprognostic (5.92e-3)" "prognostic unfavorable (1.94e-4)" "unprognostic (6.81e-2)" "unprognostic (3.26e-2)" "unprognostic (9.03e-3)" "unprognostic (8.33e-2)" "unprognostic (1.08e-1)" "unprognostic (2.02e-1)" "unprognostic (3.78e-3)" "unprognostic (3.34e-2)" "unprognostic (2.03e-2)" "unprognostic (6.24e-3)" "unprognostic (6.04e-2)" "unprognostic (3.58e-4)" "unprognostic (2.30e-3)" 4.0 7.2 298.1 8.1 324.5 1.0 5.0 348.4 387.9 9.9 154.0 17.0 2.4 4.2 45.5 2.4 3.3 3.8 4.6 258.8 356.9 11.6 1.0 1.4 8.1 363.3 349.9 1.1 5.7 0.0 35.1 4.4 354.5 3.7 2.6 65.3 10.8 4.6 6.2 3.9 6.1 7.3 337.2 0.7 4.5 1.0 369.1 2.3 0.9 1.6 5.7 2.6 5.6 383.9 0.0 8.2 541.9 164.2 0.6 0.2 0.9 5.1 7.4 20.8 45.0 415.3 2.0 0.9 5.6 5.7 0.0 1.3 212.8 0.7 12.0 1.6 98.3 0.2 0.0 33.2 1.1 0.1 6.1 3.1 0.0 2.3 0.0 7.6 1.4 0.5 6.8 1.2 7.6 0.3 1.5 0.4 268.0 1.0 17.6 0.6 26.3 277.7 2.9 0.8 797.7 390.2 0.3 1.7 4.3 245.9 3.2 0.0 0.0 1.9 89.9 6.3 2.2 51.6 0.1 0.0 0.8 0.1 30.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 298.1 324.5 348.4 387.9 258.8 356.9 363.3 349.9 354.5 337.2 369.1 383.9 3.6 0.0 0.0 109.4 1.9 8.7 2.3 1.8 4.6 63.5 3.9 31.9 40.1 5.7 0.3 7.3 16.7 0.7 1.0 0.9 414.8 15.4 5.8 2.7 3.3 7.6 66.7 0.0 2.4 3.5 1.2 18.7 7.1 3.9 0.0 0.5 0.7 0.6 3.0 430.7 19.4 1.0 24.4 0.0 12.4 7.1 0.3 1.0 92.5 9.4 3.6 847.3 0.0 37.2 21.6 12.0 0.1 0.0 8.4 3.9 0.2 2.0 0.0 43.1 0.0 350.1 19.1 1.3 6.2 3.1 2.7 0.8 0.6 0.0 0.6 1.1 TUBB3 "beta-4, CFEOM3, CFEOM3A, FEOM3" ENSG00000258947 "Tubulin beta 3 class III" Q13509 16 89921392-89938761 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 313.3" "Cell type enhanced" "Detected in some" "Astrocytes: 20.2;Ductal cells: 28.7;Excitatory neurons: 37.9;Exocrine glandular cells: 21.4;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 45.1;Pancreatic endocrine cells: 49.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "naive B-cell: 2.5" "Lineage enriched" "Detected in single" 9 "B-cells: 2.5" "Cell line enhanced" "Detected in many" "A549: 421.3;SCLC-21H: 424.9;SH-SY5Y: 433.8" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA 89000000 "Cluster 24: B-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 1: Pancreatic cells - Digestion" Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (7.08e-2)" "unprognostic (3.37e-4)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (8.01e-2)" "unprognostic (3.12e-2)" "unprognostic (4.04e-3)" "unprognostic (1.12e-3)" "unprognostic (1.22e-2)" "unprognostic (6.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.38e-2)" "unprognostic (7.57e-2)" "unprognostic (1.27e-3)" "unprognostic (3.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.91e-2)" 5.7 24.8 99.4 12.1 93.3 3.4 2.1 100.5 127.6 3.3 0.0 18.4 3.7 9.7 0.2 3.6 2.3 8.8 5.5 88.6 313.3 13.3 0.9 4.1 7.1 208.8 132.7 3.9 3.2 0.4 55.1 1.8 266.2 3.0 2.6 24.8 10.6 0.4 0.6 5.2 8.0 12.7 74.2 1.3 7.2 38.0 183.4 1.0 2.5 0.3 5.2 7.3 5.3 82.5 30.1 421.3 152.6 173.9 17.9 170.8 6.8 181.0 31.0 105.8 48.2 57.2 53.5 89.6 93.6 136.8 74.3 112.1 148.9 26.7 26.3 22.7 15.5 0.7 32.5 383.7 6.0 0.0 67.6 98.4 7.9 161.9 14.0 136.8 88.4 5.9 9.2 2.5 122.3 288.6 1.2 31.5 274.3 11.2 237.3 0.1 54.1 9.5 131.8 8.1 424.9 433.8 251.2 4.4 137.1 27.5 15.0 1.9 110.9 142.8 156.9 197.3 185.3 1.4 19.6 35.2 150.2 11.5 260.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 99.4 93.3 100.5 127.6 88.6 313.3 208.8 132.7 266.2 74.2 183.4 82.5 0.4 0.0 0.0 20.2 0.0 0.0 0.0 0.0 3.4 1.8 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.0 28.7 8.2 0.5 2.6 3.8 4.9 0.0 37.9 21.4 0.7 6.1 27.0 0.7 0.0 0.0 0.0 0.0 0.2 5.0 45.1 0.1 0.0 0.0 0.0 16.8 0.3 0.2 0.0 9.4 0.0 0.3 0.0 16.1 9.2 49.2 0.0 0.4 0.4 0.0 0.0 0.1 0.0 1.4 0.0 0.0 5.1 0.2 0.4 3.0 0.0 1.0 0.1 0.0 0.2 0.0 TUBB4A "beta-5, DYT4, TUBB4" ENSG00000104833 "Tubulin beta 4A class IVa" P04350 19 6494319-6502848 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Dystonia, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 828.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 22.2;Muller glia cells: 33.0;Oligodendrocytes: 94.1;Theca cells: 81.7" "Group enriched" "Detected in many" 9 "glioma: 50.1;melanoma: 83.2;testis cancer: 49.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 13 "B-cells: 3.8;T-cells: 5.4" "Cell line enhanced" "Detected in many" "AN3-CA: 100.7;HAP1: 58.3;HEL: 91.7;PC-3: 49.6;REH: 43.4;SH-SY5Y: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010768, HPA043640, HPA046280" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA 110000000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010768: AB_261775, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.05e-1)" "unprognostic (1.97e-1)" "unprognostic (2.72e-1)" "prognostic unfavorable (8.42e-7)" "unprognostic (3.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.11e-1)" "unprognostic (8.08e-2)" "unprognostic (6.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.58e-1)" "unprognostic (2.06e-1)" "unprognostic (2.30e-1)" 0.9 203.4 209.7 1.7 404.6 0.2 0.6 452.3 388.7 0.6 0.0 6.3 1.1 0.6 0.3 0.7 0.9 0.6 2.5 249.2 229.1 2.2 1.2 0.6 1.1 425.9 254.4 1.5 3.0 0.6 4.0 0.7 440.0 0.8 0.8 22.6 1.2 0.4 4.4 5.2 3.0 0.8 221.4 9.5 2.1 76.0 373.5 0.3 0.6 1.0 0.7 0.6 1.8 828.2 0.2 28.3 0.1 100.7 0.2 0.0 0.2 0.7 0.0 0.1 0.0 1.4 0.4 0.1 30.3 0.0 3.5 0.7 58.3 0.0 0.6 0.0 10.7 91.7 1.9 0.9 0.0 0.0 5.5 0.0 0.0 2.3 0.0 1.0 0.0 17.1 8.6 0.8 0.0 3.0 18.1 4.1 7.5 0.0 49.6 43.4 0.1 20.3 10.9 0.1 0.2 36.6 0.3 0.2 30.9 2.7 0.8 1.9 0.0 0.2 12.2 0.1 0.4 2.4 1.7 11.7 1.1 0.1 0.5 0.0 0.0 0.0 5.4 0.0 3.3 3.8 0.7 5.0 0.0 1.1 1.6 3.8 0.1 0.3 0.0 0.0 0.0 1.4 209.7 404.6 452.3 388.7 249.2 229.1 425.9 254.4 440.0 221.4 373.5 828.2 0.1 0.0 0.0 6.8 3.2 1.9 0.7 0.3 0.0 2.8 0.1 0.1 9.8 1.5 0.0 0.0 0.0 0.2 1.6 0.1 5.9 1.6 2.9 0.1 0.2 1.2 0.0 2.1 22.2 0.0 0.2 1.8 0.0 0.1 0.0 16.3 1.4 0.3 0.4 10.1 15.0 0.0 0.0 0.0 1.2 9.4 5.3 0.3 14.2 13.1 0.0 33.0 1.0 8.5 94.1 0.1 0.0 0.4 0.9 0.2 0.0 1.8 0.5 2.3 6.6 0.4 4.6 1.9 1.1 0.0 1.6 0.1 3.8 81.7 0.0 0.2 TUBB4B "Beta2, TUBB2C" ENSG00000188229 "Tubulin beta 4B class IVb" P68371 9 137241287-137243707 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Deafness, Disease variant, FDA approved drug targets, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 2190.0;Late spermatids: 2907.1;Spermatocytes: 1717.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010880, HPA043640, HPA046280" Enhanced Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes Yes "Cluster 38: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.24e-1)" "unprognostic (1.77e-3)" "unprognostic (1.50e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.29e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (9.98e-4)" "unprognostic (9.92e-3)" "unprognostic (2.90e-1)" "unprognostic (3.63e-1)" "unprognostic (2.34e-1)" "unprognostic (4.09e-2)" "unprognostic (2.47e-3)" "unprognostic (6.37e-2)" "unprognostic (1.36e-2)" "prognostic favorable (6.36e-6)" "unprognostic (1.69e-1)" 134.5 112.6 162.0 97.2 163.4 423.9 94.4 149.4 182.7 88.1 482.7 198.3 142.0 107.7 209.1 343.3 507.2 106.0 435.8 174.0 185.2 122.5 140.1 130.5 95.5 184.1 233.6 72.9 123.8 87.8 118.0 86.3 213.9 120.2 111.9 261.8 177.9 121.5 202.5 240.0 166.4 119.8 162.9 85.6 161.4 765.7 192.6 162.9 115.7 96.6 119.7 188.3 139.4 133.9 706.2 1032.5 431.7 314.2 213.2 223.6 600.5 643.7 536.0 872.4 598.6 1101.0 840.2 429.0 480.2 631.2 848.2 1305.1 539.5 1039.2 330.2 307.9 458.5 311.2 789.6 877.8 134.5 370.0 331.5 145.0 291.5 667.5 183.1 215.7 631.7 300.6 443.0 239.7 731.2 1936.4 337.4 504.2 457.8 1234.8 1778.1 423.5 822.2 394.2 666.8 647.8 301.5 323.6 853.9 485.8 173.2 244.2 699.0 397.6 495.6 618.1 685.0 710.0 863.6 92.4 274.9 475.1 503.6 286.9 549.8 95.7 30.0 43.2 40.5 30.1 38.2 32.6 31.3 34.4 34.9 30.8 19.7 26.7 56.4 24.4 30.5 36.3 44.7 32.6 162.0 163.4 149.4 182.7 174.0 185.2 184.1 233.6 213.9 162.9 192.6 133.9 478.5 221.2 146.3 21.5 315.8 326.2 945.7 458.7 327.2 508.1 286.9 389.5 91.9 143.0 284.1 143.5 300.3 346.6 640.9 744.1 221.1 348.6 2190.0 1191.6 224.8 203.9 391.5 419.9 30.1 446.8 545.5 247.8 274.7 415.0 189.2 200.9 142.5 139.2 265.9 244.0 24.3 503.6 323.5 59.9 214.9 2907.1 254.2 299.3 138.7 22.5 224.0 299.3 49.4 15.6 19.7 477.4 697.2 153.1 264.0 475.1 540.7 345.5 1558.7 763.3 111.7 261.8 416.0 1717.5 740.9 419.1 297.6 321.1 362.9 89.8 487.3 592.7 TUBB6 "HsT1601, MGC4083" ENSG00000176014 "Tubulin beta 6 class V" Q9BUF5 18 12307669-12344320 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 190.2;Extravillous trophoblasts: 494.3;Pancreatic endocrine cells: 221.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 157.3" "Group enriched" "Detected in many" 6 "B-cells: 58.7;dendritic cells: 157.3" "Cell line enhanced" "Detected in many" "TIME: 821.6" "Region enriched" "Detected in many" 6 "olfactory bulb: 19.9" "Region enhanced" "Detected in all" "spinal cord: 10.3" "HPA043640, HPA046280" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes Yes 52000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.40e-2)" "unprognostic (8.28e-3)" "unprognostic (1.22e-2)" "unprognostic (5.20e-3)" "unprognostic (8.42e-2)" "unprognostic (3.37e-3)" "unprognostic (1.17e-1)" "unprognostic (2.74e-2)" "unprognostic (4.95e-2)" "unprognostic (4.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.25e-2)" "prognostic unfavorable (1.22e-7)" "unprognostic (5.83e-3)" "unprognostic (1.99e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (9.69e-4)" 197.9 37.9 12.3 82.1 11.7 34.8 134.6 14.7 14.6 106.5 28.6 193.6 31.4 173.5 24.9 217.5 121.2 66.4 166.2 11.8 13.7 66.0 40.8 92.9 31.6 19.2 16.3 81.2 52.7 5.6 33.1 59.7 15.1 84.2 28.8 3.6 69.6 91.3 37.3 78.2 75.8 151.9 14.1 34.0 89.1 28.3 18.4 12.2 52.2 20.2 31.3 129.9 124.2 12.5 211.8 142.3 149.5 76.1 149.0 208.8 108.1 648.5 424.2 492.0 459.1 113.0 65.2 1.3 281.7 440.8 148.6 99.5 84.7 653.6 380.6 1.8 46.1 32.3 159.2 73.6 151.0 2.7 59.5 219.1 146.0 429.4 222.7 148.8 366.1 12.5 159.7 2.5 432.5 216.1 0.8 162.4 79.1 3.3 70.0 1.6 260.0 2.2 99.7 5.8 19.3 27.2 360.3 34.8 113.9 153.7 76.5 203.8 821.6 600.0 510.6 565.7 574.2 11.5 3.8 3.8 458.9 46.9 219.8 2.0 19.4 0.3 0.6 7.6 0.3 42.0 0.1 0.2 25.5 58.7 0.2 0.3 0.4 0.9 7.5 157.3 0.2 13.2 12.3 11.7 14.7 14.6 11.8 13.7 19.2 16.3 15.1 14.1 18.4 12.5 67.0 83.3 7.9 0.7 16.1 69.6 42.7 151.4 16.5 1.2 30.4 44.8 54.3 8.6 37.4 7.3 0.0 53.8 23.6 0.6 1.9 167.6 190.2 6.4 76.9 128.9 0.0 12.2 0.8 104.9 494.3 112.8 1.5 7.1 45.6 7.4 82.5 0.4 69.4 0.0 0.6 0.4 42.7 13.2 85.2 114.9 70.2 36.5 33.8 12.2 65.9 0.2 0.0 0.5 0.4 221.1 0.1 91.4 1.0 51.5 0.1 1.2 18.2 1.6 26.3 89.2 130.5 4.3 6.3 55.7 66.9 22.2 3.6 9.5 0.5 65.2 TUBB8 bA631M21.2 ENSG00000261456 "Tubulin beta 8 class VIII" Q3ZCM7 10 46888-74163 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 2.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 3.4;Early spermatids: 11.7;Late spermatids: 3.4;Spermatocytes: 13.0;Spermatogonia: 15.9" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.3" "HPA043640, HPA046280" Uncertain Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 49: Eosinophils - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.75e-2)" "unprognostic (6.02e-2)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (2.78e-1)" "unprognostic (1.80e-1)" "unprognostic (7.74e-2)" "unprognostic (8.33e-3)" "unprognostic (1.50e-1)" "unprognostic (4.15e-3)" "unprognostic (7.17e-2)" "unprognostic (3.30e-2)" "unprognostic (1.33e-3)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (2.19e-2)" "unprognostic (6.86e-3)" 0.1 0.1 0.4 0.1 0.4 0.0 0.2 0.3 0.6 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.3 0.3 0.7 0.0 0.1 0.1 0.3 0.3 0.4 0.3 0.3 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.1 2.4 0.3 0.0 0.7 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.3 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.1 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.7 0.4 0.1 0.1 0.0 0.0 0.7 0.0 0.2 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 13.0 15.9 0.0 0.0 0.0 0.0 0.4 0.0 0.6 TUBB8B TUBB8P12 ENSG00000173213 "Tubulin beta 8B" A6NNZ2 18 47390-49557 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 2.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043640, HPA046280" Uncertain Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.34e-1)" "unprognostic (3.15e-2)" "unprognostic (1.29e-1)" "unprognostic (6.73e-2)" "unprognostic (1.76e-1)" "unprognostic (6.91e-2)" "unprognostic (1.92e-1)" "unprognostic (4.36e-2)" "unprognostic (1.29e-1)" "unprognostic (2.09e-1)" "unprognostic (4.46e-2)" "unprognostic (7.42e-4)" "unprognostic (3.96e-2)" "unprognostic (5.98e-2)" "unprognostic (4.88e-2)" "unprognostic (3.21e-2)" "unprognostic (1.78e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP44 FLJ14528 ENSG00000136014 "Ubiquitin specific peptidase 44" Q9H0E7 12 95516560-95551476 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 7.1;testis: 24.2" "Cell type enriched" "Detected in many" 4 "Early spermatids: 482.2" "Cancer enhanced" "Detected in some" "testis cancer: 3.0" "Region enriched" "Detected in many" 6 "cerebellum: 7.1" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 6.1" "Group enriched" "Detected in many" 41 "B-cells: 4.6;T-cells: 6.1" "Cell line enhanced" "Detected in some" "HEL: 26.4;JURKAT: 58.4;NTERA-2: 138.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA026543 Approved "Nucleoli fibrillar center,Microtubules" NA NA "Cluster 30: Non-specific - Translation" "Cluster 78: Testis - Spermatogenesis" "Cluster 5: NTERA-2 - Transcription" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoli fibrillar center, Microtubules" "HPA026543: AB_1858692" "unprognostic (2.12e-2)" "unprognostic (1.14e-1)" "unprognostic (4.68e-2)" "unprognostic (1.01e-3)" "unprognostic (1.83e-4)" "unprognostic (7.18e-4)" "unprognostic (5.55e-2)" "unprognostic (1.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.73e-2)" "unprognostic (6.88e-2)" "unprognostic (2.97e-2)" "unprognostic (8.12e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-1)" "unprognostic (7.41e-2)" "unprognostic (7.07e-2)" 0.7 0.6 0.6 1.0 0.8 0.3 0.9 7.1 1.0 0.9 0.0 1.2 0.3 1.3 0.7 0.4 1.2 0.8 0.5 0.6 0.5 1.4 0.1 3.9 1.1 0.8 0.9 0.9 2.3 1.7 1.3 0.1 1.0 0.7 0.4 1.7 1.1 1.6 0.2 0.3 0.8 0.9 0.7 1.5 0.6 24.2 0.5 3.6 1.3 0.3 1.2 0.5 0.5 1.2 0.2 0.4 11.4 0.0 0.1 0.1 0.4 1.1 3.3 1.4 0.5 0.0 0.1 0.1 3.4 0.0 0.0 0.1 0.0 0.0 1.9 0.0 5.8 26.4 0.0 0.0 5.8 10.8 0.5 0.1 0.0 0.8 0.0 0.6 0.6 58.4 4.3 0.0 0.0 0.0 13.9 0.1 138.3 0.0 0.0 0.0 0.0 0.0 2.4 0.8 8.8 5.9 0.0 0.0 0.1 13.2 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.3 4.6 0.0 1.0 0.3 0.0 0.0 0.0 1.1 0.0 2.4 4.6 1.7 1.5 0.0 3.7 6.1 4.0 0.1 0.1 0.0 0.0 0.2 1.0 0.6 0.8 7.1 1.0 0.6 0.5 0.8 0.9 1.0 0.7 0.5 1.2 1.9 12.8 31.0 1.3 5.7 1.0 3.4 0.3 4.6 8.6 1.5 3.2 1.8 0.0 3.8 7.3 6.2 2.8 0.6 0.1 0.0 4.4 482.2 0.9 2.2 2.5 0.0 0.4 5.1 3.1 0.5 3.5 1.1 1.8 0.0 10.6 1.8 0.0 0.1 0.0 16.2 0.0 0.0 0.3 1.0 116.6 5.6 0.8 3.6 1.9 0.6 2.4 1.0 15.6 4.0 0.9 0.1 3.4 1.1 5.0 0.1 1.0 0.3 9.5 6.6 2.9 3.7 77.6 6.7 0.6 0.9 1.1 3.2 2.5 0.1 1.9 VPS13C "FLJ10381, FLJ20136, KIAA1421" ENSG00000129003 "Vacuolar protein sorting 13 homolog C" Q709C8 15 61852389-62060473 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 272.2;Oligodendrocytes: 291.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043507 Uncertain Approved Microtubules NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Microtubules "HPA043507: AB_10960840" "unprognostic (1.09e-2)" "unprognostic (5.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.94e-2)" "unprognostic (5.90e-2)" "unprognostic (2.31e-2)" "unprognostic (3.92e-1)" "unprognostic (3.18e-2)" "unprognostic (2.15e-1)" "unprognostic (1.48e-1)" "unprognostic (3.61e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-2)" "unprognostic (3.92e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (5.58e-3)" 9.3 8.3 6.0 13.3 13.8 10.5 9.6 10.2 8.4 11.7 3.1 8.9 6.8 12.0 7.6 4.1 9.4 9.1 6.7 4.4 6.9 8.9 7.2 10.9 17.7 12.9 8.3 16.9 8.6 12.3 5.5 7.9 15.2 7.9 9.1 18.8 8.0 6.1 7.1 5.7 7.7 9.4 8.3 17.8 12.8 6.1 9.9 14.6 11.5 12.8 15.1 9.1 3.5 24.6 8.2 13.9 5.2 5.5 22.8 20.1 6.1 6.4 25.4 6.2 7.5 5.8 5.3 27.9 7.4 12.5 11.6 9.3 18.8 7.2 5.5 20.1 3.4 28.3 7.9 5.4 11.3 13.7 17.6 14.3 4.8 6.7 13.9 14.0 19.2 28.1 8.9 19.5 9.9 3.5 8.1 5.4 3.4 8.7 3.7 19.0 16.1 7.5 10.5 32.5 7.7 9.4 11.5 6.6 7.0 9.1 7.2 19.9 28.9 14.0 7.8 8.5 8.2 9.8 9.4 16.3 11.1 28.8 6.8 3.7 4.2 2.5 3.3 3.1 2.8 4.9 2.7 2.7 3.0 5.3 3.0 2.5 1.1 2.2 5.4 5.9 2.3 1.2 6.0 13.8 10.2 8.4 4.4 6.9 12.9 8.3 15.2 8.3 9.9 24.6 92.5 67.3 61.6 161.6 108.5 18.6 32.3 33.1 26.7 84.9 41.8 24.5 75.2 25.8 83.2 57.0 146.0 14.8 141.1 16.7 9.8 36.7 6.4 92.9 79.6 57.3 53.0 30.7 182.8 29.6 8.3 56.2 83.1 118.9 89.7 51.8 43.2 22.7 31.3 124.5 272.2 29.9 44.7 71.0 58.1 7.3 50.4 107.2 35.6 148.9 118.5 29.6 84.5 217.1 291.3 26.7 21.0 51.6 83.9 25.2 21.6 12.3 113.1 84.5 32.9 86.5 66.9 20.8 20.4 5.9 23.3 8.2 98.8 88.2 23.9 28.3 VPS45 "h-vps45, H1, VPS45A, VPS45B" ENSG00000136631 "Vacuolar protein sorting 45 homolog" Q9NRW7 1 150067279-150145329 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 202.8;Late spermatids: 267.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027425, HPA027441" Uncertain Approved Microtubules NA NA "Cluster 44: Non-specific - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 34: Spermatids - Unknown function" Microtubules "HPA027425: AB_10599415, HPA027441: AB_10602284" "unprognostic (1.57e-1)" "unprognostic (2.75e-1)" "unprognostic (2.03e-1)" "unprognostic (5.51e-2)" "unprognostic (1.56e-2)" "unprognostic (8.36e-3)" "prognostic unfavorable (6.57e-6)" "unprognostic (4.76e-2)" "unprognostic (2.94e-2)" "unprognostic (2.65e-3)" "unprognostic (2.52e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.49e-2)" "unprognostic (1.58e-1)" "unprognostic (1.72e-1)" "unprognostic (2.32e-2)" 19.1 26.8 32.3 12.0 34.6 6.6 17.8 40.2 43.0 20.1 27.7 22.0 12.6 18.7 22.5 16.7 16.1 13.7 38.6 34.0 33.2 21.1 12.5 15.4 13.5 30.6 31.4 14.0 11.1 26.4 19.1 17.3 31.5 18.8 17.2 29.2 14.3 20.1 19.3 16.5 15.3 25.2 31.5 16.2 17.4 11.0 32.9 17.0 19.8 16.6 15.3 18.5 15.9 32.8 31.5 24.3 40.9 27.0 37.1 29.4 19.0 44.7 23.7 45.3 37.4 17.7 26.1 19.3 26.5 37.0 19.9 26.0 42.4 27.0 49.0 38.7 31.1 24.6 33.5 16.8 24.7 17.6 30.2 25.8 24.8 43.5 22.8 29.7 37.1 38.6 34.4 28.3 40.0 53.5 34.7 17.5 28.4 28.7 38.4 23.7 41.9 27.4 31.2 30.0 28.5 59.7 34.9 29.8 46.9 46.2 48.9 45.6 32.6 20.8 25.1 18.7 31.3 21.3 49.4 18.9 30.9 24.4 30.2 23.6 26.6 4.7 16.0 28.0 15.0 15.6 13.6 15.1 25.9 12.8 13.2 13.9 2.5 14.1 19.9 14.6 16.8 18.4 32.3 34.6 40.2 43.0 34.0 33.2 30.6 31.4 31.5 31.5 32.9 32.8 9.4 12.8 14.0 85.8 11.9 7.4 8.2 12.7 13.1 20.9 11.0 10.2 44.0 8.6 11.0 16.5 18.8 20.9 12.5 8.3 7.9 12.3 202.8 9.7 14.2 10.4 7.8 4.6 79.4 7.2 9.5 14.7 12.8 10.1 6.3 24.6 12.1 7.2 19.0 30.3 90.2 8.1 14.2 18.0 8.6 267.9 21.5 13.6 10.6 45.9 19.7 17.9 6.2 92.5 59.5 11.4 11.6 14.7 8.4 6.4 13.6 9.2 11.5 23.8 32.9 7.3 17.1 18.1 15.1 11.6 7.7 14.8 11.2 21.2 9.7 7.9 WBP1L "C10orf26, FLJ20154, OPAL1" ENSG00000166272 "WW domain binding protein 1 like" Q9NX94 10 102743948-102834516 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037635, HPA038371" Uncertain Approved Nucleoplasm,Microtubules NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 59: Non-specific - Transcription" Microtubules Nucleoplasm "HPA037635: AB_10672462, HPA038371: AB_2675980" "unprognostic (3.28e-2)" "unprognostic (6.46e-2)" "unprognostic (1.14e-2)" "prognostic favorable (4.03e-4)" "unprognostic (5.35e-3)" "unprognostic (2.73e-2)" "unprognostic (3.33e-2)" "unprognostic (1.25e-1)" "unprognostic (1.69e-1)" "unprognostic (2.43e-3)" "unprognostic (2.55e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.56e-6)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (4.88e-2)" "unprognostic (1.53e-1)" 34.9 43.2 21.3 22.3 23.1 5.0 25.8 20.7 20.1 26.4 28.7 27.7 15.2 27.4 18.9 21.1 29.4 25.1 24.1 19.8 22.4 20.8 42.1 24.5 21.4 32.0 23.9 26.5 15.5 41.7 22.9 23.5 23.6 26.9 15.0 5.7 22.6 22.4 54.6 37.5 19.9 26.2 25.9 21.3 25.7 14.2 24.7 33.7 41.1 49.0 18.9 24.5 20.5 22.6 21.0 26.8 14.5 24.5 47.0 37.9 29.5 21.0 56.7 20.5 25.8 18.3 31.9 18.1 27.8 32.5 16.5 22.7 10.7 18.2 15.5 18.3 11.3 36.6 11.6 13.3 30.3 17.8 41.7 41.2 32.0 26.4 20.3 47.0 40.5 21.6 18.1 22.0 35.6 27.5 21.7 19.8 11.0 16.1 12.9 42.9 38.3 11.7 18.2 20.4 3.4 13.9 11.5 11.6 24.1 26.0 47.2 19.5 30.4 19.6 20.1 22.3 19.1 40.6 22.9 13.0 27.7 33.6 8.8 7.8 12.2 16.2 8.7 14.8 7.0 6.5 7.3 8.4 8.7 6.1 6.5 6.9 15.2 12.9 19.4 5.4 8.2 10.6 21.3 23.1 20.7 20.1 19.8 22.4 32.0 23.9 23.6 25.9 24.7 22.6 13.3 22.4 19.0 29.4 12.2 8.2 8.0 17.0 11.4 6.4 25.0 15.4 15.7 12.8 17.8 12.9 0.0 33.9 17.2 26.4 1.9 14.2 2.0 9.7 11.0 20.4 9.1 11.1 24.6 25.3 14.6 29.3 16.8 12.7 38.1 16.4 27.1 56.2 27.7 13.5 26.4 14.6 14.2 46.6 13.1 1.8 13.1 28.8 10.6 40.3 28.9 9.8 29.9 19.1 26.3 24.6 13.7 19.5 9.0 29.9 18.3 8.9 20.5 3.8 19.7 16.6 17.7 4.4 5.8 11.3 11.8 40.0 14.4 8.9 12.2 11.3 WDR11 "BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15" ENSG00000120008 "WD repeat domain 11" Q9BZH6 10 120851305-120909524 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038980 Approved Approved Microtubules,Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Microtubules, Cytosol" "HPA038980: AB_10675955" "unprognostic (8.98e-2)" "unprognostic (8.83e-3)" "unprognostic (1.27e-1)" "unprognostic (5.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.57e-3)" "unprognostic (1.45e-1)" "unprognostic (2.98e-3)" "unprognostic (2.84e-1)" "unprognostic (3.84e-1)" "unprognostic (8.31e-2)" "unprognostic (1.80e-3)" "prognostic favorable (5.04e-4)" "unprognostic (5.09e-2)" "unprognostic (1.87e-1)" "unprognostic (8.99e-2)" "unprognostic (2.38e-2)" 15.2 12.3 5.9 16.9 5.7 6.6 15.3 6.7 5.1 15.4 10.8 15.2 14.2 15.3 10.8 14.8 17.7 15.0 7.8 6.0 7.1 24.4 20.2 15.2 18.6 10.1 6.5 16.0 13.6 38.6 5.3 16.8 10.9 15.6 16.6 15.1 14.4 14.2 3.5 9.7 14.9 16.9 10.3 18.5 16.1 11.5 6.6 17.9 22.5 6.5 20.2 15.7 8.6 14.7 28.5 25.1 24.8 43.4 35.4 42.2 18.0 26.0 52.4 28.3 34.9 14.7 29.1 19.9 13.1 37.5 22.5 26.5 29.1 35.8 35.4 26.5 24.2 20.8 19.9 15.3 33.6 29.6 23.6 36.7 28.5 26.2 42.2 51.7 53.1 14.0 16.9 23.3 30.1 12.1 18.7 12.9 12.8 24.8 16.1 7.7 43.3 17.4 33.7 21.8 12.2 21.8 22.6 24.9 68.8 43.3 18.4 18.7 40.0 18.6 11.6 2.8 25.1 12.9 8.6 24.3 26.4 24.8 9.9 27.4 8.5 3.8 4.5 11.2 3.6 8.5 3.0 4.1 9.7 4.6 3.1 3.3 0.6 5.9 25.3 2.3 4.3 5.2 5.9 5.7 6.7 5.1 6.0 7.1 10.1 6.5 10.9 10.3 6.6 14.7 23.7 6.4 16.4 77.7 42.3 12.0 13.5 15.5 10.8 42.8 16.6 13.6 8.3 27.1 20.1 25.8 98.0 19.3 30.5 24.3 11.7 18.3 3.8 31.7 33.1 24.4 27.1 16.6 57.0 10.5 12.1 21.8 29.6 32.7 9.5 34.2 33.9 33.9 32.2 25.2 54.2 24.5 12.2 43.2 16.5 4.4 43.5 34.9 3.6 30.9 42.4 21.0 20.6 112.1 84.7 25.3 23.4 38.7 25.6 17.9 34.8 19.9 30.1 85.3 19.7 28.9 17.9 25.8 16.3 15.6 14.2 15.2 18.9 41.7 20.6 19.3 WWC2 "BOMB, FLJ22029" ENSG00000151718 "WW and C2 domain containing 2" Q6AWC2 4 183099257-183320777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 262.8;Microglial cells: 129.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SiHa: 84.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044005 Uncertain Approved Microtubules NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 39: CACO-2 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" Microtubules "HPA044005: AB_10960552" "unprognostic (1.07e-1)" "prognostic unfavorable (8.61e-4)" "unprognostic (7.16e-4)" "unprognostic (1.70e-1)" "unprognostic (2.00e-2)" "unprognostic (4.48e-3)" "unprognostic (2.05e-1)" "unprognostic (3.93e-2)" "unprognostic (4.42e-2)" "unprognostic (1.97e-1)" "unprognostic (9.52e-3)" "unprognostic (2.22e-1)" "prognostic favorable (9.29e-4)" "unprognostic (3.27e-2)" "unprognostic (3.44e-1)" "unprognostic (3.23e-1)" "unprognostic (2.52e-2)" 9.0 5.5 4.7 4.6 5.9 0.6 7.8 5.5 4.4 7.7 10.0 5.0 2.0 8.9 3.3 5.2 6.9 6.9 12.1 4.4 4.4 18.8 19.2 28.2 2.3 7.3 5.8 11.5 12.6 9.7 1.8 14.5 6.3 7.9 2.9 21.3 6.1 8.8 4.2 4.1 2.1 9.9 6.6 6.3 6.8 15.5 5.4 1.0 15.9 5.5 2.2 6.2 3.8 7.7 26.0 10.9 23.1 20.7 16.9 18.8 26.7 34.5 27.1 37.2 26.6 48.2 24.7 0.0 16.9 55.7 13.0 9.2 35.7 14.3 46.9 0.0 11.0 26.3 25.4 24.9 17.5 12.5 27.6 14.3 10.7 24.6 22.9 30.8 25.1 3.7 18.9 1.4 28.6 7.5 0.0 8.3 22.0 0.7 9.3 0.0 21.1 14.0 52.7 6.9 1.5 11.7 84.2 72.7 11.1 36.5 17.6 4.2 37.8 13.8 38.2 8.2 25.1 0.0 0.0 0.3 13.5 5.7 24.7 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 4.7 5.9 5.5 4.4 4.4 4.4 7.3 5.8 6.3 6.6 5.4 7.7 27.8 262.8 65.4 23.2 0.4 24.0 9.3 6.3 8.6 5.4 15.0 11.4 30.0 37.1 24.0 7.3 64.6 15.4 1.4 0.7 27.4 16.3 36.9 26.7 26.6 27.4 1.2 3.6 62.1 14.6 9.8 25.0 9.2 35.4 19.0 39.5 17.2 39.0 10.5 0.0 98.1 0.2 4.1 15.6 7.7 26.9 17.7 9.0 12.4 129.3 7.6 11.7 0.0 52.3 44.0 30.3 0.1 21.1 0.8 29.3 0.0 24.7 11.5 58.6 26.3 34.2 24.2 41.8 19.7 7.7 15.3 6.6 3.2 19.9 0.4 12.2 ZBTB49 "FLJ38559, ZNF509" ENSG00000168826 "Zinc finger and BTB domain containing 49" Q6ZSB9 4 4290251-4321786 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024450 Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Microtubules, Cytosol" "HPA024450: AB_1859311" "unprognostic (4.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.30e-1)" "unprognostic (2.49e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.24e-4)" "unprognostic (3.56e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.11e-1)" "prognostic favorable (1.76e-4)" "unprognostic (5.54e-3)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (9.09e-2)" "unprognostic (1.98e-1)" "prognostic favorable (2.88e-5)" 2.3 1.8 0.8 2.2 0.7 5.1 2.4 1.0 1.6 2.4 1.1 2.1 1.6 2.2 2.4 1.8 1.9 1.9 2.3 0.8 0.8 1.8 1.9 2.4 3.0 0.9 0.7 3.7 2.9 2.1 3.1 2.0 1.2 2.8 1.6 3.4 2.2 2.2 2.9 2.2 1.9 2.3 0.4 3.5 1.7 4.0 1.0 2.0 2.9 2.1 3.0 2.4 2.1 2.3 1.4 2.2 2.7 4.6 3.6 3.7 3.2 1.6 3.2 3.6 2.8 1.9 2.6 4.9 1.7 1.9 4.4 2.3 4.8 2.8 3.7 1.6 1.9 5.7 1.5 2.8 2.8 3.5 2.0 2.4 2.3 3.3 2.1 2.0 3.6 5.2 3.0 2.6 3.4 2.2 6.9 6.7 4.7 2.0 3.0 4.1 3.6 3.1 1.4 2.4 3.3 3.2 3.7 1.4 3.7 3.6 2.0 3.3 3.6 3.2 1.4 2.0 3.7 3.1 3.3 4.3 2.3 2.9 3.2 2.9 2.0 9.8 4.6 2.1 3.8 1.6 2.6 4.5 1.5 2.4 2.9 3.4 4.6 2.8 1.8 0.3 2.6 1.5 0.8 0.7 1.0 1.6 0.8 0.8 0.9 0.7 1.2 0.4 1.0 2.3 3.1 0.0 1.1 3.9 5.3 2.5 1.9 1.8 2.2 2.9 2.2 3.4 1.9 1.5 2.1 1.8 4.2 2.0 5.8 0.8 0.0 1.9 2.7 1.2 2.7 3.1 1.2 3.6 11.5 2.6 1.5 3.1 2.0 1.3 1.3 5.4 3.9 2.2 1.8 1.7 12.5 1.8 2.0 3.1 2.4 0.7 1.5 2.7 3.6 4.7 4.5 1.7 9.2 11.6 10.0 1.1 2.9 2.2 6.6 2.1 1.8 0.9 1.3 8.2 0.0 2.2 2.1 9.7 5.5 1.7 2.6 1.5 6.3 4.6 1.6 1.2 ZC4H2 "HCA127, KIAA1166, MCS, MRXS4, WWS" ENSG00000126970 "Zinc finger C4H2-type containing" Q9NQZ6 X 64915802-65034713 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 37.4;Inhibitory neurons: 39.4;Oligodendrocyte precursor cells: 58.3;Oligodendrocytes: 59.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 37.3;REH: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049584 Approved Approved Vesicles,Microtubules NA NA "Cluster 30: Non-specific - Translation" "Cluster 57: Non-specific - Angiogenesis" "Cluster 5: NTERA-2 - Transcription" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Vesicles, Microtubules" "HPA049584: AB_2680825" "unprognostic (9.55e-3)" "unprognostic (1.03e-1)" "unprognostic (4.40e-1)" "unprognostic (1.56e-1)" "unprognostic (7.29e-3)" "unprognostic (9.71e-2)" "unprognostic (1.64e-3)" "unprognostic (9.72e-2)" "unprognostic (2.98e-1)" "unprognostic (3.34e-1)" "unprognostic (2.31e-2)" "unprognostic (6.44e-2)" "unprognostic (1.84e-3)" "unprognostic (2.06e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.51e-5)" "unprognostic (5.34e-2)" 4.5 6.3 7.1 2.5 7.2 2.5 4.1 7.0 8.0 5.9 6.9 9.6 3.9 7.0 4.3 3.4 6.1 3.7 5.7 7.0 7.9 5.4 5.3 3.4 2.8 7.5 7.6 7.2 3.6 11.8 8.6 0.9 7.6 5.3 4.4 5.0 4.3 5.8 1.8 3.8 5.3 7.9 7.2 4.2 6.3 1.0 7.2 8.0 5.4 1.9 2.6 5.3 4.1 7.3 0.0 1.5 23.4 11.0 0.2 0.0 3.7 4.4 9.3 6.3 11.5 2.2 8.8 4.4 2.5 3.9 0.0 0.1 10.4 4.0 6.2 0.0 9.5 7.4 3.3 3.2 1.4 6.8 2.2 4.7 3.3 2.9 6.5 9.5 11.5 25.1 2.4 9.9 7.5 0.0 20.2 0.0 37.3 4.2 10.2 29.8 11.3 0.2 6.5 0.0 0.0 16.8 0.0 0.1 0.9 13.9 2.0 1.3 7.2 3.2 6.7 0.3 0.0 1.8 0.2 14.9 9.9 6.2 0.0 0.0 0.7 0.0 1.7 1.0 3.0 2.6 2.4 2.4 0.9 1.9 3.9 2.4 0.0 2.1 0.2 2.4 1.2 1.4 7.1 7.2 7.0 8.0 7.0 7.9 7.5 7.6 7.6 7.2 7.2 7.3 2.9 3.2 0.0 20.5 6.6 0.6 2.0 1.9 1.8 3.8 1.5 2.2 4.0 4.3 1.8 1.8 4.2 0.1 1.2 1.9 1.9 7.7 0.6 1.7 3.0 4.5 3.6 3.4 37.4 5.7 0.8 4.0 3.6 0.5 2.5 5.2 5.0 4.1 1.1 0.0 39.4 1.9 8.2 0.9 0.0 0.8 7.2 0.8 0.0 22.5 0.5 5.1 2.1 58.3 59.0 4.7 2.2 8.6 1.5 1.0 3.8 5.6 0.6 1.6 13.1 2.8 4.1 0.6 0.5 1.8 0.6 0.0 1.9 4.5 3.3 1.0 ZDHHC18 DKFZp667O2416 ENSG00000204160 "Zinc finger DHHC-type palmitoyltransferase 18" Q9NUE0 1 26826688-26857604 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 113.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 48.8" "Lineage enriched" "Detected in many" 18 "granulocytes: 48.8" "Cell line enhanced" "Detected in all" "HDLM-2: 132.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040234 Approved Approved Microtubules NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Microtubules "HPA040234: AB_10805709" "unprognostic (2.68e-1)" "unprognostic (1.21e-2)" "unprognostic (2.35e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.01e-1)" "prognostic unfavorable (7.42e-7)" "unprognostic (1.53e-1)" "unprognostic (2.90e-2)" "unprognostic (2.38e-2)" "unprognostic (2.13e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (1.36e-10)" "unprognostic (3.85e-2)" "unprognostic (2.70e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" 23.4 8.1 26.0 27.4 24.6 113.9 17.0 25.7 29.0 12.9 16.9 14.6 12.9 13.6 4.6 24.3 11.3 14.8 15.0 25.4 30.0 8.8 18.6 16.2 22.1 29.1 28.7 9.6 10.5 8.6 11.7 23.3 33.5 11.4 15.0 19.3 16.9 9.1 10.8 18.5 13.9 18.4 22.2 31.3 12.4 7.4 28.5 14.7 15.3 16.1 20.9 22.7 14.4 25.1 45.3 19.8 31.5 21.8 25.6 17.8 30.9 26.7 31.5 45.9 33.9 18.3 28.4 20.9 16.7 35.5 24.0 31.3 33.8 15.9 39.2 132.6 28.7 20.3 15.3 25.7 22.0 18.1 16.9 15.5 21.3 42.3 27.9 16.5 25.9 31.6 21.4 41.8 18.4 22.1 34.5 14.6 30.4 28.1 18.8 28.3 27.2 22.2 19.2 11.3 14.6 17.7 17.9 13.4 19.3 23.9 12.1 17.6 22.2 31.5 24.2 52.3 31.0 49.7 38.8 18.1 17.9 32.5 21.9 0.0 0.5 10.0 1.6 1.1 1.1 0.4 1.2 1.2 0.8 0.3 0.7 0.8 48.8 1.0 0.8 0.4 2.7 0.5 26.0 24.6 25.7 29.0 25.4 30.0 29.1 28.7 33.5 22.2 28.5 25.1 12.9 9.6 7.9 6.5 7.5 25.6 8.6 4.4 6.8 39.8 8.4 6.6 6.0 10.0 6.8 1.8 27.1 10.6 21.2 27.0 0.0 4.1 3.8 6.1 7.0 9.1 3.0 9.3 10.2 2.8 7.1 7.1 4.6 12.7 1.3 5.9 7.9 12.0 7.3 18.5 10.2 3.9 2.0 8.5 17.0 2.1 6.2 11.0 10.6 5.6 26.6 5.7 12.3 4.0 6.3 8.0 25.6 3.8 8.3 19.3 10.4 2.2 4.6 35.3 0.0 7.1 6.2 3.5 11.4 14.6 36.2 6.2 17.4 8.0 7.0 34.7 ZNF165 "CT53, ZSCAN7" ENSG00000197279 "Zinc finger protein 165" P49910 6 28080568-28089563 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 17.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 94.6;Early spermatids: 152.7;Glandular and luminal cells: 75.8;Paneth cells: 120.3;Syncytiotrophoblasts: 79.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 14.4;BEWO: 22.9;GAMG: 16.9" "Low region specificity" "Detected in all" HPA007247 Approved "Nuclear speckles,Microtubules" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 1: Thyroid gland - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear speckles, Microtubules" "HPA007247: AB_2797217" "unprognostic (1.85e-1)" "unprognostic (2.01e-3)" "unprognostic (1.12e-2)" "unprognostic (2.43e-3)" "unprognostic (1.45e-1)" "unprognostic (4.32e-3)" "unprognostic (3.42e-1)" "unprognostic (2.09e-1)" "unprognostic (1.93e-2)" "prognostic favorable (2.10e-4)" "unprognostic (1.18e-3)" "unprognostic (1.29e-2)" "prognostic favorable (1.19e-5)" "unprognostic (1.10e-1)" "unprognostic (2.40e-1)" "unprognostic (2.18e-1)" "prognostic favorable (9.82e-5)" 0.4 0.8 0.4 1.0 0.5 1.4 2.1 0.6 0.8 1.4 2.1 2.4 2.2 1.1 5.1 2.2 1.8 0.9 0.5 0.5 0.5 4.5 2.4 1.9 1.3 0.9 0.7 0.7 4.6 4.8 3.8 3.1 1.0 1.0 3.3 1.7 2.0 1.2 0.7 1.0 1.8 0.5 0.4 0.9 2.5 17.2 0.4 0.5 2.9 0.1 1.7 2.5 1.1 0.7 14.4 0.9 0.8 1.1 0.3 0.5 22.9 0.5 0.5 0.9 0.8 9.0 10.3 1.2 3.9 0.2 16.9 5.4 2.0 6.2 0.6 0.4 3.6 0.7 1.5 9.7 0.3 2.3 2.0 0.3 3.2 0.7 8.8 0.6 0.3 0.8 2.3 1.1 0.5 3.9 0.6 2.7 1.9 12.2 1.4 1.9 0.8 7.7 4.7 6.5 9.6 0.7 1.2 11.1 1.3 2.5 5.5 0.5 0.4 0.8 1.1 0.4 1.0 3.4 9.6 3.6 0.5 2.6 0.4 5.8 1.7 3.4 1.3 1.4 1.6 7.0 1.5 1.0 1.8 8.6 2.5 2.0 2.5 1.4 1.7 5.5 0.7 0.9 0.4 0.5 0.6 0.8 0.5 0.5 0.9 0.7 1.0 0.4 0.4 0.7 0.8 6.4 7.0 0.0 23.2 8.5 16.5 2.3 2.8 0.8 24.5 9.4 0.4 4.3 5.0 3.7 0.0 9.4 4.2 94.6 3.9 18.2 152.7 55.4 5.9 1.3 53.9 0.0 1.2 12.3 9.0 0.6 13.7 75.8 0.0 0.6 0.0 0.4 1.5 0.0 0.9 53.7 6.1 0.6 3.2 19.5 0.9 2.8 5.4 0.0 1.6 1.5 0.0 0.0 0.1 17.5 120.3 2.2 12.4 6.5 9.0 2.0 12.0 2.6 0.0 0.6 1.5 33.6 4.4 8.5 11.8 79.6 8.5 0.3 34.9 40.8 ZNF347 ZNF1111 ENSG00000197937 "Zinc finger protein 347" Q96SE7 19 53124072-53159075 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023448 Uncertain Approved Microtubules NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 6: Brain - Smell perception" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Microtubules "HPA023448: AB_1859214" "unprognostic (1.39e-2)" "unprognostic (1.62e-1)" "unprognostic (1.98e-1)" "unprognostic (1.48e-1)" "unprognostic (6.48e-2)" "unprognostic (3.01e-3)" "unprognostic (6.20e-2)" "unprognostic (3.82e-2)" "unprognostic (3.65e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-2)" "unprognostic (8.39e-2)" "unprognostic (3.22e-3)" "unprognostic (3.60e-1)" "unprognostic (1.05e-1)" "unprognostic (8.99e-2)" "unprognostic (7.59e-3)" 4.8 4.7 6.7 5.7 5.3 19.3 5.1 17.5 6.8 4.7 0.8 3.6 2.7 6.2 5.5 3.8 3.9 6.0 4.5 6.0 7.7 3.5 2.0 5.0 5.8 6.9 5.3 6.3 5.3 4.6 2.9 5.0 6.4 4.4 3.7 14.9 4.4 4.8 3.6 6.8 3.1 4.9 1.9 9.5 4.2 3.8 5.8 5.7 6.8 3.6 4.1 3.7 3.5 15.8 0.8 0.8 7.9 13.2 5.0 5.4 7.4 8.6 8.6 10.0 11.8 1.3 2.2 7.6 3.3 7.3 11.2 3.7 0.9 1.5 12.8 1.5 5.8 1.4 5.1 2.4 3.1 1.7 7.7 6.1 0.6 7.4 0.0 3.5 2.5 4.6 6.4 2.3 5.2 0.9 12.9 3.9 9.6 0.4 4.0 3.5 0.3 1.7 4.0 20.1 5.7 5.9 1.3 2.6 3.4 10.1 7.1 3.5 4.2 12.5 8.1 6.8 12.4 1.1 7.1 13.4 2.0 1.4 7.1 3.8 1.1 1.6 1.8 0.9 1.8 1.9 1.5 1.6 1.1 3.0 1.9 1.6 6.8 3.7 1.5 1.9 1.8 0.8 6.7 5.3 17.5 6.8 6.0 7.7 6.9 5.3 6.4 1.9 5.8 15.8 16.2 19.2 12.4 5.9 6.0 2.0 4.9 1.0 3.4 10.5 3.5 4.2 7.3 4.3 6.8 3.7 4.2 3.1 1.5 3.8 1.9 2.9 0.3 5.5 7.8 15.9 1.2 3.0 7.7 4.0 3.7 6.5 4.6 6.1 3.8 11.7 11.7 1.3 2.7 8.4 10.8 2.5 2.0 3.8 2.8 0.8 5.3 3.5 1.8 4.7 3.4 4.0 8.2 8.5 14.9 3.5 1.1 3.8 2.0 4.6 2.9 1.4 18.6 14.3 0.0 11.4 5.9 3.0 5.4 4.2 2.0 3.4 3.9 16.9 2.8 3.0 ZNF397 "MGC13250, ZNF47, ZSCAN15" ENSG00000186812 "Zinc finger protein 397" Q8NF99 18 35241030-35267133 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 94.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026087 Uncertain Approved "Nucleoli,Plasma membrane,Microtubules,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoli, Plasma membrane, Cytosol" Microtubules "HPA026087: AB_1859243" "unprognostic (1.97e-1)" "unprognostic (2.82e-2)" "unprognostic (2.12e-1)" "unprognostic (3.09e-1)" "unprognostic (6.35e-2)" "unprognostic (1.15e-2)" "unprognostic (1.74e-3)" "unprognostic (1.45e-2)" "unprognostic (1.48e-2)" "unprognostic (3.28e-2)" "prognostic favorable (9.44e-4)" "unprognostic (2.46e-2)" "unprognostic (2.17e-3)" "unprognostic (3.83e-2)" "unprognostic (4.44e-2)" "unprognostic (1.06e-1)" "unprognostic (2.09e-3)" 12.9 13.4 17.6 14.4 23.4 5.0 16.1 19.1 20.0 13.5 14.9 12.8 10.6 15.7 12.4 9.8 11.7 10.1 10.5 16.4 20.7 11.3 10.6 10.4 16.2 20.5 20.9 17.8 12.4 14.8 12.0 11.9 20.1 13.9 13.9 25.0 12.4 12.1 11.7 13.6 12.6 11.5 15.4 16.1 13.3 9.9 20.3 13.1 15.7 11.0 15.8 11.9 11.8 34.4 4.2 7.9 18.7 17.1 20.3 17.0 8.9 8.4 8.3 4.1 5.4 3.0 5.7 21.2 7.4 6.7 5.6 11.1 12.2 9.2 5.7 13.5 7.5 0.9 11.7 8.6 6.7 10.3 7.4 7.7 12.1 4.9 14.1 14.6 2.6 16.1 12.7 14.4 10.7 9.1 17.4 7.8 16.1 3.2 3.2 18.2 5.4 15.1 8.4 11.0 20.2 17.4 13.7 7.2 8.2 16.2 12.5 7.6 4.2 13.6 7.6 4.6 3.8 23.2 9.3 11.9 12.0 7.1 13.1 10.1 4.6 8.3 5.7 7.5 4.1 10.6 5.3 4.7 3.3 11.3 7.8 5.4 11.0 4.7 9.4 7.5 3.0 2.2 17.6 23.4 19.1 20.0 16.4 20.7 20.5 20.9 20.1 15.4 20.3 34.4 15.5 35.3 21.0 24.5 35.3 4.1 19.4 8.0 10.2 51.0 11.8 10.4 16.4 15.7 17.3 14.7 35.5 22.6 15.8 14.1 13.7 18.7 66.0 10.8 20.4 17.6 31.0 20.4 17.4 10.9 13.4 18.4 12.8 8.9 11.4 31.7 31.1 12.6 10.8 33.7 19.5 11.5 12.2 20.5 5.4 49.6 18.6 11.8 8.8 23.4 20.3 24.6 15.5 30.2 94.1 10.7 18.3 22.6 6.1 15.8 24.3 11.4 16.4 46.1 32.9 25.3 16.6 29.7 23.4 7.8 4.5 14.6 13.9 22.1 16.1 11.1 ZNF415 ENSG00000170954 "Zinc finger protein 415" Q09FC8 19 53107879-53133077 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 108.2;Late spermatids: 54.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 21.9" HPA005553 Approved Approved "Nucleoli fibrillar center,Microtubules" NA NA "Cluster 37: B-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoli fibrillar center, Microtubules" "HPA005553: AB_1859252" "unprognostic (2.15e-1)" "unprognostic (1.34e-1)" "unprognostic (1.83e-1)" "unprognostic (9.31e-2)" "unprognostic (6.30e-2)" "unprognostic (1.29e-3)" "unprognostic (2.18e-1)" "unprognostic (3.24e-2)" "unprognostic (4.05e-2)" "unprognostic (1.15e-1)" "unprognostic (7.28e-3)" "unprognostic (1.51e-1)" "unprognostic (1.06e-2)" "unprognostic (4.27e-2)" "unprognostic (1.28e-1)" "unprognostic (4.38e-2)" "unprognostic (2.84e-2)" 6.7 17.8 14.1 2.0 17.7 0.9 8.5 18.7 18.8 7.5 9.9 7.7 2.0 7.5 13.5 3.4 6.4 5.4 16.7 14.6 16.8 7.0 1.2 4.8 3.2 15.8 15.9 9.5 5.6 11.3 5.3 4.2 16.2 9.7 5.2 10.6 6.2 7.7 4.4 3.9 3.3 7.0 13.2 5.4 5.0 21.6 16.4 4.9 10.8 6.7 2.8 6.4 5.1 27.5 0.2 0.0 4.9 14.2 0.7 0.8 11.3 5.3 8.3 7.6 11.5 9.2 0.3 0.0 2.9 9.2 8.8 0.2 0.0 0.0 7.5 0.0 0.7 0.0 0.5 0.0 2.7 0.0 7.8 8.5 0.1 1.8 0.0 0.8 0.1 0.4 0.3 0.3 4.2 0.7 9.3 0.1 10.3 0.1 0.5 0.0 0.0 0.4 6.3 21.9 3.1 7.6 0.6 0.1 0.0 12.3 7.3 0.4 0.0 3.5 3.4 0.4 6.3 0.2 9.6 6.4 0.4 0.0 11.7 3.6 0.6 3.9 0.3 0.3 0.3 4.1 0.8 0.2 1.2 3.9 1.8 1.6 0.9 3.4 0.5 2.9 0.5 0.6 14.1 17.7 18.7 18.8 14.6 16.8 15.8 15.9 16.2 13.2 16.4 27.5 7.7 0.0 6.2 11.4 2.1 0.5 2.5 0.6 2.8 4.8 4.0 4.7 24.2 1.5 4.4 3.7 2.1 3.5 0.4 1.1 13.7 5.8 108.2 5.0 4.2 6.5 0.0 0.0 9.3 4.7 3.5 4.4 1.5 3.5 0.0 13.3 5.3 0.0 0.7 1.7 13.8 1.9 2.0 0.3 0.9 54.7 1.8 0.5 0.0 2.8 0.6 5.5 7.2 9.5 17.6 2.7 0.3 4.5 0.4 2.5 0.3 0.1 5.4 2.8 0.0 3.0 5.6 17.4 5.0 1.2 0.3 1.9 0.9 17.6 1.3 2.6 ZNF44 "KOX7, ZNF504, ZNF55, ZNF58" ENSG00000197857 "Zinc finger protein 44" P15621 19 12224686-12294883 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 95.9;Early spermatids: 113.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003146 Supported Approved Nucleoplasm,Microtubules,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Microtubules, Cytosol" "HPA003146: AB_1080723" "unprognostic (1.51e-1)" "unprognostic (2.47e-3)" "unprognostic (7.07e-2)" "unprognostic (4.60e-2)" "unprognostic (9.63e-2)" "prognostic favorable (8.74e-4)" "unprognostic (8.39e-2)" "prognostic favorable (7.54e-4)" "unprognostic (5.65e-3)" "unprognostic (9.17e-2)" "unprognostic (1.75e-3)" "unprognostic (3.56e-3)" "unprognostic (7.30e-3)" "unprognostic (2.75e-1)" "unprognostic (2.09e-1)" "unprognostic (5.69e-2)" "prognostic favorable (9.21e-6)" 6.9 5.7 2.5 2.7 2.7 9.6 6.8 3.8 3.1 7.5 3.8 6.9 3.3 5.4 5.2 6.8 6.3 2.1 5.2 2.5 2.7 12.1 11.0 6.1 4.4 2.8 2.7 9.4 6.8 4.0 7.1 2.7 2.8 7.4 4.9 5.0 5.7 3.1 3.5 7.9 7.4 2.6 2.3 9.4 5.0 9.7 2.8 3.2 6.7 2.4 4.2 7.0 6.9 3.4 3.0 0.9 1.8 4.3 2.1 1.9 9.6 4.2 1.7 6.5 5.9 4.2 1.7 3.0 5.0 3.4 1.9 3.2 3.0 2.6 5.6 0.0 2.7 2.9 4.4 11.3 2.9 0.0 7.4 2.5 3.9 4.1 4.9 2.6 2.6 3.8 1.9 0.6 4.2 3.2 4.6 5.7 1.8 3.0 5.2 3.2 4.7 3.8 3.7 7.1 2.6 2.9 5.4 2.2 1.4 6.2 4.5 4.6 2.8 8.3 2.3 8.3 3.7 6.5 7.5 2.8 0.2 2.7 2.4 11.9 1.7 15.8 7.3 3.2 8.5 4.2 7.9 7.9 1.3 3.4 8.4 8.4 5.6 11.5 3.2 3.2 6.1 3.4 2.5 2.7 3.8 3.1 2.5 2.7 2.8 2.7 2.8 2.3 2.8 3.4 14.6 28.9 19.9 16.6 16.1 9.1 6.6 8.2 8.0 16.1 10.6 8.3 16.9 17.2 13.9 64.4 37.5 17.2 21.5 17.9 95.9 9.9 113.1 21.1 11.6 11.8 15.6 6.5 13.8 9.3 6.8 8.3 6.1 25.1 24.1 14.4 11.0 12.4 8.5 16.8 16.1 12.9 10.2 11.1 8.7 34.1 14.0 10.9 10.6 25.3 8.8 9.8 27.8 17.6 21.7 9.6 13.0 6.0 13.7 6.2 17.1 13.6 24.8 36.7 19.7 11.6 9.8 36.5 24.8 16.4 11.6 8.6 19.2 8.4 12.9 9.6 ZNF550 MGC41917 ENSG00000251369 "Zinc finger protein 550" Q7Z398 19 57535257-57559863 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003251 Uncertain Approved Vesicles,Microtubules NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Vesicles Microtubules "HPA003251: AB_1080736" "unprognostic (3.09e-1)" "unprognostic (1.92e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-2)" "unprognostic (1.43e-1)" "unprognostic (2.15e-2)" "unprognostic (1.40e-2)" "unprognostic (3.61e-2)" "unprognostic (2.66e-3)" "unprognostic (3.46e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (8.33e-2)" "unprognostic (1.59e-1)" "unprognostic (2.69e-2)" "unprognostic (6.68e-3)" "unprognostic (1.52e-1)" 2.8 3.7 1.8 5.1 2.0 5.2 6.0 5.8 2.7 5.5 3.2 2.8 2.2 4.6 3.9 3.1 4.6 3.1 5.6 1.7 2.9 2.9 3.0 3.4 6.7 1.5 1.8 9.1 2.4 7.8 2.5 6.5 2.3 6.0 2.9 7.3 4.2 4.4 2.2 4.0 3.6 3.3 1.1 7.7 3.5 2.8 1.7 7.4 4.8 3.3 5.4 3.6 1.3 2.9 4.3 3.0 8.4 8.0 2.8 6.9 0.0 5.7 4.8 5.0 2.1 3.7 3.9 1.2 3.9 4.2 4.0 3.6 4.4 5.0 6.3 0.1 23.2 11.5 10.9 4.9 4.1 10.1 4.3 5.8 3.0 3.9 11.2 6.9 4.2 10.6 1.8 0.1 5.4 1.0 15.5 4.4 9.2 1.3 5.8 12.3 8.7 12.1 2.7 7.6 7.8 11.0 7.2 4.8 3.5 5.9 5.5 6.6 4.8 6.9 4.2 2.6 5.6 24.0 24.0 10.0 2.8 5.8 6.1 0.4 1.4 2.0 3.6 1.9 4.5 1.8 4.5 2.5 2.0 2.6 5.8 3.4 0.4 5.2 0.6 0.7 4.5 2.3 1.8 2.0 5.8 2.7 1.7 2.9 1.5 1.8 2.3 1.1 1.7 2.9 4.5 0.0 1.1 4.2 8.9 5.1 3.9 2.6 5.7 4.5 4.7 3.6 7.2 2.8 3.4 0.0 6.2 4.2 4.9 0.5 1.9 2.8 1.0 3.4 4.7 5.8 3.6 5.0 4.8 1.2 4.4 3.9 0.5 2.9 5.1 8.3 5.0 3.2 2.3 11.8 5.3 2.8 4.1 1.9 2.2 0.6 4.7 1.4 3.6 2.8 2.5 3.0 12.3 4.0 3.7 2.2 0.8 0.7 3.4 6.7 1.2 0.9 6.5 5.1 0.0 3.3 4.4 3.2 5.0 4.4 6.8 5.2 6.2 4.4 2.7 4.3 ZNF654 "FLJ10997, FLJ21142" ENSG00000175105 "Zinc finger protein 654" 3 88059255-88144660 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 9.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 51.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036172, HPA036173, HPA049262, HPA077939" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 44: Endometrium - Transcription" Microtubules "Nucleoplasm, Cytokinetic bridge, Mitotic spindle" "HPA036172: AB_10672081, HPA036173: AB_2674987, HPA049262: , HPA077939: AB_2732364" "unprognostic (2.54e-2)" "unprognostic (2.28e-1)" "unprognostic (6.89e-3)" "unprognostic (2.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.29e-2)" "unprognostic (5.74e-2)" "unprognostic (3.45e-2)" "unprognostic (7.65e-2)" "unprognostic (2.02e-1)" "unprognostic (5.72e-3)" "prognostic unfavorable (9.97e-6)" "unprognostic (1.29e-2)" "unprognostic (2.92e-1)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (2.50e-2)" 5.0 3.7 2.6 4.1 2.7 8.1 5.5 4.9 3.3 5.1 1.8 4.4 4.5 4.6 4.7 5.6 3.4 4.8 3.4 2.4 3.2 4.8 7.0 4.5 6.1 2.8 3.1 6.4 4.1 4.3 1.2 5.0 3.3 5.5 4.2 11.7 4.6 4.1 3.0 6.5 4.8 4.1 3.2 4.9 4.7 6.0 2.7 7.6 5.9 4.9 5.7 5.1 2.3 3.9 7.2 3.0 5.0 6.9 9.9 8.6 4.6 9.3 8.4 6.1 8.4 4.4 4.3 11.3 6.2 7.4 4.4 4.7 5.3 8.6 11.8 7.0 3.0 7.0 3.9 3.2 7.5 8.0 7.6 8.4 7.4 6.7 7.8 12.1 8.1 6.6 4.9 9.0 13.6 5.3 8.0 6.5 2.7 5.7 4.8 5.7 3.4 5.4 5.4 9.0 3.7 3.3 6.8 5.2 17.0 6.0 7.3 5.7 9.5 13.6 8.7 51.8 6.6 10.1 7.6 7.9 10.8 7.5 8.6 9.7 1.2 1.8 1.7 1.2 2.0 1.1 1.8 2.4 1.5 1.7 2.2 1.5 1.7 4.0 1.0 0.7 1.4 1.0 2.6 2.7 4.9 3.3 2.4 3.2 2.8 3.1 3.3 3.2 2.7 3.9 18.2 9.6 13.1 10.1 12.8 22.4 10.1 7.9 9.1 14.0 17.4 10.2 11.8 5.7 10.8 5.5 12.5 4.8 14.5 11.9 1.9 7.6 1.4 9.4 16.0 12.4 5.3 5.2 11.7 5.3 4.2 11.7 5.1 12.2 15.8 14.5 8.9 14.0 6.3 16.8 11.3 7.1 10.2 12.3 19.5 1.5 7.5 14.8 8.8 7.5 10.9 9.9 9.2 9.0 13.3 8.4 8.2 12.4 9.2 12.0 9.0 6.0 10.7 14.3 6.6 13.9 11.5 12.1 10.4 11.4 18.6 8.2 14.0 9.0 7.8 14.4 ZNF835 BC37295_3 ENSG00000127903 "Zinc finger protein 835" Q9Y2P0 19 56661980-56671783 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 5.3;Cone photoreceptor cells: 8.4;Horizontal cells: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 2.6;EFO-21: 2.0;HEL: 1.7;NTERA-2: 4.8;SH-SY5Y: 2.4;U-266/84: 4.1" HPA051136 Uncertain Approved Microtubules NA NA "Cluster 30: Non-specific - Translation" "Cluster 21: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 62: Horizontal cells - Visual perception" Microtubules "HPA051136: AB_2681357" "unprognostic (3.15e-1)" "unprognostic (4.80e-2)" "unprognostic (4.89e-1)" "unprognostic (5.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.25e-2)" "unprognostic (3.25e-2)" "unprognostic (3.39e-3)" "unprognostic (1.58e-5)" "unprognostic (6.65e-2)" "unprognostic (5.35e-4)" "unprognostic (2.33e-1)" "unprognostic (2.72e-4)" "unprognostic (5.31e-2)" "unprognostic (1.32e-1)" "unprognostic (9.29e-2)" "unprognostic (6.21e-2)" 1.5 1.4 2.4 1.1 2.6 0.3 1.0 4.2 3.5 1.8 0.5 2.4 0.3 2.1 0.8 0.9 1.9 0.5 2.2 2.5 1.9 1.3 0.2 0.8 1.2 2.2 2.0 4.2 0.9 2.3 1.5 0.6 2.1 1.2 0.2 1.5 1.8 1.4 2.2 0.3 0.8 0.9 1.5 1.7 0.8 0.4 2.2 0.3 1.6 1.3 1.0 1.8 1.0 3.0 0.0 0.0 0.5 0.0 0.0 0.0 2.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 4.1 0.2 0.0 0.0 0.0 1.8 0.3 0.3 0.3 0.2 0.7 1.7 1.3 0.8 0.5 2.1 2.2 1.5 0.5 1.6 0.3 1.5 0.7 0.8 2.4 2.6 4.2 3.5 2.5 1.9 2.2 2.0 2.1 1.5 2.2 3.0 1.5 3.2 0.0 2.0 1.1 0.0 0.1 0.0 0.0 5.3 0.5 0.6 3.1 0.0 0.6 0.0 8.4 1.1 0.6 0.0 0.0 0.4 0.0 0.2 1.6 1.2 0.0 0.8 1.7 0.5 0.4 1.7 0.0 0.1 0.0 3.6 1.8 0.1 0.3 16.8 2.3 0.0 0.0 0.3 0.5 0.0 2.1 0.6 0.0 0.0 0.8 3.5 4.1 3.0 2.4 0.1 0.0 3.4 0.2 0.1 0.0 0.8 0.0 3.1 0.0 0.5 1.1 0.0 0.6 0.0 0.1 0.3 0.2 1.7 0.0 0.1